e10vk
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Fiscal Year Ended
December 31, 2007.
|
|
|
Or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period
from to
|
Commission file
no. 001-14953
HealthMarkets,
Inc.
(Exact
name of registrant as specified in its charter)
|
|
|
Delaware
|
|
75-2044750
|
(State or other jurisdiction
of
Incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
9151
Boulevard 26, North Richland Hills, Texas 76180
(Address of principal executive offices, zip code)
(817) 255-5200
(Registrants phone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
None
Securities registered pursuant to Section 12(g) of the
Act:
Class A-2
common stock
(Title of Class)
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of Registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K
þ
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer o
|
Accelerated
filer o
|
Non-accelerated
filer þ
|
Smaller
reporting
company o
|
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
Effective April 5, 2006, all of the registrants
Class A-1
common stock (representing approximately 88.62% of its common
equity at March 10, 2007) is owned by three private
investor groups and members of management. The registrants
Class A-2
common stock is owned by its independent insurance agents and is
subject to transfer restrictions. Neither the
Class-A-1
common stock nor the
Class A-2
common stock is listed or traded on any exchange or market.
Accordingly, as of June 29, 2007, the last business day of
the registrants most recently completed second fiscal
quarter, the aggregate market value of shares of
Class A-1
and
Class A-2
common stock held by non-affiliates was $-0-. As of
March 11, 2008, there were 26,899,056.0416 outstanding
shares of
Class A-1
common stock and 3,998,738.0000 outstanding shares of
Class A-2
common stock.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the annual information statement for the annual
meeting of stockholders are incorporated by reference into
Part III.
HEALTHMARKETS,
INC.
and Subsidiaries
TABLE OF
CONTENTS
Cautionary
Statements Regarding Forward-Looking Statements
This report and other documents or oral presentations prepared
or delivered by and on behalf of the Company contain or may
contain forward-looking statements within the
meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995.
Forward-looking statements are statements based upon
managements expectations at the time such statements are
made. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of
new information, future events or otherwise. Forward-looking
statements are subject to risks and uncertainties that could
cause the Companys actual results to differ materially
from those contemplated in the statements. Readers are cautioned
not to place undue reliance on the forward-looking statements.
When used in written documents or oral presentations, the terms
anticipate, believe,
estimate, expect, may,
objective, plan, possible,
potential, project, will
and similar expressions are intended to identify
forward-looking statements. In addition to the assumptions and
other factors referred to specifically in connection with such
statements, factors that could impact the Companys
business and financial prospects include, but are not limited
to, those discussed under the caption Item 1
Business, Item 1A. Risk
Factors and Item 7 Managements
Discussion and Analysis of Financial Condition and Results of
Operations and those discussed from time to time in
the Companys various filings with the Securities and
Exchange Commission or in other publicly disseminated written
documents.
Introduction
HealthMarkets, Inc. and its subsidiaries are collectively
referred to throughout this Annual Report on
Form 10-K
as the Company or
HealthMarkets and may also be referred to as
we, us or our.
We offer insurance (primarily health and life) to niche consumer
and institutional markets. Through our subsidiaries we issue
primarily health insurance policies, covering individuals and
families, to the self-employed, association groups and small
businesses.
HealthMarkets, Inc., a Delaware corporation incorporated in
1984, is a holding company, and we conduct our insurance
businesses through our indirect, wholly-owned insurance company
subsidiaries, The MEGA Life and Health Insurance Company
(MEGA), Mid-West National Life Insurance Company of
Tennessee (Mid-West), and The Chesapeake Life
Insurance Company (Chesapeake). MEGA is an insurance
company domiciled in Oklahoma and is licensed to issue health,
life and annuity insurance policies in all states except New
York. Mid-West is an insurance company domiciled in Texas and is
licensed to issue health, life and annuity insurance policies in
Puerto Rico and all states except Maine, New Hampshire, New
York, and Vermont. Chesapeake is an insurance company domiciled
in Oklahoma and is licensed to issue health and life insurance
policies in all states except New Jersey, New York and Vermont.
Effective December 1, 2007, the Company acquired Fidelity
Life Insurance Company, an insurance company domiciled in
Pennsylvania and licensed to issue health and life insurance
policies.
On April 5, 2006, we completed a merger (the
Merger) providing for the acquisition of the Company
by affiliates of a group of private equity investors, including
affiliates of The Blackstone Group, Goldman Sachs Capital
Partners and DLJ Merchant Banking Partners (the Private
Equity Investors). As a result of the Merger, holders of
our common stock received $37.00 in cash per share. In the
transaction, HealthMarkets public shareholders received
aggregate consideration of $1.6 billion, of which
$985.0 million was contributed as equity by the private
equity investors. The balance of the Merger consideration was
financed with the proceeds of a $500.0 million term loan
facility, the proceeds of $100.0 million of trust preferred
securities issued in a private placement, and Company cash on
hand of $42.8 million. See Note 13 of Notes to
Financial Statements.
On July 11, 2006 and December 1, 2006 we sold our
former Star HRG Division and Student Insurance Division,
respectively, resulting in total pre-tax gains of
$201.7 million. We sold these businesses because they were
not part of the fundamental long term focus of the Company. We
are now generally focused on business opportunities that allow
us to maximize the value of our dedicated agency sales force.
See Note 2 of Notes to the Financial Statements.
Our principal executive offices are located at 9151 Boulevard
26, North Richland Hills, Texas
76180-5605,
and our telephone number is
(817) 255-5200.
As of March 12, 2008, approximately 86% of our common
equity securities are held by affiliates of three private equity
investors, and as such, we remain subject to the periodic
reporting and other requirements of the Securities Exchange Act
of 1934, as amended. Our periodic SEC filings, including our
annual reports on
Form 10-K,
quarterly reports on
Form 10-Q,
Current Reports on
Form 8-K,
and if applicable, amendments to those reports filed or
furnished pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 are available through our web
site at www.healthmarkets.com free of charge as soon as
reasonably practicable after such material is electronically
filed with, or furnished to, the SEC.
Overview
Through our Self-Employed Agency (SEA) Division, we
offer a broad range of health insurance products for
self-employed individuals and individuals who work for small
businesses. Our basic hospital-medical and catastrophic hospital
expense plans are designed to accommodate individual needs and
include traditional fee-for-service indemnity plans and
preferred provider organization (PPO) plans, as well
as other supplemental types of coverage. Commencing in 2006, we
began to offer on a selective
state-by-state
basis a new suite of health
1
insurance products to the self-employed and individual market,
including a basic medical-surgical expense plan, catastrophic
expense PPO plans and catastrophic expense consumer guided
health plans.
We market these products to the self-employed and individual
markets through independent contractor agents associated with
UGA-Association Field Services (UGA) and Cornerstone
America (Cornerstone),which are our
dedicated agency sales forces that primarily sell
the Companys products. We believe that we have the largest
direct selling organization in the health insurance field, with
approximately 1,900 independent writing agents per week in the
field selling health insurance to the self employed market in
44 states.
Through our Life Insurance Division, we also issue universal
life, whole life and term life insurance products to individuals
in four markets that we believe are underserved: the
self-employed market, the middle income market, the Hispanic
market and the senior market. We distribute these products
directly to individual customers through our UGA and Cornerstone
agents and other independent agents contracted through two key
unaffiliated marketing companies. These two marketing companies,
in turn, distribute our life products through managing general
agent (MGA) networks.
ZON Re-USA, LLC (ZON Re) (an 82.5%-owned subsidiary)
underwrites, administers and issues accidental death, accidental
death and dismemberment (AD&D), accident
medical, and accident disability insurance products, both on a
primary and on a reinsurance basis. We distribute these products
through professional reinsurance intermediaries and a network of
independent commercial insurance agents, brokers and third party
administrators (TPAs).
In 2007, we initiated efforts to expand into the Medicare market
by establishing a Medicare Division. In the fourth quarter of
2007, we began offering a new portfolio of Medicare Advantage
Private-Fee-for-Service Plans (Medicare Advantage
PFFS) called HealthMarkets Care Assured
Planssm
(HMCA Plans) in selected markets in
29 states with coverage effective for January 1, 2008.
Policies are issued by our Chesapeake subsidiary, under a
contract with the Centers for Medicare and Medicaid Services
(CMS).
Our HMCA Plans are offered to Medicare eligible beneficiaries as
a replacement for original Medicare and Medigap (Supplement)
policies. They provide enrollees with the benefits they would
receive under original Medicare, as well as certain additional
benefits or benefit options, such as preventive care, pharmacy
benefits and certain vision, dental and hearing services.
Enrollees can obtain services from any Medicare-eligible
provider who agrees to accept the HMCA Plans terms and
conditions. Enrollees generally pay a premium in addition to the
premium payable for original Medicare. The amount of the
additional premium varies, based on the level of benefits and
coverage. Our initial plan offerings include the HealthMarkets
Care Assured Value Plan, which has a $3,500 annual maximum
out-of-pocket for covered expenses, and the HealthMarkets Care
Assured Premier Plan, which has a $1,500 annual maximum
out-of-pocket for covered expenses. Each plan can be purchased
with Medicare Part D prescription drug coverage as an
optional benefit. Coinsurance and copayment requirements vary by
plan and service received. Covered expenses are not subject to a
deductible.
Our operating segments for financial reporting purposes include
(a) the Insurance segment, which includes the businesses of
the Companys Self-Employed Agency Division, the Life
Insurance Division and Other Insurance, (b) the Other Key
Factors segment, which includes investment income not otherwise
allocated to the Insurance segment, realized gains and losses on
sale of investments, interest expense on corporate debt,
variable stock-based compensation, costs associated with the
Companys Medicare Advantage PFFS market initiative,
general expenses relating to corporate operations and, in 2006,
the incremental costs associated with the acquisition of the
Company by a group of private equity, and (c) the Disposed
Operations segment, which includes the Companys former
Star HRG Division and former Student Insurance Division
(which operations were sold on July 11, 2006 and
December 1, 2006, respectively). See Note 19 of
Notes to Financial Statements for financial information
regarding our segments.
2
Ratings
Our principal insurance subsidiaries are rated by A.M. Best
Company (A.M. Best), Fitch Ratings
(Fitch) and Standard & Poors
(S&P). Set forth below are financial strength
ratings of the principal insurance subsidiaries.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A.M. Best
|
|
|
Fitch
|
|
|
S&P
|
|
|
MEGA
|
|
|
A- (Excellent
|
)
|
|
|
A- (Strong
|
)
|
|
|
BBB+ (Good
|
)
|
Mid-West
|
|
|
A- (Excellent
|
)
|
|
|
A- (Strong
|
)
|
|
|
BBB+ (Good
|
)
|
Chesapeake
|
|
|
A- (Excellent
|
)
|
|
|
BBB+ (Good
|
)
|
|
|
BBB (Good
|
)
|
In the table above, the A.M. Best and S&P ratings
carry a negative outlook and the Fitch and S&P
ratings carry a stable outlook.
In evaluating a company, independent rating agencies review such
factors as the companys capital adequacy, profitability,
leverage and liquidity, book of business, quality and estimated
market value of assets, adequacy of policy liabilities,
experience and competency of management, and operating profile.
A.M. Bests ratings currently range from A++
(Superior) to F (Liquidation).
A.M. Bests ratings are based upon factors relevant to
policyholders, agents, insurance brokers and intermediaries and
are not directed to the protection of investors. Fitchs
ratings provide an overall assessment of an insurance
companys financial strength and security, and the ratings
are used to support insurance carrier selection and placement
decisions. Fitchs ratings range from AAA
(Exceptionally Strong) to C (Very Weak).
S&Ps financial strength rating is a current opinion
of the financial security characteristics of an insurance
organization with respect to its ability to pay under its
insurance policies and contracts in accordance with their terms.
S&Ps financial strength ratings range from
AAA (Extremely Strong) to CC (Extremely
Weak).
A.M. Best has assigned to HealthMarkets, Inc. an issuer
credit rating of bbb- (Good) with a watch
negative outlook. A.M. Bests issuer credit
rating is a current opinion of an obligors ability to meet
its senior obligations. A.M. Bests issuer credit
ratings range from aaa (Exceptional) to
d (In Default).
Fitch has assigned to HealthMarkets, Inc. a long term issuer
default rating of BBB (Good) with a
stable outlook. Fitchs long term issuer
default rating is a current opinion of an obligors ability
to meet all of its most senior financial obligations on a timely
basis over the term of the obligation. Fitchs long term
issuer default ratings range from AAA (Exceptionally
Strong) to D (Default).
S&Ps Rating Services has assigned to HealthMarkets,
Inc. a counterparty credit rating of BB+ (Less
Vulnerable) with a stable outlook. S&Ps
counterparty credit rating is a current opinion of an
obligors overall financial capacity to pay its financial
obligations. S&Ps counterparty credit ratings range
from AAA (Extremely Strong) to D
(Default).
Insurance
Segment
Self-Employed
Agency Division
Through our Self-Employed Agency Division, we offer a broad
range of health insurance products for the individual and
self-employed market (i.e., self-employed individuals and
individuals who work for small businesses). These products are
issued by our subsidiaries, MEGA and Mid-West, and are
distributed by independent agents associated with MEGAs
and Mid-Wests marketing divisions. The Self-Employed
Agency Division generated revenues of $1.418 billion,
$1.462 billion and $1.526 billion, representing 89%,
68% and 72% of our total revenue in 2007, 2006 and 2005,
respectively. We currently have approximately 612,000 members
insured or reinsured by the Company.
3
We offer a broad range of health insurance products for
self-employed individuals and individuals who work for small
businesses:
Our
CareOne Product Suite
In the first quarter of 2006, the Company introduced and began
offering its new CareOne product portfolio to the self-employed
and individual market. In the 36 states where CareOne
products have been introduced, they have replaced the
Companys traditional health insurance product offerings as
the focus of new product sales.
The CareOne product portfolio includes a Basic Medical/Surgical
Expense Plan, two versions of a Catastrophic Expense PPO Plan
and two versions of a Catastrophic Expense Consumer Guided
Health Plan:
|
|
|
|
|
The CareOne Value Plan is a Basic Medical/Surgical Expense Plan
with a $2.0 million lifetime benefit for all injuries and
sicknesses and $500,000 lifetime maximum benefit for each injury
or sickness. Covered expenses are subject to a deductible and
coinsurance. Covered inpatient and outpatient hospital charges
are reimbursed up to pre-selected per-injury or sickness
maximums. Surgeon, assistant surgeon, anesthesia, second
surgical opinion, and ambulance services are also reimbursed to
a scheduled maximum. Additional benefits are available through
riders and include prescription drugs, emergency services and
wellness care, among others. This type of health insurance
policy is of a scheduled benefit nature, and as
such, provides benefits equal to the lesser of the actual cost
incurred for covered expenses or the maximum benefit stated in
the policy. These limitations allow for more certainty in
predicting future claims experience, and, as a result, we expect
that future premium increases for this policy will be less than
future premium increases on our more comprehensive policies. As
of January 1, 2008, the CareOne Value Plan had been
approved for issuance in 36 states.
|
|
|
|
The CareOne Plan and CareOne Plus Plan are Catastrophic Expense
PPO Plans and provide a $5.0 million lifetime maximum for
all injuries and sicknesses and a maximum benefit for each
injury or sickness of $1.0 million. These plans incorporate
features of a preferred provider organization, which
are designed to control healthcare costs through negotiating
provider discounts with a PPO network. Benefits are structured
to encourage the use of providers with which we have negotiated
lower fees for the services to be provided. These plans impose
greater policyholder cost sharing if the policyholder uses
providers outside of the PPO network. Covered expenses are
subject to a deductible and are then reimbursed at a benefit
payment rate ranging from 70% to 80%, as determined by the
policy. After a pre-selected dollar amount of covered expenses
has been reached, the remaining expenses are reimbursed at 100%
for the remainder of the period of confinement per calendar
year. As a premium and cost savings measure, the CareOne Plan
limits payment for diagnostic services (e.g., X-rays and
laboratory tests) to those diagnostic services that take place
within 21 days of, and are directly related to, a
hospitalization or outpatient surgery. The benefits for these
plans tend to increase as hospital care expenses increase and,
as a result, premiums on these policies are subject to an
increase as overall hospital care expenses rise. As of
January 1, 2008, the CareOne Plan and CareOne Plus Plan had
been approved for issuance in 36 states.
|
|
|
|
The CareOne Select Plan and the CareOne Select Plus Plan are
Catastrophic Expense Consumer Guided Health Plans and provide a
$5.0 million lifetime maximum for all injuries and
sicknesses and a maximum benefit for each injury or sickness of
$1.0 million. These plans incorporate features of a
consumer guided health plan, including information
tools available on the internet or through customer service
support via the telephone that provide customers with access to
information about their benefits and healthcare provider cost
and quality. Covered expenses are subject to a Maximum
Allowable Charge (MAC), which is the maximum
fee payable under the policy for a particular healthcare
service. As a premium and cost savings measure, the CareOne
Select Plan limits payment for diagnostic services (e.g., X-rays
and laboratory tests) to those diagnostic services that take
place within 21 days of, and are directly related to, a
hospitalization or outpatient surgery. The MAC allows for more
certainty in predicting future claims experience, and, as a
result, we expect that future premium increases for this policy
will be less than future premium increases on our catastrophic
PPO policies. As of January 1, 2008, the CareOne Select
Plan and the CareOne Select Plus Plan had been approved for
issuance in 35 states.
|
4
In the second quarter of 2007, we began to offer HSA-compatible
versions of our CareOne products. These plans known
as high deductible health plans can be
used with tax-advantaged health savings accounts for healthcare
expenses. As of January 1, 2008, our HSA-compatible plans
had been approved for issuance in 23 states.
Our
Traditional Health Products
Our traditional health insurance plan offerings for the
self-employed market have included the following:
|
|
|
|
|
Our Basic Hospital-Medical Expense Plan has a $1.0 million
lifetime maximum benefit for all injuries and sicknesses and
$500,000 lifetime maximum benefit for each injury or sickness.
Covered expenses are subject to a deductible. Covered hospital
room and board charges are reimbursed at 100% up to a
pre-selected daily maximum. Covered expenses for inpatient
hospital miscellaneous charges,
same-day
surgery facility, surgery, assistant surgeon, anesthesia, second
surgical opinion, doctor visits and ambulance services are
reimbursed at 80% to 100% up to a scheduled maximum. This type
of health insurance policy is of a scheduled benefit
nature, and, as such, provides benefits equal to the lesser of
the actual cost incurred for covered expenses or the maximum
benefit stated in the policy. These limitations allow for more
certainty in predicting future claims experience, and, as a
result, we expect that future premium increases for this policy
will be lower than future premium increases on our catastrophic
policy.
|
|
|
|
Our Preferred Provider Plan incorporates features of a
preferred provider organization, which are designed
to control healthcare costs through negotiating discounts with a
PPO network. Benefits are structured to encourage the use of
providers with which we have negotiated lower fees for the
services to be provided. The savings from these negotiated fees
reduce the costs to the individual policyholders. The policies
that provide for the use of a PPO impose greater policyholder
cost sharing if the policyholder uses providers outside of the
PPO network.
|
|
|
|
Our Catastrophic Hospital Expense Plan provides a
$2.0 million lifetime maximum for all injuries and
sicknesses and a lifetime maximum benefit for each injury or
sickness ranging from $500,000 to $1.0 million. Covered
expenses are subject to a deductible and are then reimbursed at
a benefit payment rate ranging from 50% to 100%, as determined
by the policy. After a pre-selected dollar amount of covered
expenses has been reached, the remaining expenses are reimbursed
at 100% for the remainder of the period of confinement per
calendar year. The benefits for this plan tend to increase as
hospital care expenses increase and, as a result, premiums on
these policies are subject to increase as overall hospital care
expenses rise.
|
Each of our traditional health insurance products is available
with a menu of various options (including various
deductible levels, coinsurance percentages and limited riders
that cover particular events such as outpatient, accidents, and
doctors visits), enabling the insurance product to be
tailored to meet the insurance needs and the budgetary
constraints of the policyholder. We offer as an optional benefit
the Accumulated Covered Expense (ACE) rider that
provides for catastrophic coverage on our Scheduled/Basic plans
for covered expenses under the contract that generally exceed
$100,000 or, in certain cases, $75,000. The rider pays benefits
at 100% after the stop loss amount is reached, up to the
aggregate maximum amount of the contract for expenses covered by
the rider.
The Company has substantially ceased selling these traditional
health insurance products although policy renewals continue. The
Company intends over time to replace its traditional health
insurance products with the CareOne products or other new
products that the Company may introduce from time to time.
2008 New
Product Introductions
In the first half of calendar 2008, the Company intends to
introduce a new calendar year deductible-based PPO product
called MEGA
CareChoicesm.
The MEGA CareChoice product contains many of the same features
as our CareOne and CareOne Plus Plans, but will eliminate many
of the internal benefit limits that are associated with such
plans.
Subject to receipt of applicable regulatory approvals, the
Company anticipates that these products will be issued by our
subsidiaries, MEGA, Mid-West and Fidelity Life, and will be
distributed by independent agents associated with MEGAs
and Mid-Wests marketing divisions.
5
The Company evaluates new product offerings on an ongoing basis.
In the future, we may offer new product lines, including product
lines focused on markets not traditionally served by the Company.
Ancillary
Products
We have also developed and offer ancillary product lines that
provide protection against short-term disability, as well as a
combination product that provides benefits for life, disability
and critical illness. These products have been designed to
further protect against risks to which our core customer is
typically exposed.
In the third quarter of 2008, the Company intends to introduce a
new suite of dental products that will offer more varied benefit
options than the dental products they will replace. These
products are intended to be sold both to purchasers of the
Companys health insurance products and on a stand-alone
basis.
Third
Party Product Distribution Arrangements
Our subsidiaries, MEGA and Mid-West, have entered into
agreements to distribute health insurance products underwritten
by other third-party insurance companies. The products sold
under these arrangements focus on markets not traditionally
served by the Company, including high risk customers. These
products are distributed by independent insurance agents
associated with MEGAs and Mid-Wests marketing
divisions. The Company evaluates new distribution arrangements
on an ongoing basis and may, in the future, offer new third
party products.
Marketing
and Sales
Substantially all of the health insurance products issued by our
insurance company subsidiaries are sold through independent
contractor agents. We believe that we have the largest direct
selling organization in the health insurance field, with
approximately 1,900 independent writing agents per week in the
field selling health insurance to the individual and self
employed market.
Our agents are independent contractors, and all compensation
that agents receive from us for the sale of insurance is based
upon the agents levels of sales production.
UGA Association Field Services and Cornerstone
America (the principal marketing divisions of MEGA and Mid-West)
are each organized into geographical regions, with each
geographical region having a regional director, two additional
levels of field leaders and writing agents (i.e., the
agents that are not involved in leadership of other agents).
UGA and Cornerstone are each responsible for the recruitment and
training of their field leaders and writing agents. UGA and
Cornerstone generally seek persons with previous sales
experience. The process of recruiting agents is extremely
competitive. We believe that the primary factors in successfully
recruiting and retaining effective agents and field leaders are
our practices regarding advances on commissions, the quality of
the sales leads provided to agents, the availability and
accessibility of equity ownership plans, the quality of the
products offered, proper training and agent incentives and
support. Classroom and field training with respect to product
content is required and made available to the agents under the
direction of our regulated insurance subsidiaries.
We provide health insurance products to consumers in the
individual and self-employed market in 44 states. As is the
case with many of our competitors in this market, a substantial
portion of our products is issued to members of various
independent membership associations that act as the master
policyholder for such products. The two principal membership
associations in the self-employed market that make available to
their members our health insurance products are the National
Association for the Self-Employed and the Alliance for
Affordable Services. The associations provide their membership
access to a number of benefits and products, including health
insurance underwritten by us. Subject to applicable state law,
individuals generally may not obtain insurance under an
associations master policy unless they are also members of
the association. The agreements with these associations,
requiring the associations to continue as the master
policyholder for our policies and to make our products available
to their respective members, are terminable by us and the
associations upon not less than one years advance notice
to the other party. While we believe that we are providing
association group coverage in full compliance with applicable
law, changes in our relationship with the membership
associations
and/or
changes in the laws and regulations governing so-called
association group insurance (particularly changes
that would subject the issuance
6
of policies to prior premium rate approval
and/or
require the issuance of policies on a guaranteed
issue basis) could have a material adverse impact on our
financial condition, results of operations
and/or
business.
UGA agents and Cornerstone agents also act as field service
representatives (FSRs) for the associations. In this
capacity the FSRs enroll new association members and provide
membership retention services. For such services, we and the
FSRs receive compensation. One of our subsidiaries,
HealthMarkets Lead Marketing Group Inc. (LMG),
serves as our direct marketing group and generates new
membership sales prospect leads for both UGA and Cornerstone for
use by the FSRs (agents). LMG also provides video and print
services to the associations. In addition to health insurance
premiums derived from the sale of health insurance, we receive
fee income from the associations, including fees associated with
enrollment and member retention services, fees for association
membership marketing and administrative services and fees for
certain association member benefits.
LMG generates sales prospect leads for UGA and Cornerstone for
use by their agents. LMG administers a call center (located in
Oklahoma City, Oklahoma) staffing approximately 55 tele-service
representatives. Leads are also obtained from third party
sources. LMG has developed a marketing pool of approximately
fifteen million prospects from various data sources. Prospects
initially identified by LMG that are self-employed, small
business owners or individuals may become a qualified
lead by responding through one of LMGs lead channels
and by expressing an interest in learning more about health
insurance. We believe that UGA and Cornerstone agents,
possessing the qualified leads contact information, are
able to achieve a higher close rate than is the case
with unqualified prospects.
Policy
Design and Claims Management
Our traditional health insurance products are principally
designed to limit coverages to the occurrence of significant
events that require hospitalization. This policy design, which
includes high deductibles, reduces the number of covered claims
requiring processing, thereby serving as a control on
administrative expenses. We seek to price our products in a
manner that accurately reflects our underwriting assumptions and
targeted margins, and we rely on the marketing capabilities of
our dedicated agency sales forces to sell these products at
prices consistent with these objectives.
We maintain administrative centers with full underwriting,
claims management and administrative capabilities. We believe
that by processing our own claims we can better assure that
claims are properly processed and can utilize the claims
information to periodically modify the benefits and coverages
afforded under our policies.
We have also developed an actuarial data warehouse, which is a
critical risk management tool that provides our actuaries with
rapid access to detailed exposure, claim and premium data. This
analysis tool enhances the actuaries ability to design,
monitor and adequately price the Self-Employed Agency
Divisions insurance products.
Provider
Network Arrangements and Cost Management Measures
The Company utilizes a number of cost management programs to
help it and its customers control medical costs. These measures
include maintaining contracts with selected PPO provider
networks through which our customers may obtain discounts on
hospital and physician services that would otherwise not be
available. Provider networks are made available on a regional
basis, based on the coverage and discounts available within a
particular geographic region. In situations where a customer
does not obtain services from a contracted provider, the Company
applies various usual and customary fees, which limit the amount
paid to providers within specific geographic areas. We believe
that access to provider network contracts is a critical factor
in controlling medical costs, since there is often a significant
difference between a network-negotiated rate and the
non-discounted rate.
The Company utilizes other means to control medical costs,
including providing customers with access to
supplemental network discounts if savings are not
obtained through a primary provider network contract; use of
pre- and post-payment fee negotiation services; and use of code
editing programs that evaluate claims prior to adjudication for
inappropriate billing.
In 2007, approximately 90% of submitted medical claims were
impacted by these programs, with an average discount received of
31%.
7
In addition, to control prescription drug costs, the Company
maintains a contract with a pharmacy benefits management company
that has approximately 60,000 participating pharmacies
nationwide. We also utilize co-payments, coinsurance,
deductibles and annual limits to manage prescription drug costs.
Life
Insurance Division
Our Life Insurance Division offers life insurance products to
individuals. At December 31, 2007, the Life Insurance
Division (which is based in Oklahoma City, Oklahoma) had over
$6.8 billion of net life insurance in force and over
270,000 individual policyholders. The Life Insurance Division
generated revenues of $92.0 million, $87.8 million and
$83.0 million (representing 6%, 4% and 4% of our total
revenue) in 2007, 2006 and 2005, respectively.
Markets
Served
The Life Insurance Division offers its life insurance products
to demographically growing market segments that we have
identified as underserved, including the self-employed market,
the middle-income market, the Hispanic market and the senior
market.
Products
The Life Insurance Divisions products are tailored to meet
the specific needs of customers in each of its targeted markets.
We offer universal life insurance and term life insurance
products to individuals in the self-employed market. We offer
two other universal life insurance products and other term life
insurance products to meet the needs of individuals in the
middle-income and the Hispanic markets. We also offer whole life
insurance products (level, graded and modified) to assist
seniors in meeting their needs to cover final expenses.
Distribution
The Life Insurance Division distributes its insurance products
primarily through internal and external distribution channels.
Commencing in the second quarter of 2002, our UGA and
Cornerstone agents began to market our universal life insurance
and term life insurance products to individuals in the
self-employed market. In 2003, the Life Insurance Division also
entered into new marketing relationships with two independent
marketing companies to distribute our universal life insurance,
term life insurance and whole life insurance products through
networks of managing general agents (MGAs). One marketing
company offers universal life insurance and term life insurance
products to middle-income buyers and through agencies that
specialize in sales to Hispanic buyers. The second marketing
company offers our whole life insurance product line exclusively
to seniors. At year-end 2007, these two marketing organizations
had contracted over 13,000 independent agents to distribute our
products.
Marketing
and Sales
With the help of agents associated with UGA and Cornerstone, the
Life Insurance Division seeks to leverage our significant health
insurance customer base by positioning itself to offer those
customers (self-employed individuals) universal life insurance
and term life insurance products designed to fit their changing
needs. The two independent marketing companies that we have
contracted with offer universal life insurance and term life
insurance product lines through their agents to cover the needs
of the middle-income market, the Hispanic market and the senior
market. The Life Insurance Division has also developed a needs
analysis software selling system, Blueprint for
Life®.
This selling tool allows the agent to accurately and quickly
identify the amount of insurance that should be carried by an
individual. We believe that the Blueprint for
Life®
provides a valuable service to the middle-income buyer, who has
often been overlooked or underserved by other distributors of
life insurance products.
Other
Insurance
Through our 82.5%-owned subsidiary, ZON Re, we underwrite,
administer and issue accidental death, AD&D, accident
medical and accident disability insurance products, both on a
primary and on a reinsurance basis. In the year ended
December 31, 2007, ZON Re generated revenues of
$31.9 million and operating income of $7.9 million.
8
ZON Re underwrites and manages a portfolio of personal accident
reinsurance programs on behalf of MEGA for primary life,
accident and health and property and casualty insurers that wish
to transfer risks associated with certain types of primary
personal accident insurance programs. Accident reinsurance
provides reimbursement to primary insurance carriers for covered
losses resulting from accidental bodily injury or accidental
death. For its reinsurance clients, ZON Re targets national,
regional and middle market insurers in the United States and
select international markets. ZON Re distributes accident
reinsurance products through a network of professional
reinsurance intermediaries. ZON Re underwrites both treaty and
facultative accident reinsurance programs, which may be offered
on either a quota share or excess of loss basis. The Company has
determined, as a matter of policy, that MEGAs exposure on
any single reinsurance contract issued by it and underwritten by
ZON Re will not exceed $1.0 million per person and
$10.0 million per event.
ZON Re also underwrites and distributes a limited portfolio of
primary accident insurance products issued by Chesapeake. These
products are designed for direct purchase by banks,
associations, employers and affinity groups and are distributed
through a national network of independent commercial insurance
agents, brokers and third party administrators. The Company has
determined, as a matter of policy, that Chesapeakes
maximum exposure on any single primary insurance contract issued
by it and underwritten by ZON Re will not exceed
$1.0 million per person.
Ceded
Reinsurance
Our insurance subsidiaries reinsure portions of the coverages
provided by their insurance products with other insurance
companies on both an excess-of-loss and coinsurance basis. The
maximum retention by us on one individual in the case of life
insurance is $200,000 for MEGA, Mid-West and Chesapeake. We use
reinsurance for our health insurance business solely for limited
purposes. Reinsurance agreements are intended to limit an
insurers maximum loss.
Competition
In each of our lines of business, we compete with other
insurance companies or service providers, depending on the line
and product, although we have no single competitor who competes
against us in all of the business lines in which we operate.
With respect to the business of our Self-Employed Agency
Division, the market is characterized by many competitors, and
our main competitors include health insurance companies, health
maintenance organizations and the Blue Cross/Blue Shield plans
in the states in which we write business. While we are among the
largest competitors in terms of market share in some of our
business lines, in some cases there are one or more major market
players in a particular line of business.
Competition in our businesses is based on many factors,
including quality of service, product features, price, scope of
distribution, scale, financial strength ratings and name
recognition. We compete, and will continue to compete, for
customers and distributors with many insurance companies and
other financial services companies. We compete not only for
business and individual customers, employer and other group
customers, but also for agents and distribution relationships.
Some of our competitors may offer a broader array of products
than our specific subsidiaries with which they compete in
particular markets, may have a greater diversity of distribution
resources, may have better brand recognition, may, from time to
time, have more competitive pricing, may have lower cost
structures or, with respect to insurers, may have higher
financial strength or claims paying ratings. Organizations with
sizable market share or provider-owned plans may be able to
obtain favorable financial arrangements from healthcare
providers that are not available to us. Some may also have
greater financial resources with which to compete. In addition,
from time to time, companies enter and exit the markets in which
we operate, thereby increasing competition at times when there
are new entrants. For example, several large insurance companies
have recently entered the market for individual health insurance
products
and/or
consumer guided health plans. We may lose business to
competitors offering competitive products at lower prices, or
for other reasons, which could materially adversely affect our
future results of operations and financial condition.
9
Regulatory
and Legislative Matters
Insurance
Regulation
State
Regulation General
Our insurance subsidiaries are subject to extensive regulation
in their states of domicile and the other states in which they
do business under statutes that typically delegate broad
regulatory, supervisory and administrative powers to insurance
departments. The method of regulation varies, but the subject
matter of such regulation covers, among other things, the amount
of dividends and other distributions that can be paid by the
insurance subsidiaries without prior approval or notification;
the granting and revoking of licenses to transact business;
trade practices, including with respect to the protection of
consumers; disclosure requirements; privacy standards; minimum
loss ratios; premium rate regulation; underwriting standards;
approval of policy forms; claims payment; licensing of insurance
agents and the regulation of their conduct; the amount and type
of investments that the insurance subsidiaries may hold, minimum
reserve and surplus requirements; risk-based capital
requirements; and compelled participation in, and assessments in
connection with, risk sharing pools and guaranty funds. Such
regulation is intended to protect policyholders rather than
investors.
State regulation of health insurance products varies from state
to state, although all states regulate premium rates, policy
forms and underwriting and claims practices to one degree or
another. Most states have special rules for health insurance
sold to individuals and small groups. Every state has also
adopted legislation that would make health insurance available
to all small employer groups by requiring coverage of all
employees and their dependents, by limiting the applicability of
pre-existing conditions exclusions, by requiring insurers to
offer a basic plan exempt from certain benefits as well as a
standard plan, or by establishing a mechanism to spread the risk
of high risk employees to all small group insurers.
Various states have, from time to time, proposed
and/or
enacted changes to the healthcare system that could affect the
relationship between health insurers and their customers. For
example, effective July 1, 2007, Massachusetts law requires
all residents to obtain minimum levels of health insurance and
requires employers with 11 or more full time employees to pay an
assessment if they do not offer health insurance to these
employees. Other states have adopted or are considering the
adoption of laws intended to require minimum levels of health
insurance for previously uninsured residents, including
play or pay laws requiring that employers either
offer health insurance or pay a tax to cover the costs of public
healthcare insurance. We cannot predict with certainty the
effect that the Massachusetts law, or proposed legislation in
other states, if adopted, could have on our insurance businesses
and operations.
A number of states have enacted other new health insurance
legislation over the past several years. These laws, among other
things, mandate benefits with respect to certain diseases or
medical procedures, require health insurers to offer an
independent external review of certain coverage decisions and
establish health insurer liability. There has also been an
increase in legislation regarding, among other things, prompt
payment of claims, privacy of personal health information,
health insurer liability, prohibition against insurers including
discretionary clauses in their policy forms and relationships
between health insurers and providers. We expect that this trend
of increased legislation will continue. These laws may have the
effect of increasing our costs and expenses.
We provide health insurance products to consumers in the
individual and self-employed market. As is the case with many of
our competitors in this market, a substantial portion of our
products are issued to members of various independent membership
associations that act as the master policyholder for such
products. During 2004, we, and our insurance company
subsidiaries, resolved a nationwide class action lawsuit
challenging the nature of the relationship between our insurance
companies and the membership associations that make available to
their members our insurance companies health insurance
products. A number of additional lawsuits challenging the nature
of the relationship between our insurance companies and such
membership associations are ongoing. See Note 17 of
Notes to Financial Statements. While we believe that we are
providing association group coverage in full compliance with
applicable law, changes in our relationship with the membership
associations
and/or
changes in the laws and regulations governing association group
insurance (particularly changes that would subject the issuance
of policies to prior premium rate approval
and/or
require the issuance of policies on a guaranteed
issue basis) could have a material adverse impact on our
financial condition, results of operations
and/or
business.
10
Many states have also enacted insurance holding company laws
that require registration and periodic reporting by insurance
companies controlled by other corporations. Such laws vary from
state to state, but typically require periodic disclosure
concerning the corporation that controls the controlled insurer
and prior notice to, or approval by, the applicable regulator of
inter-corporate transfers of assets and other transactions
(including payments of dividends in excess of specified amounts
by the controlled insurer) within the holding company system.
Such laws often also require the prior approval for the
acquisition of a significant ownership interest (i.e., 10% or
more) in the insurance holding company. HealthMarkets (the
holding company) and our insurance subsidiaries are subject to
such laws, and we believe that we and such subsidiaries are in
compliance in all material respects with all applicable
insurance holding company laws and regulations.
Under the risk-based capital initiatives adopted in 1992 by the
National Association of Insurance Commissioners
(NAIC), insurance companies must calculate and
report information under a risk-based capital formula.
Risk-based capital formulas are intended to evaluate risks
associated with asset quality, adverse insurance experience,
losses from asset and liability mismatching, and general
business hazards. This information is intended to permit
regulators to identify and require remedial action for
inadequately capitalized insurance companies, but it is not
designed to rank adequately capitalized companies. At
December 31, 2007, the risk-based capital ratio of each of
our domestic insurance subsidiaries significantly exceeded the
ratio for which regulatory corrective action would be required.
The states in which our insurance subsidiaries are licensed have
the authority to change the minimum mandated statutory loss
ratios to which they are subject, the manner in which these
ratios are computed and the manner in which compliance with
these ratios is measured and enforced. Loss ratios are commonly
defined as incurred claims as a percentage of earned premiums.
Most states in which our insurance subsidiaries write insurance
have adopted the minimum loss ratios recommended by the NAIC,
but frequently the loss ratio regulations do not apply to the
types of health insurance issued by our subsidiaries. A number
of states are considering the adoption of, or have adopted, laws
that would mandate minimum statutory loss ratios, or increase
existing minimum statutory loss ratios, for the products we
offer. For example, on July 1, 2007, California regulations
became effective that will require a minimum medical loss ratio
of 70% for health insurance issued after that date, as well as
business issued prior to that date if it is subject to a rate
revision. We are unable to predict the impact of (i) any
changes in the mandatory statutory loss ratios for individual or
group policies to which we may become subject, or (ii) any
change in the manner in which these minimums are computed or
enforced in the future. Such changes could result in a narrowing
of profit margins and adversely affect our business and results
of operations. We have filed new products intended to address
the California minimum medical loss ratio requirements that
became effective on July 1, 2007. Our ability to offer
these products is subject to receipt of applicable regulatory
approvals, and there can be no assurance that approvals will be
received. In the event that we are not in compliance with
minimum statutory loss ratios mandated by regulatory authorities
with respect to certain policies, we may be required to reduce
or refund premiums, which could have a material adverse effect
upon our business and results of operations.
The NAIC and state insurance departments are continually
reexamining existing laws and regulations, including those
related to reducing the risk of insolvency and related
accreditation standards. To date, the increase in
solvency-related oversight has not had a significant impact on
our insurance business.
State
Regulation Financial and Market Conduct
Examinations
Our insurance subsidiaries are required to file detailed annual
statements with the state insurance regulatory departments and
are subject to periodic financial and market conduct
examinations by such departments. The Oklahoma Insurance
Department (the regulator of MEGAs and Chesapeakes
domicile state) and the Texas Department of Insurance (the
regulator of Mid-Wests state of domicile) are currently
performing the regularly scheduled tri-annual financial exams
for the year ended December 31, 2006.
State insurance departments have also periodically conducted and
continue to conduct market conduct examinations of
HealthMarkets insurance subsidiaries. In March 2005,
HealthMarkets received notification that the Market Analysis
Working Group of the NAIC had chosen the states of Washington
and Alaska to lead a multi-state market conduct examination of
HealthMarkets principal insurance subsidiaries (the
Insurance Subsidiaries) for the examination period
January 1, 2000 through December 31, 2005. Thirty-six
states have elected to
11
participate in the examination. The examiners have completed the
onsite phases of the examination and issued a final examination
report on December 20, 2007. See Note 17 of
Notes to Financial Statements.
The findings of the final examination report cite deficiencies
in five major areas of operation: (i) insufficient training
of agents and lack of oversight of agent activities,
(ii) deficient claims handling practices,
(iii) insufficient disclosure of the relationship with
affiliates and the membership associations, (iv) deficient
handling of complaints and grievances, and (v) failure to
maintain a formal corporate compliance plan and centralized
corporate compliance department.
In connection with the issuance of the final examination report,
the Washington Office of Insurance Commissioner issued an order
adopting the findings of the final examination report and
ordering the Insurance Subsidiaries to comply with certain
required actions set forth in the report. The order requires the
Insurance Subsidiaries to file a detailed report specifying how
they have addressed each of the requirements of the order and
another report outlining, by examination area, all business
reforms, improvements and changes to policies and procedures.
During 2004, in response to state specific examination findings,
the Insurance Subsidiaries began making significant changes to
their structure and operational processes. These changes
included the enhancement of agent training and oversight
programs, the reorganization and consolidation of the
Companys compliance department, the adoption of additional
methods to monitor agent sales activities, the implementation of
a benefits confirmation telephone call program to obtain further
assurances that customers understand their health insurance
coverage and the creation of a Regulatory Advisory Panel
consisting of former regulators to provide objective advice to
the Board and management. We believe our insurance subsidiaries
have effectively addressed or are in the process of addressing
many of the findings identified in the final examination report.
Many of these enhancements occurred after the examination period
and are therefore not reflected in the examination report
findings.
Following the issuance of the final examination report, the
multi-state market conduct examination entered the
settlement phase, during which the states
participating in this phase are developing a settlement proposal
to close out the examination. Such a settlement could
potentially include, among other things, substantial monetary
assessments (portions of which may be contingent), and a
requirement that the Insurance Subsidiaries take certain
actions, subject to monitoring by certain states participating
in the examination. There can be no assurance that a settlement
of this matter will be achieved or that, if achieved, all states
participating in the examination would approve the terms of such
a settlement. Based on initial preliminary communications with
the states participating in the settlement phase, the Company
has recorded an expense of $20 million as of
December 31, 2007. Depending on the final outcome of the
settlement phase, including the ultimate disposition of any
contingent portion of a final monetary assessment, the actual
amount incurred by the Company could vary from this current
provision in an amount that is material to the Companys
consolidated financial condition or results of operations.
MEGA was named as a defendant in an action filed on
November 15, 2007 by the Department of Professional and
Financial Regulation, Maine Bureau of Insurance (In Re: MEGA
Life and Health Insurance Company Rates For Individual
Plans) pending before the Superintendent of the Maine Bureau
of Insurance, Docket
No. Ins-07-1010.
The Maine Attorney General moved to intervene and was granted
status as a party to the action. The action was initiated to
determine whether MEGA is in compliance with Maines
requirement that rates for health insurance not be excessive,
inadequate, or unfairly discriminatory as set forth in
24-A M.R.S.A
§ 2736-C(5) and Maine Rule Ch. 940,
§ 8(A). On March 21, 2008, MEGA, the Maine Bureau
of Insurance and the Attorney General agreed on a preliminary
basis to settle the action on terms that would not have a
material adverse effect upon the Companys consolidated
financial condition or results of operations and would not
require MEGA to admit wrongdoing, liability or violation of law.
The settlement is not final and discovery is ongoing.
On December 6, 2006, MEGA, Mid-West and Chesapeake entered
into a settlement agreement with the Massachusetts Division of
Insurance (MA DOI) upon the conclusion of a market conduct
examination by the MA DOI. The examination consisted of a review
of the operations of MEGA, Mid-West and Chesapeake for small
group health insurance issued to Massachusetts certificate
holders for the period January 1, 2002 to December 31,
2004. The settlement agreement provides, among other things, for
changes in certain Company operations and procedures, including
those related to claims handling, complaints and grievances,
marketing and sales and underwriting. In addition, MEGA,
Mid-West and Chesapeake agreed to conduct a claims reassessment
process, pursuant to which
12
the companies are contacting certain Massachusetts claimants and
offering to reassess certain denied claims based on specific
codes identified by the MA DOI. The reassessment covers claims
for the period January 1, 2002 through December 31,
2004, as well as claims on certificates issued through
April 30, 2005 or renewed through July 31, 2005 to the
date of their first renewal or lapse. The claims reassessment is
ongoing and the MA DOI continues to evaluate the Companys
compliance with the terms of the settlement agreement. In
entering the settlement, the Company did not admit, deny or
concede any actual or potential fault, wrongdoing, liability or
violation of law. The MA DOI will not impose fines or take other
action against the Company unless the Company fails to complete
the required actions set forth in the settlement agreement or
unless additional material information related to the required
actions becomes available to the MA DOI. The Company believes
that the terms of the settlement will not have a material
adverse effect upon the Companys consolidated financial
condition or result of operations.
In addition to the multi-state and Massachusetts market conduct
examinations, MEGA, Mid-West
and/or
Chesapeake are subject to various other pending market conduct
and other regulatory examinations, inquiries or proceedings
arising in the ordinary course of business. State insurance
regulatory agencies have authority to levy monetary fines and
penalties resulting from findings made during the course of such
matters. Historically, our insurance subsidiaries have, from
time to time, been subject to such fines and penalties, none of
which, individually or in the aggregate, have had a material
adverse effect on our results of operations or financial
condition. However, the multi-state examination and other
regulatory examinations, inquiries or proceedings could result
in, among other things, changes in business practices that
require the Company to incur substantial costs. Such results,
singly or in combination, could injure our reputation, cause
negative publicity, adversely affect our debt and financial
strength ratings, place us at a competitive disadvantage in
marketing or administering our products, or impair our ability
to sell or retain insurance policies, thereby adversely
affecting our business, and potentially materially adversely
affecting the results of operations in a period, depending on
the results of operations for the particular period.
Determination by regulatory authorities that we have engaged in
improper conduct could also adversely affect our defense of
various lawsuits.
Federal
Regulation
In 1945, the U.S. Congress enacted the McCarran-Ferguson
Act, which declared the regulation of insurance to be primarily
the responsibility of the individual states. Although repeal of
McCarran-Ferguson is debated in the U.S. Congress from time
to time, the federal government generally does not directly
regulate the insurance business. However, federal legislation
and administrative policies in several areas, including
healthcare (including Medicare), pension regulation, age and sex
discrimination, financial services regulation, securities
regulation, privacy laws, terrorism and federal taxation, do
affect the insurance business.
Privacy
Regulations
The use, disclosure and secure handling of individually
identifiable health information by our business is subject to
federal regulations, including the privacy provisions of the
federal Gramm-Leach-Bliley Act and the privacy and security
regulations of the Health Insurance Portability and
Accountability Act of 1996 (HIPAA). In addition, our
privacy and security practices are subject to various state law
and regulations.
HIPAA includes requirements for maintaining the confidentiality
and security of individually identifiable health information and
new standards for electronic healthcare transactions. The
Department of Health and Human Services promulgated final HIPAA
regulations in 2002. The privacy regulations required compliance
by April 2003, the electronic transactions regulations by
October 2003, and the security regulations by April 2005. As
have other entities in the healthcare industry, we have incurred
substantial costs in meeting the requirements of these HIPAA
regulations and expect to continue to incur costs to maintain
compliance. We have worked diligently to comply with these
regulations within the time periods required and believe that we
have complied.
HIPAA also requires certain guaranteed issuance and renewability
of health insurance coverage for individuals and small employer
groups (generally 50 or fewer employees) and limits exclusions
based on pre-existing conditions.
HIPAA and other federal and state privacy regulations continue
to evolve as a result of new legislation, regulations and
judicial and administrative interpretations. Consequently, our
efforts to measure, monitor and adjust
13
our business practices to comply with these requirements are
ongoing. Failure to comply could result in regulatory fines and
civil lawsuits. Knowing and intentional violations of these
rules may also result in federal criminal penalties.
CAN SPAM
Act and Do Not Call Regulations
From time to time, the Company utilizes, either directly or
through third party vendors,
e-mail and
telephone calls to identify prospective sales leads for use by
our agents. The federal CAN SPAM Act, which became effective
January 1, 2004 and is administered and enforced by the
Federal Trade Commission, establishes national standards for
sending bulk, unsolicited commercial
e-mail.
While targeting and prohibiting
e-marketers
to send unsolicited commercial
e-mail with
falsified headers, the CAN SPAM Act permits the use of
unsolicited commercial
e-mail if
and as long as the message contains an opt-out mechanism, a
functioning return
e-mail
address, a valid subject line indicating the
e-mail is an
advertisement and the legitimate physical address of the mailer.
The Company is also required to comply with federal Do Not
Call regulations, which require insurance companies to
develop their own do not call lists and reference
state and federal do not call registries before
making calls to market insurance products.
While the Company has taken what it believes are reasonable
steps to ensure that it, and the various third party vendors
with which it does business, are in full compliance with these
requirements, failure to comply could result in regulatory fines
and civil lawsuits.
USA
PATRIOT Act
On October 26, 2001, the International Money Laundering
Abatement and Anti-Terrorist Financing Act of 2001 was enacted
into law as part of the USA PATRIOT Act. The law requires, among
other things, that financial institutions adopt anti-money
laundering programs that include policies, procedures and
controls to detect and prevent money laundering, designate a
compliance officer to oversee the program and provide for
employee training, and periodic audits in accordance with
regulations proposed by the U.S. Treasury Department.
Treasury regulations governing portions of our life insurance
business require that we maintain procedures designed to detect
and prevent money laundering and terrorist financing. We remain
subject to U.S. regulations that prohibit business dealings
with entities identified as threats to national security. We
have licensed software to enable us to detect and prevent such
activities in compliance with existing regulations and we
continually evaluate our policies and procedures to comply with
these regulations.
Employee
Retirement Income Security Act of 1974
The Employee Retirement Income Security Act of 1974, as amended
(ERISA), regulates how goods and services are provided to or
through certain types of employer-sponsored health benefit
plans. ERISA is a set of laws and regulations subject to
periodic interpretation by the United Stated Department of Labor
(DOL) as well as the federal courts. ERISA places controls on
how our insurance subsidiaries may do business with employers
who sponsor employee health benefit plans. We believe that many
of our products are not subject to ERISA because they are
offered to and used by individuals, self-employed persons or
employers with less than two participants who are employees as
of the start of any plan year. However, some of our products or
services may be subject to the ERISA regulations. During 2005
and 2006, we received inquiries from the Boston and Dallas
offices of the DOL that alleged, among other things, that
certain policy forms in use by our insurance subsidiaries are
not ERISA compliant. We are addressing this matter with the DOL
and do not believe that its resolution will have a material
adverse effect on the Companys financial condition or
results of operations. See Note 17 of Notes to
Financial Statements.
Medicare
We are subject to federal regulations as a result of our
initiative to expand into the Medicare market. Medicare is a
complex and highly regulated federal program that provides
eligible persons age 65 and over and some disabled persons
a variety of hospital and medical insurance benefits. Our
Chesapeake subsidiary provides services to Medicare
beneficiaries under a contract with CMS. CMS performs audits of
each health plan operating under a Medicare contract to
determine the plans compliance with federal regulations
and contractual obligations. These
14
audits include review of the plans administration and
management, including marketing, enrollment and disenrollment
activities, claims processing and complaint systems and
management information and data collection systems. CMS
regulations also require submission of annual financial
statements. Failure to comply with the Medicare regulations
could subject us to significant penalties and could affect our
ability to operate under the Medicare program.
Legislative
Developments
Legislation has been introduced in the U.S. Congress which
would allow residents of any state to purchase health insurance
approved by the regulators in any other state. Such legislation
would allow persons to avoid certain mandates or other
requirements of their state of residence in favor of less
expensive policies in another state. We do not believe that such
legislation will be enacted during the current Congressional
term.
Numerous proposals to reform the current healthcare system have
been introduced in the U.S. Congress and in various state
legislatures. Proposals have included, among other things,
modifications to the existing employer-based insurance system, a
quasi-regulated system of managed competition
among health insurers and a single-payer, public program.
Changes in healthcare policy could significantly affect our
business. For example, federally mandated, comprehensive major
medical insurance, if proposed and implemented, could partially
or fully replace some of our current products. Furthermore,
legislation has been introduced from time to time in the
U.S. Congress that could result in the federal government
assuming a more direct role in regulating insurance companies.
There is also legislation pending in the U.S. Congress and
in various states designed to provide additional privacy
protections to customers of financial institutions. These
statutes and similar legislation and regulations in the United
States or other jurisdictions could affect our ability to market
our products or otherwise limit the nature or scope of our
insurance operations.
The NAIC and individual states have been studying small face
amount life insurance in recent years. Some initiatives that
have been raised at the NAIC include further disclosure for
small face amount policies and restrictions on premium to
benefit ratios. The NAIC is also studying other issues such as
suitability of insurance products for certain
customers. This may have an effect on our pre-funded funeral
insurance business. Suitability requirements such as a customer
assets and needs worksheet could extend and complicate the sale
of pre-funded funeral insurance products. Individual states are
also considering changes to minimum loss ratios which could
alter policy forms and rates
and/or
distribution systems.
We are unable to evaluate new legislation that may be proposed
and when or whether any such legislation will be enacted and
implemented. However, many of the proposals, if adopted, could
have a material adverse effect on our financial condition, cash
flows or results of operations, while others, if adopted, could
potentially benefit our business.
Employees
We had approximately 2,000 employees at December 31,
2007. We consider our employee relations to be good. Agents
associated with MEGAs UGA and Mid-Wests Cornerstone
field forces are independent contractors and are not employees
of the Company.
Executive
Officers of the Company
The Chairman of the Company is elected, and all other executive
officers listed below are appointed, by the Board of Directors
of the Company at its Annual Meeting each year or by the
Executive Committee of the Board of Directors to hold office
until the next Annual Meeting or until their successors are
elected or appointed. None of these officers have family
relationships with any other executive officer or director.
15
|
|
|
|
|
|
|
|
|
Name of Officer
|
|
Principal Position
|
|
Age
|
|
|
Business Experience During Past Five Years
|
|
William J. Gedwed
|
|
Director, President and Chief Executive Officer
|
|
|
52
|
|
|
Mr. Gedwed has served as a director of the Company since June
2000 and as the President and Chief Executive Officer of the
Company since July 1, 2003. He was named Chairman of the Board
in September 2005 and served in such position until April 2006.
He has served as a Director and/or executive officer of NMC
Holdings, Inc. and/or its subsidiaries since 1993. Mr. Gedwed
currently serves as Chairman and Director of the Companys
insurance subsidiaries.
|
David W. Fields
|
|
Executive Vice President and Chief Operating Officer
|
|
|
50
|
|
|
Mr. Fields joined the Company in November 2007 as Executive Vice
President and Chief Operating Officer. Effective March 25,
2008, Mr. Fields was appointed President and Director of
the Companys insurance subsidiaries. Prior to joining
HealthMarkets, Mr. Fields served as President and Chief
Executive Officer of UniCare Life and Health Insurance Company,
a subsidiary of WellPoint Inc., from 2004 to 2007. Mr. Fields
served as Vice President and General Manager of Blue Cross
& Blue Shield of Georgia from 2001 to 2004.
|
Michael E. Boxer
|
|
Executive Vice President and Chief Financial Officer
|
|
|
46
|
|
|
Mr. Boxer joined the Company in September 2006 as Executive Vice
President and Chief Financial Officer. He also serves as a
Director, Executive Vice President and Chief Financial Officer
of the Companys insurance subsidiaries. Prior to joining
the Company, Mr. Boxer served as President of The Enterprise
Group Ltd., a health care financial advisory firm. Mr. Boxer
served as Executive Vice President and Chief Financial Officer
of Mariner Health Care, Inc., a skilled nursing company, from
2003 until its sale in 2004. Prior to Mariner, Mr. Boxer was
Senior Vice President and Chief Financial Officer at Watson
Pharmaceuticals, Inc.
|
Michael A. Colliflower
|
|
Executive Vice President and General Counsel
|
|
|
53
|
|
|
Mr. Colliflower was named as Executive Vice President and
General Counsel effective August 30, 2006. He also served as
the Companys Chief Compliance Officer until March 14,
2007. Mr. Colliflower joined HealthMarkets in July 2005 as
Senior Vice President and General Counsel-Insurance Operations.
He currently serves as a Director, Executive Vice President and
General Counsel of the Companys insurance subsidiaries.
Prior to joining the Company, Mr. Colliflower served from 2002
to 2005 as Senior Vice President and Chief Insurance Counsel for
the insurance subsidiaries of Universal American Financial Corp.
From 1996 until 2002, Mr. Colliflower held various management
positions at the Conseco Companies, including Senior Vice
President Legal and Chief Compliance Officer.
|
Nancy G. Cocozza
|
|
Executive Vice President
|
|
|
47
|
|
|
Ms. Cocozza joined the Company on March 30, 2007 as Executive
Vice President. Ms. Cocozza serves as President of the
Companys Medicare Division. Ms. Cocozza has served as
Executive Vice President of the Companys insurance
subsidiaries since May 2007. Prior to joining the Company, Ms.
Cocozza served as Senior Vice President - Government Programs
for Coventry Health Care from 2001 until 2006.
|
16
|
|
|
|
|
|
|
|
|
Name of Officer
|
|
Principal Position
|
|
Age
|
|
|
Business Experience During Past Five Years
|
|
Asher M. Schoor
|
|
Senior Vice President
|
|
|
36
|
|
|
Mr. Schoor has served as a Senior Vice President since May
2006. Mr. Schoor has served as Executive Vice President of the
Companys insurance subsidiaries since May 2007. Prior to
joining the Company, Mr. Schoor was a consultant at McKinsey
& Company, where he worked from 2001 until 2006.
|
The following factors could impact our business and financial
prospects:
We may
lose business to competitors offering competitive products at
lower prices.
We compete, and will continue to compete, for customers and
distributors with many insurance companies and other financial
services companies. We compete not only for business and
individual customers, employer and other group customers, but
also for agents and distribution relationships. Our competitors
may offer a broader array of products than we do, have a greater
diversity of distribution resources, have better brand
recognition, have more competitive pricing or have higher
financial strength or claims paying ratings. Competitors with
sizable market share or provider-owned plans may be able to
obtain favorable financial arrangements from healthcare
providers that are not available to us.
Failure
to accurately estimate medical claims and healthcare costs may
have a significant impact on our business and results of
operation.
If we are unable to accurately estimate medical claims and
control healthcare costs, our results of operations may be
materially and adversely affected. We estimate the cost of
future medical claims and other expenses using actuarial methods
based upon historical data, medical inflation, product mix,
seasonality, utilization of healthcare services and other
relevant factors. We establish premiums based on these methods.
The premiums we charge our customers generally are fixed for
six-month or one-year periods, and costs we incur in excess of
our medical claim projections generally are not recovered in the
contract year through higher premiums.
Failure
of our insurance subsidiaries to maintain their current
insurance ratings could materially adversely affect our business
and results of operations.
Our principal insurance subsidiaries are currently rated by
A.M. Best, Fitch and S&P. If our insurance
subsidiaries are not able to maintain their current rating by
A.M. Best, Fitch
and/or
S&P, our results of operations could be materially
adversely affected. Decreases in operating performance and other
financial measures may result in a downward adjustment of the
rating of our insurance subsidiaries assigned by A.M. Best,
Fitch or S&P. Other factors beyond our control, such as
general downward economic cycles and changes implemented by the
rating agencies, including changes in the criteria for the
underwriting or the capital adequacy model, may also result in a
decrease in the rating. A downward adjustment in rating by
A.M. Best, Fitch
and/or
S&P of our insurance subsidiaries could have a material
adverse effect on our business and results of operations.
Changes
in our relationship with membership associations that make
available to their members our health insurance products and/or
changes in the laws and regulations governing so-called
association group insurance could materially
adversely affect our business and results of
operations.
As is the case with many of our competitors in the self-employed
market, a substantial portion of our health insurance products
are issued to members of various independent membership
associations that act as the master policyholder for such
products. The two principal membership associations in the
self-employed market that make available to their members our
health insurance products are the National Association for the
Self-Employed and the Alliance for Affordable Services. The
associations provide their members access to a number of
benefits and products, including health insurance underwritten
by us. Subject to applicable state law, individuals generally
may not obtain insurance under an associations master
policy unless they are also members of the association. The
17
agreements with these associations requiring the associations to
continue as the master policyholder for our policies and to make
our products available to their respective members are
terminable by us or the association upon not less than one
years advance notice to the other party.
MEGAs UGA agents and Mid-Wests Cornerstone America
agents also act as field service representatives (FSRs) for the
associations. In this capacity, the FSRs enroll new association
members and provide membership retention services. For such
services, we and the FSRs receive compensation. One of our
subsidiaries, HealthMarkets Lead Marketing Group, Inc., serves
as our direct marketing group and generates new membership sales
prospect leads for both UGA and Cornerstone for use by the FSRs.
HealthMarkets Lead Marketing Group also provides video and print
services to the associations. In addition to health insurance
premiums derived from the sale of health insurance, we receive
fee income from the associations, including fees associated with
enrollment and member retention services, fees for association
membership marketing and administrative services and fees for
certain association member benefits.
While we believe that we are providing association group
coverage in full compliance with applicable law, changes in our
relationship with the membership associations
and/or
changes in the laws and regulations governing so-called
association group insurance, particularly changes
that would subject the issuance of policies to prior premium
rate approval
and/or
require the issuance of policies on a guaranteed
issue basis, could have a material adverse impact on our
financial condition, results of operations
and/or
business.
Our
domestic insurance subsidiaries are currently the subject of a
multi-state market conduct examination, and an adverse finding
or outcome from that examination could adversely affect our
results of operations and financial condition.
In March 2005, we received notification that the Market Analysis
Working Group of the NAIC had chosen the states of Washington
and Alaska to lead a multi-state market conduct examination of
our principal insurance subsidiaries, The MEGA Life and Health
Insurance Company, Mid-West National Life Insurance Company of
Tennessee and The Chesapeake Life Insurance Company. The
examiners completed the onsite phases of the examination and
issued a final examination report on December 20, 2007.
See Note 17 of Notes to Financial Statements.
The Companys insurance subsidiaries are subject to various
other pending market conduct and other regulatory examinations,
inquiries or proceedings arising in the ordinary course of
business. State insurance regulatory agencies have authority to
levy significant fines and penalties and require remedial action
resulting from findings made during the course of such matters.
Historically, our insurance subsidiaries have from time to time
been subject to such fines and penalties, none of which
individually or in the aggregate have had a material adverse
effect on our results of operations or financial condition.
However, the multi-state examination and other regulatory
examinations, inquiries or proceedings could result in, among
other things, changes in business practices that require the
Company to incur substantial costs. Such results, singly or in
combination, could injure our reputation, cause negative
publicity, adversely affect our debt and financial strength
ratings, place us at a competitive disadvantage in marketing or
administering our products, or impair our ability to sell or
retain insurance policies, thereby adversely affecting our
business, and potentially materially adversely affecting the
results of operations in a period, depending on the results of
operations for the particular period. Determination by
regulatory authorities that we have engaged in improper conduct
could also adversely affect our defense of various lawsuits.
Negative
publicity regarding our business practices and about the health
insurance industry in general may harm our business and
adversely affect our results of operations and financial
condition.
The health and life insurance industry and related products and
services we provide attracts negative publicity from consumer
advocate groups and the media. Negative publicity regarding the
industry generally or our Company in particular may result in
increased regulation and legislative scrutiny as well as
increased litigation, which may further increase our costs of
doing business and adversely affect our profitability by
impeding our ability to market our products and services,
requiring us to change our products or services or increasing
the regulatory burdens under which we operate.
18
Our
failure to secure and enhance cost-effective healthcare provider
network contracts may result in a loss of insureds and/or higher
medical costs and adversely affect our results of
operations.
Our results of operations and competitive position could be
adversely affected by our inability to enter into or maintain
satisfactory relationships with networks of hospitals,
physicians, dentists, pharmacies and other healthcare providers.
The failure to secure cost-effective healthcare provider network
contracts or the inability to maintain rental access
to health care provider networks may result in a loss of
insureds or higher medical costs. In addition, the inability to
contract with provider networks, the inability to terminate
contracts with existing provider networks and enter into
arrangements with new provider networks to serve the same
market,
and/or the
inability of providers to provide adequate care, could adversely
affect our results of operations.
HealthMarkets
inability to obtain funds from its insurance subsidiaries may
cause it to experience reduced cash flow, which could affect the
Companys ability to pay its obligations to creditors as
they become due.
We are a holding company, and our principal assets are our
investments in our separate operating subsidiaries, including
our regulated insurance subsidiaries. Our ability to fund our
cash requirements is largely dependent upon our ability to
access cash from our subsidiaries. Our insurance subsidiaries
are subject to regulations that limit their ability to transfer
funds to us. We have a significant amount of debt outstanding
that contains restrictive covenants. If we are unable to obtain
funds from our insurance subsidiaries, we will experience
reduced cash flow, which could affect our ability to pay our
obligations to creditors as they become due.
A
failure of our information systems to provide timely and
accurate information could adversely affect our business and
results of operations.
Information processing is critical to our business, and a
failure of our information systems to provide timely and
accurate information could adversely affect our business and
results of operations. The failure to maintain an effective and
efficient information system or disruptions in our information
system could cause disruptions in our business operations,
including (a) failure to comply with prompt pay laws;
(b) loss of existing insureds; (c) difficulty in
attracting new insureds; (d) disputes with insureds,
providers and agents; (e) regulatory problems;
(f) increases in administrative expenses; and
(g) other adverse consequences.
Changes
in government regulation could increase the costs of compliance
or cause us to discontinue marketing our products in certain
states.
We conduct business in a heavily regulated industry, and changes
in government regulation could increase the costs of compliance
or cause us to discontinue marketing our products in certain
states. Some of the federal and state regulations promulgated
under the Health Insurance Portability and Accountability Act of
1996, or HIPAA, for example required us to implement changes in
our programs and systems in order to maintain compliance. We
have incurred significant expenditures as a result of HIPAA
regulations and expect to continue to incur expenditures as
various regulations become effective.
We may
not have enough statutory capital and surplus to continue to
write business.
Our continued ability to write business is dependent on
maintaining adequate levels of statutory capital and surplus to
support the policies we write. Our new business writing
typically results in net losses on a statutory basis during the
early years of a policy. The resulting reduction in statutory
surplus, or surplus strain, limits our ability to seek new
business due to statutory restrictions on premium to surplus
ratios and statutory surplus requirements. If we cannot generate
sufficient statutory surplus to maintain minimum statutory
requirements through increased statutory profitability,
reinsurance or other capital generating alternatives, we will be
limited in our ability to realize additional premium revenue
from new business writing, which could have a material adverse
effect on our financial condition and results of operations or,
in the event that our statutory surplus is not sufficient to
meet minimum premium to surplus and risk-based capital ratios in
any state, we could be prohibited from writing new policies in
such state.
19
Our
reserves for current and future claims may be inadequate and any
increase to such reserves could have a material adverse effect
on our financial condition and results of
operations.
We calculate and maintain reserves for current and future claims
using assumptions about numerous variables, including our
estimate of the probability of a policyholder making a claim,
the severity and duration of such claim, the mortality rate of
our policyholders, the persistency or renewal of our policies in
force and the amount of interest we expect to earn from the
investment of premiums. The adequacy of our reserves depends on
the accuracy of our assumptions. We cannot assure you that our
actual experience will not differ from the assumptions used in
the establishment of reserves. Any variance from these
assumptions could have a material adverse effect on our
financial condition
and/or
results of operations.
Litigation
may result in financial losses or harm our reputation and may
divert management resources.
Current and future litigation may result in financial losses,
harm our reputation and require the dedication of significant
management resources. We are regularly involved in litigation.
The litigation naming us as a defendant ordinarily involves our
activities as an insurer. In recent years, many insurance
companies, including us, have been named as defendants in class
actions relating to market conduct or sales practices.
For our general claim litigation, we maintain reserves based on
experience to satisfy judgments and settlements in the normal
course. Management expects that the ultimate liability, if any,
with respect to general claim litigation, after consideration of
the reserves maintained, will not be material to the
consolidated financial condition of the Company. Nevertheless,
given the inherent unpredictability of litigation, it is
possible that an adverse outcome in certain claim litigation
involving punitive damages could, from time to time, have a
material adverse effect on our consolidated results of
operations in a period, depending on the results of our
operations for the particular period.
If we
fail to comply with extensive state and federal regulations, we
will be subject to penalties, which may include fines and
suspension and which may adversely affect our results of
operations and financial condition.
We are subject to extensive governmental regulation and
supervision. Most insurance regulations are designed to protect
the interests of policyholders rather than stockholders and
other investors. This regulation, generally administered by a
department of insurance in each state in which we do business,
relates to, among other things:
|
|
|
|
|
approval of policy forms and premium rates;
|
|
|
|
standards of solvency, including risk-based capital
measurements, which are a measure developed by the National
Association of Insurance Commissioners and used by state
insurance regulators to identify insurance companies that
potentially are inadequately capitalized;
|
|
|
|
licensing of insurers and their agents;
|
|
|
|
restrictions on the nature, quality and concentration of
investments;
|
|
|
|
restrictions on transactions between insurance companies and
their affiliates;
|
|
|
|
restrictions on the size of risks insurable under a single
policy;
|
|
|
|
requiring deposits for the benefit of policyholders;
|
|
|
|
requiring certain methods of accounting;
|
|
|
|
prescribing the form and content of records of financial
condition required to be filed; and
|
|
|
|
requiring reserves for losses and other purposes.
|
State insurance departments also conduct periodic examinations
of the affairs of insurance companies and require the filing of
annual and other reports relating to the financial condition of
insurance companies, holding company issues and other matters.
20
There is also substantial federal regulation of our business.
Laws and regulations adopted by the federal government,
including the Sarbanes-Oxley Act of 2002, Medicare Modernization
Act of 2003, the Gramm-Leach-Bliley Act, HIPAA, the USA PATRIOT
Act and Do Not Call regulations, establish administrative and
compliance requirements applicable to the Company.
Our business depends on compliance with applicable laws and
regulations and our ability to maintain valid licenses and
approvals for our operations. Regulatory authorities have broad
discretion to grant, renew or revoke licenses and approvals.
Regulatory authorities may deny or revoke licenses for various
reasons, including the violation of regulations. In some
instances, we follow practices based on our interpretations of
regulations, or those that we believe to be generally followed
by the industry, which may be different from the requirements or
interpretations of regulatory authorities. If we do not have the
requisite licenses and approvals and do not comply with
applicable regulatory requirements, the insurance regulatory
authorities could preclude or temporarily suspend us from
carrying on some or all of our activities or otherwise penalize
us. That type of action could have a material adverse effect on
our business. Our failure to comply with new or existing
government regulation could subject us to significant fines and
penalties. Our efforts to measure, monitor and adjust our
business practices to comply with current laws are ongoing.
Failure to comply with enacted regulations could result in
significant fines, penalties or the loss of one or more of our
licenses. As governmental regulation changes, the costs of
compliance may cause us to change our operations significantly,
or adversely impact the healthcare provider networks with which
we do business, which may adversely affect our business and
results of operations. In addition, changes in the level of
regulation of the insurance industry (whether federal, state or
foreign), or changes in laws or regulations themselves or
interpretations by regulatory authorities, could have a material
adverse effect on our business.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
None
We currently own and occupy our executive offices located at
9151 Boulevard 26, North Richland Hills, Texas
76180-5605
and 8825 Bud Jensen Drive, North Richland Hills, Texas
76180-5605
comprising in the aggregate approximately 281,000 and
30,000 square feet, respectively, of office and warehouse
space. In addition, we lease office space at various locations.
|
|
Item 3.
|
Legal
Proceedings
|
See Note 17 of Notes to Financial Statements, the
terms of which are incorporated by reference herein.
|
|
Item 4.
|
Submissions
of Matters to a Vote of Security Holders
|
None.
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
The Companys shares were traded on the New York Stock
Exchange (NYSE) under the symbol UCI
until April 5, 2006, the date of the Merger. The table
below sets forth on a per share basis, for the periods
indicated, the high and low closing sales prices of the Common
Stock on the NYSE.
21
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
1st Quarter
|
|
$
|
36.99
|
|
|
$
|
35.79
|
|
2nd Quarter
|
|
|
37.00
|
|
|
|
36.97
|
|
3rd Quarter
|
|
|
N/A
|
|
|
|
N/A
|
|
4th Quarter
|
|
|
N/A
|
|
|
|
N/A
|
|
Fiscal Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
1st Quarter
|
|
|
N/A
|
|
|
|
N/A
|
|
2nd Quarter
|
|
|
N/A
|
|
|
|
N/A
|
|
3rd Quarter
|
|
|
N/A
|
|
|
|
N/A
|
|
4th Quarter
|
|
|
N/A
|
|
|
|
N/A
|
|
Upon completion of the Merger on April 5, 2006, between the
Company and affiliates of The Blackstone Group, Goldman Sachs
Capital Partners and DLJ Merchant Banking Partners, shares of
the Companys Common Stock were delisted from trading on
the New York Stock Exchange. Subsequent to such delisting, there
has been no established public trading market in our shares.
As of March 6, 2008, there were approximately 30 holders of
record of
Class A-1
Common Stock and 1,371 holders of record of
Class A-2
Common Stock.
On May 3, 2007, the Companys Board of Directors
declared an extraordinary cash dividend in the amount of $10.51
per share for
Class A-1
and
Class A-2
common stock to holders of record as of close of business on
May 9, 2007, payable on May 14, 2007. In connection
with the extraordinary cash dividend, the Company paid dividends
to stockholders in the aggregate amount of $317.0 million.
The Company did not declare or pay dividends on shares of its
common stock in 2006.
In addition, dividends paid by the Companys domestic
insurance subsidiaries to the Company out of earned surplus in
any year that are in excess of limits set by the laws of the
state of domicile require prior approval of state regulatory
authorities in that state.
During the year ended December 31, 2007, the Company issued
an aggregate of 33,000 unregistered shares of its
Class A-1
common stock for an aggregate consideration of
$1.5 million. During the year ended December 31, 2006,
the Company issued an aggregate of 74,365 unregistered shares of
its
Class A-1
common stock for an aggregate consideration of
$2.8 million. All such sales of securities were made to
certain newly-appointed executive officers and directors of the
Company and in reliance upon the exemption from registration
provided by Section 4(2) of the Securities Act of 1933, as
amended (and/or Regulation D promulgated thereunder) for
transactions by an issuer not involving a public offering. The
proceeds of such sales were used for general corporate purposes.
Issuer
Purchases of Equity Securities
Set forth below is a summary of the Companys purchases of
shares of HealthMarkets, Inc.
Class A-1
common stock during each of the months in the twelve-month
period ended December 31, 2007.
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuer Purchase of Equity Securities Class A-1
|
|
|
|
|
|
|
|
|
|
Total Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Purchased as
|
|
|
Maximum Number of
|
|
|
|
|
|
|
|
|
|
Part of Publicly
|
|
|
Shares That May Yet
|
|
|
|
Total Number of
|
|
|
Average Price Paid
|
|
|
Announced Plans or
|
|
|
Be Purchased Under
|
|
Period
|
|
Shares Purchased(1)
|
|
|
per Share ($)
|
|
|
Programs
|
|
|
The Plan or Program
|
|
|
01/1/07-01/31/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/1/07-02/28/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03/1/07-03/31/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04/1/07-04/30/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05/1/07-05/31/07
|
|
|
30,464
|
|
|
|
40.22
|
|
|
|
|
|
|
|
|
|
06/1/07-06/30/07
|
|
|
34,586
|
|
|
|
40.22
|
|
|
|
|
|
|
|
|
|
07/1/07-07/31/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08/1/07-08/31/07
|
|
|
35,590
|
|
|
|
40.97
|
|
|
|
|
|
|
|
|
|
09/1/07-09/30/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/1/07-10/31/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/1/07-11/30/07
|
|
|
11,006
|
|
|
|
42.03
|
|
|
|
|
|
|
|
|
|
12/1/07-12/31/07
|
|
|
14,360
|
|
|
|
42.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
|
|
126,006
|
|
|
|
40.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The number of shares purchased other than through a publicly
announced plan or program includes 126,006
Class A-1 shares
purchased from current or former officers of the Company. These
shares were reflected as treasury shares on the Companys
Consolidated Balance Sheet at the time of purchase. |
Set forth below is a summary of the Companys purchases of
shares of HealthMarkets, Inc.
Class A-2
common stock during each of the months in the twelve-month
period ended December 31, 2007, pursuant to the terms of
the Companys agent stock accumulation plans established
for the benefit of the Companys agents (See
Note 14 of the Notes to Financial Statements):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuer Purchase of Equity Securities Class A-2
|
|
|
|
|
|
|
|
|
|
Total Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Purchased as
|
|
|
Maximum Number of
|
|
|
|
|
|
|
|
|
|
Part of Publicly
|
|
|
Shares That May Yet
|
|
|
|
Total Number of
|
|
|
Average Price Paid
|
|
|
Announced Plans or
|
|
|
Be Purchased Under
|
|
Period
|
|
Shares Purchased(1)
|
|
|
per Share ($)
|
|
|
Programs
|
|
|
The Plan or Program
|
|
|
01/1/07-01/31/07
|
|
|
952
|
|
|
|
39.66
|
|
|
|
|
|
|
|
|
|
02/1/07-02/28/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03/1/07-03/31/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04/1/07-04/30/07
|
|
|
218,247
|
|
|
|
49.98
|
|
|
|
|
|
|
|
|
|
05/1/07-05/31/07
|
|
|
118,311
|
|
|
|
45.54
|
|
|
|
|
|
|
|
|
|
06/1/07-06/30/07
|
|
|
59,526
|
|
|
|
40.22
|
|
|
|
|
|
|
|
|
|
07/1/07-07/31/07
|
|
|
39,332
|
|
|
|
40.22
|
|
|
|
|
|
|
|
|
|
08/1/07-08/31/07
|
|
|
95,101
|
|
|
|
40.97
|
|
|
|
|
|
|
|
|
|
09/1/07-09/30/07
|
|
|
49,743
|
|
|
|
40.97
|
|
|
|
|
|
|
|
|
|
10/1/07-10/31/07
|
|
|
37,263
|
|
|
|
40.53
|
|
|
|
|
|
|
|
|
|
11/1/07-11/30/07
|
|
|
138,257
|
|
|
|
42.03
|
|
|
|
|
|
|
|
|
|
12/1/07-12/31/07
|
|
|
67,431
|
|
|
|
42.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
|
|
824,163
|
|
|
|
44.16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The number of shares purchased other than through a publicly
announced plan or program includes 820,090
Class A-2 shares
purchased from the stock accumulation plans established for the
benefit of the Companys agents |
23
|
|
|
|
|
and 4,073
Class A-2 shares
purchased from former participants in the stock accumulation
plans. These shares were reflected as treasury shares on the
Companys Consolidated Balance Sheet at the time of the
purchase. |
Securities
Authorized for Issuance under Equity Compensation
Plans
The following table sets forth certain information with respect
to shares of the Companys
Class A-1
and
Class A-2
common stock that may be issued under HealthMarkets equity
compensation plans as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Remaining Available
|
|
|
|
|
|
|
Weighted-Average
|
|
|
for Future Issuance
|
|
|
|
Number of Securities to
|
|
|
Exercise Price
|
|
|
Under Equity
|
|
|
|
be Issued Upon Exercise
|
|
|
of Outstanding
|
|
|
Compensation Plans
|
|
|
|
of Outstanding Options,
|
|
|
Options, Warrants
|
|
|
(Excluding Securities
|
|
|
|
Warrants and Rights
|
|
|
and Rights
|
|
|
Reflected in Column (a))
|
|
Plan Category
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
Equity compensation plans approved by security holders
|
|
|
1,437,202
|
(1)
|
|
$
|
30.29
|
|
|
|
2,592,195
|
(2)
|
Equity compensation plans not approved by security holders(5)
|
|
|
1,527,662
|
(3)
|
|
$
|
0.00
|
|
|
|
4,034,261
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,964,864
|
|
|
$
|
14.68
|
|
|
|
6,626,456
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes 53,473 stock options exercisable at a weighted average
exercise price of $7.34 under the UICI 1987 Stock Option Plan.
Also includes 1,383,729 stock options granted at a weighted
average exercise price of $31.18 under the HealthMarkets 2006
Management Stock Option Plan. |
|
(2) |
|
Includes securities available for future issuance as follows:
UICI 1987 Stock Option Plan, 2,534,857 shares;
HealthMarkets 2006 Management Stock Option Plan,
57,338 shares. |
|
(3) |
|
Includes (a) 969,045 shares issuable upon vesting of
matching credits granted to participants under the Agency
Matching Total Ownership Plan established for the benefit of
agents associated with UGA Association Field
Services and (b) 558,617 shares issuable upon vesting
of matching credits granted to participants under the Matching
Agency Contribution Plan established for the benefit of agents
associated with Cornerstone America. |
|
(4) |
|
Includes securities available for future issuance as follows:
Agents Matching Total Ownership Plan,
1,737,984 shares; Matching Agency Contribution Plan,
2,296,277 shares. |
|
(5) |
|
Effective April 5, 2006, the Agency Matching Total
Ownership Plan I and the Agents Matching Total Ownership
Plan II (which were established for the benefit of agents
associated with UGA Association Field Services) were
consolidated, amended and restated and thereafter renamed the
HealthMarkets Agency Matching Total Ownership Plan. Also
effective April 5, 2006, the Matching Agency Contribution
Plan I and the Matching Agency Contribution Plan II (which
were established for the benefit of agents associated with
Cornerstone America) were consolidated, amended and restated and
thereafter renamed the HealthMarkets Matching Agency
Contribution Plan. The amended and restated plans were not
approved by security holders. See Note 14 of Notes
to Financial Statements for additional information regarding the
Agency Matching Total Ownership Plan and the Matching Agency
Contribution Plan. |
24
|
|
Item 6.
|
Selected
Financial Data
|
The following selected consolidated financial data as of and for
each of the five years in the period ended December 31,
2007 has been derived from the audited Consolidated Financial
Statements of the Company. The following data should be read in
conjunction with the Consolidated Financial Statements and the
notes thereto and Managements Discussion and Analysis
of Financial Condition and Results of Operations included
herein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
|
(In thousands, except per share amounts and operating
ratios)
|
|
|
Income Statement Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues from continuing operations
|
|
$
|
1,595,267
|
|
|
$
|
2,146,571
|
|
|
$
|
2,121,218
|
|
|
$
|
2,069,109
|
|
|
$
|
1,825,162
|
|
Income from continuing operations before income taxes
|
|
|
119,054
|
|
|
|
352,298
|
|
|
|
313,150
|
|
|
|
221,149
|
|
|
|
131,916
|
|
Income from continuing operations
|
|
|
69,370
|
|
|
|
216,568
|
|
|
|
202,970
|
|
|
|
145,881
|
|
|
|
87,324
|
|
Income (loss) from discontinued operations
|
|
|
789
|
|
|
|
21,170
|
|
|
|
531
|
|
|
|
15,677
|
|
|
|
(72,990
|
)
|
Net income
|
|
|
70,159
|
|
|
$
|
237,738
|
|
|
$
|
203,501
|
|
|
$
|
161,558
|
|
|
$
|
14,334
|
|
Per Share Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share from continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share
|
|
$
|
2.28
|
|
|
$
|
6.19
|
|
|
$
|
4.40
|
|
|
$
|
3.16
|
|
|
$
|
1.88
|
|
Diluted earnings per common share
|
|
$
|
2.21
|
|
|
$
|
6.07
|
|
|
$
|
4.31
|
|
|
$
|
3.07
|
|
|
$
|
1.82
|
|
Earnings (loss) per share from discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per common share
|
|
$
|
0.03
|
|
|
$
|
0.61
|
|
|
$
|
0.01
|
|
|
$
|
0.34
|
|
|
$
|
(1.57
|
)
|
Diluted earnings (loss) per common share
|
|
$
|
0.03
|
|
|
$
|
0.59
|
|
|
$
|
0.01
|
|
|
$
|
0.33
|
|
|
$
|
(1.52
|
)
|
Earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share
|
|
$
|
2.31
|
|
|
$
|
6.80
|
|
|
$
|
4.41
|
|
|
$
|
3.50
|
|
|
$
|
0.31
|
|
Diluted earnings per common share
|
|
$
|
2.24
|
|
|
$
|
6.66
|
|
|
$
|
4.32
|
|
|
$
|
3.40
|
|
|
$
|
0.30
|
|
Operating Ratios:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Ratios:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio
|
|
|
57
|
%
|
|
|
57
|
%
|
|
|
57
|
%
|
|
|
61
|
%
|
|
|
65
|
%
|
Expense ratio
|
|
|
38
|
%
|
|
|
32
|
%
|
|
|
31
|
%
|
|
|
33
|
%
|
|
|
34
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined health ratio
|
|
|
95
|
%
|
|
|
89
|
%
|
|
|
88
|
%
|
|
|
94
|
%
|
|
|
99
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments, cash and cash overdraft
|
|
$
|
1,495,910
|
|
|
$
|
1,834,600
|
|
|
$
|
1,774,188
|
|
|
$
|
1,710,589
|
|
|
$
|
1,579,131
|
|
Total assets
|
|
|
2,155,582
|
|
|
|
2,594,829
|
|
|
|
2,371,530
|
|
|
|
2,345,658
|
|
|
|
2,126,959
|
|
Total policy liabilities
|
|
|
1,006,006
|
|
|
|
1,135,174
|
|
|
|
1,174,264
|
|
|
|
1,258,671
|
|
|
|
1,184,984
|
|
Total debt
|
|
|
481,070
|
|
|
|
556,070
|
|
|
|
15,470
|
|
|
|
15,470
|
|
|
|
18,951
|
|
Student loan credit facilities
|
|
|
97,400
|
|
|
|
118,950
|
|
|
|
130,900
|
|
|
|
150,000
|
|
|
|
150,000
|
|
Stockholders equity
|
|
|
306,260
|
|
|
|
524,385
|
|
|
|
871,081
|
|
|
|
714,145
|
|
|
|
587,568
|
|
Stockholders equity per share
|
|
$
|
10.03
|
|
|
$
|
17.53
|
|
|
$
|
18.88
|
|
|
$
|
15.62
|
|
|
$
|
12.68
|
|
Loss ratio. The loss ratio is defined as
benefits, claims and settlement expenses as a percentage of
earned premiums (excludes Life Insurance Division).
25
Expense ratio. The expense ratio is defined as
underwriting, policy acquisition costs and insurance expenses as
a percentage of earned premiums (excludes Life Insurance
Division).
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
Overview
We offer insurance (primarily health and life) to niche consumer
and institutional markets. Through our subsidiaries we issue
primarily health insurance policies, covering individuals and
families, to the self-employed, association groups and small
businesses, and life insurance policies to markets that we
believe are underserved. We believe we have one of the largest
direct selling organizations in the health insurance field, with
approximately 1,900 independent writing agents per week in the
field selling health insurance to the self employed market in
44 states.
Our revenues consist primarily of premiums derived from sales of
our indemnity, PPO and voluntary employer group health plans and
from life insurance policies. Premiums on health insurance
contracts are recognized as earned over the period of coverage
on a pro rata basis. Premiums on traditional life insurance are
recognized as revenue when due. Revenues also include investment
income derived from our investment portfolio and other income,
which consists primarily of income derived by the Self-Employed
Agency Division from ancillary services and membership marketing
and administrative services provided to the membership
associations that make available to their members the
Companys health insurance products.
The table below sets forth premium by insurance division for
each of the three most recent fiscal years (excluding for all
periods presented premium associated with our former Star HRG
Division and Student Insurance Division, which we disposed of in
July and December 2006, respectively):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Premium:
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
1,282,249
|
|
|
$
|
1,330,298
|
|
|
$
|
1,394,644
|
|
Life Insurance Division
|
|
|
69,949
|
|
|
|
65,716
|
|
|
|
61,936
|
|
Other Insurance
|
|
|
29,995
|
|
|
|
33,873
|
|
|
|
33,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total premium
|
|
$
|
1,382,193
|
|
|
$
|
1,429,887
|
|
|
$
|
1,490,436
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Companys expenses consist primarily of insurance
claims expense and expenses associated with the underwriting and
acquisition of insurance policies. Claims expenses consist
primarily of payments to physicians, hospitals and other
healthcare providers under health policies and include an
estimated amount for incurred but not reported and unpaid
claims. Underwriting, policy acquisition costs and insurance
expenses consist of direct expenses incurred across all
insurance lines in connection with issuance, maintenance and
administration of in-force insurance policies, including
amortization of deferred policy acquisition costs, commissions
paid to agents, administrative expenses and premium taxes. The
Company also incurs other direct expenses in connection with
generating income derived by the Self-Employed Agency Division
from ancillary services and membership marketing and
administrative services provided to the membership associations
that make available to their members the Companys health
insurance products.
The Company establishes liabilities for benefit claims that have
been reported but not paid and claims that have been incurred
but not reported under health and life insurance contracts.
These claim liabilities are developed using actuarial principles
and assumptions. See discussion below under the caption
Critical Accounting Policies and Estimates
Claims Liabilities and Note 6 of
Notes to Financial Statements.
In connection with various stock-based compensation plans that
we maintain for the benefit of our independent agents, we record
non-cash variable stock-based compensation expense in amounts
that depend and fluctuate based upon the fair value (as
determined by the Companys Board of Directors since the
Merger) of the Companys common stock. See
discussion below under the caption Variable
Stock-Based Compensation and Note 14 of Notes to
Financial Statements.
26
The Companys business segments for financial reporting
purposes include (i) the Insurance segment, which includes
the businesses of the Companys Self-Employed Agency
Division, the Life Insurance Division and Other Insurance;
(ii) the Other Key Factors segment, which includes
investment income not otherwise allocated to the Insurance
segment, realized gains and losses on sale of investments,
interest expense on corporate debt, variable stock-based
compensation, pre-operational costs associated with the
Companys Medicare Advantage PFFS market initiative,
general expenses relating to corporate operations and in 2006,
the incremental costs associated with the acquisition of the
Company by a group of private equity investors, and
(iii) the Disposed Operations segment, which includes the
Companys former Star HRG Division and former Student
Insurance Division.
2006
Sales of Student Insurance Division and Star HRG
Division
In July 2006 and December 2006, in two separate transactions, we
sold the assets comprising our former Star HRG Division and our
former Student Insurance Division. In connection with these
sales, we recorded an aggregate pre-tax gain in the amount of
$201.7 million, of which $101.5 million was
attributable to the Star HRG transaction and $100.2 million
was attributable to the Student Insurance transaction.
As part of the sale transactions, insurance subsidiaries of the
Company entered into 100% coinsurance arrangements with each of
the purchasers, pursuant to which (a) the purchasers agreed
to assume liability for all future claims associated policies in
force as of the respective closing dates and (b) the
Companys insurance subsidiaries transferred to the
purchasers cash in an amount equal to the actuarial estimate of
those future claims. While under the terms of the coinsurance
agreements the Companys insurance subsidiaries have ceded
liability for all future claims made on the insurance policies
in force at the closing date, the insurance subsidiaries remain
primarily liable on those policies. Accordingly, at
December 31, 2006 and 2007 the Company continues to report
the policy liabilities ceded to and assumed by the purchasers
under the coinsurance agreements as Policy
liabilities, with a corresponding Reinsurance
receivable asset on its Consolidated Balance Sheet. In
addition, the Company will continue to report in future periods
the residual results of operations of these businesses
(anticipated to consist solely of residual wind-down expenses
and any
true-up
provision associated with the sales, primarily of the Student
Insurance Division) in continuing operations and classified to
the Companys Disposed Operations business segment.
See Note 2 of Notes to Financial Statements for
additional information regarding the terms of the sales of the
Star HRG Division and Student Insurance Division assets.
2006
Change in Accounting Policy
Effective December 31, 2006, the Company changed its
accounting policy with respect to the amortization of a portion
of deferred acquisition costs associated with commissions paid
to agents.
The Company formerly capitalized commissions and premium taxes
associated with its SEA Division business (classified as
deferred acquisition costs (DAC)) and
amortized all of these costs over the period (and in proportion
to the amount) that the associated unearned premium was earned.
The Company utilized this accounting methodology in preparing
its reported 2006 interim financial statements.
Following adoption of SEC Staff Accounting
Bulletin No. 108 (SAB 108), Considering the
Effects of Prior Year Misstatements when Quantifying
Misstatements in the Current Year Financial Statements, the
Company performed an analysis to determine the appropriate
portion of commissions to be deferred over the lives of the
underlying policies. Generally, first year and second year
commission rates are higher than the renewal year commission
rates, and the Company has determined that the preferred
approach is to capitalize the excess commissions associated with
those earlier years and amortize the capitalized costs ratably
over the estimated life of the policy. Accordingly, effective
January 1, 2006, the Company has elected to change its
accounting methodology by amortizing the first and second year
excess commissions ratably over the average life of the policy
which approximates a two year period .
The Company has elected to utilize the one time special
transition provisions of SAB 108 and recorded an adjustment
to retained earnings effective January 1, 2006 to reflect
this change in accounting policy with respect to the
capitalization and amortization of deferred acquisition costs
associated with excess first and second year
27
commissions. As of January 1, 2006, the change in
accounting policy resulted in an increase in the Companys
capitalized DAC of $77.6 million, a related increase to its
deferred tax liability by $27.1 million, and a net increase
to shareholders equity of $50.5 million. The adoption
of this new accounting policy had the effect of increasing
reported underwriting, policy acquisition costs and insurance
expenses (classified to its SEA Division) in 2006 by
$15.5 million and, correspondingly, reducing after-tax net
income by $10.1 million.
Results
of Operations
The table below sets forth certain summary information about our
consolidated operating results for each of the three most recent
fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Premiums
|
|
$
|
1,311,733
|
|
|
|
(22
|
)%
|
|
$
|
1,671,571
|
|
|
|
(10
|
)%
|
|
$
|
1,855,969
|
|
Life premiums and other considerations
|
|
|
70,460
|
|
|
|
7
|
%
|
|
|
65,675
|
|
|
|
7
|
%
|
|
|
61,565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,382,193
|
|
|
|
(20
|
)%
|
|
|
1,737,246
|
|
|
|
(9
|
)%
|
|
|
1,917,534
|
|
Investment income
|
|
|
102,984
|
|
|
|
(1
|
)%
|
|
|
104,147
|
|
|
|
7
|
%
|
|
|
97,788
|
|
Other income
|
|
|
106,615
|
|
|
|
2
|
%
|
|
|
104,634
|
|
|
|
(2
|
)%
|
|
|
106,656
|
|
Gains (losses) on sale of investments
|
|
|
3,475
|
|
|
|
(98
|
)%
|
|
|
200,544
|
|
|
|
N/A
|
|
|
|
(760
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
1,595,267
|
|
|
|
(26
|
)%
|
|
|
2,146,571
|
|
|
|
1
|
%
|
|
|
2,121,218
|
|
Benefits and Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits, claims, and settlement expenses
|
|
|
801,783
|
|
|
|
(20
|
)%
|
|
|
996,617
|
|
|
|
(9
|
)%
|
|
|
1,092,136
|
|
Underwriting, policy acquisition costs, and insurance expenses
|
|
|
536,168
|
|
|
|
(10
|
)%
|
|
|
597,766
|
|
|
|
(5
|
)%
|
|
|
628,746
|
|
Other expenses
|
|
|
88,702
|
|
|
|
(44
|
)%
|
|
|
158,749
|
|
|
|
96
|
%
|
|
|
81,177
|
|
Interest expense
|
|
|
49,560
|
|
|
|
20
|
%
|
|
|
41,141
|
|
|
|
>100
|
%
|
|
|
6,009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses
|
|
|
1,476,213
|
|
|
|
(18
|
)%
|
|
|
1,794,273
|
|
|
|
(1
|
)%
|
|
|
1,808,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
|
119,054
|
|
|
|
(66
|
)%
|
|
|
352,298
|
|
|
|
13
|
%
|
|
|
313,150
|
|
Federal income taxes
|
|
|
49,684
|
|
|
|
(63
|
)%
|
|
|
135,730
|
|
|
|
23
|
%
|
|
|
110,180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
69,370
|
|
|
|
(68
|
)%
|
|
|
216,568
|
|
|
|
7
|
%
|
|
|
202,970
|
|
Income from discontinued operations (net of income tax)
|
|
|
789
|
|
|
|
(96
|
)%
|
|
|
21,170
|
|
|
|
>100
|
%
|
|
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
70,159
|
|
|
|
(70
|
)%
|
|
$
|
237,738
|
|
|
|
17
|
%
|
|
$
|
203,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28
The table below sets forth certain summary information about our
consolidated operating results for each of the three most recent
fiscal years. For purposes of this presentation, we have
reclassified and netted the operating revenues and expenses
attributable to our former Star HRG Division and Student
Insurance Division (which we disposed of in July and December
2006, respectively) to the line item Income (loss) from
Student Insurance operations and Star HRG Division (net of
income tax):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Premiums
|
|
$
|
1,311,733
|
|
|
|
(4
|
)%
|
|
$
|
1,364,212
|
|
|
|
(5
|
)%
|
|
$
|
1,428,871
|
|
Life premiums and other considerations
|
|
|
70,460
|
|
|
|
7
|
%
|
|
|
65,675
|
|
|
|
7
|
%
|
|
|
61,565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,382,193
|
|
|
|
(3
|
)%
|
|
|
1,429,887
|
|
|
|
(4
|
)%
|
|
|
1,490,436
|
|
Investment income
|
|
|
102,984
|
|
|
|
4
|
%
|
|
|
98,896
|
|
|
|
9
|
%
|
|
|
90,964
|
|
Other income
|
|
|
106,615
|
|
|
|
5
|
%
|
|
|
101,817
|
|
|
|
(2
|
)%
|
|
|
103,562
|
|
Gains (losses) on sale of investments
|
|
|
3,475
|
|
|
|
(98
|
)%
|
|
|
200,544
|
|
|
|
N/A
|
|
|
|
(760
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
1,595,267
|
|
|
|
(13
|
)%
|
|
|
1,831,144
|
|
|
|
9
|
%
|
|
|
1,684,202
|
|
Benefits and Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits, claims, and settlement expenses
|
|
|
802,385
|
|
|
|
2
|
%
|
|
|
784,896
|
|
|
|
1
|
%
|
|
|
777,695
|
|
Underwriting, policy acquisition costs, and insurance expenses
|
|
|
535,957
|
|
|
|
5
|
%
|
|
|
508,606
|
|
|
|
2
|
%
|
|
|
498,735
|
|
Other expenses
|
|
|
88,702
|
|
|
|
(44
|
)%
|
|
|
158,749
|
|
|
|
96
|
%
|
|
|
81,177
|
|
Interest expense
|
|
|
49,560
|
|
|
|
20
|
%
|
|
|
41,141
|
|
|
|
>100
|
%
|
|
|
6,009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses
|
|
|
1,476,604
|
|
|
|
(1
|
)%
|
|
|
1,493,392
|
|
|
|
10
|
%
|
|
|
1,363,616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
|
118,663
|
|
|
|
(65
|
)%
|
|
|
337,752
|
|
|
|
5
|
%
|
|
|
320,586
|
|
Federal income taxes
|
|
|
49,547
|
|
|
|
(62
|
)%
|
|
|
130,639
|
|
|
|
16
|
%
|
|
|
112,782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations (excluding Student Insurance
operations and Star HRG operations)
|
|
|
69,116
|
|
|
|
(67
|
)%
|
|
|
207,113
|
|
|
|
1
|
%
|
|
|
207,804
|
|
Income from discontinued operation, net of tax
|
|
|
789
|
|
|
|
(96
|
)%
|
|
|
21,170
|
|
|
|
>100
|
%
|
|
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income excluding Student Insurance and Star HRG Divisions
|
|
|
69,905
|
|
|
|
(69
|
)%
|
|
|
228,283
|
|
|
|
10
|
%
|
|
|
208,335
|
|
Income (loss) from Student Insurance and Star HRG Divisions, net
of tax
|
|
|
254
|
|
|
|
(97
|
)%
|
|
|
9,455
|
|
|
|
N/A
|
|
|
|
(4,834
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
70,159
|
|
|
|
(70
|
)%
|
|
$
|
237,738
|
|
|
|
17
|
%
|
|
$
|
203,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29
Revenues and income from continuing operations before federal
income taxes (operating income) for each of the
Companys business segments and divisions in 2007, 2006 and
2005 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
1,417,952
|
|
|
$
|
1,462,088
|
|
|
$
|
1,525,968
|
|
Life Insurance Division
|
|
|
92,022
|
|
|
|
87,782
|
|
|
|
83,037
|
|
Other Insurance
|
|
|
31,866
|
|
|
|
35,337
|
|
|
|
34,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance
|
|
|
1,541,840
|
|
|
|
1,585,207
|
|
|
|
1,643,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Key Factors
|
|
|
54,458
|
|
|
|
246,847
|
|
|
|
41,104
|
|
Intersegment Eliminations
|
|
|
(1,031
|
)
|
|
|
(910
|
)
|
|
|
(706
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues excluding disposed operations
|
|
|
1,595,267
|
|
|
|
1,831,144
|
|
|
|
1,684,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
|
|
|
|
240,050
|
|
|
|
290,378
|
|
Star HRG
|
|
|
|
|
|
|
75,377
|
|
|
|
146,638
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Disposed Operations
|
|
|
|
|
|
|
315,427
|
|
|
|
437,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
1,595,267
|
|
|
$
|
2,146,571
|
|
|
$
|
2,121,218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before federal income
taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
150,449
|
|
|
$
|
236,466
|
|
|
$
|
310,466
|
|
Life Insurance Division
|
|
|
2,550
|
|
|
|
5,264
|
|
|
|
7,053
|
|
Other Insurance
|
|
|
7,909
|
|
|
|
5,488
|
|
|
|
4,658
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance
|
|
|
160,908
|
|
|
|
247,218
|
|
|
|
322,177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Key Factors:
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment income on equity, realized gains and losses, general
corporate expenses and other (including interest on corporate
debt)
|
|
|
(43,927
|
)
|
|
|
(46,507
|
)
|
|
|
14,680
|
|
Gain on Sale of Star HRG and Student
|
|
|
1,200
|
|
|
|
201,663
|
|
|
|
|
|
Merger transaction costs
|
|
|
|
|
|
|
(48,019
|
)
|
|
|
(9,057
|
)
|
Variable stock-based compensation
|
|
|
482
|
|
|
|
(16,603
|
)
|
|
|
(7,214
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Other Key Factors
|
|
|
(42,245
|
)
|
|
|
90,534
|
|
|
|
(1,591
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating income excluding disposed operations
|
|
|
118,663
|
|
|
|
337,752
|
|
|
|
320,586
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
192
|
|
|
|
12,238
|
|
|
|
(8,870
|
)
|
Star HRG Division
|
|
|
199
|
|
|
|
2,308
|
|
|
|
1,434
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Disposed Operations
|
|
|
391
|
|
|
|
14,546
|
|
|
|
(7,436
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total income from continuing operations before federal income
taxes
|
|
$
|
119,054
|
|
|
$
|
352,298
|
|
|
$
|
313,150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30
2007
Compared to 2006
In 2007, the Company reported consolidated revenues and income
from continuing operations of $1.6 billion and
$69.4 million, respectively, compared to revenues and
income from continuing operations in 2006 of $2.147 billion
and $216.6 million, respectively. Reflecting results from
discontinued operations, the Company reported overall
2007 net income of $70.2 million compared to
2006 net income of $237.7 million.
The following comparative discussion of results of operations is
by segment and division, including our disposed operations
consisting of the Student Insurance Division and the Star HRG
Division.
The Company operates three business segments, the Insurance
segment, the Other Key Factors and Disposed Operations. The
Insurance segment includes the Companys Self-Employed
Agency Division, the Life Insurance Division and Other Insurance
Division. The Other Key Factors segment includes investment
income not otherwise allocated to the Insurance segment,
realized gains and losses on sale of investments, interest
expense on corporate debt, variable stock-based compensation,
pre-operational costs associated with the Companys
Medicare Advantage PFFS market initiative, general expenses
relating to corporate operations and in 2006, the incremental
costs associated with the acquisition of the Company. The
Disposed Operations segment includes the Companys former
Star HRG Division and former Student Insurance Division.
Investment income and certain other expenses are allocated to
the divisions in the Insurance segment based on a variety of
assumptions and estimates.
Self-Employed
Agency Division
Set forth below is certain summary financial and operating data
for the Companys Self-Employed Agency Division for each of
the three most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned premium revenue
|
|
$
|
1,282,249
|
|
|
|
(4
|
)%
|
|
$
|
1,330,298
|
|
|
|
(5
|
)%
|
|
$
|
1,394,644
|
|
Investment income
|
|
|
30,840
|
|
|
|
(3
|
)%
|
|
|
31,809
|
|
|
|
(3
|
)%
|
|
|
32,725
|
|
Other income
|
|
|
104,863
|
|
|
|
5
|
%
|
|
|
99,981
|
|
|
|
1
|
%
|
|
|
98,599
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
1,417,952
|
|
|
|
(3
|
)%
|
|
|
1,462,088
|
|
|
|
(4
|
)%
|
|
|
1,525,968
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits expenses
|
|
|
735,701
|
|
|
|
2
|
%
|
|
|
721,688
|
|
|
|
0
|
%
|
|
|
718,502
|
|
Underwriting and acquisition expenses
|
|
|
478,106
|
|
|
|
8
|
%
|
|
|
444,032
|
|
|
|
0
|
%
|
|
|
445,411
|
|
Other expenses
|
|
|
53,696
|
|
|
|
(10
|
)%
|
|
|
59,902
|
|
|
|
16
|
%
|
|
|
51,589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
1,267,503
|
|
|
|
3
|
%
|
|
|
1,225,622
|
|
|
|
1
|
%
|
|
|
1,215,502
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
150,449
|
|
|
|
(36
|
)%
|
|
$
|
236,466
|
|
|
|
(24
|
)%
|
|
$
|
310,466
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other operating data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio
|
|
|
57.4
|
%
|
|
|
6
|
%
|
|
|
54.3
|
%
|
|
|
5
|
%
|
|
|
51.5
|
%
|
Expense ratio
|
|
|
37.3
|
%
|
|
|
12
|
%
|
|
|
33.3
|
%
|
|
|
4
|
%
|
|
|
32.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined health ratio
|
|
|
94.7
|
%
|
|
|
8
|
%
|
|
|
87.6
|
%
|
|
|
5
|
%
|
|
|
83.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin
|
|
|
11.7
|
%
|
|
|
(34
|
)%
|
|
|
17.8
|
%
|
|
|
(20
|
)%
|
|
|
22.3
|
%
|
Average number of writing agents in period
|
|
|
1,874
|
|
|
|
(13
|
)%
|
|
|
2,143
|
|
|
|
5
|
%
|
|
|
2,039
|
|
Submitted annualized volume
|
|
$
|
680,060
|
|
|
|
(14
|
)%
|
|
$
|
791,152
|
|
|
|
10
|
%
|
|
$
|
720,448
|
|
Loss Ratio. The Loss ratio is defined as
Benefits expense as a percentage of Earned premium revenue.
31
Expense Ratio. The Expense ratio is defined as
Underwriting and acquisition expenses as a percentage of Earned
premium revenue.
Operating Margin. Operating margin is defined
as Operating income as a percentage of Earned premium revenue.
Submitted Annualized Volume. Submitted
annualized premium volume in any period is the aggregate
annualized premium amount associated with health insurance
applications submitted by the Companys agents in such
period for underwriting by the Company.
For 2007, the SEA Division reported operating income of
$150.4 million compared to $236.5 million in 2006, a
decrease of $86.0 million or 36%. Operating margin in 2007
was 13.3% compared to 11.7% in 2006. Operating income for the
SEA Division in 2007 was negatively impacted by a decrease in
earned premium revenue, an increase in the loss ratio (benefits
as a percentage of earned premium), and an increase in
underwriting, policy acquisition costs and insurance expenses.
Earned premium revenue at the SEA Division decreased to
$1.282 billion in 2007 compared to $1.330 billion in
2006, a decrease of $48.0 million or 4%. This decrease in
earned premium revenue was primarily attributable to a slight
increase in policy lapse rates, a decline in submitted
annualized premium volume, and a decrease in the conversion rate
of submitted policies to issue policies. The period over period
decrease in submitted annualized premium volume was due to a
decrease in the average number of writing agents in the field
from 2,143 during 2006 to 1,874 during 2007 and a 6% decrease in
the productivity per agent based on the average number of weekly
applications submitted per writing agent. The decrease in
conversion experience on submitted policies was at least partly
expected as it reflects the implementation of more rigorous
underwriting procedures.
Benefits expense increased in 2007 compared to 2006 as reflected
in the loss ratio of 57.4% versus 54.3%, respectively. The
increase in the loss ratio reflects an ongoing gradual shift in
product mix to the Companys CareOne product suite and
other PPO products which are designed to provide a higher
proportion of premium dollars as benefits. The amount of benefit
expenses reported each year is impacted by the estimate of claim
liabilities. See discussion below in Critical Accounting
Policies in the sections titled Estimates of Claim
Liabilities and Changes in SEA Claim Liability
Estimates.
Underwriting, policy acquisition costs and insurance expenses
increased to $478.1 million in 2007 from
$444.0 million in 2006, an increase of $34.1 million
or 8%. In 2007, the Company recognized a $20.0 million
expense associated with the potential settlement of the
multi-state market conduct examination; see Note 17 of
Notes to Financial Statements. This increase also resulted from
an $8.0 million asset impairment charge in 2007 associated
with two technology assets that we determined were no longer of
value to the Company and additional consulting and professional
fees incurred for various operational and technology focused
initiatives.
32
Life
Insurance Division
Set forth below is certain summary financial and operating data
for the Companys Life Insurance Division for each of the
three most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned premium revenue
|
|
$
|
69,949
|
|
|
|
6
|
%
|
|
$
|
65,716
|
|
|
|
6
|
%
|
|
$
|
61,936
|
|
Investment income
|
|
|
20,602
|
|
|
|
2
|
%
|
|
|
20,222
|
|
|
|
(1
|
)%
|
|
|
20,349
|
|
Other income
|
|
|
1,471
|
|
|
|
(20
|
)%
|
|
|
1,844
|
|
|
|
145
|
%
|
|
|
752
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
92,022
|
|
|
|
5
|
%
|
|
|
87,782
|
|
|
|
6
|
%
|
|
|
83,037
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits expenses
|
|
|
54,041
|
|
|
|
22
|
%
|
|
|
44,459
|
|
|
|
12
|
%
|
|
|
39,684
|
|
Underwriting and acquisition expenses
|
|
|
35,431
|
|
|
|
(7
|
)%
|
|
|
38,059
|
|
|
|
5
|
%
|
|
|
36,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
89,472
|
|
|
|
8
|
%
|
|
|
82,518
|
|
|
|
9
|
%
|
|
|
75,984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
2,550
|
|
|
|
(52
|
)%
|
|
$
|
5,264
|
|
|
|
(25
|
)%
|
|
$
|
7,053
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annualized paid premium volume
|
|
$
|
18,407
|
|
|
|
(8
|
)%
|
|
$
|
20,007
|
|
|
|
(39
|
)%
|
|
$
|
32,878
|
|
The Life Insurance Division reported operating income in 2007 of
$2.6 million compared to operating income of
$5.3 million in 2006, a decrease of $2.7 million. This
decrease was largely attributable to a $9.6 million
increase in benefits expenses partially offset by a
$4.2 million increase in premium and a $2.6 million
decrease in underwriting and acquisition expenses.
Earned premium revenue at the Life Insurance Division increased
to $69.9 million in 2007 compared to $65.7 million in
2006, an increase of $4.2 million or 6%. This increase
reflects a greater level of renewal premiums from sales that
originated in 2006 and prior years through our relationships
with two independent marketing companies. The number of policies
in force grew during 2007 as new sales exceeded the
deterioration in existing blocks of business of older products.
Benefits expenses increased substantially in 2007 to
$54.0 million from $44.5 million in 2006. This
$9.6 million or 22% increase resulted from unusually
adverse mortality experience. Underwriting, policy acquisition
costs and insurance expenses decreased in 2007 to
$35.4 million from $38.1 million in 2006, a decrease
of $2.7 million or 7%. This reduction in expenses reflects
a decrease in new sales and a decrease in the amortization of
deferred acquisition costs based on more current actuarial
assumptions.
In 2007, the Companys Life Insurance Division generated
annualized paid premium volume (i.e., the aggregate annualized
life premium amount associated with new life insurance policies
issued by the company) in the amount of $18.4 million
compared to $20.0 million in 2006.
33
Other
Insurance
Set forth below is certain summary financial and operating data
for the Companys Other Insurance Division for each of the
three most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned premium revenue
|
|
$
|
29,995
|
|
|
|
(11
|
)%
|
|
$
|
33,873
|
|
|
|
0
|
%
|
|
$
|
33,856
|
|
Investment income
|
|
|
1,599
|
|
|
|
18
|
%
|
|
|
1,356
|
|
|
|
73
|
%
|
|
|
783
|
|
Other income
|
|
|
272
|
|
|
|
152
|
%
|
|
|
108
|
|
|
|
(33
|
)%
|
|
|
160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
31,866
|
|
|
|
(10
|
)%
|
|
|
35,337
|
|
|
|
2
|
%
|
|
|
34,799
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits expenses
|
|
|
12,643
|
|
|
|
(33
|
)%
|
|
|
18,748
|
|
|
|
(4
|
)%
|
|
|
19,508
|
|
Underwriting and acquisition expenses
|
|
|
11,314
|
|
|
|
2
|
%
|
|
|
11,101
|
|
|
|
4
|
%
|
|
|
10,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
23,957
|
|
|
|
(20
|
)%
|
|
|
29,849
|
|
|
|
(1
|
)%
|
|
|
30,141
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
7,909
|
|
|
|
44
|
%
|
|
$
|
5,488
|
|
|
|
18
|
%
|
|
$
|
4,658
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other operating data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio
|
|
|
42.2
|
%
|
|
|
(24
|
)%
|
|
|
55.3
|
%
|
|
|
(4
|
)%
|
|
|
57.6
|
%
|
Expense ratio
|
|
|
37.7
|
%
|
|
|
15
|
%
|
|
|
32.8
|
%
|
|
|
4
|
%
|
|
|
31.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined ratio
|
|
|
79.9
|
%
|
|
|
(9
|
)%
|
|
|
88.1
|
%
|
|
|
(1
|
)%
|
|
|
89.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin
|
|
|
26.4
|
%
|
|
|
63
|
%
|
|
|
16.2
|
%
|
|
|
17
|
%
|
|
|
13.8
|
%
|
Loss Ratio. The loss ratio is defined as
Benefits expense as a percentage of Earned premium revenue.
Expense Ratio. The Expense ratio is defined as
Underwriting and acquisition expenses as a percentage of Earned
premium revenue.
Operating Margin. Operating margin is defined
as Operating income as a percentage of Earned premium revenue.
The Other Insurance Division consists of the operations of ZON
Re-USA, LLC (an 82.5%-owned subsidiary), which underwrites,
administers and issues accidental death, AD&D, accident
medical and accident disability insurance products, both on a
primary and on a reinsurance basis. In 2007, ZON Re generated
operating income of $7.9 million compared to
$5.5 million in 2006, an increase of $2.4 million or
44%. This increase in operating income largely resulted from a
substantial decrease in benefits expenses.
Earned premium revenue decreased by $3.9 million or 11% to
$30.0 million in 2007 compared to $33.9 million in
2006. During 2007, we experienced an increase in competitive
pressure, which impacted new and renewal business.
Benefits expenses decreased in both dollars and in relation to
earned premium revenue as expressed by the loss ratio of 42.2%
in 2007, or 24% lower than the loss ratio in 2006 of 55.3%. The
reduction in the loss ratio in 2007 reflected favorable claim
experience in the current year including refinements to the
reserve calculations.
Other Key
Factors
The Companys Other Key Factors segment includes investment
income not otherwise allocated to the Insurance segment,
realized gains and losses on sale of investments, interest
expense on corporate debt, variable stock-based compensation,
costs associated with the Companys Medicare Advantage PFFS
market initiative and general expenses relating to corporate
operations. In 2006, the incremental costs associated with the
acquisition of the Company by a group of private equity
investors were reported in the Other Key Factors segment.
34
Set forth below is a summary of the components of operating
income at the Companys Other Key Factors segment for each
of the three most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Operating income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment income on equity
|
|
$
|
40,971
|
|
|
|
15
|
%
|
|
$
|
35,563
|
|
|
|
10
|
%
|
|
$
|
32,418
|
|
Realized gain on sale of Star HRG
|
|
|
|
|
|
|
NM
|
|
|
|
101,497
|
|
|
|
NM
|
|
|
|
|
|
Realized gain on sale of Student Insurance
|
|
|
1,200
|
|
|
|
(99
|
)%
|
|
|
100,166
|
|
|
|
NM
|
|
|
|
|
|
Realized gains (losses) on investments
|
|
|
5,201
|
|
|
|
NM
|
|
|
|
1,518
|
|
|
|
NM
|
|
|
|
(760
|
)
|
Expense related to early extinguishment of debt
|
|
|
(2,926
|
)
|
|
|
11
|
%
|
|
|
(2,637
|
)
|
|
|
NM
|
|
|
|
|
|
Merger transaction expenses
|
|
|
|
|
|
|
NM
|
|
|
|
(48,019
|
)
|
|
|
430
|
%
|
|
|
(9,057
|
)
|
Interest expense on corporate debt
|
|
|
(43,609
|
)
|
|
|
25
|
%
|
|
|
(34,823
|
)
|
|
|
NM
|
|
|
|
(1,148
|
)
|
Interest expense on student loan debt
|
|
|
(5,951
|
)
|
|
|
(6
|
)%
|
|
|
(6,318
|
)
|
|
|
30
|
%
|
|
|
(4,861
|
)
|
Variable stock-based compensation (expense) benefit
|
|
|
482
|
|
|
|
NM
|
|
|
|
(16,603
|
)
|
|
|
130
|
%
|
|
|
(7,214
|
)
|
Medicare startup costs
|
|
|
(12,425
|
)
|
|
|
NM
|
|
|
|
|
|
|
|
NM
|
|
|
|
|
|
General corporate expenses and other
|
|
|
(25,188
|
)
|
|
|
(37
|
)%
|
|
|
(39,810
|
)
|
|
|
263
|
%
|
|
|
(10,969
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
$
|
(42,245
|
)
|
|
|
NM
|
|
|
$
|
90,534
|
|
|
|
NM
|
|
|
$
|
(1,591
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NM: Not meaningful
Investment income on equity. Includes
investment income not otherwise allocated to the Insurance
segment.
The Other Key Factors segment reported an operating loss in 2007
of $42.2 million, compared to operating income of
$90.5 million in 2006. On a comparative basis, the 2006
results were particularly impacted by the total
$201.7 million of gains resulting from the sales of the
Star HRG and Student Insurance Divisions partially offset by the
$48.0 million of Merger costs.
In 2007, total investment income on equity and realized gains on
investments of $46.2 million were $9.2 million greater
than the $37.0 million earned in 2006. The 2007 results
reflected particularly favorable earnings on an international
fund investment which is not anticipated to recur based on the
most recent activity in that market and a reduction in the size
of our commitment in that investment vehicle.
Interest expense on corporate debt of $43.6 million in 2007
represents an $8.8 million or 25% increase over the
$34.8 million incurred in 2006. This increase in interest
expense is a function of a greater average outstanding debt
balance in 2007 associated with the additional borrowings
undertaken in connection with the Merger transaction in 2006.
See Note 8 of Notes to the Financial Statements.
Variable stock-based compensation expense decreased
substantially between 2007 and 2006. We maintain for the benefit
of our independent agents various stock-based compensation
plans, in connection with which we record non-cash variable
stock-based compensation expense or benefit based on the
performance of the fair value of the Companys common
stock. In 2007, we recognized a benefit of $482,000 compared to
an expense of $16.6 million in 2006. These results
primarily reflect a decrease in the fair value of our common
stock from 2006 to 2007 and an increase in the fair value of our
common stock from 2005 to 2006.
In 2007, we incurred $12.4 million of expenses associated
with our decision to enter the Medicare Advantage PFFS market
beginning with the calendar year 2008 enrollment period. These
expenses included compensation costs, lead generation expense,
marketing, printing and other costs.
35
General corporate expenses of $25.2 million in 2007
represented a $14.5 million decrease from the
$39.7 million spent in 2006. The 2006 results included
substantially more costs for a corporate branding initiative and
other professional fees incurred for various special projects
that were undertaken following the Merger.
Disposed
Operations
On July 11, 2006 and December 1, 2006, the Company
completed the sales of the assets formerly comprising its Star
HRG and Student Insurance Divisions, respectively. See
Note 2 of Notes to Financial Statements.
Set forth below is certain summary financial and operating data
for the Companys former Student Insurance Division for
each of the three most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned premium revenue
|
|
$
|
|
|
|
|
(100
|
)%
|
|
$
|
233,280
|
|
|
|
(17
|
)%
|
|
$
|
282,486
|
|
Investment income
|
|
|
|
|
|
|
(100
|
)%
|
|
|
4,882
|
|
|
|
(20
|
)%
|
|
|
6,121
|
|
Other income
|
|
|
|
|
|
|
(100
|
)%
|
|
|
1,888
|
|
|
|
7
|
%
|
|
|
1,771
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
|
|
|
|
(100
|
)%
|
|
|
240,050
|
|
|
|
(17
|
)%
|
|
|
290,378
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits expenses
|
|
|
(634
|
)
|
|
|
(100
|
)%
|
|
|
165,334
|
|
|
|
(26
|
)%
|
|
|
222,306
|
|
Underwriting and acquisition expenses
|
|
|
442
|
|
|
|
(99
|
)%
|
|
|
62,478
|
|
|
|
(19
|
)%
|
|
|
76,942
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
(192
|
)
|
|
|
(100
|
)%
|
|
|
227,812
|
|
|
|
(24
|
)%
|
|
|
299,248
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
192
|
|
|
|
NM
|
|
|
$
|
12,238
|
|
|
|
(238
|
)%
|
|
$
|
(8,870
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Companys Student Insurance Division (which offered
tailored health insurance programs that generally provided
single school year coverage to individual students at colleges
and universities) reported operating income of $192,000 in 2007
compared to $12.2 million in 2006. Very little activity
remains in the Student Insurance Division since the sale on
December 1, 2006.
Set forth below is certain summary financial and operating data
for the Companys former Star HRG Division (which designed,
marketed and administered limited benefit health insurance plans
for entry level, high turnover and hourly employees) for each of
the three most recent fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Increase
|
|
|
|
|
|
Increase
|
|
|
|
|
|
|
2007
|
|
|
(Decrease)
|
|
|
2006
|
|
|
(Decrease)
|
|
|
2005
|
|
|
|
(Dollars in thousands)
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned premium revenue
|
|
$
|
|
|
|
|
(100
|
)%
|
|
$
|
74,079
|
|
|
|
(49
|
)%
|
|
$
|
144,612
|
|
Investment income
|
|
|
|
|
|
|
(100
|
)%
|
|
|
369
|
|
|
|
(48
|
)%
|
|
|
703
|
|
Other income
|
|
|
|
|
|
|
(100
|
)%
|
|
|
929
|
|
|
|
(30
|
)%
|
|
|
1,323
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
|
|
|
|
(100
|
)%
|
|
|
75,377
|
|
|
|
(49
|
)%
|
|
|
146,638
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits expenses
|
|
|
32
|
|
|
|
(100
|
)%
|
|
|
46,387
|
|
|
|
(50
|
)%
|
|
|
92,135
|
|
Underwriting and acquisition expenses
|
|
|
(231
|
)
|
|
|
(101
|
)%
|
|
|
26,682
|
|
|
|
(50
|
)%
|
|
|
53,069
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
(199
|
)
|
|
|
(100
|
)%
|
|
|
73,069
|
|
|
|
(50
|
)%
|
|
|
145,204
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
199
|
|
|
|
NM
|
|
|
$
|
2,308
|
|
|
|
61
|
%
|
|
$
|
1,434
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36
The Companys Star HRG Division reported an operating
income in 2007 in the amount of $199,000 compared to
$2.3 million in 2006. Very little activity remains in the
Star HRG Division since it was sold on July 11, 2006.
Discontinued
Operations
The Company reported income from discontinued operations in 2007
in the amount of $789,000, net of tax, compared to income from
discontinued operations of $21.2 million, net of tax, in
2006. The income for the year ended December 31, 2006
consisted primarily of a tax benefit attributable to the release
of certain tax reserves and valuation allowances on deferred tax
assets related to capital loss carryovers and other capital
items that are currently recoverable as a result of the sale of
the Star HRG Division at a gain. A significant portion of the
released tax allowances and reserves were originally established
during 2003.
2006
Compared to 2005
In 2006 HealthMarkets reported consolidated revenues and income
from continuing operations of $2.147 billion and
$216.6 million, respectively, compared to revenues and
income from continuing operations in 2005 of $2.121 billion
and $203.0 million, respectively. Reflecting results from
discontinued operations, the Company reported overall
2006 net income of $237.7 million, compared to
2005 net income of $203.5 million.
Unless the context indicates otherwise, the following
comparative discussion of our 2006 and 2005 results of
operations excludes the operations of the Companys Student
Insurance Division and Star HRG Division which were sold in July
and December 2006, respectively.
Continuing
Operations
Revenues. HealthMarkets revenues
increased to $1.831 billion in 2006 from
$1.684 billion in 2005, an increase of $146.9 million,
or 9%. The Companys revenues were particularly impacted by
the following factors:
|
|
|
|
|
The Company experienced a 5% decrease in health premium revenue
(to $1.364 billion in 2006 from $1.429 billion in
2005). This decrease was attributable to the decline in
submitted annualized premium volume at the SEA Division in years
prior to 2006. However, during 2006, annualized premium volume
increased by 10% over annualized premium volume in 2005.
|
|
|
|
Life premiums and other considerations increased by 7%, to
$65.7 million in 2006 from $61.6 million in 2005. This
increase was attributable primarily to incremental sales of life
products through relationships with two independent marketing
companies and growth in renewal business from life products sold
during 2004 and 2005.
|
|
|
|
Due to an increase in the prevailing yield on short-term
securities, student loans and other investments, investment
income increased to $98.9 million in 2006 compared to
$91.0 million in 2005.
|
|
|
|
Other income (consisting primarily of income derived by the SEA
Division from ancillary services and membership marketing and
administrative services provided to the membership associations
that make available to their members the Companys health
insurance products) decreased by 2% to $101.8 million in
2006 from $103.6 million in 2005. The decrease in other
income was primarily attributable to a decrease in fee and other
income earned by the Companys former real estate
subsidiary, the activities of which were immaterial and which
the Company dissolved in the first quarter of 2007.
|
|
|
|
In 2006, the Company recognized net gains on sale of investments
of $200.5 million compared to losses on sales of
investments of $(760,000) in 2005. The increase in 2006 was
primarily attributable to gains realized from the sales of the
Companys Star HRG Division and the Student Insurance
Division in 2006.
|
37
Benefits and Expenses. HealthMarkets
total benefits and expenses increased to $1.493 billion in
2006 from $1.364 billion in 2005, an increase of
$129.8 million, or 10%. The Companys benefits and
expenses were particularly impacted by the following factors:
|
|
|
|
|
Benefits, claims and settlement expenses increased nominally to
$784.9 million in 2006 from $777.7 million in 2005,
primarily as a result of an increase in the claim benefits as a
percentage of earned premium associated with business written at
the SEA Division. See Self-Employed Agency discussion
below.
|
|
|
|
Underwriting costs, policy acquisition costs and insurance
expenses remained virtually unchanged in the periods
($508.6 million in 2006 and $498.7 million in 2005). A
decrease in administrative expenses in 2006 at the SEA Division
was somewhat offset by additional amortization of capitalized
acquisition costs in the amount of $15.5 million associated
with a change in the Companys method of accounting for a
portion of deferred acquisition costs. See discussion
above under the caption 2006 Change in Accounting
Policy. The Company maintains for the benefit of its
independent agents various stock-based compensation plans, in
connection with which we record non-cash variable stock-based
compensation expense (benefit) in amounts that depend and
fluctuate based upon the performance of the Companys
common stock. In 2006, the Company recognized a non-cash stock
based compensation expense in the amount of $16.6 million,
compared to non-cash stock based compensation expense of
$7.2 million in 2005. The increase is principally due to
greater change in share price during 2006 compared to 2005.
|
|
|
|
Other expenses (consisting primarily of direct expenses incurred
by the Company in connection with providing ancillary services
and membership marketing and administrative services provided to
the membership associations that make available to their members
the Companys health insurance products and general
expenses relating to corporate operations) increased to
$158.7 million in 2006 from $81.2 million in 2005. The
majority of the increase is attributed to incremental costs in
the amount of $48.0 million associated with the Merger,
$9.4 million of advisory fees incurred since the Merger
date for services provided by the Private Equity Investors and
additional overhead expenses incurred in connection with the
previously announced corporate name change and branding
initiative.
|
|
|
|
Total interest expense on corporate debt and the Companys
student loan credit facilities increased to $41.1 million
in 2006 from $6.0 million in 2005, primarily due to the
incremental indebtedness incurred in connection with the Merger
and the increase in borrowing rates on the student loan debt.
|
Operating Income. Operating income (exclusive
of operating results at the Companys Star HRG Division and
Student Insurance Division) increased by 5% to
$337.8 million in 2006 from $320.6 million in 2005. As
discussed more fully below, the Companys 2006 results from
continuing operations benefited from realized gains of
$201.7 million recorded upon the sales of the Star HRG and
Student Insurance Divisions. These gains were offset by an
increase in Merger costs of $39.0 million (from
$9.0 million in 2005 to $48.0 million in 2006), a
$35.1 million increase in interest expense (from
$6.0 million in 2005 to $41.1 million in
2006) and a 24% decrease in operating income at the SEA
Division (from $310.5 million in 2005 to
$236.5 million in 2006).
Self-Employed
Agency Division
For 2006, the SEA Division reported operating income of
$236.5 million compared to operating income of
$310.5 million in 2005. Operating income at the SEA
Division as a percentage of earned premium revenue (i.e.,
operating margin) in 2006 was 17.8% compared to 22.3% in
2005.
Operating income at the SEA Division in 2006 was negatively
impacted by a decrease in earned premium revenue, an increase in
the loss ratio (benefits as a percentage of earned premium), and
an increase in underwriting, policy acquisition costs and
insurance expenses as a percentage of earned premium. Earned
premium revenue at the SEA Division decreased to
$1.330 billion in 2006 compared to earned premium revenue
of $1.395 billion in 2005. The decrease in earned premium
revenue at the Self-Employed Agency division during 2006 was due
to the decline in submitted annualized premium volume in 2004
and 2005. However, during 2006, annualized premium volume
increased by 10% over annualized premium volume in 2005. The
increase in the loss ratio was due to a product mix shift to new
health insurance products in the Companys CareOne product
suite and cost containment expenses resulting from the
Companys initiatives to control medical costs. Products in
the CareOne product suite (sales of
38
which in 2006 represented approximately 14% of total SEA
Division earned premium revenue) are expected to provide a
higher proportion of the premium as benefits. In 2006,
underwriting, policy acquisition costs and insurance expenses
included additional amortization of capitalized policy
acquisition costs in the amount of $15.5 million associated
with a change in the Companys method of accounting for a
portion of deferred acquisition costs. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations - 2006 Change
in Accounting Policy above.
The amount of benefit expenses reported each year is impacted by
the estimate of claim liabilities. See discussion below in
Critical Accounting Policies in the sections titled
Estimates of Claim Liabilities and Changes in
SEA Claim Liability Estimates.
The decrease in operating margin to 17.8% in 2006 compared to
22.3% in 2005 was attributable primarily to the increase in loss
ratio and increase in underwriting, policy acquisition costs and
insurance expenses in the amount of $15.5 million
associated with a change in accounting policy with respect to
amortization of a portion of deferred acquisition costs. See
Note 1 of Notes to Financial Statements.
Total submitted annualized premium volume at the SEA Division
increased by 10%, to $791.2 million in 2006 from
$720.4 million in 2005. The increase in submitted
annualized premium volume can be attributed primarily to an
increase in the average number of writing agents per week in the
field (from 2,039 in 2005 to 2,143 in 2006) and an increase
in writing agent productivity. During 2006, the amount of weekly
submitted annualized premium volume per writing agent increased
by 4.5%, even as the average premium per policy decreased by
4.5%.
Life
Insurance Division
The Companys Life Insurance Division reported operating
income in 2006 of $5.3 million compared to operating income
of $7.1 million in 2005. The year-over-year decrease in
operating income was attributable to an increase in death claims
during the first half of 2006 and an increase in administrative
expenses The increase in administrative expenses is due to a
decrease in capitalized deferred acquisition costs
(administration costs) related to a decline in first year sales
volume.
In 2006, the Companys Life Insurance Division generated
annualized paid premium volume (i.e., the aggregate
annualized life premium amount associated with new life
insurance policies issued by the Company) in the amount of
$20.0 million compared to $32.9 million in 2005.
Annualized paid premium volume for 2006 was negatively impacted
by service issues associated with an outside vendor that assists
the Company in gathering key underwriting information and a
delay in production due to the introduction of redesigned
products that are expected to improve return on capital.
Other
Insurance
The Other Insurance Division consists of the operations of ZON
Re (an 82.5%-owned subsidiary), which underwrites, administers
and issues accidental death, AD&D, accident medical and
accident disability insurance products, both on a primary and on
a reinsurance basis. In 2006, ZON Re generated revenues and
operating income of $35.3 million and $5.5 million,
respectively, compared to revenues and operating income of
$34.8 million and $4.7 million, respectively, in 2005.
Other Key
Factors
The Companys Other Key Factors segment includes investment
income not otherwise allocated to the Insurance segment,
realized gains and losses, interest expense on corporate debt,
variable stock compensation and other unallocated items and
general expenses relating to corporate operations. In 2005 and
2006, the incremental costs associated with the acquisition of
the Company by a group of private equity investors were also
reflected in the results of the Other Key Factors segment.
The Other Key Factors segment reported income in 2006 of
$90.5 million, compared to a loss of $1.6 million in
2005.
39
The increase in income in the Other Key Factors segment in 2006
reflected the gains of approximately $201.7 million on the
sales of substantially all of the assets comprising the
Companys Star HRG and Student Insurance Divisions
completed in 2006. Results in 2006 also included Merger
transaction costs in the amount of $48.0 million. The
increase in interest expense on non-student loan debt in the
2006 period was due to the Merger-related indebtedness incurred
in the second quarter of 2006. In connection with the Merger,
the Company borrowed $500.0 million under a term loan
credit facility and issued $100.0 million of Floating Rate
Junior Subordinated Notes. See Note 8 of Financial
Statements.
Other significant items affecting the 2006 results in the Other
Key Factors segment included a $9.4 million increase in
variable stock-based compensation and an increase in general
corporate expenses for the period to $39.8 million compared
to $11.0 million incurred in the comparable period in 2005.
These additional overhead expenses were principally associated
with the change of the Companys corporate name, the
Companys corporate branding initiative and monitoring fees
paid to the Private Equity Investors.
Disposed
Operations
On July 11, 2006 and December 1, 2006, the Company
completed the sales of the assets formerly comprising its Star
HRG and Student Insurance Divisions, respectively. See
Note 2 of Notes to Financial Statements.
The Companys Student Insurance Division (which offered
tailored health insurance programs that generally provide single
school year coverage to individual students at colleges and
universities) reported operating income of $12.2 million in
2006 compared to operating losses of $(8.9) million in
2005. Results for 2006 at the Student Insurance Division
reflected a significant improvement in loss experience on the
Student Insurance book of business. The loss ratio on this
business decreased to 70.9% in 2006, from 78.7% in 2005, which
reflected the benefits of non-renewing certain underperforming
schools for the
2005-2006
school year. For 2006, operating results also benefited from
lower administrative expenses as a percentage of earned premium
and from better utilization of network service agreements with
healthcare providers. Earned premium revenue at the Student
Insurance Division decreased to $233.3 million in 2006,
from $282.5 million in 2005. The decrease in premium
reflected, in part, the non-renewal in the
2005-2006
school year of certain accounts that had performed poorly in the
2004-2005
school year. In addition, premium in 2006 reflected eleven
months of activity through the date of sale.
The Companys Star HRG Division reported operating income
in 2006 in the amount of $2.3 million, compared to
operating income of $1.4 million in 2005. The loss ratio
associated with the Star HRG business decreased slightly to
62.6% in 2006 from 63.7% in 2005, and the underwriting and
acquisition expense ratio decreased slightly to 36.0% in 2006
from 36.7% in 2005 from initiatives established in the fourth
quarter of 2005. Earned premium revenue at the Star HRG Division
was $74.1 million in 2006, compared to $144.6 million
in 2005, reflecting the sale of the division effective
July 11, 2006.
Discontinued
Operations
The Company reported income from discontinued operations in 2006
in the amount of $21.2 million, net of tax ($0.59 per
diluted share), compared to income from discontinued operations
of $531,000, net of tax ($0.01 per diluted share), in 2005. The
income for the year ended December 31, 2006 consisted
primarily of a tax benefit attributable to the release of
certain tax reserves and valuation allowances on deferred tax
assets related to capital loss carryovers and other capital
items that are currently recoverable as a result of the sale of
the Star HRG Division at a gain. A significant portion of the
released tax allowances and reserves were originally established
during 2003 primarily because management did not anticipate
realizing before its expiration the tax benefits of the capital
loss carryover from the 2003 sale of the Companys former
student finance subsidiary.
Variable
Stock-Based Compensation
The Company sponsors a series of stock accumulation plans
established for the benefit of the independent insurance agents
and independent sales representatives associated with its
independent agent field forces, including UGA
Association Field Services and Cornerstone America. In
connection with these plans, the Company has from time to time
recorded and will continue to record non-cash variable
stock-based compensation expense in amounts that depend and
fluctuate based upon the fair value of the Companys common
stock. For financial
40
reporting purposes, the Company reflects all non-cash variable
stock based compensation associated with its agent stock plans
in its Other Key Factors business segment. See
Note 14 of Notes to Financial Statements.
The accounting treatment of the Companys agent plans has
resulted and will continue to result in unpredictable non-cash
stock-based compensation charges, primarily dependent upon
future fluctuations in the prevailing fair value of
HealthMarkets common stock. These unpredictable fluctuations in
stock based compensation charges may result in material non-cash
fluctuations in the Companys results of operations.
Unvested benefits under the agent plans vest in January of each
year; accordingly, in periods of general appreciation in the
price of HealthMarkets common stock, the Companys
cumulative liability, and corresponding charge to income, for
unvested stock-based compensation is expected to be greater in
each successive quarter during any given year.
Liquidity
and Capital Resources
Consolidated
On a consolidated level, the Companys primary sources of
liquidity have been premium revenues from policies issued,
investment income, fees and other income, proceeds from
corporate borrowings and borrowings to fund student loans. The
primary uses of cash have been payments for benefits, claims and
commissions under those policies, operating expenses, cash
dividends to shareholders, stock repurchases and the funding of
student loans. During 2007, the Company generated on a
consolidated basis net cash from operations in the amount of
$78.8 million, compared to net cash from operations of
$42.8 million in 2006 and $185.4 million in 2005.
In connection with the Merger, the Company borrowed
$500.0 million under a term loan credit facility and issued
$100.0 million of Floating Rate Junior Subordinated Notes
during 2006. The Companys consolidated short and long-term
indebtedness (exclusive of indebtedness secured by student
loans) was $481.1 million and $556.1 million at
December 31, 2007 and 2006, respectively.
At December 31, 2007 and 2006, the Company had an aggregate
of $97.4 million and $119.0 million, respectively, of
indebtedness outstanding under a secured student loan credit
facility, which indebtedness is represented by Student Loan
Asset-Backed Notes issued by a bankruptcy-remote special purpose
entity (the SPE). See Note 9 of Notes to
Financial Statements. At December 31, 2007 and 2006,
indebtedness outstanding under the secured student loan credit
facility was secured by alternative (i.e., non-federally
guaranteed) student loans and accrued interest in the carrying
amount of $98.7 million and $111.2 million,
respectively, and by a pledge of cash, cash equivalents and
other qualified investments in the amount of $6.5 million
and $14.2 million, respectively. Prior to February 1,
2007, the SPE was authorized by the terms of the agreements
governing the securitization to purchase from the Company
additional student loans generated under the Companys
College First Alternative Loan program. Subsequent to
February 1, 2007 the Company funded loans with cash on hand
from HealthMarkets LLC.
Holding
Company
HealthMarkets Inc. is a holding company, the principal asset of
which is its investment in its wholly owned subsidiary,
HealthMarkets LLC (collectively referred to as holding
company in this section). HealthMarkets LLCs
principal assets are its investment in its separate operating
subsidiaries, including its regulated insurance subsidiaries.
The holding companys ability to fund its cash requirements
is largely dependent upon its ability to access cash, by means
of dividends or other means from its subsidiaries. The laws
governing the Companys insurance subsidiaries restrict
dividends paid by the Companys domestic insurance
subsidiaries in any year. Inability to access cash from its
subsidiaries could have a material adverse effect upon the
Companys liquidity and capital resources.
41
At December 31, 2007 and 2006, HealthMarkets, Inc. and
HealthMarkets LLC at the holding company level held cash and
cash equivalents (including short-term investments) in the
amount of $63.0 million and $311.5 million,
respectively. Set forth below is a summary statement of
aggregate cash flows for HealthMarkets, Inc and HealthMarkets
LLC for each of the three most recent years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Cash and cash equivalents on hand at beginning of year
|
|
$
|
311,481
|
|
|
$
|
151,423
|
|
|
$
|
39,573
|
|
Sources of cash:
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends from domestic insurance subsidiaries
|
|
|
171,200
|
|
|
|
213,200
|
|
|
|
146,000
|
|
Dividends from offshore insurance subsidiaries
|
|
|
5,040
|
|
|
|
6,950
|
|
|
|
9,000
|
|
Dividends from non-insurance subsidiaries
|
|
|
|
|
|
|
1,607
|
|
|
|
9,037
|
|
Contribution by private equity firms
|
|
|
|
|
|
|
985,000
|
|
|
|
|
|
Debt proceeds
|
|
|
|
|
|
|
600,000
|
|
|
|
|
|
Proceeds from non-consolidated qualifying special purpose entity
related to the promissory Note received as consideration in the
sale of Star HRG
|
|
|
|
|
|
|
144,294
|
|
|
|
|
|
Proceeds from other financing activities
|
|
|
54,185
|
|
|
|
27,870
|
|
|
|
12,253
|
|
Proceeds from stock option activities
|
|
|
1,164
|
|
|
|
337
|
|
|
|
2,582
|
|
Net tax treaty payments from subsidiaries
|
|
|
36,029
|
|
|
|
40,499
|
|
|
|
5,536
|
|
Net investment activities
|
|
|
140
|
|
|
|
3,221
|
|
|
|
1,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total sources of cash
|
|
|
267,758
|
|
|
|
2,022,978
|
|
|
|
186,181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Uses of cash:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash to operations
|
|
|
(26,508
|
)
|
|
|
(34,173
|
)
|
|
|
(14,767
|
)
|
Contributions/investment in subsidiaries
|
|
|
(15,484
|
)
|
|
|
(635
|
)
|
|
|
(1,690
|
)
|
Interest on debt
|
|
|
(36,911
|
)
|
|
|
(23,808
|
)
|
|
|
(1,023
|
)
|
Repayment of debt
|
|
|
(75,000
|
)
|
|
|
(62,500
|
)
|
|
|
|
|
Financing activities
|
|
|
(3,800
|
)
|
|
|
(150
|
)
|
|
|
(370
|
)
|
Dividends paid to shareholders
|
|
|
(316,996
|
)
|
|
|
|
|
|
|
(34,705
|
)
|
Purchases of HealthMarkets common stock
|
|
|
(41,535
|
)
|
|
|
(8,744
|
)
|
|
|
(13,359
|
)
|
Merger transaction costs
|
|
|
|
|
|
|
(120,921
|
)
|
|
|
(8,417
|
)
|
Treasury stock purchase in Merger
|
|
|
|
|
|
|
(1,611,989
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total uses of cash
|
|
|
(516,234
|
)
|
|
|
(1,862,920
|
)
|
|
|
(74,331
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents on hand at end of year
|
|
$
|
63,005
|
|
|
$
|
311,481
|
|
|
$
|
151,423
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at HealthMarkets, Inc.
|
|
$
|
37,675
|
|
|
$
|
48,578
|
|
|
$
|
151,423
|
|
Cash and cash equivalents at HealthMarkets LLC
|
|
|
25,330
|
|
|
|
262,903
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents on hand at end of year
|
|
$
|
63,005
|
|
|
$
|
311,481
|
|
|
$
|
151,423
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sources
of Cash and Liquidity
|
|
|
|
|
During 2007, the Company received an aggregate of
$176.2 million in cash dividends from our subsidiaries
compared to $221.7 million in 2006. Prior approval by
insurance regulatory authorities is required for the payment by
a domestic insurance company of dividends that exceed certain
limitations based on statutory surplus and net income. During
2008, the Companys domestic insurance companies can pay,
without prior approval of the regulatory authorities, aggregate
dividends in the ordinary course of business to the holding
company of approximately $153.6 million ($76.3 million
was paid in January 2008). However, as it has done in the past,
the Company will assess the results of operations of the
regulated domestic insurance companies
|
42
|
|
|
|
|
to determine the prudent dividend capability of the
subsidiaries, consistent with HealthMarkets practice of
maintaining risk-based capital ratios at each of the
Companys domestic insurance subsidiaries significantly in
excess of minimum requirements.
|
|
|
|
|
|
On April 5, 2006, the Company received $985.0 million
for the purchase of common stock by the group of private equity
firms in connection with the Merger.
|
|
|
|
In April 2006, the Company utilized proceeds from additional
indebtedness in the amount of $600.0 million, consisting of
$500.0 million under a term loan credit facility and
$100.0 million of Floating Rate Junior Subordinated Notes
to finance the Merger.
|
|
|
|
During 2006, the Company received a total of $144.3 million
in distributions from the non-consolidated qualifying special
purpose entity, Grapevine Finance LLC. Of this total
$72.4 million resulted from a principal repayment by CIGNA
on the $150.8 million note issued as consideration in the
sale of Star HRG. The other $71.9 million resulted from
Grapevines issuance of senior secured notes.
|
|
|
|
In 2007, the Company received $54.2 million in proceeds
from other financing activities largely consisting of
$50.4 million in proceeds from subsidiaries to acquire
shares in the agent stock plans. The corresponding amount in
2006 was $20.4 million. The 2007 activity was unusually
greater in large part due to a $27.9 million reinvestment
of the extraordinary cash dividend in May 2007.
|
Uses of
Cash and Liquidity
|
|
|
|
|
During 2007, the Company made contributions or investments in
subsidiaries of $15.4 million substantially representing
the acquisition of Fidelity Life Insurance Company for
$13.4 million.
|
|
|
|
During 2007 and 2006, the Company made voluntary principal
prepayments of $75.0 million and $62.5 million,
respectively, on the $500.0 million term loan facility.
|
|
|
|
During 2007, the holding company paid an extraordinary cash
dividend of $317.0 million.
|
|
|
|
During 2007, the Company paid $41.5 million mostly to
repurchase shares of its common stock from subsidiaries in
connection with the agent stock plans and also to purchase
common stock from officers.
|
|
|
|
During 2006, the holding company expended significant amounts of
cash for expenses related to the Merger totaling
$120.9 million.
|
|
|
|
On April 5, 2006, the Company utilized $1.6 billion to
repurchase 43,567,252 shares of its common stock in the
Merger.
|
Contractual
Obligations and Off Balance Sheet Arrangements
Set forth below is a summary of the Companys contractual
obligations (on a consolidated basis) at December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment Due by Period
|
|
|
|
|
|
|
Less Than
|
|
|
|
|
|
|
|
|
More Than
|
|
|
|
Total
|
|
|
1 Year
|
|
|
1-3 Years
|
|
|
3-5 Years
|
|
|
5 Years
|
|
|
|
(In thousands)
|
|
|
Corporate debt
|
|
$
|
481,070
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
362,500
|
|
|
$
|
118,570
|
|
Student loan credit facility
|
|
|
97,400
|
|
|
|
12,150
|
|
|
|
25,150
|
|
|
|
22,150
|
|
|
|
37,950
|
|
Future policy benefits
|
|
|
463,277
|
|
|
|
16,027
|
|
|
|
42,816
|
|
|
|
41,392
|
|
|
|
363,042
|
|
Claim liabilities
|
|
|
435,099
|
|
|
|
352,991
|
|
|
|
78,701
|
|
|
|
2,571
|
|
|
|
836
|
|
Capital lease obligations
|
|
|
364
|
|
|
|
184
|
|
|
|
180
|
|
|
|
|
|
|
|
|
|
Operating lease obligations
|
|
|
16,777
|
|
|
|
4,947
|
|
|
|
6,902
|
|
|
|
3,241
|
|
|
|
1,687
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,493,987
|
|
|
$
|
386,299
|
|
|
$
|
153,749
|
|
|
$
|
431,854
|
|
|
$
|
522,085
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43
All indebtedness issued under the secured student loan credit
facility represent obligations solely of the SPE and not of the
Company or any other subsidiary and is secured by student loans,
accrued investment income, cash, cash equivalents and qualified
investments. The payments related to the future policy benefits
and claim liabilities reflected in the table above have been
projected utilizing assumptions based on the Companys
historical experience and anticipated future experience.
The Companys off balance sheet arrangements consist of
commitments to fund student loans generated by its former
College Fund Life Division and letters of credit.
Through the Companys former College Fund Life
Division, the Company previously offered an interest-sensitive
whole life insurance product issued with a child term rider,
under which the Company committed to provide private student
loans to help fund the named childs higher education if
certain restrictions and qualifications are satisfied. At
December 31, 2007, the Company had outstanding commitments
to fund student loans under the College Fund Life Division
program for the years 2008 through 2025. Loans are limited to
the cost of school or prescribed maximums. These loans are
generally guaranteed as to principal and interest by a private
guarantee agency and are also collateralized by either the
related insurance policy or the co-signature of a parent or
guardian. The total student loan funding commitments for each of
the next five school years and thereafter, as well as the amount
the Company expects to be required to fund based on historical
utilization rates and policy lapse rates, are as follows as of
December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
Expected
|
|
|
|
Commitment
|
|
|
Funding
|
|
|
|
(In thousands)
|
|
|
2008
|
|
$
|
20,011
|
|
|
$
|
1,367
|
|
2009
|
|
|
16,605
|
|
|
|
1,167
|
|
2010
|
|
|
17,038
|
|
|
|
987
|
|
2011
|
|
|
19,282
|
|
|
|
875
|
|
2012
|
|
|
21,735
|
|
|
|
689
|
|
2013 and thereafter
|
|
|
75,594
|
|
|
|
1,265
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
170,265
|
|
|
$
|
6,350
|
|
|
|
|
|
|
|
|
|
|
Interest rates on the above commitments are principally variable
(prime plus 2%).
Through February 1, 2007, the Company has funded its
College Fund Life Division student loan commitments with
the proceeds of indebtedness issued by a bankruptcy-remote
special purpose entity (the SPE Notes). The
indenture governing the terms of the SPE Notes provided that the
proceeds of such SPE Notes could be used to fund student loan
commitments only until February 1, 2007, after which any
monies then remaining on deposit in the acquisition fund created
by the indenture not used to purchase additional student loans
are required to be used to redeem the SPE Notes. After
February 1, 2007, the Company will fund loans with cash on
hand from HealthMarkets LLC. During 2006, principal payments on
the Notes were made in the amount of $12.0 million from the
proceeds from the repayment on the student loan receivables.
See Note 9 of Notes to Financial Statements.
At each of December 31, 2007 and 2006, the Company had
$14.3 million and $9.6 million, respectively, of
letters of credit outstanding relating to its insurance
operations.
Investments
The Companys Investment Committee monitors the investment
portfolio of the Company and its subsidiaries. The Investment
Committee receives investment management services from external
professionals and from the Companys in-house investment
management team. The internal investment management team
monitors the performance of the external managers as well as
directly managing approximately 68% of the investment portfolio.
Investments are selected based upon the parameters established
in the Companys investment policies. Emphasis is given to
the selection of high quality, liquid securities that provide
current investment returns. Maturities or liquidity
characteristics of the securities are managed by continually
structuring the duration of the investment portfolio to be
consistent with the duration of the policy liabilities.
Consistent with regulatory
44
requirements and internal guidelines, the Company invests in a
range of assets, but limits its investments in certain classes
of assets, and limits its exposure to certain industries and to
single issuers.
Investments are reviewed quarterly (or more frequently if
certain indicators arise) to determine if they have suffered an
impairment of value that is considered other than temporary.
Managements review considers the following indicators of
impairment: fair value significantly below cost; decline in fair
value attributable to specific adverse conditions affecting a
particular investment; decline in fair value attributable to
specific conditions, such as conditions in an industry or in a
geographic area; decline in fair value for an extended period of
time; downgrades by rating agencies from investment grade to
non-investment grade; financial condition deterioration of the
issuer and situations where dividends have been reduced or
eliminated or scheduled interest payments have not been made.
Management monitors investments where two or more of the above
indicators exist. The Company also identifies investments in
economically challenged industries. If investments are
determined to be other than temporarily impaired, a loss is
recognized at the date of determination.
Fixed maturity securities represented 88.0% and 76.3% of the
Companys total investments at December 31, 2007 and
2006, respectively. Fixed maturity securities at
December 31, 2007 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
% of Total
|
|
|
|
Carrying
|
|
|
Carrying
|
|
|
|
Value
|
|
|
Value
|
|
|
|
(Dollars in thousands)
|
|
|
U.S. Treasury and U.S. Government agency obligations
|
|
$
|
72,940
|
|
|
|
5.6
|
%
|
Corporate bonds
|
|
|
878,159
|
|
|
|
67.3
|
%
|
Mortgage-backed securities issued by U.S. Government agencies
and authorities
|
|
|
205,917
|
|
|
|
15.8
|
%
|
Other mortgage and asset backed securities
|
|
|
142,727
|
|
|
|
10.9
|
%
|
Other
|
|
|
4,681
|
|
|
|
0.4
|
%
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
1,304,424
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Corporate bonds included in the fixed maturity portfolio consist
primarily of short term and medium term investment grade bonds.
The Companys investment policy with respect to
concentration risk limits individual investment grade bonds to
3% of assets and non-investment grade bonds to 2% of assets. The
policy also limits the investments in any one industry to 20% of
assets. As of December 31, 2007, the largest concentration
in any one investment grade corporate bond was
$92.4 million, which represented 6.3% of total invested
assets. This security was received as payment on the sale of the
Student Insurance Division. To limit its credit risk, the
Company has taken out $75.0 million of credit default
insurance on this bond, reducing its default exposure to
$19.8 million, or 1.3% of total invested assets. The
largest concentration in any one non-investment grade corporate
bond was $4.6 million, which represented less than 1% of
total invested assets. The largest concentration to any one
industry was less than 10%. Additionally, due primarily to long
standing conservative investment guidelines, our direct exposure
to sub prime investments and auction rate securities is limited
to 3.5% of investments.
Included in the fixed maturity portfolio are mortgage-backed
securities, including collateralized mortgage obligations,
mortgage-backed pass-through certificates and commercial
mortgage-backed securities. To limit its credit risk, the
Company invests in mortgage-backed securities that are rated
investment grade by the public rating agencies. The
Companys mortgage-backed securities portfolio is a
conservatively structured portfolio that is concentrated in the
less volatile tranches, such as planned amortization classes and
sequential classes. The Company seeks to minimize prepayment
risk during periods of declining interest rates and minimize
duration extension risk during periods of rising interest rates.
The Company has less than 1% of its investment portfolio
invested in the more volatile tranches.
45
A quality distribution for fixed maturity securities at
December 31, 2007 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
|
Carrying
|
|
|
Carrying
|
|
|
|
|
Rating
|
|
Value
|
|
|
Value
|
|
|
|
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
U.S. Government and AAA
|
|
$
|
623,167
|
|
|
|
47.8
|
%
|
|
|
|
|
AA
|
|
|
200,547
|
|
|
|
15.4
|
%
|
|
|
|
|
A
|
|
|
354,718
|
|
|
|
27.2
|
%
|
|
|
|
|
BBB
|
|
|
105,491
|
|
|
|
8.1
|
%
|
|
|
|
|
Less than BBB
|
|
|
20,501
|
|
|
|
1.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,304,424
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company has classified its entire fixed maturity portfolio
as available for sale. This classification requires
the portfolio to be carried at fair value with the resulting
unrealized gains or losses, net of applicable income taxes,
reported in accumulated other comprehensive income as a separate
component of stockholders equity. As a result,
fluctuations in fair value, which is affected by changes in
interest rates, will result in increases or decreases to the
Companys stockholders equity.
Set forth below is a summary of the Companys gross
unrealized losses in its portfolio of fixed maturity securities
as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized Loss
|
|
|
Unrealized Loss
|
|
|
|
|
|
|
Less Than 12 Months
|
|
|
12 Months or longer
|
|
|
Total
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
Description of Securities
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
|
U.S. Treasury obligations and direct obligations of U.S.
Government agencies
|
|
$
|
7,245
|
|
|
$
|
12
|
|
|
$
|
15,200
|
|
|
$
|
93
|
|
|
$
|
22,445
|
|
|
$
|
105
|
|
Mortgage backed securities issued by U.S. Government agencies
and authorities
|
|
|
|
|
|
|
|
|
|
|
134,294
|
|
|
|
1,575
|
|
|
|
134,294
|
|
|
|
1,575
|
|
Other mortgage and asset backed securities
|
|
|
461
|
|
|
|
38
|
|
|
|
89,764
|
|
|
|
1,470
|
|
|
|
90,225
|
|
|
|
1,508
|
|
Corporate bonds
|
|
|
152,855
|
|
|
|
5,713
|
|
|
|
303,871
|
|
|
|
12,315
|
|
|
|
456,726
|
|
|
|
18,028
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
4,681
|
|
|
|
1,737
|
|
|
|
4,681
|
|
|
|
1,737
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
160,561
|
|
|
$
|
5,763
|
|
|
$
|
547,810
|
|
|
$
|
17,190
|
|
|
$
|
708,371
|
|
|
$
|
22,953
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2007, the Company had $23.0 million of
unrealized losses in its fixed maturities portfolio. Of the
$5.8 million in unrealized losses that have existed for
less than twelve months, two securities have unrealized losses
in excess of 10% of the securitys cost. The amount of
unrealized loss with respect to those securities was
$2.4 million at December 31, 2007. Of the
$17.2 million in unrealized losses that have existed for
twelve months or longer, nine securities had an unrealized loss
in excess of 10% of the securitys cost. The amount of
unrealized loss with respect to those securities was
$6.8 million at December 31, 2007. Included with the
nine securities that had unrealized losses in excess of 10% and
classified as Other in the table above is the
Companys residual interest in Grapevine Finance LLC.
At December 31, 2007, Grapevine Finance LLC had an
unrealized loss of $1.7 million, or 27.1% of cost. See
Notes 3 and 11 of Notes to Financial Statements. The
Company believes that the cash flows received from the security
have not changed from those that were expected when the
securitization was complete in 2006.
The Company continually monitors these investments and believes
that, as of December 31, 2007, the unrealized loss in these
investments is temporary.
The Company regularly monitors its investment portfolio to
attempt to minimize its concentration of credit risk in any
single issuer. Set forth in the table below is a schedule of all
investments representing greater than 1% of the
46
Companys aggregate investment portfolio at
December 31, 2007 and 2006, excluding investments in
U.S. Government securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
% of Total
|
|
|
|
Carrying
|
|
|
Carrying
|
|
|
Carrying
|
|
|
Carrying
|
|
|
|
Amount
|
|
|
Value
|
|
|
Amount
|
|
|
Value
|
|
|
|
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
Issuer Fixed Maturities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UnitedHealth Group(1)
|
|
$
|
92,393
|
|
|
|
6.2
|
%
|
|
$
|
94,763
|
|
|
|
5.3
|
%
|
Morgan Stanley Dean Witter
|
|
|
22,560
|
|
|
|
1.5
|
%
|
|
|
|
|
|
|
|
|
Household Finance Corporation
|
|
|
15,035
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
Federal National Mortgage Corporation
|
|
|
15,028
|
|
|
|
1.0
|
%
|
|
|
17,992
|
|
|
|
1.0
|
%
|
General Electric Capital Corporation
|
|
|
15,022
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
Issuer Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fidelity Institutional Money Market Fund(2)
|
|
$
|
88,657
|
|
|
|
6.0
|
%
|
|
$
|
325,677
|
|
|
|
18.1
|
%
|
|
|
|
(1) |
|
Represents security received from the purchaser as consideration
upon sale of the Companys former Student Insurance
Division on December 1, 2006. To reduce the Companys
credit risk, the Company has taken out $75.0 million of
credit default insurance on this security, reducing the
Companys default exposure to $19.8 million. |
|
(2) |
|
The Fidelity Institutional Money Market Fund is a diversified
institutional money market fund that invests solely in high
quality United States dollar denominated money market securities
of domestic and foreign issuers. |
Critical
Accounting Policies and Estimates
The Companys discussion and analysis of its financial
condition and results of operations are based upon the
Companys consolidated financial statements, which have
been prepared in accordance with accounting principles generally
accepted in the United States of America. The preparation of
these financial statements requires the Company to make
estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses and related
disclosure of contingent assets and liabilities. On an on-going
basis, the Company evaluates its estimates, including those
related to health and life insurance claims, bad debts,
investments, intangible assets, income taxes, financing
operations and contingencies and litigation. The Company bases
its estimates on historical experience and on various other
assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. Actual results
may differ from these estimates under different assumptions or
conditions.
The Company believes the following critical accounting policies
affect its more significant judgments and estimates used in the
preparation of its consolidated financial statements.
Claims
Liabilities
The Company establishes liabilities for benefit claims that have
been reported but not paid and claims that have been incurred
but not reported under health and life insurance contracts. The
claim liability estimate, as determined, is expected to be
adequate under reasonably likely circumstances. The estimate is
developed using actuarial principles and assumptions that
consider a number of items, including but not limited to
historical and current claim payment patterns, product
variations, the timely implementation of rate increases and
seasonality. The Company does not develop ranges in the setting
of the claims liability reported in the financial statements
For the majority of health insurance products in the
Self-Employed Agency Division, the Companys claim
liabilities are estimated using the developmental method, which
involves the use of completion factors for most incurral months,
supplemented with additional estimation techniques, such as loss
ratio estimates, in the most recent
47
incurral months. This method applies completion factors to claim
payments in order to estimate the ultimate amount of the claim.
These completion factors are derived from historical experience
and are dependent on the incurred dates of the claim payments.
The completion factors are selected so that they are equally
likely to be redundant as deficient.
In estimating the ultimate level of claims for the most recent
incurral months, the Company uses what it believes are prudent
estimates that reflect the uncertainty involved in these
incurral months. An extensive degree of judgment is used in this
estimation process. For healthcare costs payable, the claim
liability balances and the related benefit expenses are highly
sensitive to changes in the assumptions used in the claims
liability calculations. With respect to health claims, the items
that have the greatest impact on the Companys financial
results are the medical cost trend, which is the rate of
increase in healthcare costs, and the unpredictable variability
in actual experience. Any adjustments to prior period claim
liabilities are included in the benefit expense of the period in
which adjustments are identified. Due to the considerable
variability of healthcare costs and actual experience,
adjustments to health claim liabilities usually occur each
quarter and may be significant.
The Company establishes the claims liability using the original
incurred date, with certain adjustments as described below.
Under this incurred date methodology, claims liabilities for the
cost of all medical services related to the accident or sickness
are recorded at the earliest date of diagnosis or treatment,
even though the medical services associated with such accident
or sickness might not be rendered to the insured until a later
financial reporting period. A break in service of more than six
months will result in the establishment of a new incurred date
for subsequent services. A new incurred date will be established
if claims payments continue for more than thirty-six months
without a six month break in service.
The completion factors and loss ratio estimates in the most
recent incurred months are the most significant factors
affecting the estimate of the claim liability. The Company
believes that the greatest potential for variability from
estimated results is likely to occur at its SEA Division. The
following table illustrates the sensitivity of these factors and
the estimated impact to the December 31, 2007 unpaid claim
liability for the SEA Division. The scenarios selected are
reasonable based on the Companys past experience, however
future results may differ.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Completion Factor(a)
|
|
|
Loss Ratio Estimate(b)
|
|
Increase
|
|
|
Increase (Decrease)
|
|
|
Increase
|
|
|
Increase (Decrease) in
|
|
(Decrease)
|
|
|
in Estimated Claim
|
|
|
(Decrease) in
|
|
|
Estimated Claim
|
|
in Factor
|
|
|
Liability
|
|
|
Ratio(c)
|
|
|
Liability
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
(In thousands)
|
|
|
|
0.015
|
|
|
$
|
(28,419
|
)
|
|
|
6
|
|
|
$
|
33,687
|
|
|
0.010
|
|
|
|
(19,726
|
)
|
|
|
3
|
|
|
|
16,844
|
|
|
0.005
|
|
|
|
(10,112
|
)
|
|
|
(3
|
)
|
|
|
(16,844
|
)
|
|
(0.005
|
)
|
|
|
10,224
|
|
|
|
(6
|
)
|
|
|
(33,687
|
)
|
|
(0.010
|
)
|
|
|
20,561
|
|
|
|
(9
|
)
|
|
|
(50,531
|
)
|
|
(0.015
|
)
|
|
|
31,015
|
|
|
|
(12
|
)
|
|
|
(67,375
|
)
|
|
|
|
(a) |
|
Impact due to change in completion factors for incurred months
prior to the most recent five months. |
|
(b) |
|
Impact due to change in estimated loss ratio for the most recent
five months. |
|
(c) |
|
For example, if the loss ratio increased from 50% to 56% this
would be an increase of 6. |
The SEA Division also makes various refinements to the claim
liabilities as appropriate. These refinements estimate
liabilities for circumstances, such as inventories of pending
claims in excess of historical levels and disputed claims. When
the level of pending claims appears to be in excess of normal
levels, the Company typically establishes a liability for excess
pending claims. The Company believes that such an excess pending
claims liability is appropriate under such circumstances because
of the operation of the developmental method used to calculate
the principal claim liability, which method develops
or completes paid claims to estimate the claim
liability. When the pending claims inventory is higher than
would ordinarily be expected, the level of paid claims is
correspondingly lower than would ordinarily be expected. This
lower level of paid claims, in turn, results in the
developmental method yielding a smaller claim liability than
would have been yielded with a normal level of paid claims,
resulting in the need for an augmented claim liability.
48
With respect to business at its Disposed Operations segment, the
Company assigned incurred dates based on the date of service.
This definition estimated the liability for all medical services
received by the insured prior to the end of the applicable
financial period. Appropriate adjustments were made in the
completion factors to account for pending claim inventory
changes and contractual continuation of coverage beyond the end
of the financial period.
Set forth below is a summary of claim liabilities by business
unit at each of December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
371,861
|
|
|
$
|
417,571
|
|
|
$
|
438,857
|
|
Life Insurance Division
|
|
|
12,148
|
|
|
|
11,472
|
|
|
|
10,989
|
|
Other Insurance
|
|
|
13,747
|
|
|
|
14,289
|
|
|
|
16,247
|
|
Disposed Operations(1)
|
|
|
50
|
|
|
|
1,218
|
|
|
|
79,908
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
397,806
|
|
|
|
444,550
|
|
|
|
546,001
|
|
Reinsurance recoverable(2)
|
|
|
37,293
|
|
|
|
72,582
|
|
|
|
12,105
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total claim liabilities
|
|
$
|
435,099
|
|
|
$
|
517,132
|
|
|
$
|
558,106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Reflects claims liabilities associated with the Companys
former Student Insurance Division and Star HRG Division. The
claims liabilities remaining at December 31, 2006 and 2007
represent the residual liability associated with a closed block
short-term product previously offered by, and retained by the
Company in the 2006 sale of, the Student Insurance Division. |
|
(2) |
|
Reflects liability related to unpaid losses recoverable. The
amount associated with Disposed Operations in 2007, 2006 and
2005 is $26.8 million, $61.3 million, and
$2.7 million, respectively. |
The developmental method used by the Company to estimate most of
its claim liabilities produces a single estimate of reserves for
both in course of settlement (ICOS) and incurred but not
reported (IBNR) claims on an integrated basis. Since the IBNR
portion of the claim liability represents claims that have not
been reported to the Company, this portion of the liability is
inherently more imprecise and difficult to estimate than other
liabilities. A separate IBNR or ICOS reserve is estimated from
the combined reserve by allocating a portion of the combined
reserve based on historical payment patterns. Approximately
83-85% of
the Companys claim liabilities represent IBNR claims.
49
Set forth in the table below is the summary of the incurred but
not reported claim liability by business unit at each of
December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Self Employed Agency Division
|
|
$
|
309,462
|
|
|
$
|
346,060
|
|
|
$
|
368,556
|
|
Life Insurance Division
|
|
|
3,907
|
|
|
|
4,254
|
|
|
|
4,725
|
|
Other Insurance
|
|
|
13,700
|
|
|
|
14,177
|
|
|
|
16,007
|
|
Disposed Operations
|
|
|
50
|
|
|
|
1,182
|
|
|
|
75,809
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
327,119
|
|
|
|
365,673
|
|
|
|
465,097
|
|
Reinsurance recoverable
|
|
|
32,270
|
|
|
|
65,341
|
|
|
|
7,971
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total IBNR claim liability
|
|
|
359,389
|
|
|
|
431,014
|
|
|
|
473,068
|
|
ICOS claim liability
|
|
|
70,687
|
|
|
|
78,877
|
|
|
|
80,904
|
|
Reinsurance recoverable
|
|
|
5,023
|
|
|
|
7,241
|
|
|
|
4,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total ICOS claim liability
|
|
|
75,710
|
|
|
|
86,118
|
|
|
|
85,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total claim liability
|
|
$
|
435,099
|
|
|
$
|
517,132
|
|
|
$
|
558,106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of IBNR to Total
|
|
|
83
|
%
|
|
|
83
|
%
|
|
|
85
|
%
|
Claims
Liability Development Experience
Activity in the claims liability is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Claims liability at beginning of year, net of reinsurance
|
|
$
|
444,550
|
|
|
$
|
546,001
|
|
|
$
|
610,779
|
|
Less: Claims liability paid on business disposed
|
|
|
|
|
|
|
(68,617
|
)
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
Incurred losses, net of reinsurance, occurring during:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
851,575
|
|
|
|
1,059,032
|
|
|
|
1,191,723
|
|
Prior years
|
|
|
(75,024
|
)
|
|
|
(90,697
|
)
|
|
|
(124,996
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total incurred losses, net of reinsurance
|
|
|
776,551
|
|
|
|
968,335
|
|
|
|
1,066,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deduct:
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for claims, net of reinsurance, occurring during:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
535,987
|
|
|
|
664,220
|
|
|
|
765,767
|
|
Prior years
|
|
|
287,308
|
|
|
|
336,949
|
|
|
|
365,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total paid claims, net of reinsurance
|
|
|
823,295
|
|
|
|
1,001,169
|
|
|
|
1,131,505
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims liability at end of year, net of related reinsurance
recoverable (2007 $37,293; 2006 $72,582;
2005 $12,105)
|
|
$
|
397,806
|
|
|
$
|
444,550
|
|
|
$
|
546,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As indicated in the table above, incurred losses developed in
amounts less than originally anticipated.
50
Set forth in the table below is a summary of the claims
liability development experience (favorable) unfavorable by
business unit in the Companys Insurance segment for each
of the years ended December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Self-Employed Agency Division
|
|
$
|
(75,552
|
)
|
|
$
|
(85,784
|
)
|
|
$
|
(121,362
|
)
|
Life Insurance Division
|
|
|
(163
|
)
|
|
|
(510
|
)
|
|
|
337
|
|
Other Insurance
|
|
|
734
|
|
|
|
(2,530
|
)
|
|
|
805
|
|
Disposed Operations
|
|
|
(43
|
)
|
|
|
(1,873
|
)
|
|
|
(4,776
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total favorable development
|
|
$
|
(75,024
|
)
|
|
$
|
(90,697
|
)
|
|
$
|
(124,996
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact on SEA Division. As indicated in the
table above, incurred losses developed at the SEA Division in
amounts less than originally anticipated due to
better-than-expected experience on the health business in each
of the years.
For the SEA Division, the favorable claims liability development
experience in the prior years reserve for each of the
years ended December 31, 2007, 2006 and 2005 is set forth
in the table below by source:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Development in the most recent incurral months
|
|
$
|
(25,957
|
)
|
|
$
|
(31,949
|
)
|
|
$
|
(64,587
|
)
|
Development in completion factors
|
|
|
(9,536
|
)
|
|
|
(4,606
|
)
|
|
|
(9,677
|
)
|
Development in reserves for regulatory and legal matters
|
|
|
(14,991
|
)
|
|
|
(4,762
|
)
|
|
|
(6,971
|
)
|
Development in ACE rider
|
|
|
(13,670
|
)
|
|
|
(29,726
|
)
|
|
|
(27,171
|
)
|
Development in non-renewed blanket policies
|
|
|
(6,669
|
)
|
|
|
|
|
|
|
|
|
Development in large claim reserve
|
|
|
|
|
|
|
(10,555
|
)
|
|
|
(8,455
|
)
|
Other
|
|
|
(4,729
|
)
|
|
|
(4,186
|
)
|
|
|
(4,501
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total favorable development
|
|
$
|
(75,552
|
)
|
|
$
|
(85,784
|
)
|
|
$
|
(121,362
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total favorable claims liability development experience for
2007, 2006 and 2005 in the amount of $75.6 million,
$85.8 million and $121.4 million, respectively,
represented 18.1%, 19.5% and 24.6% of total claim liabilities
established for the SEA Division as of December 31, 2006,
2005 and 2004, respectively.
Development
in the most recent incurral months and Development in completion
factors
As indicated in the table above, considerable favorable
development ($35.5 million, $36.6 million and
$74.3 million for year ended December 31, 2007, 2006
and 2005, respectively) is associated with the estimate of claim
liabilities for the most recent incurral months and development
of completion factors. The completion factors are derived from
historical experience, and favorable or unfavorable development
may result when current claim payment patterns differ from
historical patterns. The completion factors are selected so that
they are equally likely to be redundant as deficient. In
estimating the ultimate level of claims for the most recent
incurral months, the Company uses what it believes are prudent
estimates that reflect the uncertainty involved in these
incurral months. An extensive degree of judgment is used in this
estimation process. Over time, the developmental method replaces
anticipated experience with actual experience, resulting in an
ongoing re-estimation of the claims liability. Since the
greatest degree of estimation is used for more recent periods,
the most recent prior year is subject to the greatest change.
Recent actual experience has produced lower levels of claims
payment experience than originally expected. The favorable
development also reflects changes in the assumptions used to
calculate the estimate of the claim liability. See discussion
below regarding Changes in SEA Claim Liability Estimates.
51
Development
in reserves for regulatory and legal matters
The Company experienced favorable development for each of the
three years presented in the table above associated with its
reserves for regulatory and legal matters due to settlements of
certain matters on terms more favorable than originally
anticipated.
Development
in the ACE rider
The Accumulated Covered Expense (ACE) rider is an
optional benefit rider available with certain scheduled/basic
health insurance products that provides for catastrophic
coverage for covered expenses under the contract that generally
exceed $100,000 or, in certain cases, $75,000. This rider pays
benefits at 100% after the stop loss amount is reached up to the
aggregate maximum amount of the contract for expenses covered by
the rider. Development in the ACE rider is presented separately
due to the greater level of volatility in the ACE product
resulting from the nature of the benefit design where there are
less frequent claims but larger dollar value claims. The
development experience presented in the table above is partially
attributable to development in the most recent incurral months
and development in the completion factors. The favorable
development also reflects changes in the assumptions used to
calculate the estimate of the claim liability. See discussion
below regarding Changes in the SEA Claim Liability
Estimates.
Development
in non-renewed blanket policies
In 2007, the SEA Division benefited from favorable development
in its claim liability of $6.7 million related to its
reserve for benefits provided through group blanket contracts to
the members of certain associations. These contracts were not
renewed and the Companys subsequent actual experience was
favorable in comparison to the reserve estimates established
prior to the termination of the contracts.
Development
in large claim reserve
The Company experienced favorable development of
$8.5 million during 2005 in its reserve for large claims as
a result of lower frequency and severity of large claims than
anticipated. During 2006, the Company determined that sufficient
provision for large claims could be made within its normal
reserve process, thus eliminating the need for the separate
large claim reserve and producing favorable development in the
amount of $10.6 million. Since this reserve was eliminated
in 2006, there is no subsequent development in 2007, either
favorable or unfavorable.
Other
The remaining favorable experience in the claim liability
development was $4.7 million, $4.2 million and
$4.5 million in 2007, 2006 and 2005, respectively, which in
each year, represented less than 1.1% of total claim liability
established at the end of each preceding year.
Impact on Life Insurance Division. The varied
claim liability development experience at the Life Insurance
Division for each of the years presented is due to the
development of a closed block of workers compensation
business.
Impact on Other Insurance. Through our
82.5%-owned subsidiary, ZON Re, we underwrite, administer and
issue accidental death, AD&D, accident medical and accident
disability insurance products, both on a primary and on a
reinsurance basis. The unfavorable claim liability development
experience at ZON Re in 2007 in the amount of $734,000 was due
to certain large claims reported in 2007 associated with claims
incurred in prior years. The favorable claim liability
experience of $2.5 million in 2006 is due to the release of
reserves held at December 31, 2005 for catastrophic excess
of loss contracts expiring during 2006.
Impact on Disposed Operations. The products of
the Companys former Student Insurance and Star HRG
Divisions consist principally of medical insurance. In general,
medical insurance business, for which incurred dates are
assigned based on date of service, has a short tail,
which means that a favorable development or unfavorable
development shown for prior years relates primarily to actual
experience in the most recent prior year. During 2007, the
development of the claim liabilities for the Disposed Operations
showed a small favorable development of $43,000.
52
The favorable claim liability development experience at the
Student Insurance Division in 2006 and 2005 was $478,000 and
$5.2 million, respectively. This favorable development was
due to claims in the current year developing more favorably than
indicated by the loss trends used to determine the claim
liability at December 31 of the preceding year.
The favorable claims liability development experience at Star
HRG Division of $1.4 million in 2006 included the effects
of claims in 2006 developing more favorably than indicated by
the loss trends in 2005 used to determine the claim liability at
December 31, 2005. The unfavorable claim liability
development at the Star HRG Division in 2005 of $410,000 was
within the normal statistical variation in the model used to
develop the reserve. The actual development of prior years
claims exceeded the expected development of the claim liability.
Changes
in SEA Claim Liability Estimates
As presented in the table above, the SEA Division has reported
particularly favorable development experience for the last
several years. In response to these results, the Company has
endeavored and will continue in its efforts to refine its
estimates and assumptions in calculating the claim liability
estimate. To the extent the changes in estimates described below
related to prior year incurral months at the time the change was
implemented, that portion or amount of the change is included in
the development experience table. The Company made the following
changes in estimate, by year, as described below:
2007 Change in Claim Liability
Estimates. During 2007, the Company made the
following refinements to its claim liability estimate.
|
|
|
|
|
A reduction in the claim liability of $11.2 million
recorded in the fourth quarter was attributable to an update of
the completion factors used in the developmental method of
estimating the unpaid claim liability to reflect more recent
claims payment experience.
|
|
|
|
In 2007, the Company made certain refinements to reduce its
estimate of the claim liability for the ACE rider totaling
$10.9 million. The refinement of $5.9 recorded in the third
quarter was attributable to an update of the completion factors
used in estimating the claim liability for the ACE rider. A
benefit recorded in the second quarter of $5.0 million
reflected an increasing reliance on actual historical data for
the ACE rider in lieu of large claim data derived from other
products.
|
|
|
|
During the third quarter of 2007, the claim liability was
reduced by $12.3 million resulting from a refinement to the
estimate of unpaid claim liability specifically for the most
recent incurral months. In particular, the Company reassessed
its claim liability estimates among product lines between the
more mature scheduled benefit products that have more historical
data and are more predictable, and the newer products that are
less mature, have less historical data and are more susceptible
to adverse deviation.
|
2006 Change in Claim Liability
Estimates. During 2006, the Company made the
following refinements to its claim liability estimate.
|
|
|
|
|
In the third quarter, the Company reduced the claim liability
estimate by $11.2 million due to refinements of the
estimate of the unpaid claim liability for the most recent
incurral months. This update to the calculation distinguished
between more mature products with reliable historical data and
newer or lower volume products that had not established a
reliable historical trend.
|
|
|
|
During 2006, the Company reduced the claim liability estimate by
a total of $25.1 million for the ACE rider,
$10.5 million was recorded in the third quarter and
$14.6 million was recorded in the fourth quarter. These
reductions were attributable to an update of the completion
factors used in estimating the claim liability, reflecting both
actual historical data for the ACE rider and historical data
derived from other products. In 2005, the completion factors
were calculated with more emphasis placed on historical data
derived from other products since there was insufficient data
related to the ACE product rider to provide accurate and
reliable completion factors.
|
2005 Change in Claim Liability
Estimates. During 2005, the Company made the
following refinements to its claim liability estimate.
53
|
|
|
|
|
In the third quarter, the Company reduced the claim liability
estimate by $21.0 million. This reduction was attributable
to a refinement of the estimate of the unpaid claim liability
for the most recent incurral months. The Company utilizes
anticipated loss ratios to calculate the estimated claim
liability for the most recent incurral months. Despite
negligible premium rate increases implemented on the most
popular scheduled health insurance products, the SEA Division
has continued to observe favorable claims experience and, as a
result, loss ratios have not increased as rapidly as
anticipated. This favorable claims experience has been reflected
in the refinement of the anticipated loss ratios used in
estimating the unpaid claim liability for the most recent
incurral months.
|
|
|
|
In addition, in the third quarter, an additional
$12.3 million reduction was made as a result of updates to
the completion factors used in the developmental method of
estimating the unpaid claim liability, reflecting more current
claims administration practices.
|
|
|
|
In the first quarter, the Company made certain refinements to
its claim liability calculations related to the ACE rider, the
effect of which decreased claim liabilities by
$7.6 million. Prior to January 1, 2005, the Company
utilized a technique that is commonly used to estimate claims
liabilities with respect to developing blocks of business, until
sufficient experience is obtained to allow more precise
estimates. The Company believed that the technique produced
appropriate reserve estimates in all prior periods. During the
first quarter of 2005, the Company believed that there were
sufficient claims paid on this benefit to produce a reserve
estimate utilizing the completion factor technique. As a result,
effective January 1, 2005, the Company refined its
technique used to estimate claim liabilities to utilize
completion factors for older incurral dates. The technique
utilizes anticipated loss ratios in the most recent incurral
months. This completion factor technique utilized historical
data derived from other products since there was insufficient
data related to the ACE product rider to provide accurate and
reliable completion factors.
|
Accounting
for Policy Acquisition Costs
Health
Policy Acquisition Costs
The Company incurs various costs in connection with the
origination and initial issuance of its health insurance
policies, including underwriting and policy issuance costs,
costs associated with lead generation activities and
distribution costs (i.e., sales commissions paid to
agents). The Company defers those costs that vary with
production. The Company generally defers commissions paid to
agents and premium taxes with respect to the portion of health
premium collected but not yet earned and the Company amortizes
the deferred expense over the period as and when the premium is
earned. Costs associated with generating sales leads with
respect to the health business issued through the SEA Division
are capitalized and amortized over the average life of a policy,
which approximates a two-year period. Other underwriting and
policy issuance costs (which the Company estimates are more
fixed than variable) are expensed as incurred.
At December 31, 2006, the Company changed its accounting
policy, effective January 1, 2006, with respect to the
amortization of a portion of deferred acquisition costs
associated with commissions paid to agents. Generally, the first
year and second year commission rates on policies issued by the
Companys SEA Division are higher than renewal year
commission rates. Commencing in 2006, the Company changed its
accounting methodology with respect to the first year and second
year excess commissions and now amortizes those excess
commissions over a two year period, which approximates the
average life of the policy. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations 2006 Change in Accounting
Policy.
Life
Policy Acquisition Costs
The Company incurs various costs in connection with the
origination and initial issuance of its life insurance policies,
including underwriting and policy issuance costs. The Company
defers those costs that vary with production. The Company
capitalizes commission and issue costs primarily associated with
the new business of its Life Insurance Division. Deferred
acquisition costs consist primarily of sales commissions and
other underwriting costs of new life insurance sales. Policy
acquisition costs associated with traditional life business are
capitalized and amortized over the estimated premium-paying
period of the related policies, in proportion to the ratio of
the annual premium revenue to the total premium revenue
anticipated. Such anticipated premium revenue,
54
which is modified to reflect actual lapse experience, is
estimated using the same assumptions as are used for computing
policy benefits. For universal life-type and annuity contracts,
capitalized costs are amortized at a constant rate based on the
present value of the estimated gross profits expected to be
realized on the book of contracts.
Other
The cost of business acquired through acquisition of
subsidiaries or blocks of business is determined based upon
estimates of the future profits inherent in the business
acquired. Such costs are capitalized and amortized over the
estimated premium-paying period. Anticipated investment income
is considered in determining whether a premium deficiency
exists. The amortization period is adjusted when estimates of
current or future gross profits to be realized from a group of
products are revised.
We monitor and assesses the recoverability of deferred health
and life policy acquisition costs on a quarterly basis.
Goodwill
and Other Identifiable Intangible Assets
The Company accounts for goodwill and other intangibles
according to Financial Accounting Standards Board
(FASB) FAS No. 142, Goodwill and Other
Intangible Assets (FAS 142). FAS 142
requires that goodwill and other intangible assets with
indefinite useful lives be tested for impairment at least
annually or more frequently if certain indicators arise. An
impairment loss would be recorded in the period such
determination was made. FAS 142 also requires that
intangible assets with estimable useful lives be amortized over
their respective estimated useful lives to their estimated
residual values and reviewed for impairment. The Company
amortizes its intangible assets with estimable useful lives over
a period ranging from one to twenty-five years. See
Note 5 of Notes to Financial Statements.
Accounting
for Agent Stock Accumulation Plans
The Company sponsors a series of stock accumulation plans (the
Agent Plans) established for the benefit of the
independent insurance agents and independent sales
representatives associated with UGA Association
Field Services and Cornerstone America. The Company has
established a liability for future unvested benefits under the
Agent Plans and adjusts the liability based on the fair value of
the Companys Common Stock. The accounting treatment of the
Companys Agent Plans has resulted and will continue to
result in unpredictable stock-based compensation charges,
dependent upon fluctuations in the fair value of HealthMarkets
Class A-2
common stock. These unpredictable fluctuations in stock based
compensation charges may result in material non-cash
fluctuations in the Companys results of operations. See
discussion above under the caption Variable
Stock-Based Compensation and Note 14 of Notes to
Financial Statements.
Investments
The Company has classified its investments in securities with
fixed maturities as available for sale. Investments in equity
securities and securities with fixed maturities have been
recorded at fair value, and unrealized investment gains and
losses are reflected in stockholders equity. Investment
income is recorded when earned, and capital gains and losses are
recognized when investments are sold. Investments are reviewed
quarterly to determine if they have suffered an impairment of
value that is considered other than temporary. If investments
are determined to be other than temporarily impaired, a loss is
recognized at the date of determination.
Testing for impairment of investments also requires significant
management judgment. The identification of potentially impaired
investments, the determination of their fair value and the
assessment of whether any decline in value is other than
temporary are the key judgment elements. The discovery of new
information and the passage of time can significantly change
these judgments. Revisions of impairment judgments are made when
new information becomes known, and any resulting impairments are
made at that time. The economic environment and volatility of
securities markets increase the difficulty of determining fair
value and assessing investment impairment. The same influences
tend to increase the risk of potentially impaired assets.
55
Investments are reviewed quarterly (or more frequently if
certain indicators arise) to determine if they have suffered an
impairment of value that is considered other than temporary.
Managements review considers the following indicators of
impairment: fair value significantly below cost; decline in fair
value attributable to specific adverse conditions affecting a
particular investment; decline in fair value attributable to
specific conditions, such as conditions in an industry or in a
geographic area; decline in fair value for an extended period of
time; downgrades by rating agencies from investment grade to
non-investment grade; financial condition of the issuer
deterioration and situations where dividends have been reduced
or eliminated or scheduled interest payments have not been made.
Management monitors investments where two or more of the above
indicators exist. The Company also identifies investments in
economically challenged industries. If investments are
determined to be other than temporarily impaired, a loss is
recognized at the date of determination.
The Company seeks to match the cash flows of invested assets
with the payment of expected liabilities. By doing this, the
Company attempts to make cash available as payments become due.
If a significant mismatch of the maturities of assets and
liabilities were to occur, the impact on the Companys
results of operations could be significant.
Non-Consolidated
Subsidiary
On August 3, 2006, Grapevine Finance LLC
(Grapevine) was incorporated in the State of
Delaware as a wholly owned subsidiary of HealthMarkets, LLC. On
August 16, 2006, the Company distributed and assigned to
Grapevine the $150.8 million promissory note (CIGNA
Note) and related Guaranty Agreement issued by Connecticut
General Corporation in the Star HRG sale transaction (see
Note 2 of Notes to Financial Statements). On
August 16, 2006, Grapevine issued $72.4 million of its
senior secured notes to an institutional purchaser
collateralized by Grapevines assets including the CIGNA
Note. The net proceeds from the senior secured notes were
distributed to HealthMarkets, LLC.
Grapevine is a non-consolidated qualifying special purpose
entity as defined in FASB 140, Accounting for Transfers and
Servicing of Financial Assets and Extinguishments of
Liabilities. As a qualifying special purpose entity,
HealthMarkets does not consolidate the financial results of
Grapevine and accounts for its residual interest in Grapevine as
an investment in fixed maturity securities pursuant to
EITF 99-20,
Recognition of Interest Income and Impairment on Purchase and
Retained Beneficial Interests in Securitized Financial
Assets.
The Company measures the fair value of its residual interest in
Grapevine using a present value model incorporating the
following two key economic assumptions: (1) the timing of
the collections of interest on the CIGNA Note, payments of
interest expense on the senior secured notes and payment of
other administrative expenses and (2) an assumed discount
rate equal to the 15 year swap rate.
Deferred
Taxes
The Company records deferred tax assets to reflect the impact of
temporary differences between the financial statement carrying
amounts and tax bases of assets. Realization of the net deferred
tax asset is dependent on generating sufficient future taxable
income. The amount of the deferred tax asset considered
realizable, however, could be reduced in the near term if
estimates of future taxable income during the carryforward
period are reduced.
The Company establishes a valuation allowance when management
believes, based on the weight of the available evidence, that it
is more likely than not that some portion of the deferred tax
asset will not be realized. The Company considers future taxable
income and ongoing prudent and feasible tax planning strategies
in assessing the continued need for a recorded valuation
allowance. Establishing or increasing the valuation allowance
would result in a charge to income in the period such
determination was made. In the event the Company were to
determine that it would be able to realize its deferred tax
assets in the future in excess of its net recorded amount, an
adjustment to the deferred tax asset would increase income in
the period such determination was made.
In 2003, the Company realized net capital losses that were
carried forward and available to offset future capital gains, if
any, realized in the following 5 years. In 2003, the
Company established a valuation allowance for the deferred tax
asset resulting from the capital loss carryforward reflecting
the uncertainty in the Companys ability to realize that
asset in subsequent years through the generation of sufficient
capital gains. In 2006, the sales of the
56
Student Insurance and the Star HRG Divisions generated capital
gains in excess of the capital loss carryover. Accordingly, in
2006, the Company released the valuation allowance of
$18.1 million thereby realizing the deferred tax benefits
of the capital loss carryforwards.
Loss
Contingencies
The Company is subject to proceedings and lawsuits related to
insurance claims and other matters. See Note 17 of
Notes to Financial Statements. The Company is required to assess
the likelihood of any adverse judgments or outcomes to these
matters, as well as potential ranges of probable losses. A
determination of the amount of accruals required, if any, for
these contingencies is made after careful analysis of each
individual issue. The required accruals may change in the future
due to new developments in each matter or changes in approach,
such as a change in settlement strategy in dealing with these
matters.
Privacy
Initiatives
The business of insurance is primarily regulated by the states
and is also affected by a range of legislative developments at
the state and federal levels. Recently-adopted legislation and
regulations governing the use and security of individuals
nonpublic personal data by financial institutions, including
insurance companies, may have a significant impact on the
Companys business and future results of operations. See
Business Regulatory and Legislative
Matters.
Other
Matters
The state of domicile of each of the Companys domestic
insurance subsidiaries imposes minimum risk-based capital
requirements that were developed by the NAIC. The formulas for
determining the amount of risk-based capital specify various
weighting factors that are applied to financial balances and
premium levels based on the perceived degree of risk. Regulatory
compliance is determined by a ratio of a companys
regulatory total adjusted capital, as defined, to its authorized
control level risk-based capital, as defined. Companies
specific trigger points or ratios are classified within certain
levels, each of which requires specified corrective action. At
December 31, 2007, the risk-based capital ratio of each of
the Companys domestic insurance subsidiaries significantly
exceeded the ratios for which regulatory corrective action would
be required.
Dividends paid by domestic insurance companies out of earned
surplus in any year are limited by the law of the state of
domicile. See Item 5 Market for
Registrants Common Stock and Related Stockholder Matters
and Note 13 of Notes to Financial Statements.
Inflation
Inflation historically has had a significant impact on the
health insurance business. In recent years, inflation in the
costs of medical care covered by such insurance has exceeded the
general rate of inflation. Under basic hospital medical
insurance coverage, established ceilings for covered expenses
limit the impact of inflation on the amount of claims paid.
Under catastrophic hospital expense plans and preferred provider
contracts, covered expenses are generally limited only by a
maximum lifetime benefit and a maximum lifetime benefit per
accident or sickness. Thus, inflation may have a significantly
greater impact on the amount of claims paid under catastrophic
hospital expense and preferred provider plans as compared to
claims under basic hospital medical coverage. As a result,
trends in healthcare costs must be monitored and rates adjusted
accordingly. Under the health insurance policies issued in the
self-employed market, the primary insurer generally has the
right to increase rates upon
30-60 days
written notice and subject to regulatory approval in some cases.
The annuity and universal life-type policies issued directly and
assumed by the Company are significantly impacted by inflation.
Interest rates affect the amount of interest that existing
policyholders expect to have credited to their policies.
However, the Company believes that the annuity and universal
life-type policies are generally competitive with those offered
by other insurance companies of similar size, and the investment
portfolio is managed to minimize the effects of inflation.
57
Recently
Issued Accounting Pronouncements
On March 19, 2008 the FASB issued FAS No. 161,
Disclosures about Derivative Instruments and Hedging
Activities, which amends FASB Statement No. 133,
Accounting for Derivative Instruments and Hedging Activities.
The Statement requires companies with derivative instruments
to disclose information that should enable financial statement
users to understand how and why a company uses derivative
instruments, how derivative instruments and related hedged items
are accounted for under FAS No. 133, and how
derivative instruments and related hedged items affect a
companys financial position, financial performance, and
cash flows. The required disclosures include the fair value of
derivative instruments and their gains or losses in tabular
format, information about credit risk related contingent
features in derivative agreements, counterparty credit risk, and
a companys strategies and objectives for using derivative
instruments. The Statement expands the current disclosure
framework in FAS No. 133. FAS No. 161 is
effective prospectively for period beginning on or after
November 15, 2008. The Company is currently evaluating the
impact of this pronouncement on its financial position and
results of operations.
In December 2007, FAS No. 160, Noncontrolling
Interests in Consolidated Financial Statements an
amendment of ARB No. 51, was issued. The objective of
FAS 160 is to improve the relevance, comparability, and
transparency of the financial information related to minority
interest that a reporting entity provides in its consolidated
financial statements. This Statement is effective for fiscal
years, and interim periods within those fiscal years, beginning
on or after December 15, 2008. The Company believes this
statement will not have a material impact on its financial
position or results of operations.
In February 2007, FAS No. 159, The Fair Value
Option for Financial Assets and Financial Liabilities was
issued. FAS 159 permits an entity to elect fair value as
the initial and subsequent measurement attribute for many
financial assets and liabilities. Entities electing the fair
value option would be required to recognize changes in fair
value in earnings. Entities electing the fair value option are
required to distinguish on the face of the statement of
financial position, the fair value of assets and liabilities for
which the fair value option has been elected and similar assets
and liabilities measured using another measurement attribute.
FAS 159 is effective for fiscal year 2008. The adjustment
to reflect the difference between the fair value and the
carrying amount would be accounted for as a cumulative-effect
adjustment to retained earnings as of the date of initial
adoption. The Company believes this statement will not have a
material impact on its financial position or results of
operations.
On January 1, 2007, the Company adopted the provisions of
the FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes an interpretation of
FAS No. 109, (FIN 48). FIN 48 clarifies
the accounting for income taxes by prescribing a minimum
recognition threshold that a tax position is required to meet
before being recognized in the financial statements. FIN 48
also provides guidance on derecognition, measurement,
classification, interest and penalties, disclosure and
transition. The adoption of FIN 48 did not impact the
Companys financial condition or results of operations.
In February 2006, the FASB issued FAS No. 155,
Hybrid Instruments. SFAS No. 155 amends
FAS No. 133 and FAS No. 140, Accounting
for Transfers and Servicing of Financial Assets and
Extinguishments of Liabilities. FAS No. 155 also
resolves issues addressed in Statement 133 Implementation Issue
No. D1, Application of Statement 133 to Beneficial
Interests in Securitized Financial Assets.
FAS No. 155: a) permits fair value remeasurement
for any hybrid financial instrument that contains an embedded
derivative that otherwise would require bifurcation,
b) clarifies which interest-only strips and principal-only
strips are not subject to the requirements of
SFAS No. 133, c) establishes a requirement to
evaluate interests in securitized financial assets to identify
interests that are freestanding derivatives or that are hybrid
financial instruments that contain an embedded derivative
requiring bifurcation, d) clarifies that concentrations of
credit risk in the form of subordination are not embedded
derivatives, and e) amends FAS No. 140 to
eliminate the prohibition on a qualifying special purpose entity
from holding a derivative financial instrument that pertains to
a beneficial interest other than another derivative financial
instrument. The Company adopted FAS No. 155 effective
January 1, 2007; however, there was no material impact.
In September 2006, the FASB issued Statement No. 157,
Fair Value Measurement (FAS 157), which defines fair
value as the price that would be received to sell an asset or
that would be paid to transfer a liability in an orderly
transaction between market participants at the measurement date.
FAS 157 establishes a framework for measuring
58
fair value and expands disclosures about fair value
measurements. FAS 157 is effective for fiscal year 2008.
The Company is currently evaluating the impact of this
pronouncement on its financial position and results of
operations.
In 2005, the American Institute of Certified Public Accountants
issued Statement of Position (SOP)
05-1,
Accounting by Insurance Enterprises for Deferred Acquisition
Costs in Connection With Modifications or Exchanges of Insurance
Contracts, for implementation in the first quarter of 2007.
The SOP requires that deferred acquisition costs be expensed in
full when the original contract is substantially changed by
election or amendment of an existing contract feature or by
replacement with a new contract. The Company implemented the SOP
for contract changes beginning in the first quarter of 2007 with
no material effects to the financial statements at
implementation.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
Market risk is the risk of loss arising from adverse changes in
market rates and prices, such as interest rates, foreign
currency exchange rates and other relevant market rate or price
changes. Market risk is directly influenced by the volatility
and liquidity in the markets in which the related underlying
assets are traded.
The primary market risk to the Companys investment
portfolio is interest rate risk associated with investments and
the amount of interest that policyholders expect to have
credited to their policies. The interest rate risk taken in the
investment portfolio is managed relative to the duration of the
liabilities. The Companys investment portfolio consists
mainly of high quality, liquid securities that provide current
investment returns. The Company believes that the annuity and
universal life-type policies are generally competitive with
those offered by other insurance companies of similar size. The
Company does not anticipate significant changes in the primary
market risk exposures or in how those exposures are managed in
the future reporting periods based upon what is known or
expected to be in effect in future reporting periods.
Sensitivity analysis is defined as the measurement of potential
loss in future earnings, fair values or cash flows of market
sensitive instruments resulting from one or more selected
hypothetical changes in interest rates and other market rates or
prices over a selected time. In the Companys sensitivity
analysis model, a hypothetical change in market rates is
selected that is expected to reflect reasonably possible
near-term changes in those rates. Near term is
defined as a period of time going forward up to one year from
the date of the consolidated financial statements.
In this sensitivity analysis model, the Company uses fair values
to measure its potential loss. The primary market risk to the
Companys market sensitive instruments is interest rate
risk. The sensitivity analysis model uses a 100 basis point
change in interest rates to measure the hypothetical change in
fair value of financial instruments included in the model. For
invested assets, duration modeling is used to calculate changes
in fair values. Duration on invested assets is adjusted to call,
put and interest rate reset features.
The sensitivity analysis model produces a loss in fair value of
market sensitive instruments of $55.0 million based on a
100 basis point increase in interest rates as of
December 31, 2007. This loss value only reflects the impact
of an interest rate increase on the fair value of the
Companys financial instruments.
The Company uses interest rate swaps as part of its risk
management activities to protect against the risk of changes in
prevailing interest rates adversely affecting future cash flows
associated with $300.0 million of debt. Approximately
$129.5 million of the Companys outstanding debt at
December 31, 2007, was exposed to the fluctuation of the
three month London Inter-bank Offer Rate (LIBOR). The
sensitivity analysis shows that if the three-month LIBOR rate
changed by 100 basis points (1%), the Companys
interest expense would change by approximately $1.3 million.
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
The audited consolidated financial statements of the Company and
other information required by this Item 8 are included in
this
Form 10-K
beginning on
page F-1.
59
|
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A(T).
|
Controls
and Procedures
|
Disclosure
Controls and Procedures
The Company maintains a set of disclosure controls and
procedures designed to ensure that information required to be
disclosed in reports that it files or submits under the
Securities Exchange Act of 1934, as amended (the Exchange Act),
is recorded, processed, summarized and reported within the time
periods specified in Securities and Exchange Commission rules
and forms. In addition, the disclosure controls and procedures
ensure that information required to be disclosed is accumulated
and communicated to management, including the principal
executive officer and principal financial officer, allowing
timely decisions regarding required disclosure. Under the
supervision and with the participation of our management,
including our principal executive officer and principal
financial officer, we conducted an evaluation of our disclosure
controls and procedures, as such term is defined under
Rule 13a-15(e)
promulgated under the Exchange Act. Based on this evaluation,
our principal executive officer and our principal financial
officer concluded that our disclosure controls and procedures
were effective as of the end of the period covered by this
annual report.
Managements
Report on Internal Control Over Financial
Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, as such term
is defined in Exchange Act
Rules 13a-15(f).
The Companys internal control system was designed to
provide reasonable assurance to the Companys management
and its Board of Directors regarding the preparation and fair
presentation of published financial statements. However,
internal control systems, no matter how well designed, cannot
provide absolute assurance. Therefore, even those systems
determined to be effective can provide only reasonable assurance
with respect to financial statement preparation and presentation.
The Companys management assessed the effectiveness of the
Companys internal control over financial reporting as of
December 31, 2007. Under the supervision and with the
participation of our management, including our principal
executive officer and principal financial officer, we conducted
an evaluation of the effectiveness of our internal control over
financial reporting based on the framework contained in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission (the COSO Report).
Based on our evaluation under the framework in the COSO Report
our management concluded that our internal control over
financial reporting was effective as of December 31, 2007.
This annual report does not include an attestation report of the
Companys registered public accounting firm regarding
internal control over financial reporting. Managements
report was not subject to attestation by the Companys
registered public accounting firm pursuant to temporary rules of
the Securities and Exchange Commission that permit the Company
to provide only managements report in this annual report.
During the Companys fourth fiscal quarter, there has been
no change in the Companys internal control over financial
reporting that has materially affected, or is reasonably likely
to materially affect, the Companys internal controls over
financial reporting.
|
|
Item 9B.
|
Other
Information
|
None
60
PART III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
See the Companys Information Statement to be filed
in connection with the 2008 Annual Meeting of Shareholders,
which is incorporated herein by reference.
For information on executive officers of the Company, reference
is made to the item entitled Executive Officers of the
Company in Part I of this report.
|
|
Item 11.
|
Executive
Compensation
|
See the Companys Information Statement to be filed
in connection with the 2008 Annual Meeting of Stockholders,
which is incorporated herein by reference.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
See the Companys Information Statement to be filed
in connection with the 2008 Annual Meeting of Stockholders,
which is incorporated herein by reference.
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
See the Companys Information Statement to be filed
in connection with the 2008 Annual Meeting of Stockholders,
which is incorporated herein by reference. See
Note 16 of Notes to Financial Statements.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
See the Companys Information Statement to be filed
in connection with the 2008 Annual Meeting of Stockholders, of
which the subsection captioned Independent Registered
Public Accounting Firm is incorporated herein by reference.
61
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a) Financial Statements
The following consolidated financial statements of HealthMarkets
and subsidiaries are included in Item 8:
|
|
|
|
|
|
|
Page
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
Financial
Statement Schedules
All other schedules for which provision is made in the
applicable accounting regulations of the Securities and Exchange
Commission are not required under the related instructions or
are not applicable and therefore have been omitted.
Exhibits:
The response to this portion of Item 15 is submitted as a
separate section of this report entitled
Exhibit Index.
62
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
HealthMarkets, Inc.
|
|
|
|
By:
|
/s/ WILLIAM
J. GEDWED*
|
William J. Gedwed,
President, Chief Executive Officer and Director
Date: March 31, 2008
Pursuant to the requirements of Securities Exchange Act of 1934,
this report has been signed below by the following persons on
behalf of the registrant and in the capacities and on the dates
indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ ALLEN
F. WISE*
Allen
F. Wise
|
|
Chairman of the Board and Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ WILLIAM
J. GEDWED*
William
J. Gedwed
|
|
President, Chief Executive Officer and Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ MICHAEL
E. BOXER*
Michael
E. Boxer
|
|
Executive Vice President and Chief Financial Officer
|
|
March 31, 2008
|
|
|
|
|
|
/s/ PHILIP
RYDZEWSKI
Philip
Rydzewski
|
|
Chief Accounting Officer
|
|
March 31, 2008
|
|
|
|
|
|
/s/ CHINH
E. CHU*
Chinh
E. Chu
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ HARVEY
C. DEMOVICK, JR.*
Harvey
C. DeMovick, Jr.
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ ADRIAN
M. JONES*
Adrian
M. Jones
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ MURAL
R. JOSEPHSON*
Mural
R. Josephson
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ MATTHEW
KABAKER*
Matthew
Kabaker
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ ANDREW
S. KAHR*
Andrew
S. Kahr
|
|
Director
|
|
March 31, 2008
|
63
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ SUMIT
RAJPAL*
Sumit
Rajpal
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ KAMIL
M. SALAME*
Kamil
M. Salame
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
/s/ STEVEN
J. SHULMAN*
Steven
J. Shulman
|
|
Director
|
|
March 31, 2008
|
|
|
|
|
|
*By: /s/ MICHAEL
A. COLLIFLOWER
Michael
A. Colliflower
(Attorney-in-fact)
|
|
(Attorney-in-fact)
|
|
March 31, 2008
|
64
ANNUAL
REPORT ON
FORM 10-K
ITEM 8,
ITEM 15(A)(1) and (2), (C), and (D)
FINANCIAL
STATEMENTS and SUPPLEMENTAL DATA
FINANCIAL
STATEMENT SCHEDULES
CERTAIN
EXHIBITS
YEAR
ENDED DECEMBER 31, 2007
HEALTHMARKETS,
INC.
and
SUBSIDIARIES
NORTH
RICHLAND HILLS, TEXAS
F-1
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
HealthMarkets, Inc.:
We have audited the accompanying consolidated balance sheets of
HealthMarkets, Inc. and subsidiaries (the Company) as of
December 31, 2007 and 2006, and the related consolidated
statements of operations, stockholders equity and
comprehensive income, and cash flows for each of the years in
the three-year period then ended December 31, 2007. In
connection with our audits of the consolidated financial
statements, we have also audited the financial statement
schedules as listed in the Index at Item 15(a). These
consolidated financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements and financial
statement schedules based on our audits.
We conducted our audits in accordance with generally accepted
auditing standards as established by the Auditing Standards
Board (United States) and in accordance with the auditing
standards of the Public Company Accounting Oversight Board
(United States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. The
Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. Our
audit included consideration of internal control over financial
reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Companys
internal control over financial reporting. Accordingly, we
express no such opinion. An audit also includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of HealthMarkets, Inc. and subsidiaries as of
December 31, 2007 and 2006, and the results of their
operations and their cash flows for the years then ended in
conformity with U.S. generally accepted accounting
principles. Also, in our opinion, the related financial
statement schedules, when considered in relation to the
consolidated financial statements, taken as a whole, present
fairly, in all material respects, the information set forth
therein.
As discussed in Note 1 and Note 15 to the consolidated
financial statements, effective January 1, 2006,
HealthMarkets, Inc. adopted Securities and Exchange Commission
Staff Accounting Bulletin No. 108 (SAB 108),
Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in the Current Year Financial
Statements, and the provisions of Statement of Financial
Accounting Standards No. 123R (revised 2004),
Share-Based Payment, respectively. The Company used the
one time special transition provisions of SAB 108 and
recorded an adjustment to retained earnings effective
January 1, 2006 for correction of prior period errors in
recording deferred acquisition costs.
(signed) KPMG LLP
Dallas, Texas
March 31, 2008
F-2
HEALTHMARKETS,
INC.
and Subsidiaries
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands, except
|
|
|
|
per share data)
|
|
|
ASSETS
|
Investments:
|
|
|
|
|
|
|
|
|
Securities available for sale
|
|
|
|
|
|
|
|
|
Fixed maturities, at fair value (cost: 2007
$1,314,069; 2006 $1,391,275)
|
|
$
|
1,304,424
|
|
|
$
|
1,374,403
|
|
Equity securities, at fair value (cost: 2007 $300;
2006 $283)
|
|
|
346
|
|
|
|
318
|
|
Policy loans
|
|
|
14,279
|
|
|
|
14,625
|
|
Short-term and other investments, at fair value (cost:
2007 $163,727; 2006 $412,498)
|
|
|
162,552
|
|
|
|
412,498
|
|
|
|
|
|
|
|
|
|
|
Total Investments
|
|
|
1,481,601
|
|
|
|
1,801,844
|
|
Cash and cash equivalents
|
|
|
14,309
|
|
|
|
32,756
|
|
Student loans
|
|
|
96,254
|
|
|
|
105,846
|
|
Restricted cash
|
|
|
8,496
|
|
|
|
16,238
|
|
Investment income due and accrued
|
|
|
20,114
|
|
|
|
22,633
|
|
Due premiums
|
|
|
4,055
|
|
|
|
3,299
|
|
Reinsurance receivable
|
|
|
73,032
|
|
|
|
155,283
|
|
Agents and other receivables
|
|
|
63,965
|
|
|
|
45,732
|
|
Deferred acquisition costs
|
|
|
197,979
|
|
|
|
197,757
|
|
Property and equipment, net
|
|
|
69,939
|
|
|
|
64,436
|
|
Goodwill and other intangible assets, net
|
|
|
89,194
|
|
|
|
86,871
|
|
Recoverable federal income taxes
|
|
|
4,962
|
|
|
|
23,929
|
|
Other assets
|
|
|
31,682
|
|
|
|
38,205
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,155,582
|
|
|
$
|
2,594,829
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Policy liabilities:
|
|
|
|
|
|
|
|
|
Future policy and contract benefits
|
|
$
|
463,277
|
|
|
$
|
453,715
|
|
Claims
|
|
|
435,099
|
|
|
|
517,132
|
|
Unearned premiums
|
|
|
96,866
|
|
|
|
151,758
|
|
Other policy liabilities
|
|
|
10,764
|
|
|
|
12,569
|
|
Accounts payable and accrued expenses
|
|
|
48,233
|
|
|
|
48,363
|
|
Other liabilities
|
|
|
129,010
|
|
|
|
134,518
|
|
Deferred income taxes payable
|
|
|
84,968
|
|
|
|
73,575
|
|
Debt
|
|
|
481,070
|
|
|
|
556,070
|
|
Student loan credit facility
|
|
|
97,400
|
|
|
|
118,950
|
|
Net liabilities of discontinued operations
|
|
|
2,635
|
|
|
|
3,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,849,322
|
|
|
|
2,070,444
|
|
Commitments and Contingencies (Note 17)
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share
authorized 10,000,000 shares, none issued
|
|
|
|
|
|
|
|
|
Common Stock,
Class A-1,
par value $0.01 per share authorized
90,000,000 shares, 27,000,062 issued and 26,899,056
outstanding in 2007, 26,889,457 issued and outstanding in 2006;
Class A-2,
par value $0.01 per share authorized
20,000,000 shares, 3,952,204 issued and 3,623,266
outstanding in 2007, 3,131,503 issued and 3,032,642 outstanding
in 2006
|
|
|
310
|
|
|
|
300
|
|
Additional paid-in capital
|
|
|
55,754
|
|
|
|
12,529
|
|
Accumulated other comprehensive loss
|
|
|
(13,132
|
)
|
|
|
(12,552
|
)
|
Retained earnings
|
|
|
281,141
|
|
|
|
527,978
|
|
Treasury stock, at cost (101,006
Class A-1
common shares and 328,938
Class A-2
common shares in 2007, 98,861
Class A-2
common shares in 2006)
|
|
|
(17,813
|
)
|
|
|
(3,870
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
306,260
|
|
|
|
524,385
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,155,582
|
|
|
$
|
2,594,829
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-3
HEALTHMARKETS,
INC.
and Subsidiaries
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands, except per share data)
|
|
|
REVENUE
|
|
|
|
|
|
|
|
|
|
|
|
|
Health premiums
|
|
$
|
1,311,733
|
|
|
$
|
1,671,571
|
|
|
$
|
1,855,969
|
|
Life premiums and other considerations
|
|
|
70,460
|
|
|
|
65,675
|
|
|
|
61,565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,382,193
|
|
|
|
1,737,246
|
|
|
|
1,917,534
|
|
Investment income
|
|
|
102,984
|
|
|
|
104,147
|
|
|
|
97,788
|
|
Other income
|
|
|
106,615
|
|
|
|
104,634
|
|
|
|
106,656
|
|
Gains (losses) on sale of investments
|
|
|
3,475
|
|
|
|
200,544
|
|
|
|
(760
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,595,267
|
|
|
|
2,146,571
|
|
|
|
2,121,218
|
|
BENEFITS AND EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits, claims, and settlement expenses
|
|
|
801,783
|
|
|
|
996,617
|
|
|
|
1,092,136
|
|
Underwriting, policy acquisition costs, and insurance expenses
|
|
|
536,168
|
|
|
|
597,766
|
|
|
|
628,746
|
|
Other expenses, (includes amounts paid to related parties of
$14,228, $21,230 and $1,676 in 2007, 2006 and 2005, respectively)
|
|
|
88,702
|
|
|
|
158,749
|
|
|
|
81,177
|
|
Interest expense
|
|
|
49,560
|
|
|
|
41,141
|
|
|
|
6,009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,476,213
|
|
|
|
1,794,273
|
|
|
|
1,808,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
|
119,054
|
|
|
|
352,298
|
|
|
|
313,150
|
|
Federal income taxes
|
|
|
49,684
|
|
|
|
135,730
|
|
|
|
110,180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
69,370
|
|
|
|
216,568
|
|
|
|
202,970
|
|
Income from discontinued operations, (net of income tax
(expense) benefit of $(425), $19,495 and $(2,614) in 2007, 2006
and 2005, respectively)
|
|
|
789
|
|
|
|
21,170
|
|
|
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
70,159
|
|
|
$
|
237,738
|
|
|
$
|
203,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
2.28
|
|
|
$
|
6.19
|
|
|
$
|
4.40
|
|
Income from discontinued operations
|
|
|
0.03
|
|
|
|
0.61
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, basic
|
|
$
|
2.31
|
|
|
$
|
6.80
|
|
|
$
|
4.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
2.21
|
|
|
$
|
6.07
|
|
|
$
|
4.31
|
|
Income from discontinued operations
|
|
|
0.03
|
|
|
|
0.59
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, diluted
|
|
$
|
2.24
|
|
|
$
|
6.66
|
|
|
$
|
4.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-4
HEALTHMARKETS,
INC.
and Subsidiaries
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY AND
COMPREHENSIVE INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Comprehensive
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
|
|
|
Paid-In
|
|
|
Income
|
|
|
Retained
|
|
|
Treasury
|
|
|
|
|
|
|
Stock
|
|
|
Capital
|
|
|
(Loss)
|
|
|
Earnings
|
|
|
Stock
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
(In thousands, except per share data)
|
|
|
|
|
|
Balance at December 31, 2004
|
|
$
|
476
|
|
|
$
|
202,139
|
|
|
$
|
20,137
|
|
|
$
|
528,447
|
|
|
$
|
(37,054
|
)
|
|
$
|
714,145
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
203,501
|
|
|
|
|
|
|
|
203,501
|
|
Change in unrealized losses on securities
|
|
|
|
|
|
|
|
|
|
|
(43,016
|
)
|
|
|
|
|
|
|
|
|
|
|
(43,016
|
)
|
Deferred income tax expense
|
|
|
|
|
|
|
|
|
|
|
15,056
|
|
|
|
|
|
|
|
|
|
|
|
15,056
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
(27,960
|
)
|
|
|
|
|
|
|
|
|
|
|
(27,960
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
175,541
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(34,705
|
)
|
|
|
|
|
|
|
(34,705
|
)
|
Vesting of Agent Plan credits
|
|
|
|
|
|
|
11,245
|
|
|
|
|
|
|
|
|
|
|
|
9,990
|
|
|
|
21,235
|
|
Exercise stock options
|
|
|
3
|
|
|
|
2,579
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,582
|
|
Stock-based compensation
|
|
|
|
|
|
|
1,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,136
|
|
Stock-based compensation tax benefit
|
|
|
|
|
|
|
1,861
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,861
|
|
Retirement of treasury stock
|
|
|
(3
|
)
|
|
|
(7,519
|
)
|
|
|
|
|
|
|
|
|
|
|
7,522
|
|
|
|
|
|
Purchase of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,514
|
)
|
|
|
(11,514
|
)
|
Other
|
|
|
|
|
|
|
890
|
|
|
|
|
|
|
|
|
|
|
|
(90
|
)
|
|
|
800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2005
|
|
|
476
|
|
|
|
212,331
|
|
|
|
(7,823
|
)
|
|
|
697,243
|
|
|
|
(31,146
|
)
|
|
|
871,081
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
237,738
|
|
|
|
|
|
|
|
237,738
|
|
Change in unrealized losses on securities
|
|
|
|
|
|
|
|
|
|
|
(4,801
|
)
|
|
|
|
|
|
|
|
|
|
|
(4,801
|
)
|
Change in unrealized losses on cash flow hedging relationship
|
|
|
|
|
|
|
|
|
|
|
(2,475
|
)
|
|
|
|
|
|
|
|
|
|
|
(2,475
|
)
|
Deferred income tax expense
|
|
|
|
|
|
|
|
|
|
|
2,547
|
|
|
|
|
|
|
|
|
|
|
|
2,547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
(4,729
|
)
|
|
|
|
|
|
|
|
|
|
|
(4,729
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
233,009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative effect of change in accounting policy (see
Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,462
|
|
|
|
|
|
|
|
50,462
|
|
Additional paid-in capital reclassification
|
|
|
|
|
|
|
425,815
|
|
|
|
|
|
|
|
(425,815
|
)
|
|
|
|
|
|
|
|
|
Merger costs reducing equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(31,650
|
)
|
|
|
|
|
|
|
(31,650
|
)
|
Vesting of Agent Plan credits
|
|
|
|
|
|
|
10,698
|
|
|
|
|
|
|
|
|
|
|
|
6,812
|
|
|
|
17,510
|
|
Exercise stock options
|
|
|
|
|
|
|
337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
337
|
|
Stock-based compensation
|
|
|
|
|
|
|
3,819
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,819
|
|
Stock-based compensation tax benefit
|
|
|
|
|
|
|
1,390
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,390
|
|
Retirement of treasury stock
|
|
|
(179
|
)
|
|
|
(1,636,143
|
)
|
|
|
|
|
|
|
|
|
|
|
1,636,322
|
|
|
|
|
|
Contribution from private equity investors
|
|
|
|
|
|
|
985,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
985,000
|
|
Contribution of derivatives from private equity investors
|
|
|
|
|
|
|
1,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,963
|
|
Purchase of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,620,733
|
)
|
|
|
(1,620,733
|
)
|
Sale of treasury stock
|
|
|
|
|
|
|
4,779
|
|
|
|
|
|
|
|
|
|
|
|
4,875
|
|
|
|
9,654
|
|
Other
|
|
|
3
|
|
|
|
2,540
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,543
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
300
|
|
|
|
12,529
|
|
|
|
(12,552
|
)
|
|
|
527,978
|
|
|
|
(3,870
|
)
|
|
|
524,385
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,159
|
|
|
|
|
|
|
|
70,159
|
|
Change in unrealized losses on securities
|
|
|
|
|
|
|
|
|
|
|
6,063
|
|
|
|
|
|
|
|
|
|
|
|
6,063
|
|
Change in unrealized losses on cash flow hedging relationship
|
|
|
|
|
|
|
|
|
|
|
(6,995
|
)
|
|
|
|
|
|
|
|
|
|
|
(6,995
|
)
|
Deferred income tax expense
|
|
|
|
|
|
|
|
|
|
|
352
|
|
|
|
|
|
|
|
|
|
|
|
352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
(580
|
)
|
|
|
|
|
|
|
|
|
|
|
(580
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,579
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock
|
|
|
6
|
|
|
|
18,636
|
|
|
|
|
|
|
|
|
|
|
|
23,596
|
|
|
|
42,238
|
|
Vesting of Agent Plan credits
|
|
|
3
|
|
|
|
17,285
|
|
|
|
|
|
|
|
|
|
|
|
3,996
|
|
|
|
21,284
|
|
Exercise stock options
|
|
|
1
|
|
|
|
1,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,164
|
|
Stock-based compensation
|
|
|
|
|
|
|
5,828
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,828
|
|
Stock-based compensation tax benefit
|
|
|
|
|
|
|
313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
313
|
|
Dividends paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(316,996
|
)
|
|
|
|
|
|
|
(316,996
|
)
|
Purchase of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(41,535
|
)
|
|
|
(41,535
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
$
|
310
|
|
|
$
|
55,754
|
|
|
$
|
(13,132
|
)
|
|
$
|
281,141
|
|
|
$
|
(17,813
|
)
|
|
$
|
306,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-5
HEALTHMARKETS,
INC.
and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
|
(Unaudited)
|
|
|
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
70,159
|
|
|
$
|
237,738
|
|
|
$
|
203,501
|
|
Income from discontinued operations
|
|
|
(789
|
)
|
|
|
(21,170
|
)
|
|
|
(531
|
)
|
Adjustments to reconcile net income to cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gains) losses on sale of investments
|
|
|
(3,475
|
)
|
|
|
(200,544
|
)
|
|
|
760
|
|
Acquisition costs deferred
|
|
|
(138,596
|
)
|
|
|
(170,937
|
)
|
|
|
(103,185
|
)
|
Amortization of deferred acquisition costs
|
|
|
138,374
|
|
|
|
172,112
|
|
|
|
82,567
|
|
Depreciation and amortization
|
|
|
33,938
|
|
|
|
28,007
|
|
|
|
31,154
|
|
Deferred income taxes
|
|
|
11,745
|
|
|
|
61,054
|
|
|
|
19,523
|
|
Equity based compensation
|
|
|
5,828
|
|
|
|
3,734
|
|
|
|
1,006
|
|
Variable stock compensation
|
|
|
(482
|
)
|
|
|
16,603
|
|
|
|
7,214
|
|
Cash transferred for net liabilities of Student Insurance
Division and Star HRG
|
|
|
|
|
|
|
(85,498
|
)
|
|
|
|
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued investment income
|
|
|
(2,401
|
)
|
|
|
(3,648
|
)
|
|
|
(5,951
|
)
|
Due premiums
|
|
|
(756
|
)
|
|
|
(19,576
|
)
|
|
|
33,792
|
|
Reinsurance receivables
|
|
|
82,251
|
|
|
|
(131,803
|
)
|
|
|
535
|
|
Other receivables
|
|
|
(21,112
|
)
|
|
|
(5,335
|
)
|
|
|
6,606
|
|
Current federal income taxes
|
|
|
18,967
|
|
|
|
(10,781
|
)
|
|
|
(16,503
|
)
|
Policy liabilities
|
|
|
(120,291
|
)
|
|
|
141,394
|
|
|
|
(72,162
|
)
|
Other liabilities and accrued expenses
|
|
|
8,102
|
|
|
|
12,851
|
|
|
|
(952
|
)
|
Other items, net
|
|
|
(2,284
|
)
|
|
|
3,948
|
|
|
|
392
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Provided by Continuing Operations
|
|
|
79,178
|
|
|
|
28,149
|
|
|
|
187,766
|
|
Cash Provided by (Used in) Discontinued Operations
|
|
|
(370
|
)
|
|
|
18,679
|
|
|
|
(2,377
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by Operating Activities
|
|
|
78,808
|
|
|
|
46,828
|
|
|
|
185,389
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities available-for-sale
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases
|
|
|
(166,694
|
)
|
|
|
(170,927
|
)
|
|
|
(295,919
|
)
|
Sales
|
|
|
156,027
|
|
|
|
220,493
|
|
|
|
166,901
|
|
Maturities, calls and redemptions
|
|
|
84,363
|
|
|
|
146,497
|
|
|
|
131,701
|
|
Student loans
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and originations
|
|
|
(2,720
|
)
|
|
|
(5,032
|
)
|
|
|
(7,065
|
)
|
Maturities
|
|
|
15,202
|
|
|
|
14,272
|
|
|
|
10,244
|
|
Short-term and other investments net
|
|
|
260,980
|
|
|
|
(127,056
|
)
|
|
|
(105,320
|
)
|
Distribution from investment in Grapevine Finance LLC
|
|
|
581
|
|
|
|
144,594
|
|
|
|
|
|
Additional cost of purchase of subsidiary
|
|
|
|
|
|
|
|
|
|
|
(7,110
|
)
|
Decrease in restricted cash
|
|
|
7,742
|
|
|
|
6,279
|
|
|
|
16,938
|
|
Purchases of property and equipment
|
|
|
(33,204
|
)
|
|
|
(14,457
|
)
|
|
|
(11,440
|
)
|
Intangible asset acquired
|
|
|
(4,044
|
)
|
|
|
(47,500
|
)
|
|
|
|
|
Change in agents receivables
|
|
|
4,756
|
|
|
|
(7,926
|
)
|
|
|
(5,141
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by (Used in) Investing Activities
|
|
|
322,989
|
|
|
|
159,237
|
|
|
|
(106,211
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayment of debt
|
|
|
(75,000
|
)
|
|
|
(62,500
|
)
|
|
|
|
|
Repayment of student loan credit facilities
|
|
|
(21,550
|
)
|
|
|
(11,950
|
)
|
|
|
(19,100
|
)
|
Debt proceeds received in Merger
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
Decrease in cash overdraft
|
|
|
|
|
|
|
(3,736
|
)
|
|
|
(5,013
|
)
|
Capitalized debt issuance costs
|
|
|
|
|
|
|
(32,539
|
)
|
|
|
|
|
Equity costs related to Merger
|
|
|
|
|
|
|
(31,650
|
)
|
|
|
|
|
Proceeds from issuance of trust securities
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
Proceeds from issuance of common stock, net of expenses
|
|
|
450
|
|
|
|
2,799
|
|
|
|
|
|
Increase in investment products
|
|
|
(8,877
|
)
|
|
|
(9,478
|
)
|
|
|
(12,245
|
)
|
Proceeds from stock option exercises
|
|
|
1,164
|
|
|
|
337
|
|
|
|
2,582
|
|
Excess tax benefits from equity-based compensation
|
|
|
313
|
|
|
|
1,390
|
|
|
|
1,861
|
|
Contributions from private equity investors
|
|
|
|
|
|
|
985,000
|
|
|
|
|
|
Proceeds from sale of shares to agents
|
|
|
40,784
|
|
|
|
9,654
|
|
|
|
|
|
Purchase of treasury stock
|
|
|
(41,535
|
)
|
|
|
(1,620,733
|
)
|
|
|
(13,359
|
)
|
Dividends paid to shareholders
|
|
|
(316,996
|
)
|
|
|
|
|
|
|
(34,705
|
)
|
Other
|
|
|
1,003
|
|
|
|
97
|
|
|
|
801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Used in Financing Activities
|
|
|
(420,244
|
)
|
|
|
(173,309
|
)
|
|
|
(79,178
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Increase) Decrease in Cash
|
|
|
(18,447
|
)
|
|
|
32,756
|
|
|
|
|
|
Cash and Cash Equivalents at beginning of period
|
|
|
32,756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents at end of period
|
|
$
|
14,309
|
|
|
$
|
32,756
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 23 for supplemental disclosure of non-cash
activities related to the consolidated statement of cash flows.
See accompanying notes to consolidated financial statements.
F-6
|
|
Note 1.
|
Significant
Accounting Policies
|
Principles
of Consolidation
The consolidated financial statements include the accounts of
HealthMarkets, Inc. and its subsidiaries. HealthMarkets, Inc.
and its subsidiaries are collectively referred to throughout
this Annual Report on
Form 10-K
as the Company or
HealthMarkets. All significant intercompany
accounts and transactions have been eliminated in consolidation.
HealthMarkets is a holding company, and the Company conducts its
insurance businesses through its indirect wholly owned insurance
company subsidiaries, The MEGA Life and Health Insurance Company
(MEGA), Mid-West National Life Insurance Company of
Tennessee (Mid-West) and The Chesapeake Life
Insurance Company (Chesapeake). MEGA is an insurance
company domiciled in Oklahoma and is licensed to issue health,
life and annuity insurance policies in all states except New
York. Mid-West is an insurance company domiciled in Texas and is
licensed to issue health, life and annuity insurance policies in
Puerto Rico and all states except Maine, New Hampshire, New
York, and Vermont. Chesapeake is an insurance company domiciled
in Oklahoma and is licensed to issue health and life insurance
policies in all states except New Jersey, New York and Vermont.
Effective December 1, 2007, the Company acquired all of the
outstanding capital stock of Fidelity Life Insurance Company, an
insurance company domiciled in Pennsylvania and licensed to
issue health and life insurance policies.
Merger
Completed
On April 5, 2006, the Company completed a merger (the
Merger) providing for the acquisition of the Company
by affiliates of a group of private equity investors, including
affiliates of The Blackstone Group, Goldman Sachs Capital
Partners and DLJ Merchant Banking Partners (the Private
Equity Investors). See Note 13.
Nature
of Operations
The Company offers insurance (primarily health and life) to
niche consumer and institutional markets. Through its
subsidiaries the Company issues primarily health insurance
policies, covering individuals and families, to the
self-employed, association groups and small businesses.
Through the Companys Self-Employed Agency Division
(SEA), the Company offers a broad range of health
insurance products for self-employed individuals and individuals
who work for small businesses. HealthMarkets basic
hospital-medical and catastrophic hospital expense plans are
designed to accommodate individual needs and include traditional
fee-for-service indemnity plans and preferred provider
organization (PPO) plans, as well as other
supplemental types of coverage. The Company offers insurance
products including a basic medical-surgical expense plan,
catastrophic expense PPO plans and catastrophic expense consumer
guided health plans. The Company markets these products to the
self-employed and individual markets through independent
contractor agents associated with UGA-Association Field Services
and Cornerstone America, the Companys
dedicated agency sales forces that primarily sell
the Companys products.
Through its Life Insurance Division, the Company distributes its
life insurance products to the middle income, individuals in the
self-employed market, the Hispanic market and the senior market
through marketing relationships with two independent marketing
companies and agents associated with UGA-Association Field
Services and Cornerstone America.
Through its Zon
Re-USA, LLC unit, the Company underwrites, administers and
issues accidental death, accidental death and dismemberment
(AD&D), accident medical and accident disability insurance
products, both on a primary and on a reinsurance basis. The
Company distributes these products through professional
reinsurance intermediaries and a network of independent
commercial insurance agents, brokers and third party
administrators.
F-7
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Business
Segments
The Company operates three business segments, the Insurance
segment, the Other Key Factors segment and the Disposed
Operations segment. The Insurance segment includes the
Companys Self-Employed Agency Division, the Life Insurance
Division and Other Insurance Division. The Other Key Factors
segment includes investment income not otherwise allocated to
the Insurance segment, realized gains and losses on sale of
investments, interest expense on corporate debt, variable
stock-based compensation, costs associated with the
Companys Medicare Advantage PFFS market initiative,
general expenses relating to corporate operations and, in 2006,
the incremental costs associated with the acquisition of the
Company. The Disposed Operations segment includes the
Companys former Star HRG Division and former Student
Insurance Division.
Disposed
Operations Star HRG Division and Student Insurance
Division
During 2006, the Company completed the sale of two of its former
business units. On July 11, 2006, the Company sold
substantially all of the assets comprising its former Star HRG
Division, through which the Company marketed limited benefit
health insurance plans for entry level, high turnover and hourly
employees. On December 1, 2006, the Company sold the assets
comprising its former Student Insurance Division, through which
the Company offered tailored health insurance programs that
generally provided single school year coverage to individual
students at colleges and universities.
The Companys insurance subsidiaries remain parties to
coinsurance agreements with the purchasers of those businesses.
Consequently, the Company reports the policy liabilities ceded
to and assumed by the purchasers under the coinsurance
agreements as Policy liabilities on its Consolidated
Balance Sheet, with a corresponding asset as a Reinsurance
receivable. In addition, the Company will continue to
report in future periods the residual results of operations of
these businesses (anticipated to consist solely of residual
wind-down expenses and any
true-up
provision associated with the sales, primarily Student Insurance
Division) in continuing operations and classified to the
Companys Disposed Operations business segment. See
Note 2 of the Financial Statements.
Discontinued
Operations
The Company reports as discontinued operations the results of
its former Academic Management Services (AMS)
subsidiary and its former Special Risk Division operations.
See Note 21 of the Financial Statements.
Basis
of Presentation
The consolidated financial statements have been prepared on the
basis of accounting principles generally accepted in the United
States of America (GAAP). The more significant
variances between GAAP and statutory accounting practices
prescribed or permitted by regulatory authorities for insurance
companies are: fixed maturities are carried at fair value for
investments classified as available for sale for GAAP rather
than generally at amortized cost; the deferral of new business
acquisition costs, rather than expensing them as incurred; the
determination of the liability for future policyholder benefits
based on realistic assumptions, rather than on statutory rates
for mortality and interest; the recording of reinsurance
receivables as assets for GAAP rather than as reductions of
liabilities; and the exclusion of non-admitted assets for
statutory purposes. See Note 13 for
stockholders equity and net income from insurance
subsidiaries as determined using statutory accounting practices.
Use of
Estimates
Preparation of the financial statements in accordance with GAAP
requires management to make estimates and assumptions that
affect the amounts reported in the consolidated financial
statements and accompanying notes. Actual results could differ
from those estimates.
F-8
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Investments
Fixed maturities consist of bonds and notes issued by
governments, businesses, or other entities, mortgage and asset
backed securities and similar securitized loans. All fixed
maturity investments are classified as available for
sale and reported at fair value. Equity securities consist
of common stocks and are carried at fair value. Mortgage loans
are carried at unpaid balances, less allowance for losses.
Policy loans are carried at the aggregate unpaid balance.
Short-term investments are generally carried at cost which
approximates fair value. Other investments primarily consist of
investments in equity investees which are accounted for under
the equity method of accounting. In addition, Short-term and
other investments contains one alternative investment recorded
at fair value. Premiums and discounts on mortgage-backed
securities are amortized over a period based on estimated future
principal payments, including prepayments. Prepayment
assumptions are reviewed periodically and adjusted to reflect
actual prepayments and changes in expectations. The most
significant determinants of prepayments are the differences
between interest rates of the underlying mortgages and current
mortgage loan rates and the structure of the security. Other
factors affecting prepayments include the size, type and age of
underlying mortgages, the geographic location of the mortgaged
properties and the creditworthiness of the borrowers. Variations
from anticipated prepayments will affect the life and yield of
these securities.
Realized gains and losses on sales of investments are recognized
in net income on the specific identification basis and include
write downs on those investments deemed to have an
other-than-temporary decline in fair values. Unrealized
investment gains or losses on securities carried at fair value,
net of applicable deferred income tax, are reported in
accumulated other comprehensive income (loss) as a separate
component of stockholders equity and accordingly have no
effect on net income (loss).
Purchases and sales of short-term financial instruments are part
of investing activities and not necessarily a part of the cash
management program. Short-term financial instruments are
classified as investments in the Consolidated Balance Sheets and
are included as investing activities in the Consolidated
Statements of Cash Flows.
Investments are reviewed quarterly (or more frequently if
certain indicators arise) to determine if they have suffered an
impairment of value that is considered other than temporary. In
its review, management considers the following indicators of
impairment: fair value significantly below cost; decline in fair
value attributable to specific adverse conditions affecting a
particular investment; decline in fair value attributable to
specific conditions, such as conditions in an industry or in a
geographic area; decline in fair value for an extended period of
time; downgrades by rating agencies from investment grade to
non-investment grade; financial condition deterioration of the
issuer and situations where dividends have been reduced or
eliminated or scheduled interest payments have not been made.
Management monitors investments where two or more of the above
indicators exist and investments are identified by the Company
in economically challenged industries. If investments are
determined to be other than temporarily impaired, a loss is
recognized at the date of determination.
Cash
and Cash Equivalents
The Company classifies as cash and cash equivalents unrestricted
cash on deposit in banks and invested temporarily in various
instruments with maturities of three months or less at the time
of purchase.
Student
Loans
Student loans (consisting of student loans originated under the
Companys former College First Alternative Loan program)
are carried at their unpaid principal balances less any
applicable allowance for losses.
F-9
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Deferred
Acquisition Costs
Health
Policy Acquisition Costs
The Company incurs various costs in connection with the
origination and initial issuance of its health insurance
policies, including underwriting and policy issuance costs,
costs associated with lead generation activities and
distribution costs (i.e., sales commissions paid to
agents). The Company defers those costs that vary with
production. The Company generally defers commissions paid to
agents and premium taxes with respect to the portion of health
premium collected but not yet earned and the Company amortizes
the deferred expense over the period as premium is earned. Costs
associated with generating sales leads with respect to the
health business issued through the SEA Division are capitalized
and amortized over the average life of a policy, which
approximates a two-year period. Other underwriting and policy
issuance costs (which the Company estimates are more fixed than
variable) are expensed as incurred.
At December 31, 2006, the Company changed its accounting
policy, effective January 1, 2006, with respect to the
amortization of a portion of deferred acquisition costs
associated with commissions paid to agents. Generally, the first
year and second year commission rates on policies issued by the
Companys SEA Division are higher than renewal year
commission rates. The Company changed its accounting methodology
with respect to the first year and second year excess
commissions and now amortizes them over the average life of a
policy, which approximates a two-year period. See the
discussion below under the caption 2006 Change in
Accounting Policy.
Life
Policy Acquisition Costs
The Company incurs various costs in connection with the
origination and initial issuance of its life insurance policies,
including underwriting and policy issuance costs. The Company
defers those costs that vary with production. The Company
capitalizes commission and issue costs primarily associated with
the new business of its Life Insurance Division. Deferred
acquisition costs consist primarily of sales commissions and
other underwriting costs of new life insurance sales. Policy
acquisition costs associated with traditional life business are
capitalized and amortized over the estimated premium-paying
period of the related policies, in proportion to the ratio of
the annual premium revenue to the total premium revenue
anticipated. Such anticipated premium revenue, which is modified
to reflect actual lapse experience, is estimated using the same
assumptions as are used for computing policy benefits. For
universal life-type and annuity contracts, capitalized costs are
amortized at a constant rate based on the present value of the
estimated gross profits expected to be realized on the book of
contracts.
Other
The cost of business acquired through acquisition of
subsidiaries or blocks of business is determined based on
estimates of the future profits inherent in the business
acquired. Such costs are capitalized and amortized over the
estimated premium-paying period. Anticipated investment income
is considered in determining whether a premium deficiency
exists. The amortization period is adjusted when estimates of
current or future gross profits to be realized from a group of
products are revised.
The Company monitors and assesses the recoverability of deferred
health and life policy acquisition costs on a quarterly basis.
F-10
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Set forth below is an analysis of cost of policies acquired and
deferred acquisition costs of policies issued:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Costs of policies acquired:
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of year
|
|
$
|
1,878
|
|
|
$
|
3,206
|
|
|
$
|
4,991
|
|
Additions
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization
|
|
|
(918
|
)
|
|
|
(1,328
|
)
|
|
|
(1,785
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
End of year
|
|
|
960
|
|
|
|
1,878
|
|
|
|
3,206
|
|
Deferred costs of policies issued (reflects change in accounting
policy discussed below)
|
|
|
197,019
|
|
|
|
195,879
|
|
|
|
127,914
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
197,979
|
|
|
$
|
197,757
|
|
|
$
|
131,120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Set forth below is an analysis of deferred costs of policies
issued and the related deferral and amortization in each of the
years then ended:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Deferred costs of policies issued:
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of year
|
|
$
|
195,879
|
|
|
$
|
127,914
|
|
|
$
|
105,511
|
|
DAC adjustment (reflects change in accounting policy discussed
below)
|
|
|
|
|
|
|
77,633
|
|
|
|
|
|
Disposal (sale of Student Insurance Division)
|
|
|
|
|
|
|
(9,821
|
)
|
|
|
|
|
Additions
|
|
|
138,596
|
|
|
|
170,937
|
|
|
|
103,185
|
|
Amortization
|
|
|
(137,456
|
)
|
|
|
(170,784
|
)
|
|
|
(80,782
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
End of year
|
|
$
|
197,019
|
|
|
$
|
195,879
|
|
|
$
|
127,914
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The estimated amortization for the next five years and
thereafter of capitalized costs of policies acquired at
December 31, 2007 is as follows:
|
|
|
|
|
|
|
(In thousands)
|
|
|
2008
|
|
$
|
208
|
|
2009
|
|
|
193
|
|
2010
|
|
|
189
|
|
2011
|
|
|
185
|
|
2012
|
|
|
185
|
|
2013 and thereafter
|
|
|
|
|
|
|
|
|
|
|
|
$
|
960
|
|
|
|
|
|
|
Restricted
Cash
The Companys restricted cash consisted primarily of cash
and cash equivalents held by a bankruptcy-remote, special
purpose entity to be used only for repayment of existing student
loan borrowings. See Note 9.
F-11
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Allowance
for Doubtful Accounts
The Company maintains an allowance for potential losses that
could result from defaults or write-downs on various assets.
The allowance for losses consists of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Agent receivables
|
|
$
|
3,488
|
|
|
$
|
4,164
|
|
Other receivables
|
|
|
|
|
|
|
668
|
|
Mortgage loans
|
|
|
5
|
|
|
|
33
|
|
Student loans
|
|
|
2,925
|
|
|
|
3,256
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
6,418
|
|
|
$
|
8,121
|
|
|
|
|
|
|
|
|
|
|
Property
and Equipment
Property and equipment is stated at cost and depreciated using
straight line and accelerated methods over their estimated
useful lives (generally 3 to 7 years for furniture,
software and equipment and 30 to 39 years for buildings).
During 2007, the Company incurred an asset impairment charge in
an amount of $8.0 million associated with two technology
assets that we determined were no longer of value to the Company
and additional consulting and professional fees incurred for
various operational and technology focused initiatives.
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Land and improvements
|
|
$
|
2,431
|
|
|
$
|
2,431
|
|
Buildings and leasehold improvements
|
|
|
36,140
|
|
|
|
32,884
|
|
Software
|
|
|
90,503
|
|
|
|
75,362
|
|
Furniture and equipment
|
|
|
44,989
|
|
|
|
39,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
174,063
|
|
|
|
150,444
|
|
Less accumulated depreciation
|
|
|
104,124
|
|
|
|
86,008
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
69,939
|
|
|
$
|
64,436
|
|
|
|
|
|
|
|
|
|
|
Goodwill
and Other Intangibles
The Company accounts for goodwill and other intangibles
according to FAS No. 142, Goodwill and Other
Intangible Assets. FAS 142 requires that goodwill and
other intangible assets with indefinite useful lives be tested
for impairment at least annually or more frequently if certain
indicators arise. An impairment loss would be recorded in the
period such determination was made. FAS 142 also requires
that intangible assets with estimable useful lives be amortized
over their respective estimated useful lives to their estimated
residual values and reviewed for impairment. The Company
amortizes its intangible assets with estimable useful lives over
a period ranging from one to twenty-five years.
F-12
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Capitalized
Debt Issuance Costs
Debt issuance costs are amortized over the life of the
underlying debt using the effective interest method. These costs
primarily represent legal fees associated with the issuance of
the term loan credit facility and the trust preferred securities
which were capitalized and recorded in Other assets.
See Note 8.
Derivatives
The Company uses derivative instruments as part of its risk
management activities to protect against the risk of changes in
prevailing interest rates adversely affecting future cash flows
associated with certain debt. The derivative instruments are
carried at fair value on the balance sheet. The Company values
its derivative instruments using a third party. See
Note 10.
Future
Policy and Contract Benefits
With respect to accident and health insurance, future policy
benefits are primarily attributable to a
return-of-premium
(ROP) rider that the Company has issued with certain health
policies. The Company records an ROP liability to fund
longer-term obligations associated with the ROP rider. The
future policy benefits for the ROP are computed using the net
level premium method. A claim offset for actual benefits paid
through the reporting date is applied to the ROP liability for
all policies on a
contract-by-contract
basis. See Note 6.
The remainder of the future policy benefits for accident and
health are principally contract reserves on issue-age rated
policies, reserves for other riders providing future benefits,
and reserves for the refund of a portion of premium as required
by state law. These liabilities are typically calculated as the
present value of future benefits less the present value of
future net premiums, computed using the net level premium method.
Traditional life insurance future policy benefit liabilities are
computed using the net level premium. Future contract benefits
related to universal life-type and annuity contracts are
generally based on policy account values.
Claim
Liabilities
Claim liabilities represent the estimated liabilities for claims
reported plus claims incurred but not yet reported. The Company
uses the developmental method to estimate its health claim
liabilities, which involves the use of completion factors for
most incurral months, supplemented with additional estimation
techniques, such as loss ratio estimates, in the most recent
incurral months. This method applies completion factors to claim
payments in order to estimate the ultimate amount of the claim.
These completion factors are derived from historical experience
and are dependent on the incurred dates of the claim payments.
See Note 6.
Unearned
Premiums
Premiums on health insurance contracts are recognized as earned
over the period of coverage on a pro rata basis. The Company
records as a liability the portion of premiums unearned.
Recognition
of Premium Revenues and Costs
Premiums on traditional life insurance are recognized as revenue
when due. Benefits and expenses are matched with premiums so as
to result in recognition of income over the term of the
contract. This matching is accomplished by means of the
provision for future policyholder benefits and expenses and the
deferral and amortization of acquisition costs.
Premiums and annuity considerations collected on universal
life-type and annuity contracts are recorded using deposit
accounting, and are credited directly to an appropriate policy
reserve account, without recognizing premium income. Revenues
from universal life-type and annuity contracts are amounts
assessed to the policyholder for the
F-13
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
cost of insurance (mortality charges), policy administration
charges and surrender charges and are recognized as revenue when
assessed based on one-year service periods. Amounts assessed for
services to be provided in future periods are reported as
unearned revenue and are recognized as revenue over the benefit
period. Contract benefits that are charged to expense include
benefit claims incurred in the period in excess of related
contract balances and interest credited to contract balances.
Other
Income
Other income consists primarily of income derived by the SEA
Division from ancillary services and membership marketing and
administrative services provided to the membership associations
that make available to their members the Companys health
insurance products. Income is recognized as services are
provided.
Underwriting,
Policy Acquisition Costs and Insurance Expenses
Underwriting, policy acquisition costs and insurance expenses
consist of direct expenses incurred across all insurance lines
in connection with issuance, maintenance and administration of
in-force insurance policies, including amortization of deferred
policy acquisition costs, commissions paid to agents,
administrative expenses and premium taxes.
Other
Expenses
Other expenses consist primarily of direct expenses incurred by
the Company in connection with generating other income at the
SEA Division. Also included among other expenses in 2006 are the
incremental costs associated with the Merger transaction in the
amount of $48.0 million.
Variable
Stock-Based Compensation Expense
The Company sponsors a series of stock accumulation plans
established for the benefit of the independent insurance agents
and independent sales representatives associated with its
independent agent field forces, including UGA
Association Field Services and Cornerstone America. In
connection with these plans, the Company incurs non-cash
variable stock-based compensation expense (benefit) in amounts
that fluctuate based on the fair value of the Companys
common stock. The Company records this expense (benefit) in
Underwriting, policy acquisition costs and insurance
expenses. See Note 14.
Reinsurance
Insurance liabilities are reported before the effects of ceded
reinsurance. Reinsurance receivables and prepaid reinsurance
premiums are reported as assets. The cost of reinsurance is
accounted for over the terms of the underlying reinsured
policies using assumptions consistent with those used to account
for the policies.
Advertising
Expense
The Company incurred advertising costs not included in deferred
acquisition costs of $2.3 million, $1.6 million and
$1.8 million in 2007, 2006 and 2005, respectively.
Advertising costs not included in deferred acquisition costs are
expensed as incurred. These amounts are included in
Underwriting, policy acquisition costs and insurance
expenses.
Federal
Income Taxes
Deferred income taxes are recorded to reflect the tax
consequences of differences between the tax bases of assets and
liabilities and their financial reporting amounts. In the event
that the Company were to determine that it would not be able to
realize all or part of its net deferred tax asset in the future,
a valuation allowance would be
F-14
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
recorded to reduce its deferred tax assets to the amount that it
believes is more likely than not to be realized. Interest and
penalties associated with uncertain income tax positions are
classified as income taxes in the financial statements.
Comprehensive
Income
Included in comprehensive income is the reclassification
adjustments for realized gain (losses) included in net income of
$871,000 ($566,000 net of tax), $(2.3) million
($(1.5 million) net of tax) and $(1.2) million
($(768,000) net of tax) in 2007, 2006 and 2005, respectively.
Guaranty
Funds and Similar Assessments
The Company is assessed amounts by state guaranty funds to cover
losses of policyholders of insolvent or rehabilitated insurance
companies, by state insurance oversight agencies and by other
similar legislative entities to cover the operating expenses of
such agencies and entities. The Company is also assessed for
other health related expenses of high-risk and health
reinsurance pools maintained in the various states. These
mandatory assessments may be partially recovered through a
reduction in future premium taxes in certain states. At each of
December 31, 2007 and 2006, the Company had accrued and
reported as Other liabilities $5.5 million to
cover the cost of these assessments. The Company expects to pay
these assessments over a period of up to five years, and the
Company expects to realize the allowable portion of the premium
tax offsets
and/or
policy surcharges over a period of up to ten years. The Company
incurred guaranty fund and other health related assessments in
the amount of $6.9 million, $6.2 million and
$6.6 million in 2007, 2006 and 2005, respectively, reported
in Underwriting, policy acquisition costs and insurance
expenses.
2006
Change in Accounting Policy
Effective December 31, 2006, the Company changed its
accounting policy with respect to the amortization of a portion
of deferred acquisition costs associated with commissions paid
to agents.
The Company formerly capitalized commissions and premium taxes
associated with its SEA Division business (presented as
Deferred acquisition costs (DAC)) and amortized all
of these costs over the period (and in proportion to the amount)
that the associated unearned premium is earned.
Following adoption of SEC Staff Accounting
Bulletin No. 108 (SAB 108), Considering the
Effects of Prior Year Misstatements when Quantifying
Misstatements in the Current Year Financial Statements, the
Company performed an analysis to determine the appropriate
portion of commissions to be deferred over the lives of the
underlying policies. Generally, first year and second year
commission rates are higher than the renewal year commission
rates, and the Company has determined, after performing
analysis, to capitalize the excess commissions associated with
those earlier years and amortize the capitalized costs ratably
over the estimated life of the policy. Accordingly, effective
January 1, 2006 the Company changed its accounting method
by amortizing the first and second year excess commissions
ratably over a two year period which approximates the average
life of the policy.
The Company utilized the one time special transition provisions
of SAB 108 and recorded an adjustment to retained earnings
effective January 1, 2006 to reflect this change in
accounting policy. As of January 1, 2006, the change in
accounting policy resulted in an increase in the Companys
capitalized deferred acquisition cost (DAC) of
$77.6 million, a related increase to its deferred tax
liability of $27.1 million, and a net increase to
shareholders equity of $50.5 million. The adoption of
this new accounting policy had the effect of increasing reported
underwriting, policy acquisition costs and insurance expenses
(classified to its SEA Division) in 2006 by $15.5 million
and, correspondingly, reducing after-tax net income by
$10.1 million.
F-15
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
New
Accounting Pronouncements
On March 19, 2008 the Financial Accounting Standards Board
(FASB) issued FAS No. 161, Disclosures
about Derivative Instruments and Hedging Activities, which
amends FASB Statement No. 133, Accounting for Derivative
Instruments and Hedging Activities. The Statement requires
companies with derivative instruments to disclose information
that should enable financial statement users to understand how
and why a company uses derivative instruments, how derivative
instruments and related hedged items are accounted for under
FAS No. 133, and how derivative instruments and
related hedged items affect a companys financial position,
financial performance, and cash flows. The required disclosures
include the fair value of derivative instruments and their gains
or losses in tabular format, information about credit risk
related contingent features in derivative agreements,
counterparty credit risk, and a companys strategies and
objectives for using derivative instruments. The Statement
expands the current disclosure framework in
FAS No. 133. FAS No. 161 is effective
prospectively for period beginning on or after November 15,
2008. The Company is currently evaluating the impact of this
pronouncement on its financial position and results of
operations.
In December 2007, FAS No. 160, Noncontrolling
Interests in Consolidated Financial Statements an
amendment of ARB No. 51 (FAS 160), was issued. The
objective of FAS 160 is to improve the relevance,
comparability, and transparency of the financial information
related to minority interest that a reporting entity provides in
its consolidated financial statements. FAS 160 is effective
for fiscal years, and interim periods within those fiscal years,
beginning on or after December 15, 2008. The Company
believes this statement will not have a material impact on its
financial position or results of operations.
In February 2007, FAS No. 159, The Fair Value
Option for Financial Assets and Financial Liabilities
(FAS 159), was issued. FAS 159 permits an
entity to elect fair value as the initial and subsequent
measurement attribute for many financial assets and liabilities.
Entities electing the fair value option would be required to
recognize changes in fair value in earnings. Entities electing
the fair value option are required to distinguish on the face of
the statement of financial position, the fair value of assets
and liabilities for which the fair value option has been elected
and similar assets and liabilities measured using another
measurement attribute. FAS 159 is effective for fiscal year
2008. The adjustment to reflect the difference between the fair
value and the carrying amount would be accounted for as a
cumulative-effect adjustment to retained earnings as of the date
of initial adoption. The Company believes this statement will
not have a material impact on its financial position or results
of operations.
On January 1, 2007, the Company adopted the provisions of
the FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes an interpretation of
FAS No. 109, (FIN 48). FIN 48 clarifies
the accounting for income taxes by prescribing a minimum
recognition threshold that a tax position is required to meet
before being recognized in the financial statements. FIN 48
also provides guidance on derecognition, measurement,
classification, interest and penalties, disclosure and
transition. The adoption of FIN 48 did not impact the
Companys financial condition or results of operations.
In February 2006, the FASB issued FAS No. 155,
Hybrid Instruments. SFAS No. 155 amends
FAS No. 133 and FAS No. 140, Accounting
for Transfers and Servicing of Financial Assets and
Extinguishments of Liabilities. FAS No. 155 also
resolves issues addressed in Statement 133 Implementation Issue
No. D1, Application of Statement 133 to Beneficial
Interests in Securitized Financial Assets.
FAS No. 155: a) permits fair value remeasurement
for any hybrid financial instrument that contains an embedded
derivative that otherwise would require bifurcation,
b) clarifies which interest-only strips and principal-only
strips are not subject to the requirements of
SFAS No. 133, c) establishes a requirement to
evaluate interests in securitized financial assets to identify
interests that are freestanding derivatives or that are hybrid
financial instruments that contain an embedded derivative
requiring bifurcation, d) clarifies that concentrations of
credit risk in the form of subordination are not embedded
derivatives, and e) amends FAS No. 140 to
eliminate the prohibition on a qualifying special purpose entity
from holding a derivative financial instrument that pertains to
a beneficial interest other than another
F-16
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
derivative financial instrument. The Company adopted
FAS No. 155 effective January 1, 2007; however,
there was no material impact.
In September 2006, the FASB issued Statement No. 157,
Fair Value Measurement (FAS 157), which defines fair
value as the price that would be received to sell an asset or
that would be paid to transfer a liability in an orderly
transaction between market participants at the measurement date.
FAS 157 establishes a framework for measuring fair value
and expands disclosures about fair value measurements.
FAS 157 is effective for fiscal year 2008. The Company is
currently evaluating the impact of this pronouncement on its
financial position and results of operations.
In 2005, the American Institute of Certified Public Accountants
issued Statement of Position (SOP)
05-1,
Accounting by Insurance Enterprises for Deferred Acquisition
Costs in Connection With Modifications or Exchanges of Insurance
Contracts, for implementation in the first quarter of 2007.
The SOP requires that deferred acquisition costs be expensed in
full when the original contract is substantially changed by
election or amendment of an existing contract feature or by
replacement with a new contract. The Company implemented the SOP
for contract changes beginning in the first quarter of 2007 with
no material effects to the financial statements at
implementation.
Reclassification
Certain amounts in the 2006 and 2005 financial statements have
been reclassified to conform to the 2007 financial statement
presentation.
|
|
Note 2.
|
Acquisitions
and Dispositions
|
Acquisitions
Acquisition
of Fidelity Life Insurance Company
Effective December 1, 2007, the Company acquired all of the
outstanding capital stock of Fidelity Life Insurance Company, an
insurance company domiciled in Pennsylvania and licensed to
issue health and life insurance policies. Consideration
consisted of cash payments totaling $13.4 million and
$200,000 in related transaction costs. The Company acquired
$9.6 million of cash and investments, some of which are
held as deposits with state insurance departments, and
recognized the remaining consideration of $4.0 million as
an intangible asset primarily for the state insurance licenses.
Termination
of SIR Obligation
On March 3, 1997, the Company and SIR entered into a Sale
of Assets Agreement providing for the transfer and sale to the
Company of substantially all of the equipment, fixed assets and
contracts associated with SIRs former United Group
Association, Inc., a general insurance agency. In partial
consideration for the transfer and sale, (i) SIR retained
the right to receive all commissions on policies marketed and
sold by SIR and written prior to January 1, 1997 and (ii),
with respect to policies marketed and sold by SIR and written
after January 1, 1997, the Company agreed to pay to SIR
120 basis points (1.20%) times the UGA Commissionable
Renewal Premium Revenue (as such term is defined in the Asset
Sale Agreement) collected in any period (such streams of
payments owing to SIR collectively referred to as the
Future Obligation). See Note 16.
On May 19, 2006, the Company and Special Investment Risks,
Limited (SIR) executed a Termination Agreement to
the existing Sale of Assets Agreement entered into in 1997,
pursuant to which (a) SIR received an aggregate of
$47.5 million, (b) the Future Obligation was
discharged in full, (c) SIR released the Company from all
liability under the Asset Sale Agreement, and (d) the Asset
Sale Agreement was terminated. The Company accounted for the
transaction as additional purchase price which was recorded as
an intangible asset. The Company
F-17
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
is amortizing the intangible asset over an approximate period of
twenty-five years based on estimated future cash flows
associated with the related premium stream.
Dispositions
2006 Sale
of Star HRG Division
On July 11, 2006, the Company sold substantially all of the
assets formerly comprising MEGAs Star HRG Division. Star
HRG, based in Phoenix, Arizona, provided voluntary, limited
benefit, low-cost health plans and other employee benefits
coverage for hourly and part-time workers and their families. In
connection with the sale of Star HRG, the Company recognized a
pre-tax gain of $101.5 million.
As consideration for the receipt of Star HRG assets, a unit of
the CIGNA Corporation issued a promissory note to MEGA in the
principal amount of $150.8 million (the CIGNA
Note) and the CIGNA Corporation entered into a Guaranty
Agreement with MEGA, pursuant to which the CIGNA Corporation
unconditionally guaranteed the payment when due of the CIGNA
Note. The CIGNA Note required a principal payment of
$72.4 million (which was due and paid on November 1,
2006), with the remaining principal amount of $78.4 million
due on June 15, 2021. The CIGNA Note initially bore
interest at an annual rate of 5.4% from its inception to
August 2, 2006. After August 2, 2006, the portion of
the CIGNA Note Payable on November 1, 2006 bore interest at
an annual rate of 5.4%, while the remaining principal amount
bears interest at an annual rate of 6.37%. The interest is to be
paid semi-annually on June 15th and
December 15th of each year. On August 16, 2006,
MEGA subsequently distributed the CIGNA Note and guaranty to
HealthMarkets, LLC as a dividend in kind, and HealthMarkets,
LLC, in turn, contributed the CIGNA Note and guaranty to a
non-consolidated qualifying special purpose entity of the
Company. See Note 11.
The historical results of operations of the Star HRG Division
are reported in continuing operations and classified in the
Disposed Operations business segment for all periods presented.
As part of the sale transaction, MEGA and Chesapeake entered
into 100% coinsurance arrangements with the purchaser. For
financial reporting purposes, at December 31, 2007 and
2006, the Company reports the policy liabilities ceded to the
purchaser under the coinsurance agreement as Policy
liabilities with a corresponding asset reported as
Reinsurance receivable.
In addition, the Company will continue to report in future
periods the residual results of operations of the business
(anticipated to consist solely of residual wind-down expenses)
in continuing operations and classified in the Disposed
Operations business segment.
2006 Sale
of Student Insurance Division
On December 1, 2006, the Company sold substantially all of
the assets formerly comprising MEGAs Student Insurance
Division. The Student Insurance Division offered health
insurance programs that generally provided single school year
coverage to individual students at colleges and universities.
The Student Insurance Division also provides accident policies
for students at public and private schools in pre-kindergarten
through grade twelve. In connection with the sale of the Student
Insurance Division, the Company recognized in 2006 a pre-tax
gain in the amount of approximately $100.2 million.
As consideration for the sale of the Student Insurance Division
assets, the Company received a promissory Note in the principal
amount of $94.8 million issued by UnitedHealth Group Inc.
(the UHG Note). The UHG Note bears interest at a
fixed rate of 5.36% and matures on November 30, 2016, with
the full principal payment due at maturity. The interest is to
be paid semi-annually on May 30th and
November 30th of each year. The Company has concluded
that the UHG Note meets the requirements established in
FAS 115, Accounting for Certain Investments
F-18
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
in Debt and Equity Securities, and may be classified as a
security with a fixed maturity. Accordingly, the UHG Note is
included in Fixed maturities available for sale.
The historical results of operations of the Student Insurance
Division are reported in continuing operations and classified in
the Disposed Operations business segment for all periods
presented.
The purchase price is subject to downward or upward adjustment
based on the amount of premium to be generated with respect to
the
2007-2008
school year and actual claims experience with respect to the
in-force block of student insurance business at the time of the
sale. The Company has recorded $1.2 million and
$6.5 million of realized gains as an adjustment to the
purchase price related to positive claim experience in 2007 and
2006, respectively. The Company has made no adjustment to the
purchase price due to the premium provision. The Company will
continue to examine whether any additional adjustments should be
made in the future.
As part of the sale transaction, MEGA, Mid-West and Chesapeake
entered into 100% coinsurance arrangements with the purchaser.
For financial reporting purposes, at December 31, 2007 and
2006, the Company reports the policy liabilities ceded to the
purchaser under the coinsurance agreement as Policy
liabilities with a corresponding asset reported as
Reinsurance receivable.
In addition, the Company will continue to report in future
periods the residual results of operations of the business
(anticipated to consist solely of residual wind-down expenses
and any
true-up,
premium provision associated with the sale) in continuing
operations and classified to the Companys Disposed
Operations business segment.
A summary of net investment income sources is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Fixed maturities
|
|
$
|
64,810
|
|
|
$
|
70,998
|
|
|
$
|
76,418
|
|
Equity securities
|
|
|
17
|
|
|
|
154
|
|
|
|
89
|
|
Mortgage loans
|
|
|
2
|
|
|
|
96
|
|
|
|
227
|
|
Policy loans
|
|
|
933
|
|
|
|
947
|
|
|
|
1,051
|
|
Short-term and other investments
|
|
|
25,054
|
|
|
|
19,505
|
|
|
|
9,778
|
|
Agent receivables
|
|
|
3,829
|
|
|
|
3,649
|
|
|
|
3,692
|
|
Student loans
|
|
|
10,459
|
|
|
|
10,721
|
|
|
|
8,692
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105,104
|
|
|
|
106,070
|
|
|
|
99,947
|
|
Less investment expenses
|
|
|
2,120
|
|
|
|
1,923
|
|
|
|
2,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
102,984
|
|
|
$
|
104,147
|
|
|
$
|
97,788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-19
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Realized gains and (losses) and the change in unrealized
investment gains and (losses) on fixed maturity and equity
security investments are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains
|
|
|
|
Fixed
|
|
|
Equity
|
|
|
Other
|
|
|
(Losses) on
|
|
|
|
Maturities
|
|
|
Securities
|
|
|
Investments
|
|
|
Investments
|
|
|
|
(In thousands)
|
|
|
Year Ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized
|
|
$
|
871
|
|
|
$
|
|
|
|
$
|
2,604
|
|
|
$
|
3,475
|
|
Change in unrealized
|
|
|
7,227
|
|
|
|
11
|
|
|
|
(1,175
|
)
|
|
|
6,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
$
|
8,098
|
|
|
$
|
11
|
|
|
$
|
1,429
|
|
|
$
|
9,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized
|
|
$
|
(2,264
|
)
|
|
$
|
(32
|
)
|
|
$
|
202,840
|
|
|
$
|
200,544
|
|
Change in unrealized
|
|
|
(4,997
|
)
|
|
|
196
|
|
|
|
|
|
|
|
(4,801
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
$
|
(7,261
|
)
|
|
$
|
164
|
|
|
$
|
202,840
|
|
|
$
|
195,743
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized
|
|
$
|
(1,192
|
)
|
|
$
|
10
|
|
|
$
|
422
|
|
|
$
|
(760
|
)
|
Change in unrealized
|
|
|
(42,902
|
)
|
|
|
(114
|
)
|
|
|
|
|
|
|
(43,016
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
$
|
(44,094
|
)
|
|
$
|
(104
|
)
|
|
$
|
422
|
|
|
$
|
(43,776
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross unrealized investment gains pertaining to equity
securities were $46,000, $35,000 and $28,000, at
December 31, 2007, 2006 and 2005, respectively. Gross
unrealized investment losses pertaining to equity securities
were $-0-, $-0- and $189,000 at December 31, 2007, 2006 and
2005, respectively.
The amortized cost and fair value of investments in fixed
maturities are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
U.S. Treasury and U.S. Government agency obligations
|
|
$
|
72,292
|
|
|
$
|
753
|
|
|
$
|
(105
|
)
|
|
$
|
72,940
|
|
Mortgage-backed securities issued by U.S. Government agencies
and authorities
|
|
|
206,519
|
|
|
|
973
|
|
|
|
(1,575
|
)
|
|
|
205,917
|
|
Other mortgage and asset backed securities
|
|
|
143,133
|
|
|
|
1,102
|
|
|
|
(1,508
|
)
|
|
|
142,727
|
|
Other corporate bonds
|
|
|
885,707
|
|
|
|
10,480
|
|
|
|
(18,028
|
)
|
|
|
878,159
|
|
Other
|
|
|
6,418
|
|
|
|
|
|
|
|
(1,737
|
)
|
|
|
4,681
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturities
|
|
$
|
1,314,069
|
|
|
$
|
13,308
|
|
|
$
|
(22,953
|
)
|
|
$
|
1,304,424
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-20
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
U.S. Treasury and U.S. Government agency obligations
|
|
$
|
73,872
|
|
|
$
|
137
|
|
|
$
|
(726
|
)
|
|
$
|
73,283
|
|
Mortgage-backed securities issued by U.S. Government agencies
and authorities
|
|
|
229,818
|
|
|
|
392
|
|
|
|
(4,810
|
)
|
|
|
225,400
|
|
Other mortgage and asset backed securities
|
|
|
160,983
|
|
|
|
459
|
|
|
|
(3,136
|
)
|
|
|
158,306
|
|
Other corporate bonds
|
|
|
919,603
|
|
|
|
9,008
|
|
|
|
(16,034
|
)
|
|
|
912,577
|
|
Other
|
|
|
6,999
|
|
|
|
|
|
|
|
(2,162
|
)
|
|
|
4,837
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturities
|
|
$
|
1,391,275
|
|
|
$
|
9,996
|
|
|
$
|
(26,868
|
)
|
|
$
|
1,374,403
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair values for fixed maturity securities are based on quoted
market prices, where available. For fixed maturity securities
not actively traded, fair values are estimated using values
obtained from quotation services.
As of December 31, 2007, the largest concentration in any
one investment grade corporate bond was $92.4 million,
which represented 6.3% of total invested assets. This security
was received from UnitedHealth Group as payment on the sale of
the Student Insurance Division. This security is carried at fair
value which is derived by a similar publicly traded UnitedHealth
Group security. The Company maintains a $75.0 million
credit default insurance policy on this bond, reducing its
default exposure to $19.8 million, or 1.3% of total
invested assets. See Note 2. The largest
concentration in any one non-investment grade corporate bond was
$4.6 million, which represented less than 1% of total
invested assets. The largest concentration to any one industry
was less than 10%.
The amortized cost and fair value of fixed maturities at
December 31, 2007, by contractual maturity, are set forth
in the table below. Fixed maturities subject to early or
unscheduled prepayments have been included based upon their
contractual maturity dates. Actual maturities will differ from
contractual maturities because borrowers may have the right to
call or prepay obligations with or without call or prepayment
penalties.
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
Amortized
|
|
|
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
Maturity:
|
|
|
|
|
|
|
|
|
One year or less
|
|
$
|
88,022
|
|
|
$
|
87,917
|
|
Over 1 year through 5 years
|
|
|
336,809
|
|
|
|
337,521
|
|
Over 5 years through 10 years
|
|
|
302,165
|
|
|
|
294,832
|
|
Over 10 years
|
|
|
237,421
|
|
|
|
235,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
964,417
|
|
|
|
955,780
|
|
Mortgage and asset backed securities
|
|
|
349,652
|
|
|
|
348,644
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturities
|
|
$
|
1,314,069
|
|
|
$
|
1,304,424
|
|
|
|
|
|
|
|
|
|
|
Proceeds from the sale and call of investments in fixed
maturities were $161.3 million, $225.4 million and
$181.8 million for 2007, 2006 and 2005, respectively. Gross
gains of $1.3 million, $2.6 million and
$4.6 million, and gross losses of $405,000,
$2.5 million and $1.7 million were realized on the
sale and call of fixed maturity investments during 2007, 2006
and 2005, respectively.
F-21
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Proceeds from the sale of equity investments were
$1.5 million and $10,000 for 2006 and 2005, respectively.
Gross gains of $-0- and $10,000 and gross losses of $32,000 and
$-0- were realized on sales of equity investments during 2006
and 2005, respectively. There were no sales of securities in
2007.
The fair value, which represents carrying amounts of equity
securities, is based on quoted market prices.
The carrying amounts of the Companys investment in policy
loans approximate fair value which is estimated using discounted
cash flow analysis at a rate for similar loans at contractual
rates for policy loans from currently marketed policies.
The Company minimizes its credit risk associated with its fixed
maturities portfolio by investing primarily in investment grade
securities. Included in fixed maturities is a concentration of
mortgage and asset backed securities. At December 31, 2007,
the Company had a carrying amount of $348.6 million of
mortgage and asset backed securities, of which
$205.9 million were government backed, $124.1 million
were rated AAA, $2.1 million were rated AA,
$11.2 million were rated A, and $5.3 million were
rated BBB by external rating agencies. At December 31,
2006, the Company had a carrying amount of $383.7 million
of mortgage and asset backed securities, of which
$225.4 million were government backed, $130.0 million
were rated AAA, $2.4 million were rated AA,
$18.0 million were rated A, $7.4 million were rated
BBB, and $467,000 were rated below investment grade by external
rating agencies. Additionally, our direct exposure to sub prime
investments and auction rate securities is limited to 3.5% of
investments.
During 2007, 2006 and 2005, the Company recorded impairment
charges for certain fixed maturities in the amount of $-0-,
$2.4 million and $4.1 million, respectively. There
were no impairment charges on equity securities. The impairment
charges are reported as Gains (losses) on sale of
investments.
Set forth below is a summary of gross unrealized losses in its
fixed maturities as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized Loss
|
|
|
Unrealized Loss
|
|
|
|
|
|
|
Less Than 12 Months
|
|
|
12 Months or longer
|
|
|
Total
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
Description of Securities
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
|
(In thousands)
|
|
|
U.S. Treasury obligations and direct obligations of U.S.
Government agencies
|
|
$
|
7,245
|
|
|
$
|
12
|
|
|
$
|
15,200
|
|
|
$
|
93
|
|
|
$
|
22,445
|
|
|
$
|
105
|
|
Mortgage backed securities issued by U.S. Government agencies
and authorities
|
|
|
|
|
|
|
|
|
|
|
134,294
|
|
|
|
1,575
|
|
|
|
134,294
|
|
|
|
1,575
|
|
Other mortgage and asset backed securities
|
|
|
461
|
|
|
|
38
|
|
|
|
89,764
|
|
|
|
1,470
|
|
|
|
90,225
|
|
|
|
1,508
|
|
Corporate bonds
|
|
|
152,855
|
|
|
|
5,713
|
|
|
|
303,871
|
|
|
|
12,315
|
|
|
|
456,726
|
|
|
|
18,028
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
4,681
|
|
|
|
1,737
|
|
|
|
4,681
|
|
|
|
1,737
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
160,561
|
|
|
$
|
5,763
|
|
|
$
|
547,810
|
|
|
$
|
17,190
|
|
|
$
|
708,371
|
|
|
$
|
22,953
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2007, the Company had $23.0 million of
unrealized losses in its fixed maturities portfolio. Of the
$5.8 million in unrealized losses that have existed for
less than 12 months, two securities have unrealized losses
in excess of 10% of the securitys cost. The amount of
unrealized loss with respect to those securities was
$2.4 million at December 31, 2007. Of the
$17.2 million in unrealized losses that have existed for
twelve months or longer, nine securities had an unrealized loss
in excess of 10% of the securitys cost. The amount of
unrealized loss with respect to those securities was
$6.8 million at December 31, 2007. Included with the
nine securities that had unrealized losses in excess of 10% and
classified as Other in the table above is the
Companys residual interest in Grapevine Finance LLC.
F-22
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
At December 31, 2007, Grapevine Finance LLC had an
unrealized loss of $1.7 million, or 27.1% of cost. See
Notes 2 and 11. The Company believes that the cash
flows received from the security have not changed from those
that were expected when the securitization was complete in 2006.
The Company continually monitors these investments and believes
that, as of December 31, 2007, the unrealized loss in these
investments is temporary.
At December 31, 2007, the Company had no unrealized losses
in its equity securities portfolio.
Set forth below is a summary of gross unrealized losses in its
fixed maturities as of December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized Loss
|
|
|
Unrealized Loss
|
|
|
|
|
|
|
Less Than 12 Months
|
|
|
12 Months or longer
|
|
|
Total
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
Description of Securities
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
|
(In thousands)
|
|
|
U.S. Treasury obligations and direct obligations of U.S.
Government agencies
|
|
$
|
20,353
|
|
|
$
|
75
|
|
|
$
|
36,149
|
|
|
$
|
651
|
|
|
$
|
56,502
|
|
|
$
|
726
|
|
Mortgage backed securities issued by U.S. Government agencies
and authorities
|
|
|
26,399
|
|
|
|
143
|
|
|
|
179,551
|
|
|
|
4,667
|
|
|
|
205,950
|
|
|
|
4,810
|
|
Other mortgage and asset backed securities
|
|
|
24,064
|
|
|
|
108
|
|
|
|
111,058
|
|
|
|
3,028
|
|
|
|
135,122
|
|
|
|
3,136
|
|
Corporate bonds
|
|
|
91,868
|
|
|
|
512
|
|
|
|
343,231
|
|
|
|
15,522
|
|
|
|
435,099
|
|
|
|
16,034
|
|
Other
|
|
|
4,837
|
|
|
|
2,162
|
|
|
|
|
|
|
|
|
|
|
|
4,837
|
|
|
|
2,162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
167,521
|
|
|
$
|
3,000
|
|
|
$
|
669,989
|
|
|
$
|
23,868
|
|
|
$
|
837,510
|
|
|
$
|
26,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2006, the Company had no unrealized losses
in its equity securities portfolio.
The Company regularly monitors its investment portfolio to
attempt to minimize its concentration of credit risk in any
single issuer. Set forth in the table below is a schedule of all
investments representing greater than 1% of the Companys
aggregate investment portfolio at December 31, 2007 and
2006, excluding U.S. Government securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
|
|
|
|
Carrying
|
|
|
Carrying
|
|
|
Carrying
|
|
|
% of Total
|
|
|
|
Amount
|
|
|
Value
|
|
|
Amount
|
|
|
Value
|
|
|
|
(Dollars in thousands)
|
|
|
Issuer-Fixed Maturities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UnitedHealth Group, from sale of Student Insurance Division
|
|
$
|
92,393
|
|
|
|
6.2
|
%
|
|
$
|
94,763
|
|
|
|
5.3
|
%
|
Morgan Stanley Dean Witter
|
|
|
22,560
|
|
|
|
1.5
|
%
|
|
|
|
|
|
|
|
|
Household Finance Corporation
|
|
|
15,035
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
Federal National Mortgage Corporation
|
|
|
15,028
|
|
|
|
1.0
|
%
|
|
|
17,992
|
|
|
|
1.0
|
%
|
General Electric Capital Corporation
|
|
|
15,022
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
Issuer Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fidelity Institutional Money Market Fund
|
|
$
|
88,657
|
|
|
|
6.0
|
%
|
|
$
|
325,677
|
|
|
|
18.1
|
%
|
Under the terms of various reinsurance agreements (see
Note 7), the Company is required to maintain assets in
escrow with a fair value equal to the statutory reserves assumed
under the reinsurance agreements. Under these
F-23
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
agreements, the Company had on deposit, securities with a fair
value of approximately $45.2 million and $51.8 million
as of December 31, 2007 and 2006, respectively. In
addition, domestic insurance subsidiaries had securities with a
fair value of $25.8 million and $19.2 million on
deposit with insurance departments in various states at
December 31, 2007 and 2006, respectively.
In 2005, the Company established a securities lending program,
under which the Company lends fixed-maturity securities to
financial institutions in short-term lending transactions. The
Company maintains effective control over the loaned securities
by virtue of the ability to unilaterally cause the holder to
return the loaned security on demand. These securities continue
to be carried as investment assets on the Companys balance
sheet during the term of the loans and are not reported as
sales. The Companys security lending policy requires that
the fair value of the cash and securities received as collateral
be 102% or more of the fair value of the loaned securities. The
collateral received is restricted and cannot be used by the
Company unless the borrower defaults under the terms of the
agreement. These short-term security lending arrangements
increase investment income with minimal risk. At
December 31, 2007 and 2006, securities on loan to various
borrowers totaled $190.8 million and $227.8 million,
respectively.
The Company holds alternative (i.e., non-federally
guaranteed) student loans extended to students at selected
colleges and universities. These loans were initially generated
under the Companys College First Alternative Loan program.
The student loans guaranteed by private insurers are guaranteed
100% as to principal and accrued interest.
Set forth below is a summary of the student loans at
December 31, 2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Student loans guaranteed by private insurers
|
|
$
|
73,896
|
|
|
$
|
80,615
|
|
Student loans non-guaranteed
|
|
|
25,283
|
|
|
|
28,487
|
|
Allowance for losses
|
|
|
(2,925
|
)
|
|
|
(3,256
|
)
|
|
|
|
|
|
|
|
|
|
Total student loans
|
|
$
|
96,254
|
|
|
$
|
105,846
|
|
|
|
|
|
|
|
|
|
|
Of the aggregate $96.3 million and $105.8 million
carrying amount of student loans at December 31, 2007 and
2006, $93.2 million and $105.4 million, respectively,
were pledged to secure payment of secured student loan
indebtedness. See Note 9. The fair value of the
student loans approximated the carrying value for 2006 and 2007.
The provision for losses on student loans is summarized as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Balance at beginning of year
|
|
$
|
3,256
|
|
|
$
|
2,722
|
|
|
$
|
3,608
|
|
Change in provision for losses
|
|
|
(331
|
)
|
|
|
534
|
|
|
|
(886
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of year
|
|
$
|
2,925
|
|
|
$
|
3,256
|
|
|
$
|
2,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company recognized interest income from the student loans of
$10.5 million, $10.7 million and $8.7 million in
2007, 2006 and 2005, respectively, which is included in
investment income.
F-24
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
Note 5.
|
Goodwill
and Other Intangible Assets
|
Goodwill and other intangible assets by operating division as of
December 31, 2007 and 2006 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible
|
|
|
Accumulated
|
|
|
|
|
|
|
Goodwill
|
|
|
Assets
|
|
|
Amortization
|
|
|
Net
|
|
|
|
(In thousands)
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
40,025
|
|
|
$
|
55,283
|
|
|
$
|
(6,473
|
)
|
|
$
|
88,835
|
|
Life Insurance Division
|
|
|
359
|
|
|
|
|
|
|
|
|
|
|
|
359
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
40,384
|
|
|
$
|
55,283
|
|
|
$
|
(6,473
|
)
|
|
$
|
89,194
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible
|
|
|
Accumulated
|
|
|
|
|
|
|
Goodwill
|
|
|
Assets
|
|
|
Amortization
|
|
|
Net
|
|
|
|
(In thousands)
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
40,025
|
|
|
$
|
51,239
|
|
|
$
|
(4,752
|
)
|
|
$
|
86,512
|
|
Life Insurance Division
|
|
|
359
|
|
|
|
|
|
|
|
|
|
|
|
359
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
40,384
|
|
|
$
|
51,239
|
|
|
$
|
(4,752
|
)
|
|
$
|
86,871
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other intangible assets consist primarily of state insurance
licenses related to the acquisition of Fidelity Life Insurance
Company completed in December 2007; customer lists, trademark
and non-compete agreements related to the acquisition of
substantially all of the operating assets of HEI Exchange Inc.
(formerly known as HealthMarket Inc.) in October 2004; and the
acquisition of Specialized Investment Risk rights to the renewal
commissions at the Self Employed Agency Division. See
Note 2.
The Company recorded amortization expense associated with other
intangibles in continuing operations in the amount of
$1.7 million, $2.5 million and $3.7 million in
2007, 2006 and 2005, respectively. Amortization expense in 2006
and 2005 included impairment charges of $496,000 and
$1.7 million, respectively, related to the HEI Exchange
customer list acquired in October 2004. The impairment charge
was reported in Underwriting, policy acquisition costs,
and insurance expenses.
Estimated amortization expense for the next five years and
thereafter for other intangible assets is as follows:
|
|
|
|
|
|
|
(In thousands)
|
|
|
2008
|
|
$
|
1,639
|
|
2009
|
|
|
1,582
|
|
2010
|
|
|
1,525
|
|
2011
|
|
|
1,532
|
|
2012
|
|
|
1,549
|
|
2013 and thereafter
|
|
|
36,939
|
|
|
|
|
|
|
|
|
$
|
44,766
|
|
|
|
|
|
|
F-25
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
Note 6.
|
Policy
Liabilities
|
As more fully described below, policy liabilities consist of
future policy and contract benefits, claim liabilities, unearned
premiums and other policy liabilities.
Future
Policy and Contract Benefits
Liability for future policy and contract benefits consisted of
the following at December 31, 2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Accident & Health
|
|
$
|
100,221
|
|
|
$
|
98,639
|
|
Life
|
|
|
267,860
|
|
|
|
250,615
|
|
Annuity
|
|
|
95,196
|
|
|
|
104,461
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
463,277
|
|
|
$
|
453,715
|
|
|
|
|
|
|
|
|
|
|
Benefits, claims and settlement expenses net of reinsurance
ceded consists of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Future liability and contract benefits
|
|
$
|
25,232
|
|
|
$
|
28,282
|
|
|
$
|
25,409
|
|
Claims benefits
|
|
|
776,551
|
|
|
|
968,335
|
|
|
|
1,066,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits, claims and settlement expenses
|
|
$
|
801,783
|
|
|
$
|
996,617
|
|
|
$
|
1,092,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accident
and Health Policies
With respect to accident and health insurance, future policy
benefits are primarily attributable to a
return-of-premium (ROP) rider that the Company has
issued with certain health policies. Pursuant to this rider, the
Company undertakes to return to the policyholder on or after
age 65 all premiums paid less claims reimbursed under the
policy. The ROP rider also provides that the policyholder may
receive a portion of the benefit prior to age 65. The
future policy benefits for the ROP rider are computed using the
net level premium method. A claim offset for actual benefits
paid through the reporting date is applied to the ROP liability
for all policies on a
contract-by-contract
basis. The ROP liabilities reflected in future policy and
contract benefits were $95.1 million and $93.4 million
at December 31, 2007 and 2006, respectively.
The remainder of the future policy benefits for accident and
health are principally contract reserves on issue-age rated
policies, reserves for other riders providing future benefits,
and reserves for the refund of a portion of premium as required
by state law. These liabilities are typically calculated as the
present value of future benefits less the present value of
future net premiums, computed on a net level premium basis.
Life
Policies and Annuity Contracts
With respect to traditional life insurance, future policy
benefits are computed on a net level premium method.
Substantially all liability interest assumptions range from 3.0%
to 6.0%. Such liabilities are graded to equal statutory values
or cash values prior to maturity.
Interest rates credited to future contract benefits related to
universal life-type contracts approximated 4.5% during each of
2007, 2006 and 2005. Interest rates credited to the liability
for future contract benefits related to direct annuity contracts
generally ranged from 3.0% to 5.5% during 2007, 2006 and 2005.
F-26
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The Company has assumed certain life and annuity business from
another company, utilizing the same actuarial assumptions as the
ceding company. The liability for future policy benefits related
to life business has been calculated using an interest rate
ranging from 4% to 6%, consistent with best estimate assumptions
for interest sensitive life plans and consistent with pricing
assumptions for non-interest sensitive life plans. Interest
rates credited to the liability for future contract benefits
related to these annuity contracts generally ranged from 3.0% to
4.5% during 2007, 2006 and 2005.
The carrying amounts of liabilities for investment-type
contracts (included in future policy and contract benefits and
other policy liabilities) at December 31, 2007 and 2006
were as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Direct annuities
|
|
$
|
55,409
|
|
|
$
|
59,257
|
|
Assumed annuities
|
|
|
38,358
|
|
|
|
43,720
|
|
Supplemental contracts without life contingencies
|
|
|
1,429
|
|
|
|
1,484
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
95,196
|
|
|
$
|
104,461
|
|
|
|
|
|
|
|
|
|
|
Claims
Liabilities
The Company establishes liabilities for benefit claims that have
been reported but not paid and claims that have been incurred
but not reported under health and life insurance contracts. The
claim liability estimate, as determined, is expected to be
adequate under reasonably likely circumstances. The estimate is
developed using actuarial principles and assumptions that
consider a number of items, including, but not limited to,
historical and current claim payment patterns, product
variations, the timely implementation of rate increases and
seasonality. The Company does not develop ranges in the setting
of the claims liability reported in the financial statements.
For the majority of health insurance products in the
Self-Employed Agency Division , the Companys claim
liabilities are estimated using the developmental method, which
involves the use of completion factors for most incurral months,
supplemented with additional estimation techniques, such as loss
ratio estimates, in the most recent incurral months. This method
applies completion factors to claim payments in order to
estimate the ultimate amount of the claim. These completion
factors are derived from historical experience and are dependent
on the incurred dates of the claim payments. The completion
factors are selected so that they are equally likely to be
redundant as deficient.
In estimating the ultimate level of claims for the most recent
incurral months, the Company uses what it believes are prudent
estimates that reflect the uncertainty involved in these
incurral months. An extensive degree of judgment is used in this
estimation process. For healthcare costs payable, the claim
liability balances and the related benefit expenses are highly
sensitive to changes in the assumptions used in the claims
liability calculations. With respect to health claims, the items
that have the greatest impact on the Companys financial
results are the medical cost trend, which is the rate of
increase in healthcare costs, and the unpredictable variability
in actual experience. Any adjustments to prior period claim
liabilities are included in the benefit expense of the period in
which adjustments are identified. Due to the considerable
variability of healthcare costs and actual experience,
adjustments to health claim liabilities usually occur each
quarter and may be significant.
The Company establishes the claims liability using the original
incurred date, with certain adjustments as described below.
Under this incurred date methodology, claims liabilities for the
cost of all medical services related to the accident or sickness
are recorded at the earliest date of diagnosis or treatment,
even though the medical services associated with such accident
or sickness might not be rendered to the insured until a later
financial reporting period. A break in service of more than six
months will result in the establishment of a new incurred date
F-27
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
for subsequent services. A new incurred date is established if
claims payments continue for more than thirty-six months without
a six month break in service.
The SEA Division also makes various refinements to the claim
liabilities as appropriate. These refinements estimate
liabilities for circumstances, such as inventories of pending
claims in excess of historical levels and disputed claims. When
the level of pending claims appears to be in excess of normal
levels, the Company typically establishes a liability for excess
pending claims. The Company believes that such an excess pending
claims liability is appropriate under such circumstances because
of the operation of the developmental method used to calculate
the principal claim liability, which method develops
or completes paid claims to estimate the claim
liability. When the pending claims inventory is higher than
would ordinarily be expected, the level of paid claims is
correspondingly lower than would ordinarily be expected. This
lower level of paid claims, in turn, results in the
developmental method yielding a smaller claim liability than
would have been yielded with a normal level of paid claims,
resulting in the need for augmented claim liabilities.
With respect to Disposed Operations, the Company assigns
incurred dates based on the date of service. This definition
estimates the liability for all medical services received by the
insured prior to the end of the applicable financial period.
Adjustments are made in the completion factors to account for
pending claim inventory changes and contractual continuation of
coverage beyond the end of the financial period.
Claims
Liability Development Experience
Activity in the claims liability is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Claims liability at beginning of year, net of reinsurance
|
|
$
|
444,550
|
|
|
$
|
546,001
|
|
|
$
|
610,779
|
|
Less: Claims liability paid on business disposed
|
|
|
|
|
|
|
(68,617
|
)
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
Incurred losses, net of reinsurance, occurring during:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
851,575
|
|
|
|
1,059,032
|
|
|
|
1,191,723
|
|
Prior years
|
|
|
(75,024
|
)
|
|
|
(90,697
|
)
|
|
|
(124,996
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total incurred losses, net of reinsurance
|
|
|
776,551
|
|
|
|
968,335
|
|
|
|
1,066,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deduct:
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for claims, net of reinsurance, occurring during:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
535,987
|
|
|
|
664,220
|
|
|
|
765,767
|
|
Prior years
|
|
|
287,308
|
|
|
|
336,949
|
|
|
|
365,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total payments for claims, net of reinsurance
|
|
|
823,295
|
|
|
|
1,001,169
|
|
|
|
1,131,505
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims liability at end of year, net of related reinsurance
recoverable (2007 $37,293; 2006 $72,582;
2005 $12,105)
|
|
$
|
397,806
|
|
|
$
|
444,550
|
|
|
$
|
546,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As indicated in the table above, incurred losses developed in
amounts less than originally anticipated.
F-28
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Set forth in the table below is a summary of the claims
liability development experience (favorable) unfavorable by
business unit in the Companys Insurance segment for each
of the years ended December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Self-Employed Agency Division
|
|
$
|
(75,552
|
)
|
|
$
|
(85,784
|
)
|
|
$
|
(121,362
|
)
|
Life Insurance Division
|
|
|
(163
|
)
|
|
|
(510
|
)
|
|
|
337
|
|
Other Insurance
|
|
|
734
|
|
|
|
(2,530
|
)
|
|
|
805
|
|
Disposed Operations
|
|
|
(43
|
)
|
|
|
(1,873
|
)
|
|
|
(4,776
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total favorable development
|
|
$
|
(75,024
|
)
|
|
$
|
(90,697
|
)
|
|
$
|
(124,996
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact on SEA Division. As indicated in the
table above, incurred losses developed at the SEA Division in
amounts less than originally anticipated due to
better-than-expected experience on the health business in each
of the years.
For the SEA Division, the favorable claims liability development
experience in the prior years reserve for each of the
years ended December 31, 2007, 2006 and 2005 is set forth
in the table below by source:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Development in the most recent incurral months
|
|
$
|
(25,957
|
)
|
|
$
|
(31,949
|
)
|
|
$
|
(64,587
|
)
|
Development in completion factors
|
|
|
(9,536
|
)
|
|
|
(4,606
|
)
|
|
|
(9,677
|
)
|
Development in reserves for regulatory and legal matters
|
|
|
(14,991
|
)
|
|
|
(4,762
|
)
|
|
|
(6,971
|
)
|
Development in the ACE rider
|
|
|
(13,670
|
)
|
|
|
(29,726
|
)
|
|
|
(27,171
|
)
|
Development in non-renewed blanket policies
|
|
|
(6,669
|
)
|
|
|
|
|
|
|
|
|
Development in large claim reserve
|
|
|
|
|
|
|
(10,555
|
)
|
|
|
(8,455
|
)
|
Other
|
|
|
(4,729
|
)
|
|
|
(4,186
|
)
|
|
|
(4,501
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total favorable development
|
|
$
|
(75,552
|
)
|
|
$
|
(85,784
|
)
|
|
$
|
(121,362
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total favorable claims liability development experience for
2007, 2006 and 2005 in the amount of $75.6 million,
$85.8 million and $121.4 million, respectively,
represented 18.1%, 19.5% and 24.6% of total claim liabilities
established for the SEA Division as of December 31, 2006,
2005 and 2004, respectively.
Development in the most recent incurral months and
Development in completion factors
As indicated in the table above, considerable favorable
development ($35.5 million, $36.6 million and
$74.3 million for year ended December 31, 2007, 2006
and 2005, respectively) is associated with the estimate of claim
liabilities for the most recent incurral months and development
of completion factors. The completion factors are derived from
historical experience, and favorable or unfavorable development
may result when current claim payment patterns differ from
historical patterns. The completion factors are selected so that
they are equally likely to be redundant as deficient. In
estimating the ultimate level of claims for the most recent
incurral months, the Company uses what it believes are prudent
estimates that reflect the uncertainty involved in these
incurral months. An extensive degree of judgment is used in this
estimation process. Over time, the developmental method replaces
anticipated experience with actual experience, resulting in an
ongoing re-estimation of the claims liability. Since the
greatest degree of estimation is used for more recent periods,
the most recent prior year is subject to the greatest change.
Recent actual experience has produced lower levels of claims
payment experience than originally expected.
F-29
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The favorable development also reflects changes in the
assumptions used to calculate the estimate of the claim
liability. See discussion below regarding Changes in SEA
Claim Liability Estimates.
Development
in reserves for regulatory and legal matters
The Company experienced favorable development for each of the
three years presented in the table above associated with its
reserves for regulatory and legal matters due to settlements of
certain matters on terms more favorable than originally
anticipated.
Development
in the ACE rider
The Accumulated Covered Expense (ACE) rider is an
optional benefit rider available with certain scheduled/basic
health insurance products that provides for catastrophic
coverage for covered expenses under the contract that generally
exceed $100,000 or, in certain cases, $75,000. This rider pays
benefits at 100% after the stop loss amount is reached up to the
aggregate maximum amount of the contract for expenses covered by
the rider. Development in the ACE rider is presented separately
due to the greater level of volatility in the ACE product
resulting from the nature of the benefit design where there are
less frequent claims but larger dollar value claims. The
development experience presented in the table above is partially
attributable to development in the most recent incurral months
and development in the completion factors. The favorable
development also reflects changes in the assumptions used to
calculate the estimate of the claim liability. See discussion
below regarding Changes in the SEA Claim Liability
Estimates.
Development
in non-renewed blanket policies
In 2007, the SEA Division benefited from favorable development
in its claim liability of $6.7 million related to its
reserve for benefits provided through group blanket contracts to
the members of certain associations. These contracts were not
renewed and the Companys subsequent actual experience was
favorable in comparison to the reserve estimates established
prior to the termination of the contracts.
Development
in large claim reserve
The Company experienced favorable development of
$8.5 million during 2005 in its reserve for large claims as
a result of lower frequency and severity of large claims than
anticipated. During 2006, the Company determined that sufficient
provision for large claims could be made within its normal
reserve process, thus eliminating the need for the separate
large claim reserve and producing favorable development in the
amount of $10.6 million. Since this reserve was eliminated
in 2006, there is no subsequent development in 2007, either
favorable or unfavorable.
Other
The remaining favorable experience in the claim liability
development was $4.7 million, $4.2 million and
$4.5 million in 2007, 2006 and 2005, respectively, which in
each year, represented less than 1.1% of total claim liability
established at the end of each preceding year.
Impact on Life Insurance Division. The varied
claim liability development experience at the Life Insurance
Division for each of the years presented is due to the
development of a closed block of workers compensation
business.
Impact on Other Insurance. Through our
82.5%-owned subsidiary, ZON Re, we underwrite, administer and
issue accidental death, AD&D, accident medical and accident
disability insurance products, both on a primary and on a
reinsurance basis. The unfavorable claim liability development
experience at ZON Re in 2007 in the amount of $734,000 was due
to certain large claims reported in 2007 associated with claims
incurred in prior years. The
F-30
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
favorable claim liability experience of $2.5 million in
2006 is due to the release of reserves held at December 31,
2005 for catastrophic excess of loss contracts expiring during
2006.
Impact on Disposed Operations. The products of
the Companys former Student Insurance and Star HRG
Divisions consist principally of medical insurance. In general,
medical insurance business, for which incurred dates are
assigned based on date of service, has a short tail,
which means that a favorable development or unfavorable
development shown for prior years relates primarily to actual
experience in the most recent prior year. During 2007, the
development of the claim liabilities for the Disposed Operations
showed a small favorable development of $43,000.
The favorable claim liability development experience at the
Student Insurance Division in 2006 and 2005 was $478,000 and
$5.2 million, respectively. This favorable development was
due to claims in the current year developing more favorably than
indicated by the loss trends used to determine the claim
liability at December 31 of the preceding year.
The favorable claims liability development experience at the
Star HRG Division of $1.4 million in 2006 included the
effects of claims in 2006 developing more favorably than
indicated by the loss trends in 2005 used to determine the claim
liability at December 31, 2005. The unfavorable claim
liability development at the Star HRG Division in 2005 of
$410,000 was within the normal statistical variation in the
model used to develop the reserve. The actual development of
prior years claims exceeded the expected development of
the claims liability.
Changes
in SEA Claim Liability Estimates
As presented in the table above, the SEA Division has reported
particularly favorable development experience for the last
several years. In response to these results, the Company has
endeavored and will continue in its efforts to refine its
estimates and assumptions in calculating the claim liability
estimate. To the extent the changes in estimates described below
related to prior year incurral months at the time the change was
implemented, that portion or amount of the change is included in
the development experience table. The Company made the following
changes in estimate, by year, as described below:
2007 Change in Claim Liability
Estimates. During 2007, the Company made the
following refinements to its claim liability estimate.
|
|
|
|
|
A reduction in the claim liability of $11.2 million
recorded in the fourth quarter was attributable to an update of
the completion factors used in the developmental method of
estimating the unpaid claim liability to reflect more recent
claims payment experience.
|
|
|
|
In 2007, the Company made certain refinements to reduce its
estimate of the claim liability for the ACE rider totaling
$10.9 million. The refinement of $5.9 recorded in the third
quarter was attributable to an update of the completion factors
used in estimating the claim liability for the ACE rider. A
benefit recorded in the second quarter of $5.0 million
reflected an increasing reliance on actual historical data for
the ACE rider in lieu of large claim data derived from other
products.
|
|
|
|
During the third quarter of 2007, the claim liability was
reduced by $12.3 million resulting from a refinement to the
estimate of unpaid claim liability specifically for the most
recent incurral months. In particular, the Company reassessed
its claim liability estimates among product lines between the
more mature scheduled benefit products that have more historical
data and are more predictable, and the newer products that are
less mature, have less historical data and are more susceptible
to adverse deviation.
|
F-31
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
2006 Change in Claim Liability
Estimates. During 2006, the Company made the
following refinements to its claim liability estimate.
|
|
|
|
|
In the third quarter, the Company reduced the claim liability
estimate by $11.2 million due to refinements of the
estimate of the unpaid claim liability for the most recent
incurral months. This update to the calculation distinguished
between more mature products with reliable historical data and
newer or lower volume products that had not established a
reliable historical trend.
|
|
|
|
During 2006, the Company reduced the claim liability estimate by
a total of $25.1 million for the ACE rider,
$10.5 million was recorded in the third quarter and
$14.6 million was recorded in the fourth quarter. These
reductions were attributable to an update of the completion
factors used in estimating the claim liability, reflecting both
actual historical data for the ACE rider and historical data
derived from other products. In 2005, the completion factors
were calculated with more emphasis placed on historical data
derived from other products since there was insufficient data
related to the ACE product rider to provide accurate and
reliable completion factors.
|
2005 Change in Claim Liability
Estimates. During 2005, the Company made the
following refinements to its claim liability estimate.
|
|
|
|
|
In the third quarter, the Company reduced the claim liability
estimate by $21.0 million. This reduction was attributable
to a refinement of the estimate of the unpaid claim liability
for the most recent incurral months. The Company utilizes
anticipated loss ratios to calculate the estimated claim
liability for the most recent incurral months. Despite
negligible premium rate increases implemented on the most
popular scheduled health insurance products, the SEA Division
has continued to observe favorable claims experience and, as a
result, loss ratios have not increased as rapidly as
anticipated. This favorable claims experience has been reflected
in the refinement of the anticipated loss ratios used in
estimating the unpaid claim liability for the most recent
incurral months.
|
|
|
|
In addition, in the third quarter, an additional
$12.3 million reduction was made as a result of updates to
the completion factors used in the developmental method of
estimating the unpaid claim liability, reflecting more current
claims administration practices.
|
|
|
|
In the first quarter, the Company made certain refinements to
its claim liability calculations related to the ACE rider, the
effect of which decreased claim liabilities by
$7.6 million. Prior to January 1, 2005, the Company
utilized a technique that is commonly used to estimate claims
liabilities with respect to developing blocks of business, until
sufficient experience is obtained to allow more precise
estimates. The Company believed that the technique produced
appropriate reserve estimates in all prior periods. During the
first quarter of 2005, the Company believed that there were
sufficient claims paid on this benefit to produce a reserve
estimate utilizing the completion factor technique. As a result,
effective January 1, 2005, the Company refined its
technique used to estimate claim liabilities to utilize
completion factors for older incurral dates. The technique
utilizes anticipated loss ratios in the most recent incurral
months. This completion factor technique utilized historical
data derived from other products since there was insufficient
data related to the ACE product rider to provide accurate and
reliable completion factors.
|
The Companys insurance subsidiaries, in the ordinary
course of business, reinsure certain risks with other insurance
companies. These arrangements provide greater diversification of
risk and limit the maximum net loss potential arising from large
risks. To the extent that reinsurance companies are unable to
meet their obligations under the reinsurance agreements, the
Company remains liable.
F-32
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The reinsurance receivable at December 31, 2007 and 2006
was as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Paid losses recoverable
|
|
$
|
4,351
|
|
|
$
|
13,995
|
|
Unpaid losses recoverable
|
|
|
37,293
|
|
|
|
72,582
|
|
Other net
|
|
|
31,388
|
|
|
|
68,706
|
|
|
|
|
|
|
|
|
|
|
Total reinsurance receivable
|
|
$
|
73,032
|
|
|
$
|
155,283
|
|
|
|
|
|
|
|
|
|
|
The effects of reinsurance transactions reflected in the
consolidated financial statements are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Premiums:
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums Written:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
|
|
$
|
1,503,082
|
|
|
$
|
1,815,868
|
|
|
$
|
1,871,102
|
|
Assumed
|
|
|
32,694
|
|
|
|
37,740
|
|
|
|
40,310
|
|
Ceded
|
|
|
(156,254
|
)
|
|
|
(99,029
|
)
|
|
|
(15,999
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Written
|
|
$
|
1,379,522
|
|
|
$
|
1,754,579
|
|
|
$
|
1,895,413
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums Earned:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
|
|
$
|
1,558,340
|
|
|
$
|
1,820,353
|
|
|
$
|
1,892,519
|
|
Assumed
|
|
|
30,614
|
|
|
|
37,740
|
|
|
|
39,072
|
|
Ceded
|
|
|
(206,761
|
)
|
|
|
(120,847
|
)
|
|
|
(14,057
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Earned
|
|
$
|
1,382,193
|
|
|
$
|
1,737,246
|
|
|
$
|
1,917,534
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded benefits and settlement expenses
|
|
$
|
126,051
|
|
|
$
|
72,113
|
|
|
$
|
29,259
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
Coinsurance Arrangements
In connection with the sales in 2006 of the Companys Star
HRG and Student Insurance Divisions, insurance subsidiaries of
the Company entered into 100% coinsurance arrangements with each
of the purchasers, pursuant to which the purchasers agreed to
assume liability for future claims associated with the Star HRG
Division and Student Insurance Division blocks of group accident
and health insurance policies in force as of the respective
closing dates. As of December 31, 2007, the majority of the
reinsurance receivable related to the Student Insurance Division
coinsurance arrangement. See Note 2 for additional
information with respect to these coinsurance arrangements.
F-33
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Long-term indebtedness outstanding at December 31, 2007 and
2006 (excluding outstanding indebtedness that is secured by
student loans generated by the College Fund Life
Division see Note 9):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Long-term debt:
|
|
|
|
|
|
|
|
|
Trust preferred securities
|
|
$
|
118,570
|
|
|
$
|
118,570
|
|
Term loan
|
|
|
362,500
|
|
|
|
437,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
481,070
|
|
|
|
556,070
|
|
Less: current portion of long-term debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
|
481,070
|
|
|
|
556,070
|
|
|
|
|
|
|
|
|
|
|
Total short and long term debt
|
|
$
|
481,070
|
|
|
$
|
556,070
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth additional information with
respect to the Companys debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount at
|
|
|
Interest Rate at
|
|
|
Interest Expense
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
2006 credit agreement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term loan
|
|
$
|
362,500
|
|
|
|
6.25
|
%
|
|
$
|
24,455
|
|
|
$
|
22,035
|
|
|
$
|
|
|
$75 Million revolver (non-use fee)
|
|
|
|
|
|
|
|
|
|
|
161
|
|
|
|
124
|
|
|
|
|
|
Trust preferred securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UICI Capital Trust I
|
|
|
15,470
|
|
|
|
8.37
|
%
|
|
|
1,388
|
|
|
|
1,340
|
|
|
|
1,063
|
|
HealthMarkets Capital Trust I
|
|
|
51,550
|
|
|
|
8.04
|
%
|
|
|
4,432
|
|
|
|
3,215
|
|
|
|
|
|
HealthMarkets Capital Trust II
|
|
|
51,550
|
|
|
|
8.37
|
%
|
|
|
4,373
|
|
|
|
3,235
|
|
|
|
|
|
Interest on Deferred Tax
|
|
|
|
|
|
|
8.00
|
%
|
|
|
4,284
|
|
|
|
1,140
|
|
|
|
|
|
Student loan credit facility (see Note 9)
|
|
|
97,400
|
|
|
|
6.29
|
%
|
|
|
5,951
|
|
|
|
6,318
|
|
|
|
4,861
|
|
Amortization of financing fees
|
|
|
|
|
|
|
|
|
|
|
4,516
|
|
|
|
3,734
|
|
|
|
85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
578,470
|
|
|
|
|
|
|
$
|
49,560
|
|
|
$
|
41,141
|
|
|
$
|
6,009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-34
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Supplemental calculation of financing fee amortization included
in interest expense associated with the non-student loan debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capitalized
|
|
|
|
|
|
Amortization Expense
|
|
|
|
Amount at
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
December 31, 2007
|
|
|
Life (Years)
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
2006 credit agreement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term loan
|
|
$
|
12,641
|
|
|
|
6
|
|
|
$
|
5,675
|
|
|
$
|
5,083
|
|
|
$
|
|
|
$75 Million revolver (non-use fee)
|
|
|
2,055
|
|
|
|
5
|
|
|
|
632
|
|
|
|
474
|
|
|
|
|
|
Trust preferred securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UICI Capital Trust I
|
|
|
113
|
|
|
|
5
|
|
|
|
85
|
|
|
|
85
|
|
|
|
85
|
|
HealthMarkets Capital Trust I
|
|
|
2,097
|
|
|
|
5
|
|
|
|
526
|
|
|
|
366
|
|
|
|
|
|
HealthMarkets Capital Trust II
|
|
|
2,102
|
|
|
|
5
|
|
|
|
524
|
|
|
|
363
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
19,008
|
|
|
|
|
|
|
$
|
7,442
|
|
|
$
|
6,371
|
|
|
$
|
85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The amortization of financing fees associated with the Term loan
for the years ended December 31, 2007 and December 31,
2006 includes $2.7 million and $2.5 million,
respectively, included in interest expense and an additional
$2.9 million and $2.6 million, respectively, relates
to the loss on early extinguishment due to the prepayments of
debt noted below. This additional amount is included in
Gains (losses) on sale of investments.
Principal payments required for the Companys debt for each
of the next five years and thereafter are as follows (in
thousands):
|
|
|
|
|
Year
|
|
Amount
|
|
|
2008
|
|
$
|
|
|
2009
|
|
|
|
|
2010
|
|
|
|
|
2011
|
|
|
|
|
2012
|
|
|
362,500
|
|
2013 and thereafter
|
|
|
118,570
|
|
|
|
|
|
|
|
|
$
|
481,070
|
|
|
|
|
|
|
The fair value of the Companys long-term debt (exclusive
of indebtedness outstanding under the secured student loan
funding facility) was $481.3 million and
$556.5 million at December 31, 2007 and 2006,
respectively. The fair value of such long-term debt is estimated
using discounted cash flow analyses, based on the Companys
current incremental borrowing rates for similar types of
borrowing arrangements.
2006
Credit Agreement
In connection with the Merger completed on April 5, 2006,
HealthMarkets, LLC entered into a credit agreement, providing
for a $500.0 million term loan facility and a
$75.0 million revolving credit facility (which includes a
$35.0 million letter of credit sub-facility). The full
amount of the term loan was drawn at closing, and the proceeds
thereof were used to fund a portion of the consideration paid in
the Merger. At December 31, 2007, $362.5 million
remained outstanding and bore interest at LIBOR plus 1%. During
the year ended December 31, 2006, the Company made
regularly scheduled quarterly principal payments in the amount
of $2.5 million. In addition, during 2007 and 2006, the
Company made voluntary prepayments of $75.0 million and
$60.0 million, respectively. The Company has not drawn on
the $75.0 million revolving credit facility.
F-35
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The revolving credit facility will expire on April 5, 2011,
and the term loan facility will expire on April 5, 2012.
The term loan requires nominal quarterly installments (not
exceeding 0.25% of the aggregate principal amount at the date of
issuance) until the maturity date at which time the remaining
principal amount is due. As a result of the prepayment in 2006,
the Company is not obligated to make future nominal quarterly
installments as previously required by the credit agreement.
Borrowings under the credit agreement may be subject to certain
mandatory prepayments. At HealthMarkets, LLCs election,
the interest rates per annum applicable to borrowings under the
credit agreement will be based on a fluctuating rate of interest
measured by reference to either (a) LIBOR plus a borrowing
margin, or (b) a base rate plus a borrowing margin.
HealthMarkets, LLC will pay (a) fees on the unused loan
commitments of the lenders, (b) letter of credit
participation fees for all letters of credit issued, plus
fronting fees for the letter of credit issuing bank, and
(c) other customary fees in respect of the credit facility.
Borrowings and other obligations under the credit agreement are
secured by a pledge of HealthMarkets, LLCs interest in
substantially all of its subsidiaries, including the capital
stock of MEGA, Mid-West, Chesapeake and Fidelity Life.
In connection with the financing, the Company incurred issuance
costs of $26.5 million, which were capitalized (included in
Other assets) and are being amortized over five
years as interest expense.
Trust Preferred
Securities
2006
Notes
On April 5, 2006, HealthMarkets Capital Trust I and
HealthMarkets Capital Trust II (two newly formed Delaware
statutory business trusts) (collectively the Trusts)
issued $100.0 million of floating rate trust preferred
securities (the Trust Securities) and
$3.1 million of floating rate common securities. The Trusts
invested the proceeds from the sale of the
Trust Securities, together with the proceeds from the
issuance to HealthMarkets, LLC by the Trusts of the common
securities, in $100.0 million principal amount of
HealthMarkets, LLCs Floating Rate Junior Subordinated
Notes due June 15, 2036 (the Notes), of which
$50.0 million principal amount accrue interest at a
floating rate equal to three-month LIBOR plus 3.05% and
$50.0 million principal amount accrue interest at a fixed
rate of 8.367% through but excluding June 15, 2011 and
thereafter at a floating rate equal to three-month LIBOR plus
3.05%. Distributions on the Trust Securities will be paid
at the same interest rates paid on the Notes.
The Notes, which constitute the sole assets of the Trusts, are
subordinate and junior in right of payment to all senior
indebtedness (as defined in the Indentures) of HealthMarkets,
LLC. The Company has fully and unconditionally guaranteed the
payment by the Trusts of distributions and other amounts payable
under the Trust Securities. The guarantee is subordinated
to the same extent as the Notes.
The Trusts are obligated to redeem the Trust Securities
when the Notes are paid at maturity or upon any earlier
prepayment of the Notes. Prior to June 15, 2011, the Notes
may be redeemed only upon the occurrence of certain tax or
regulatory events at 105.0% of the principal amount thereof in
the first year reducing by 1.25% per year until it reaches
100.0%. On and after June 15, 2011 the Notes are
redeemable, in whole or in part, at the option of the Company at
100.0% of the principal amount thereof.
In accordance with FASB Interpretation No. 46R,
Consolidation of Variable Interest Entities, the accounts
of the Trusts have not been consolidated with those of the
Company and its consolidated subsidiaries. The Companys
$3.1 million investment in the common equity of the Trusts
is included in short term and other investments, and
the income paid to the Company by the Trusts with respect to the
common securities, and interest received by the Trust from the
Company with respect to the $100.0 million principal amount
of the Notes, has been recorded as interest income and interest
expense, respectively. In 2007, the amount of such interest
income and interest expense was $265,000 and $8.8 million,
respectively. During 2006, the amount of such interest income
and interest expense was $194,000 and $6.5 million,
respectively. In connection with the financing, the Company
incurred issuance costs of $6.0 million, which cost was
capitalized (included in Other assets) and is being
amortized over five years as interest expense.
F-36
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
2004
Notes
On April 29, 2004, the Company through a newly formed
Delaware statutory business trust (the Trust)
completed the private placement of $15.0 million aggregate
issuance amount of floating rate trust preferred securities with
an aggregate liquidation value of $15.0 million (the
Trust Preferred Securities). The Trust invested
the $15.0 million proceeds from the sale of the
Trust Preferred Securities, together with the proceeds from
the issuance to the Company by the Trust of its floating rate
common securities in the amount of $470,000 (the Common
Securities and, collectively with the Trust Preferred
Securities, the Trust Securities), in an
equivalent face amount of the Companys Floating Rate
Junior Subordinated Notes due 2034 (the 2004 Notes).
The 2004 Notes will mature on April 29, 2034, which date
may be accelerated to a date not earlier than April 29,
2009. The Notes may be prepaid prior to April 29, 2009, at
107.5% of the principal amount thereof, upon the occurrence of
certain events, and thereafter at 100.0% of the principal amount
thereof. The 2004 Notes, which constitute the sole assets of the
Trust, are subordinate and junior in right of payment to all
senior indebtedness (as defined in the Indenture, dated
April 29, 2004, governing the terms of the 2004 Notes) of
the Company. The 2004 Notes accrue interest at a floating rate
equal to three-month LIBOR plus 3.50%, payable quarterly on
February 15, May 15, August 15 and November 15 of each
year. The quarterly distributions on the Trust Securities
are paid at the same interest rate paid on the 2004 Notes.
The Company has fully and unconditionally guaranteed the payment
by the Trust of distributions and other amounts payable under
the Trust Preferred Securities. The Trust must redeem the
Trust Securities when the 2004 Notes are paid at maturity
or upon any earlier prepayment of the 2004 Notes. Under the
provisions of the 2004 Notes, the Company has the right to defer
payment of the interest on the 2004 Notes at any time, or from
time to time, for up to twenty consecutive quarterly periods. If
interest payments on the 2004 Notes are deferred, the
distributions on the Trust Securities will also be deferred.
|
|
Note 9.
|
Student
Loan Credit Facility
|
At December 31, 2007 and 2006, the Company had an aggregate
of $97.4 million and $119.0 million, respectively, of
indebtedness outstanding under a secured student loan credit
facility, which indebtedness is represented by Student Loan
Asset-Backed Notes (the SPE Notes) issued by a
bankruptcy-remote special purpose entity (the SPE).
At December 31, 2007 and 2006, indebtedness outstanding
under the secured student loan credit facility was secured by
alternative (i.e., non-federally guaranteed) student
loans and accrued interest in the carrying amount of
$98.7 million and $111.2 million, respectively, and by
a pledge of cash, cash equivalents and other qualified
investments in the amount of $6.5 million and
$14.2 million, respectively.
All indebtedness issued under the secured student loan credit
facility is presented as student loan indebtedness on the
Companys consolidated balance sheet; all such student
loans and accrued investment income pledged to secure such
facility are reflected as student loan assets and accrued
investment income, respectively, on the Companys
consolidated balance sheet; and all such cash, cash equivalents
and qualified investments specifically pledged under the student
loan credit facility are reflected as restricted cash on the
Companys consolidated balance sheet. The SPE Notes
represent obligations solely of the SPE and not of the Company
or any other subsidiary of the Company. For financial reporting
and accounting purposes, the student loan credit facility has
been classified as a financing as opposed to a sale.
Accordingly, in connection with the financing, the Company has
recorded, and will in the future record, no gain on sale of the
assets transferred to the SPE.
The SPE Notes were issued by the SPE in three tranches
($50.0 million of
Series 2001A-1
Notes and $50.0 million of
Series 2001A-2
Notes issued on April 27, 2001, and $50.0 million of
Series 2002A Notes issued on April 10, 2002). The
interest rate on each series of SPE Notes resets monthly in a
Dutch auction process. At December 31, 2007, the
Series 2001A-1
Notes, the
Series 2001A-2
Notes and the Series 2002A Notes bore interest at the per
annum rate of 6.29%.
F-37
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The
Series 2001A-1
Notes and
Series 2001A-2
Notes have a final stated maturity of July 1, 2036; the
Series 2002A Notes have a final stated maturity of
July 1, 2037. However, the SPE Notes are subject to
mandatory redemption in whole or in part (a) on the first
interest payment date which is at least 45 days after
February 1, 2007, from any monies then remaining on deposit
in the acquisition fund not used to purchase additional student
loans, and (b) on the first interest payment date which is
at least 45 days after July 1, 2005, from any monies
then remaining on deposit in the acquisition fund received as a
recovery of the principal amount of any student loan securing
payment of the SPE Notes, including scheduled, delinquent and
advance payments, payouts or prepayments. Beginning July 1,
2005, the SPE Notes were also subject to mandatory redemption in
whole or in part on each interest payment date from any monies
received as a recovery of the principal amount of any student
loan securing payment of the SPE Notes, including scheduled,
delinquent and advance payments, payouts or prepayments. During
2007 and 2006, the Company made principal payments in the
aggregate of $21.6 million and $11.9 million,
respectively, on these SPE Notes.
The SPE and the secured student loan credit facility were
structured with an expectation that interest and recoveries of
principal to be received would be sufficient to pay principal of
and interest on the SPE Notes when due, together with operating
expenses of the SPE. This expectation was based upon analysis of
cash flow projections, and assumptions regarding the timing of
the financing of the underlying student loans to be held by the
SPE the future composition of and yield on the financed student
loan portfolio, the rate of return on monies to be invested by
the SPE, and the occurrence of future events and conditions.
There can be no assurance, however, that the student loans will
be financed as anticipated, that interest and principal payments
from the financed student loans will be received as anticipated,
that the reinvestment rates assumed on the amounts in various
funds and accounts will be realized, or other payments will be
received in the amounts and at the times anticipated.
Principal payments required for the indebtedness outstanding
under the secured student loan funding facility in each of the
next five years and thereafter are as follows (in thousands):
|
|
|
|
|
|
|
Student Loan
|
|
|
|
Credit Facility
|
|
|
2008
|
|
$
|
12,150
|
|
2009
|
|
|
12,600
|
|
2010
|
|
|
12,550
|
|
2011
|
|
|
11,750
|
|
2012
|
|
|
10,400
|
|
2013 and thereafter
|
|
|
37,950
|
|
|
|
|
|
|
|
|
$
|
97,400
|
|
|
|
|
|
|
The carrying amount of the outstanding indebtedness that is
secured by student loans generated by the College Fund Life
Division approximates fair value, since interest rates on such
indebtedness reset monthly.
The Company uses derivative instruments as part of its risk
management activities to protect against the risk of changes in
prevailing interest rates adversely affecting future cash flows
associated with certain debt. The derivative instrument used by
the Company to protect against such risk is the interest rate
swap. The Company accounts for its interest rate swaps in
accordance with FAS 133, Accounting for Derivative
Instruments and Hedging Activities.
Certain derivative instruments are formally designated in
FAS 133 hedge relationships as a hedge of one of the
following: the fair value of a recognized asset or liability,
the expected future cash flows of a recognized asset or
liability, or the expected future cash flows of a forecasted
transaction. The Company only utilizes cash flow derivatives
and, both at the inception of the hedge and on an ongoing basis,
the Company assesses the effectiveness
F-38
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
of the hedge instrument in achieving offsetting changes in cash
flows compared to the hedged item. The Company uses regression
analysis to assess the hedge effectiveness in achieving the
offsetting cash flows attributable to the risk being hedged. In
addition, the Company utilizes the hypothetical derivative
methodology for the measurement of ineffectiveness. Derivative
gains and losses not effective in hedging the expected cash
flows will be recognized immediately in earnings.
As with any financial instrument, derivative instruments have
inherent risks, primarily market and credit risk. Market risk
associated with changes in interest rates is managed as part of
the Companys overall market risk monitoring process by
establishing and monitoring limits as to the degree of risk that
may be undertaken. Credit risk occurs when a counterparty to a
derivative contract, in which the Company has an unrealized
gain, fails to perform according to the terms of the agreement.
The Company minimizes its credit risk by entering into
transactions with counterparties that maintain high credit
ratings.
Under the guidelines of FAS 133, all derivative instruments
are required to be carried on the balance sheet at fair value on
the balance sheet date. For a derivative instrument designated
as a cash flow hedge, the effective portion of changes in the
fair value of the derivative instrument is recorded under the
caption Change in unrealized gains (losses) on cash flow
hedging relationship in the Consolidated Statement of
Stockholders Equity and Comprehensive Income and is
recognized in the Consolidated Statement of Operations when the
hedged item affects results of operations. If it is determined
that (i) an interest rate swap is not highly effective in
offsetting changes in the cash flows of a hedged item,
(ii) the derivative expires or is sold, terminated or
exercised, or (iii) the derivative is undesignated as a
hedge instrument because it is unlikely that a forecasted
transaction will occur, the Company discontinues hedge
accounting prospectively.
If hedge accounting is discontinued, the derivative instrument
will continue to be carried at fair value, with changes in the
fair value of the derivative instrument recognized in the
current periods results of operations. When hedge
accounting is discontinued because it is probable that a
forecasted transaction will not occur, the accumulated gains and
losses included in accumulated other comprehensive income will
be recognized immediately in results of operations. When hedge
accounting is discontinued because the derivative instrument has
not been or will not continue to be highly effective as a hedge,
hedge accounting is discontinued and the remaining amount in
accumulated other comprehensive income is amortized into
earnings over the remaining life of the derivative.
At the effective date of the Merger, an affiliate of The
Blackstone Group assigned to the Company three interest rate
swap agreements with an aggregate notional amount of
$300.0 million. The terms of the swaps are 3, 4 and
5 years beginning on April 11, 2006. At the effective
date of the Merger, the interest rate swaps had an aggregate
fair value of approximately $2.0 million, which is recorded
in Additional paid-in capital. The Company
originally established the hedging relationship on
April 11, 2006 to hedge the risk of changes in the
Companys cash flow attributable to changes in the LIBOR
rate applicable to its variable-rate term loan. At the inception
of the hedging relationship, the interest rate swaps had an
aggregate fair value of approximately $2.6 million.
At December 31, 2006, the Company prepared its quarterly
assessment of hedge effectiveness and determined that all three
swaps were not highly effective for the period. The Company
terminated the hedging relationships as of October 1, 2006,
the beginning of the period of assessment. The Company
redesignated the hedging relationship in February 2007 to hedge
the risk of changes in the Companys cash flow attributable
to changes in the LIBOR rate applicable to its variable-rate
term loan. The Company assesses, on a quarterly basis, the
ineffectiveness of the hedging relationship and any gains or
losses related to the ineffectiveness are recorded in
Other investment income.
The derivative instruments are carried at fair value on the
balance sheet. The Company presents the fair value of the
interest rate swap agreements at the end of the period in either
Other assets or Other liabilities, as
applicable, on its Balance Sheet. The Company values its
derivative instruments using a third party.
F-39
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
As of December 31, 2007 and 2006, the recorded fair value
of derivative instruments was a liability of $7.5 million
and an asset of $257,000, respectively.
During the year ended December 31, 2007 and 2006, the
Company incurred a loss of $42,000 and $316,000, respectively,
related to the ineffectiveness of the interest rate swap which
is recorded in Investment income. The Company does
not expect the ineffectiveness related to its hedging activity
to be material to the Companys financial results in the
future. There were no components of the derivative instruments
that were excluded from the assessment of hedge effectiveness.
During the year ended December 31, 2007 and 2006, pretax
income of $1.0 million ($665,000 net of tax) and
$659,000 ($428,000 net of tax), respectively, was
reclassified into interest expense from accumulated other
comprehensive income as adjustments to interest payments on
variable rate debt. In addition, in 2007 and 2006, $655,000
($426,000 net of tax) and $158,000 ($103,000 net of
tax), respectively, was reclassified into earnings associated
with the previous termination of the hedging relationship. At
December 31, 2007, accumulated other comprehensive income
included a deferred after-tax net loss of $6.2 million
related to the interest rate swaps of which $1.8 million
($1.2 million net of tax) is the remaining amount of loss
associated with the previous terminated hedging relationship.
This amount is expected to be reclassified into earnings in
conjunction with the interest payments on the variable rate debt
through April 2011.
|
|
Note 11.
|
Grapevine
Finance LLC
|
On August 3, 2006, Grapevine Finance LLC
(Grapevine) was incorporated in the State of
Delaware as a wholly owned subsidiary of HealthMarkets, LLC. On
August 16, 2006, MEGA distributed and assigned to
HealthMarkets, LLC, as a dividend in kind, the
$150.8 million promissory note (CIGNA Note) and
related Guaranty Agreement issued by Connecticut General
Corporation in the Star HRG sale transaction (see
Note 2). After receiving the assigned CIGNA Note and
Guaranty Agreement from MEGA, HealthMarkets, LLC, in turn,
assigned the CIGNA Note and Guaranty Agreement to Grapevine.
On August 16, 2006, Grapevine issued $72.4 million of
its senior secured notes to an institutional purchaser (the
Grapevine Notes). The net proceeds from the
Grapevine Notes in the amount of $71.9 million were
distributed to HealthMarkets, LLC. The Grapevine Notes bear
interest at an annual rate of 6.712%. The interest is to be paid
semi-annually on January 15th and
July 15th of each year beginning on January 15,
2007. The principal payment is due at maturity on July 15,
2021. The Grapevine Notes are collateralized by Grapevines
assets including the CIGNA Note. Grapevine services its debt
primarily from cash receipts from the CIGNA Note. All cash
receipts from the CIGNA Note are paid into a debt service
coverage account maintained and held by an institutional trustee
(Trustee) for the benefit of the holder of the
Grapevine Notes. Pursuant to an Indenture and direction notices
from Grapevine, the Trustee uses the proceeds in the debt
service coverage account to (i) make interest payments on
the Grapevine Notes, (ii) pay for certain Grapevine
expenses and (iii) distribute cash to HealthMarkets,
subject to satisfaction of certain restricted payment tests.
Grapevine is a non-consolidated qualifying special purpose
entity as defined in FAS 140, Accounting for Transfers
and Servicing of Financial Assets and Extinguishments of
Liabilities. As a qualifying special purpose entity,
HealthMarkets does not consolidate the financial results of
Grapevine and accounts for its residual interest in Grapevine as
an investment in fixed maturity securities pursuant to
EITF 99-20,
Recognition of Interest Income and Impairment on Purchase and
Retained Beneficial Interests in Securitized Financial Assets.
On November 1, 2006, the Companys investment in
Grapevine was reduced by the receipt of cash from Grapevine in
the amount of $72.4 million. At December 31, 2006 and
2007, the Companys investment in Grapevine, at fair value,
was $4.8 million and $4.7 million, respectively, and
is recorded in Fixed maturities.
The Company measures the fair value of its residual interest in
Grapevine using a present value model incorporating the
following two key economic assumptions: (1) the timing of
the collections of interest on the
F-40
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
CIGNA Note, payments of interest expense on the senior secured
notes and payment of other administrative expenses and
(2) an assumed discount rate equal to the 15 year swap
rate. Variations in the fair value could occur due to changes in
the prevailing interest rates and changes in the counterparty
credit rating of debtor. Using a sensitivity analysis model
assuming a 100 basis point increase and a 150 basis
point increase in interest rates at December 31, 2007, the
fair market value on the Companys investment in Grapevine
would have decreased approximately $474,000 and $689,000,
respectively.
|
|
Note 12.
|
Federal
Income Taxes
|
Deferred income taxes for 2007 and 2006 reflect the impact of
temporary differences between the financial statement carrying
amounts and tax bases of assets and liabilities. Deferred tax
liabilities and assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Deferred policy acquisition and loan origination
|
|
$
|
62,467
|
|
|
$
|
61,147
|
|
Depreciable and amortizable assets
|
|
|
12,267
|
|
|
|
13,597
|
|
Gain on installment sales of assets
|
|
|
56,442
|
|
|
|
54,395
|
|
|
|
|
|
|
|
|
|
|
Total gross deferred tax liabilities
|
|
|
131,176
|
|
|
|
129,139
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Litigation accruals
|
|
|
1,543
|
|
|
|
2,782
|
|
Policy liabilities
|
|
|
15,478
|
|
|
|
23,009
|
|
Operating loss carryforwards
|
|
|
|
|
|
|
136
|
|
Unrealized losses on securities
|
|
|
7,111
|
|
|
|
6,759
|
|
Invested assets
|
|
|
465
|
|
|
|
1,522
|
|
Stock compensation accrual
|
|
|
14,906
|
|
|
|
16,751
|
|
Other
|
|
|
6,705
|
|
|
|
4,605
|
|
|
|
|
|
|
|
|
|
|
Total gross deferred tax assets
|
|
|
46,208
|
|
|
|
55,564
|
|
Less: valuation allowance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
46,208
|
|
|
|
55,564
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax asset (liability)
|
|
$
|
(84,968
|
)
|
|
$
|
(73,575
|
)
|
|
|
|
|
|
|
|
|
|
The Company establishes a valuation allowance when management
believes, based on the weight of the available evidence, that it
is more likely than not that some portion of the deferred tax
asset will not be realized. Realization of the net deferred tax
asset is dependent on generating sufficient future taxable
income.
In 2003, the Company realized net capital losses that were
carried forward and available to offset future capital gains, if
any, realized in the following 5 years. In 2003, the
Company established a valuation allowance for the deferred tax
asset resulting from the capital loss carryforward reflecting
the uncertainty in the Companys ability to realize that
asset in subsequent years through the generation of sufficient
capital gains. In 2006, the sales of the Student Insurance and
the Star HRG Divisions generated capital gains in excess of the
capital loss carryover. Accordingly, in 2006, the Company
released the valuation allowance of $18.1 million thereby
realizing the deferred tax benefits of the capital loss
carryforwards.
F-41
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
For tax purposes, the Company realized capital gains from the
2006 sales of the Student Insurance Division and the Star HRG
Division in the aggregate amount of $228.4 million, of
which $66.2 million was recognized on the installment
basis. Deferred taxes of $56.4 million will be payable on
the deferred gains of $162.2 million as the Company
receives payment on the CIGNA Note received in consideration for
the sale of the Star HRG Division assets and on the UHG Note
received in consideration for the sale of the Student Insurance
Division assets (see Notes 2 and 11).
The provision for income tax expense (benefit) consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
From operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current tax expense
|
|
$
|
37,939
|
|
|
$
|
57,506
|
|
|
$
|
92,372
|
|
|
|
|
|
Deferred tax expense
|
|
|
11,745
|
|
|
|
78,224
|
|
|
|
17,808
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total from continuing operations
|
|
|
49,684
|
|
|
|
135,730
|
|
|
|
110,180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current tax expense (benefit)
|
|
|
425
|
|
|
|
(2,325
|
)
|
|
|
899
|
|
|
|
|
|
Deferred tax expense (benefit)
|
|
|
|
|
|
|
(17,170
|
)
|
|
|
1,715
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total from discontinued operations
|
|
|
425
|
|
|
|
(19,495
|
)
|
|
|
2,614
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
50,109
|
|
|
$
|
116,235
|
|
|
$
|
112,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Companys effective income tax rates applicable to
continuing operations varied from the maximum statutory federal
income tax rate as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
|
|
Statutory federal income tax rate
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
|
|
|
|
|
|
Small life insurance company deduction
|
|
|
(0.3
|
)
|
|
|
(0.2
|
)
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
Low income housing credit
|
|
|
(0.8
|
)
|
|
|
(0.3
|
)
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
Tax basis adjustment of assets sold
|
|
|
|
|
|
|
3.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nondeductible monetary assessment
|
|
|
5.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nondeductible expenses, other
|
|
|
1.0
|
|
|
|
0.1
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
Merger transaction costs
|
|
|
1.4
|
|
|
|
1.8
|
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
Tax exempt income
|
|
|
(2.1
|
)
|
|
|
(0.6
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
|
|
|
|
Tax uncertainties
|
|
|
0.3
|
|
|
|
(0.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior tax accrual
|
|
|
1.3
|
|
|
|
(0.1
|
)
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
Other items, net
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate applicable to continuing operations
|
|
|
41.7
|
%
|
|
|
38.5
|
%
|
|
|
35.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As further discussed in Note 17, during 2007, the Company
recognized a $20 million expense associated with a
potential settlement of the multi-state market conduct
examination. As the nature and character of any final settlement
amount is subject to the execution of a final agreement between
the Company and the appropriate regulators, the Company cannot
determine at this time what amount, if any, will ultimately be
deductible for federal tax purposes. As a consequence, the
Company has currently treated this monetary assessment as
non-deductible for
F-42
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
tax purposes in the financial statements. When the
characterization of any final settlement is determined, the
Company will re-evaluate the amount, if any, to be deducted for
tax purposes.
The Company and all of its corporate subsidiaries (other than
two offshore life insurance companies that have not met the
ownership requirements to join a tax consolidation) file a
consolidated federal income tax return. The primary form of
state taxation is the tax on collected premiums. The few states
that impose an income tax generally allow the income tax to be
used as a credit against its premium tax obligation. Therefore,
any state income taxes are accounted for as premium taxes for
financial reporting purposes.
A reconciliation of the beginning and ending amount of
unrecognized tax benefits is as follows:
|
|
|
|
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Gross unrecognized tax benefits, January 1, 2007
|
|
$
|
1,092
|
|
Gross increase from prior year tax positions
|
|
|
485
|
|
|
|
|
|
|
Gross unrecognized tax benefits, December 31, 2007
|
|
$
|
1,577
|
|
|
|
|
|
|
In February of 2008, the Company resolved its outstanding
uncertain tax positions with the Internal Revenue Service. These
matters related to the 2003 and 2004 tax years. The items were
settled in amounts materially consistent with the established
liabilities for these matters. All years after 2004 remain
subject to federal tax examination. Based on an evaluation of
tax positions, the Company has concluded that there are no other
significant tax positions that require recognition in our
consolidated financial statements.
Total federal income taxes paid were $19.1 million,
$64.6 million and $107.2 million for 2007, 2006 and
2005, respectively.
F-43
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
Note 13.
|
Stockholders
Equity
|
The following table is a reconciliation of the number of shares
of the Companys common stock for the years ended
December 31.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands of shares)
|
|
|
Common stock issued:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
30,020,960
|
|
|
|
47,543,590
|
|
|
|
47,623,102
|
|
Exercise of stock options
|
|
|
923,306
|
|
|
|
38,313
|
|
|
|
246,707
|
|
Issue to officers/directors
|
|
|
8,000
|
|
|
|
312,633
|
|
|
|
|
|
Retirement of Treasury shares
|
|
|
|
|
|
|
(17,873,576
|
)
|
|
|
(326,219
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
|
30,952,266
|
|
|
|
30,020,960
|
|
|
|
47,543,590
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
98,861
|
|
|
|
1,409,391
|
|
|
|
1,907,958
|
|
Purchases of treasury stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Open market prior to merger
|
|
|
|
|
|
|
|
|
|
|
310,900
|
|
Repurchase of shares at merger
|
|
|
|
|
|
|
16,945,630
|
|
|
|
|
|
Other
|
|
|
950,169
|
|
|
|
229,682
|
|
|
|
163,319
|
|
Dispositions of treasury stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement of Treasury shares
|
|
|
|
|
|
|
(17,873,576
|
)
|
|
|
(326,219
|
)
|
Issuance upon vesting in agent plans
|
|
|
(101,908
|
)
|
|
|
(486,709
|
)
|
|
|
(646,567
|
)
|
Other
|
|
|
(517,178
|
)
|
|
|
(125,557
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
|
429,944
|
|
|
|
98,861
|
|
|
|
1,409,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares outstanding, end of year
|
|
|
30,522,322
|
|
|
|
29,922,099
|
|
|
|
46,134,199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On April 5, 2006, the Company completed its Merger with
affiliates of a group of private equity investors, including
affiliates of The Blackstone Group, Goldman Sachs Capital
Partners and DLJ Merchant Banking Partners. In the Merger,
holders of record of HealthMarkets common shares (other than
shares held by certain members of management and shares held
through HealthMarkets agent stock accumulation plans)
received $37.00 in cash per share. In the transaction,
HealthMarkets former public shareholders received
aggregate cash consideration of approximately $1.6 billion,
of which approximately $985.0 million was contributed as
equity by the private equity investors. The balance of the
merger consideration was financed with the proceeds of a
$500.0 million term loan facility extended by a group of
banks, the proceeds of $100.0 million of trust preferred
securities issued in a private placement, and Company cash on
hand in the amount of approximately $42.8 million.
At the effective date of the Merger, 58,746 of shares of
HealthMarkets common stock held by members of the Companys
senior management were converted into an equivalent number of
Class A-1
common shares of HealthMarkets, Inc., and 3,003,846 shares
of HealthMarkets common stock held by the Companys agents
were exchanged for an equivalent number of shares of
HealthMarkets, Inc.
Class A-2
common stock. In addition, in connection with the Merger,
110,612 shares of
Class A-1
common stock were issued to certain members of management. The
Company issued 26,621,622 of
Class A-1
common shares of HealthMarkets, Inc. to the designated
affiliates of the group of private equity investors as
consideration for their $985.0 million contribution to
equity.
F-44
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The Company accounted for the Merger as a leveraged
recapitalization, whereby the historical book value of the
assets and liabilities of the Company were maintained. In
connection with the Merger, the Company transferred
substantially all of its assets and liabilities to
HealthMarkets, LLC, a direct wholly-owned subsidiary of the
Company.
During the second quarter of 2006, $120.9 million of cash
was used for professional fees and expenses associated with the
Merger. Of this total, $47.3 million ($38.2 million,
net of tax) was expensed as Other expenses,
$31.7 million of fees and expenses related to raising
equity in the Merger was reflected as a direct reduction in
stockholders equity, and $41.9 million
($9.4 million of prepaid monitoring fees and
$32.5 million of capitalized financing costs attributable
to the issuance of the debt in the Merger) was capitalized
(which capitalized financing costs are reflected under the
caption Other assets). The capitalized financing
costs will be amortized over the life of the related debt.
In connection with the repurchase in the Merger of HealthMarkets
common stock held by the public, the Companys Additional
Paid in Capital account was reduced to a deficit of
$425.8 million, which amount was subsequently reclassified
to the Companys Retained Earnings account.
On May 3, 2007, the Companys Board of Directors
declared an extraordinary cash dividend in the amount of $10.51
per share for
Class A-1
and
Class A-2
common stock to holders of record as of close of business on
May 9, 2007, payable on May 14, 2007. In connection
with the extraordinary cash dividend, the Company paid dividends
to stockholders in the aggregate amount of $317.0 million.
The Company sponsors a series of stock accumulation plans (the
Agent Plans) established for the benefit of the
independent insurance agents and independent sales
representatives associated with the Company. The Agent Plans
generally combine an agent-contribution feature and a
Company-match feature. See Note 14.
Generally, the total stockholders equity of domestic
insurance subsidiaries (as determined in accordance with
statutory accounting practices) in excess of minimum statutory
capital requirements is available for transfer to the parent
company, subject to the tax effects of distribution from the
policyholders surplus account. The minimum
aggregate statutory capital and surplus requirements of the
Companys principal domestic insurance subsidiaries was
$78.5 million at December 31, 2007, of which minimum
surplus requirements for MEGA, Mid-West, Chesapeake and Fidelity
Life were $47.4 million, $14.5 million,
$8.0 million and $8.6 million, respectively.
Prior approval by insurance regulatory authorities is required
for the payment by a domestic insurance company of dividends
that exceed certain limitations based on statutory surplus and
net income. During 2007, 2006 and 2005, the domestic insurance
companies paid dividends in the amount of $171.2 million
(including the $100.0 million extraordinary dividend),
$364.0 million and $146.0 million, respectively, to
the holding company. During 2008, the Companys domestic
insurance companies are eligible to pay aggregate dividends to
the parent company of approximately $153.6 million
($76.3 million was paid in January 2008) without prior
approval by statutory authorities.
On December 29, 2006, the Oklahoma Department of Insurance
approved an extraordinary cash dividend in the amount of
$100 million payable from MEGA to HealthMarkets, LLC. MEGA
paid such dividend to HealthMarkets, LLC on January 18,
2007.
Following approval from the Oklahoma Insurance Department to pay
a special non-cash dividend, on August 16, 2006, MEGA
distributed and assigned the entire $150.8 million CIGNA
Note and the related Guaranty Agreement to HealthMarkets, LLC as
a special dividend in kind. See Note 11.
F-45
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Combined net income and stockholders equity for the
Companys domestic insurance subsidiaries determined in
accordance with statutory accounting practices, as reported in
regulatory filings are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Net income
|
|
$
|
124,747
|
|
|
$
|
353,462
|
|
|
$
|
200,222
|
|
Statutory surplus
|
|
$
|
453,066
|
|
|
$
|
504,504
|
|
|
$
|
521,224
|
|
|
|
Note 14.
|
Agent
Stock Accumulation Plans
|
The Company sponsors a series of stock accumulation plans (the
Agent Plans) established for the benefit of the
independent insurance agents and independent sales
representatives associated with UGA Association
Field Services and Cornerstone America.
The Agent Plans generally combine an agent-contribution feature
and a Company-match feature. The agent-contribution feature
generally provides that eligible participants are permitted to
allocate a portion (subject to prescribed limits) of their
commissions or other compensation earned on a monthly basis to
purchase shares of HealthMarkets
Class A-2
common stock at the fair market value of such shares at the time
of purchase. Under the Company-match feature of the Agent Plans,
participants are eligible to have posted to their respective
Agent Plan accounts book credits in the form of equivalent
shares based on the number of shares of HealthMarkets
Class A-2
common stock purchased by the participant under the
agent-contribution feature of the Agent Plans. The matching
credits vest over time (generally in prescribed increments over
a ten-year period, commencing the plan year following the plan
year during which contributions are first made under the
agent-contribution feature), and vested matching credits in a
participants plan account in January of each year are
converted from book credits to an equivalent number of shares of
HealthMarkets
Class A-2
common stock. Matching credits forfeited by participants are
reallocated each year among eligible participants and credited
to eligible participants Agent Plan accounts.
The Agent Plans do not constitute qualified plans under
Section 401(a) of the Internal Revenue Code of 1986 or
employee benefit plans under the Employee Retirement Income
Security Act of 1974 (ERISA), and the Agent Plans
are not subject to the vesting, funding, nondiscrimination and
other requirements imposed on such plans by the Internal Revenue
Code and ERISA.
The Company accounts for the Company-match feature of its Agent
Plans by recognizing compensation expense over the vesting
period in an amount equal to the fair market value of vested
shares at the date of their vesting and distribution to the
participants. The Company estimates its current liability for
unvested matching credits based on the number of unvested
credits, prevailing fair market value (as determined
by the Companys Board of Directors since the Merger) of
the
Class A-2
common stock, and an estimate of the percentage of the vesting
period that has elapsed. Changes in the liability from one
period to the next are accounted for as an increase in, or
decrease to, compensation expense, as the case may be. Upon
vesting, the Company reduces the accrued liability (equal to the
market value of the vested shares at date of vesting) with a
corresponding increase to equity. Unvested matching credits are
considered share equivalents outstanding for purposes of the
computation of earnings per share. At December 31, 2007 and
2006, the Companys liability for future unvested benefits
payable under the Agent Plans was $34.1 million and
$46.9 million, respectively, which has been recorded in
Other liabilities.
The portion of compensation expense associated with the Agent
Plans reflected in the results of the Self-Employed Agency
Division is based on the prevailing valuation of
Class A-2
common shares (as determined by the Board of Directors of the
Company since the Merger or, prior to the Merger, by reference
to the fair value of the Companys common shares) on or
about the time the unvested matching credits are granted to
participants. In accordance with the terms of the Agent Plans,
the Board of Directors of the Company establishes the fair value
of
Class A-2
common shares on a quarterly basis. The remaining portion of the
compensation expense associated with
F-46
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
the Agent Plans (consisting of variable stock-based compensation
expense) is reflected in the results of the Companys
Other Key Factors business segment. Both portions of
compensation expense are reported as Underwriting, policy
acquisition costs, and insurance expenses.
Set forth in the table below is the total compensation expense
associated with the Companys Agent Plans for each of the
years ended December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
SEA Division stock-based compensation expense
|
|
$
|
9,019
|
|
|
$
|
11,188
|
|
|
$
|
9,397
|
|
Other Key Factors variable non-cash stock-based compensation
expense (benefit)
|
|
|
(482
|
)
|
|
|
16,603
|
|
|
|
7,214
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Agent Plan compensation expense
|
|
|
8,537
|
|
|
|
27,791
|
|
|
|
16,611
|
|
Related tax benefit
|
|
|
2,988
|
|
|
|
9,727
|
|
|
|
5,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount included in financial results
|
|
$
|
5,549
|
|
|
$
|
18,064
|
|
|
$
|
10,797
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2007, the Company had recorded 1,446,624
unvested matching credits associated with the Agent Plans, of
which 430,455 vested in January 2008.
Company-match transactions are not reflected in the Statement of
Cash Flows since issuance of equity securities to settle the
Companys liabilities under the Agent Plans are non-cash
transactions.
Effective on April 5, 2006, upon closing of the Merger, the
Agent Plans were amended and restated to afford participants the
opportunity to purchase, with after-tax dollars, shares of the
Companys
Class A-2
common stock, which purchases are matched with book
credits in the form of equivalent
Class A-2
common shares. Effective upon the closing of the Merger, each
share of HealthMarkets common stock then owned by a participant
under the Agent Plans was converted into the right to receive
one share of the Companys
Class A-2
common stock, and each matching credit then posted to a
participants account under the Agent Plans then
represented an equivalent book credit representing one share of
the Companys
Class A-2
common stock.
The accounting treatment of the Companys Agent Plans
result in unpredictable stock-based compensation charges,
dependent upon fluctuations in the fair value of the
Class A-2
common stock. These fluctuations in stock-based compensation
charges may result in material fluctuations in the
Companys results of operations. In periods of decline in
the fair value of HealthMarkets
Class A-2
common stock, if any, the Company will recognize less
stock-based compensation expense than in periods of
appreciation. In addition, in circumstances where increases in
the fair value of the
Class A-2
common stock are followed by declines, negative stock-based
compensation expense may result as the cumulative liability for
unvested stock-based compensation expense is adjusted.
|
|
Note 15.
|
Employee
401(k) and Stock Plans
|
HealthMarkets
401(k) and Savings Plan
The Company maintains the HealthMarkets 401(k) and Savings Plan
(the Employee Plan) for the benefit of its
employees. The Employee Plan enables eligible employees to make
pre-tax contributions to the Employee Plan (subject to overall
limitations), to receive discretionary matching contributions
and to share in certain supplemental contributions made by the
Company. Matching contributions currently vest in prescribed
increments over a six year period.
In 2007, 2006 and 2005, the Company made supplemental
contributions to the Employee Plan in accordance with its terms
in the amount of $3.0 million, $3.9 million and
$4.0 million, respectively. In 2007, 2006 and 2005, the
F-47
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Company made matching contributions to the Employee Plan in
accordance with its terms in the amount of $2.0 million,
$2.6 million and $2.7 million, respectively.
Employee
Stock Plans
The Company adopted FAS 123R, Shared-Based Payment,
on January 1, 2006. Among other things, FAS 123R
requires expensing the fair value of stock options, a previously
optional accounting method under FAS 123 that the Company
voluntarily adopted in 2003. The Company has elected to
recognize compensation costs for an award with graded vesting on
a straight-line basis over the requisite service period for the
entire award. Prior to the adoption of FAS 123R, the
Company recognized compensation costs for fixed awards with pro
rata vesting by application of FIN 28.
At December 31, 2007, the Company had various share-based
plans for employees and directors, which plans are described
below. Set forth below are amounts recognized in the financial
statements with respect to these plans.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Amounts included in reported financial results:
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of Stock Option Plans(1)
|
|
$
|
5,828
|
|
|
$
|
3,734
|
|
|
$
|
1,006
|
|
Total cost of Other Stock-Based Plans(2)
|
|
|
1,503
|
|
|
|
6,580
|
|
|
|
5,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount charged against income, before tax
|
|
|
7,331
|
|
|
|
10,314
|
|
|
|
6,339
|
|
Related tax benefit
|
|
|
2,566
|
|
|
|
3,610
|
|
|
|
2,219
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net expense included in financial results
|
|
$
|
4,765
|
|
|
$
|
6,704
|
|
|
$
|
4,120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
2007 includes $1.9 million as a result of modifications to
stock options in connection with the extraordinary cash
dividend. 2006 includes $2.3 million as a result of the
acceleration of vesting related to the Merger. |
|
(2) |
|
Includes Restricted Stock and Phantom stock plans. 2006 includes
$1.1 million as a result of the acceleration of vesting
related to the Merger. |
The Company presented $313,000, $1.4 million and
$1.9 million of excess tax benefits from share-based
compensation as cash from financing activities in 2007, 2006 and
2005, respectively.
1987
Stock Option Plan
In accordance with the terms of the Companys 1987 Stock
Option Plan, as amended (the 1987 Plan),
4,000,000 shares of common stock of the Company have been
reserved for issuance upon exercise of options that may be
granted to officers, key employees, and certain eligible
non-employees at an exercise price equal to the fair market
value at the date of grant. The options generally vest in 20%
annual increments every twelve months, subject to continuing
employment, provided that an option will vest 100% upon the
death or permanent disability of the plan participant or upon
the change of control of the Company. Share requirements may be
met from either unissued or treasury shares.
At the Board of Directors meeting held on May 3, 2007, the
Board approved an amendment to the 1987 Stock Option Plan
(the1987 Plan), which provided that, in the event of
an extraordinary cash dividend, the Company may make such
adjustments to options granted under the 1987 Plan as it
determines are equitable
and/or
appropriate. In connection with the extraordinary cash dividend
declared on May 3, 2007, the Board approved an adjustment
to options pursuant to which the number of options increased and
the exercise price of such options decreased. Options to acquire
95,160
Class A-1
common stock at an exercise price of $9.25 were adjusted to
120,022 options to acquire
Class A-1
common shares at an exercise price of $7.34. This adjustment
maintained the
F-48
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
value of the options pre- and post-dividend. The Company
recognized $999,000 pre-tax compensation expense in connection
with the 2007 modification of the 1987 Plan options.
HealthMarkets
2006 Management Stock Option Plan
On May 8, 2006, the Board of Directors adopted the
HealthMarkets 2006 Management Stock Option Plan (the 2006
Plan), in accordance with which options to purchase up to
an aggregate of 1,489,741 shares of the Companys
Class A-1
common stock may be granted from time to time to officers,
employees and non-employee directors of the Company. Share
requirements may be met from either unissued or treasury shares.
During 2007, non-qualified options to purchase shares of
Class A-1
common stock were granted under the 2006 Plan to employees (the
Employee Options) and non-employee directors
(the Director Options). One-third of the Employee
Options vest in 20% increments over five years with an exercise
price equal to the fair value per share at the date of
grant (the Time-Based Options). One-third of the
Employee Options vest in increments of 25%, 25%, 17%, 17% and
16% over five years, provided that the Company shall have
achieved certain annually specified performance targets, with an
exercise price equal to the fair market value on the date of
grant (the Performance-Based Options). With respect
to the Performance-Based Options, the Company recognizes expense
for the particular increment that is vesting, over the requisite
service period based on the service inception date and the
probability of achieving the performance criteria. Any
Performance-Based Options as to which an optionee does not earn
the right to exercise in any year shall expire and terminate.
The remaining one-third of the Employee Options vest in
increments of 25%, 25%, 17%, 17% and 16% over five years with an
initial exercise price equal to the fair market value at the
date of grant. The exercise price increases 10% each year
beginning on the second anniversary of the grant date and ending
on the fifth anniversary of the grant date (the
Tranche C Options). Director Options vest in
20% increments over five years. Director Options, Time Based
Options, Performance-Based Options and Tranche C Options
expire ten years following the grant date and become immediately
exercisable upon the occurrence of a Change in
Control (as defined) if the optionee remains in the
continuous employ of the Company until the date of the
consummation of such Change in Control.
In connection with the extraordinary dividend declared on
May 3, 2007, and to prevent a dilution in the rights of
participants in the 2006 Plan, the Board of Directors approved
an adjustment of options granted under the 2006 Plan, pursuant
to which the exercise price was reduced by $10.51 per
share the amount of the extraordinary cash dividend.
The Company recognized a pre-tax expense of $908,000 in 2007 in
connection with the modifications. The remaining modification
expense of $1.4 million will be recognized over the
remaining life of the options.
F-49
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Set forth below is a summary of stock option transactions
including certain information with respect to the
Performance-Based Options for which no performance goals have
been established.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding for Accounting
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
|
(Excludes Options with no Performance Criteria)
|
|
|
|
|
|
Performance-Based Options(a)
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
Intrinsic
|
|
|
Remaining
|
|
|
|
|
|
|
|
|
Option
|
|
|
Intrinsic
|
|
|
Remaining
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Price per
|
|
|
Value ($)
|
|
|
Contractual
|
|
|
|
|
|
Number of
|
|
|
Price per
|
|
|
Value ($)
|
|
|
Contractual
|
|
|
Number of
|
|
|
|
|
|
|
Shares
|
|
|
Share ($)
|
|
|
in (000s)
|
|
|
Term
|
|
|
|
|
|
Shares
|
|
|
Share ($)
|
|
|
in (000s)
|
|
|
Term
|
|
|
Shares
|
|
|
Outstanding options at December 31, 2006
|
|
|
|
|
|
|
991,113
|
|
|
|
34.96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
268,002
|
|
|
|
37.54
|
|
|
|
|
|
|
|
|
|
|
|
1,259,115
|
|
Granted
|
|
|
(b
|
)
|
|
|
315,797
|
|
|
|
38.20
|
|
|
|
|
|
|
|
|
|
|
|
(c
|
)
|
|
|
112,517
|
|
|
|
40.63
|
|
|
|
|
|
|
|
|
|
|
|
428,314
|
|
Performance defined
|
|
|
(d
|
)
|
|
|
96,118
|
|
|
|
28.68
|
|
|
|
|
|
|
|
|
|
|
|
(d
|
)
|
|
|
(96,118
|
)
|
|
|
28.68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
|
|
|
|
(1,207
|
)
|
|
|
29.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,207
|
)
|
Cancelled
|
|
|
|
|
|
|
(94,540
|
)
|
|
|
30.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(36,554
|
)
|
|
|
29.94
|
|
|
|
|
|
|
|
|
|
|
|
(131,094
|
)
|
Exercised
|
|
|
|
|
|
|
(117,926
|
)
|
|
|
15.29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(117,926
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding options at December 31, 2007
|
|
|
|
|
|
|
1,189,355
|
|
|
|
29.83
|
|
|
|
6,152
|
|
|
|
8.5
|
|
|
|
|
|
|
|
247,847
|
|
|
|
32.53
|
|
|
|
612
|
|
|
|
9.0
|
|
|
|
1,437,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercisable at December 31, 2007
|
|
|
|
|
|
|
279,173
|
|
|
|
23.40
|
|
|
|
3,239
|
|
|
|
7.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
279,173
|
|
Options expected to vest
|
|
|
|
|
|
|
754,901
|
|
|
|
32.05
|
|
|
|
2,226
|
|
|
|
8.5
|
|
|
|
|
|
|
|
229,602
|
|
|
|
32.24
|
|
|
|
633
|
|
|
|
9.0
|
|
|
|
984,503
|
|
|
|
|
(a) |
|
Includes future vesting increments of Performance-Based Options
currently not considered granted and outstanding for accounting
purposes. |
|
(b) |
|
Includes 24,862 fully vested options that were issued upon
modification of 95,160 previously issued stock options in
connection with the extraordinary cash dividend. Includes 19,929
Performance-Based Options for which performance goals were
established on May 3, 2007. |
|
(c) |
|
Excludes 19,929 Performance-Based Options where performance
criteria was established on May 3, 2007 as a result of
being granted after the establishment of performance criteria. |
|
(d) |
|
Includes 82,941 Performance-Based Options originally issued in
2006 (included in Outstanding options at December 31,
2006) and 13,177 Performance-Based Options issued in 2007
(included in Granted ) where performance was established on
May 3, 2007. |
Set forth below is a summary of stock options (including future
vesting increments of Performance-Based Options currently not
considered granted and outstanding for accounting purposes)
outstanding and exercisable at December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
|
|
Outstanding
|
|
|
Weighted-
|
|
|
Weighted-
|
|
|
Exercisable
|
|
|
Weighted-
|
|
|
|
Options
|
|
|
Average
|
|
|
Average
|
|
|
Options
|
|
|
Average
|
|
|
|
December 31,
|
|
|
Remaining
|
|
|
Exercise
|
|
|
December 31,
|
|
|
Exercise
|
|
Exercise Prices
|
|
2007
|
|
|
Contractual Life
|
|
|
Price ($)
|
|
|
2007
|
|
|
Price ($)
|
|
|
$7.34
|
|
|
53,473
|
|
|
|
2.5 years
|
|
|
|
7.34
|
|
|
|
53,473
|
|
|
|
7.34
|
|
$26.49
|
|
|
625,578
|
|
|
|
8.5 years
|
|
|
|
26.49
|
|
|
|
143,339
|
|
|
|
26.49
|
|
$27.86
|
|
|
347,943
|
|
|
|
8.7 years
|
|
|
|
27.86
|
|
|
|
81,010
|
|
|
|
27.86
|
|
$39.49
|
|
|
154,150
|
|
|
|
9.3 years
|
|
|
|
39.49
|
|
|
|
|
|
|
|
39.49
|
|
$40.22
|
|
|
40,500
|
|
|
|
9.3 years
|
|
|
|
40.22
|
|
|
|
|
|
|
|
40.22
|
|
$40.97
|
|
|
37,802
|
|
|
|
9.6 years
|
|
|
|
40.97
|
|
|
|
|
|
|
|
40.97
|
|
$42.03
|
|
|
171,000
|
|
|
|
9.9 years
|
|
|
|
42.03
|
|
|
|
|
|
|
|
42.03
|
|
$63.49
|
|
|
6,756
|
|
|
|
8.5 years
|
|
|
|
63.49
|
|
|
|
1,351
|
|
|
|
63.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,437,202
|
|
|
|
|
|
|
|
|
|
|
|
279,173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-50
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
The Company measures the fair value of the Time-Based Options,
Performance-Based Options and Director Options at the date of
grant using a Black-Scholes option pricing model. The Company
measures fair value of the Tranche C options using a
binomial option valuation model. The weighted-average grant-date
fair value of stock options granted during 2007, 2006 and 2005
was $19.40, $11.27 and $8.43 per option, respectively. Set forth
below are the assumptions used in arriving at the fair value of
options during 2007, 2006 and 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
Black-Scholes Values
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Expected volatility
|
|
|
38.52
|
%
|
|
|
43.53
|
%
|
|
|
50.70
|
%
|
Expected dividend yield
|
|
|
0.00
|
%
|
|
|
5.08
|
%
|
|
|
1.78
|
%
|
Risk-free interest rate
|
|
|
4.23
|
%
|
|
|
4.99
|
%
|
|
|
3.77
|
%
|
Expected life in years
|
|
|
6.64
|
|
|
|
7.37
|
|
|
|
3.00
|
|
Weighted-average grant date fair value
|
|
$
|
20.72
|
|
|
$
|
11.56
|
|
|
$
|
8.43
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
Binomial Values
|
|
2007
|
|
2006
|
|
Range of Expected volatility
|
|
39.70% - 43.97%
|
|
40.34% - 45.07%
|
Range of Expected dividend yield
|
|
0.00%
|
|
5.08%
|
Risk-free interest rate
|
|
3.81% - 4.94%
|
|
4.50% - 5.3%
|
Expected life in years
|
|
7.01-9.00
|
|
6.92 - 9.03
|
Weighted-average grant date fair value
|
|
$16.87
|
|
$10.88
|
Risk-free interest rates are derived from the U.S. Treasury
strip yield curve in effect at the time of the grant. The
expected life of options valued in 2005 was estimated based on
historical data. The expected life of the options, valued in
2007 and 2006 with both the Black-Scholes and the binomial
pricing models, was derived from output of a binomial model and
represents the period of time that the options are expected to
be outstanding. Binomial option pricing models incorporate
ranges of assumptions for inputs, and those ranges are
disclosed. For 2007 and 2006, expected volatilities were
calculated as one-third of the Companys historical
volatility for the time period, plus one-third of the average
historical volatility of comparable companies during the time
period, plus one-third of average implied volatility of
comparable companies. For 2005, expected volatility was derived
from the Companys historical volatility data. The Company
utilized historical data to estimate share option exercise and
employee departure behavior.
The total intrinsic value of options exercised during 2007, 2006
and 2005 was $3.1 million, $1.1 million and
$4.4 million, respectively. At December 31, 2007,
there was $10.7 million of unrecognized compensation cost
related to non-vested stock options. This compensation expense
is expected to be recognized over a weighted average period of
3.7 years.
Other
Stock-Based Compensation Plans
At December 31, 2007, the Company had in place various
stock-based incentive programs, pursuant to which the Company
has agreed to distribute, in cash, an aggregate of the dollar
equivalent of 210,399 HealthMarkets shares to eligible
participants of each program. Distributions under the programs
vary from 25% annual payments to 100% payment at the end of four
years. During 2007, 2006 and 2005, the Company paid
$2.9 million, $12.5 million and $2.0 million,
respectively, under these plans. For financial reporting
purposes, the Company recognizes compensation expense, adjusted
to the value of HealthMarkets shares at each accounting
period, over the required service period. At December 31,
2007 and 2006, the Companys liability for future benefits
payable under the programs was $3.1 million and
$4.5 million, respectively, and is recorded in Other
liabilities.
F-51
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
Note 16.
|
Related
Party Transactions
|
Introduction
On April 5, 2006, the Company completed a merger (the
Merger) providing for the acquisition of the Company
by affiliates of a group of private equity investors, including
affiliates of The Blackstone Group, Goldman Sachs Capital
Partners and DLJ Merchant Banking Partners (the Private
Equity Investors). See Note 2. Immediately
prior to the Merger, Gladys J. Jensen, individually and in her
capacity as executor of the estate of the late Ronald L. Jensen
(the Companys founder and former Chairman), beneficially
held 17.04% of the outstanding shares of the Company, and the
adult children of Mrs. Jensen beneficially held in the
aggregate 10.09% of the outstanding shares of the Company. As a
result of the Merger, Mrs. Jensen and her adult children
divested their holdings in the Company, and the Private Equity
Investors acquired, as of the effective date of the Merger,
55.3%, 22.7% and 11.3%, respectively, of the Companys
outstanding equity securities. At December 31, 2007,
affiliates of The Blackstone Group, Goldman Sachs Capital
Partners and DLJ Merchant Banking Partners held 54.0%, 22.1% and
11.1%, respectively, of the Companys outstanding equity
securities.
Certain members of the Board of Directors of the Company are
affiliated with the Private Equity Investors. In particular,
Chinh E. Chu and Matthew S. Kabaker serve as a Senior Managing
Director and a Principal, respectively, of The Blackstone Group,
Adrian M. Jones and Sumit Rajpal serve as a Managing Director
and Vice President, respectively, of Goldman, Sachs &
Co., and Kamil M. Salame is a partner of DLJ Merchant Banking
Partners.
Set forth below is a summary description of all material
transactions between the Company and the Private Equity
Investors and all other parties related to the Company. The
Company believes that the terms of all such transactions with
all related parties are and have been on terms no less favorable
to the Company than could have been obtained in arms
length transactions with unrelated third parties.
Transactions
with the Private Equity Investors
Transaction
and Monitoring Fee Agreements
At the closing of the Merger, the Company entered into separate
Transaction and Monitoring Fee Agreements with advisory
affiliates of each of the Private Equity Investors. In
accordance with the terms of the Transaction and Monitoring Fee
Agreements, at the closing of the Merger, the Company paid a
one-time transaction fee in the amount of $18.9 million,
$6.0 million and $3.0 million to advisory affiliates
of The Blackstone Group, Goldman Sachs Capital Partners and DLJ
Merchant Banking Partners, respectively. The Company also
reimbursed affiliates of The Blackstone Group for loan
commitment and other fees in the amount of $13.0 million
previously incurred by such affiliates of The Blackstone Group
in connection with the Merger.
The advisory affiliates of each of the Private Equity Investors
also agreed to provide to the Company ongoing monitoring,
advisory and consulting services, for which the Company agreed
to pay to affiliates of each of The Blackstone Group, Goldman
Sachs Capital Partners and DLJ Merchant Banking Partners an
annual monitoring fee in an amount equal to $7.7 million,
$3.2 million and $1.6 million, respectively. The
annual monitoring fees are in each case subject to upward
adjustment in each year based on the ratio of the Companys
consolidated earnings before interest, taxes, depreciation and
amortization (EBITDA) in such year to consolidated EBITDA in the
prior year, provided that the aggregate monitoring fees paid to
all advisors pursuant to the Transaction and Monitoring Fee
Agreements in any year shall not exceed the greater of
$15.0 million or 3% of consolidated EBITDA in such year.
The aggregate annual monitoring fees in the amount of
$12.5 million paid with respect to 2007 were paid in full
to the advisory affiliates of the Private Equity Investors in
January 2007 and expensed ratably during the year in Other
expenses. For the year ended December 31, 2006, the
aggregate annual monitoring fees in the amount of
$12.5 million were paid in full to the advisory affiliates
of the Private Equity Investors on April 5, 2006 (the
closing date of the Merger). In addition, in accordance with the
Transaction and Monitoring Fee Agreements, on April 5,
2006, the Company paid to the advisory affiliates of the Private
Equity Investors monitoring fees in the aggregate
F-52
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
amount of approximately $3.7 million related to services
rendered by such parties during the period commencing on
September 15, 2005 (the date of execution of the Agreement
and Plan of Merger) and ended on December 31, 2005. The
aggregate annual monitoring fees in the amount of
$12.5 million paid with respect to 2008 were paid in full
to the advisory affiliates of the Private Equity Investors in
January 2008.
In accordance with the terms of the Transaction and Monitoring
Fee Agreements, the Company also agreed to reimburse the
advisory affiliates of the Private Equity Investors for
out-of-pocket
expenses incurred in connection with the monitoring services and
to indemnify the advisory affiliates for certain claims and
expenses incurred in connection with the engagement. During
2007, these costs were de minimus.
Interest
Rate Swaps
At the effective date of Merger, an affiliate of The Blackstone
Group assigned to the Company three interest rate swap
agreements with an aggregate notional amount of
$300.0 million. At the effective date of the Merger, the
interest rate swaps had an aggregate fair value of approximately
$2.0 million. See Note 10.
Transaction
Fee Agreements
In accordance with the terms of separate Future Transaction Fee
Agreements, each dated as of May 11, 2006, affiliates of
each of the Private Equity Investors agreed to provide to the
Company certain financial and strategic advisory services with
respect to future acquisitions, divestitures and
recapitalizations. For such services, affiliates of The
Blackstone Group, Goldman Sachs Capital Partners and DLJ
Merchant Banking Partners are entitled to receive 0.6193%,
0.2538% and 0.1269%, respectively, of the aggregate enterprise
value of any units acquired, sold or recapitalized by the
Company.
In connection with the July 11, 2006 sale of substantially
all of the assets comprising the Companys Star HRG
Division (see Note 2), the Company remitted to The
Blackstone Group, Goldman Sachs Capital Partners and DLJ
Merchant Banking Partners, $941,000, $386,000 and $193,000,
respectively, pursuant to the terms of the Future Transaction
Fee Agreements. In connection with the December 1, 2006
sale of substantially all of the assets comprising the
Companys Student Insurance Division (see
Note 2), on December 14, 2006, the Company
remitted to affiliates of each of The Blackstone Group, Goldman
Sachs Capital Partners and DLJ Merchant Banking Partners,
$619,000, $254,000 and $127,000, respectively, pursuant to the
terms of the Future Transaction Fee Agreements.
In accordance with the terms of the Future Transaction Fee
Agreements, the Company also agreed to reimburse the advisory
affiliates of the Private Equity Investors for
out-of-pocket
expenses incurred in connection with the advisory services and
to indemnify the advisory affiliates for certain claims and
expenses incurred in connection with the engagement. These
Transaction Fee expenses were recorded as part of the gain on
sale in Gains (losses) on sale of investments.
Group
Purchasing Organization
Effective June 1, 2006, the Company agreed to participate
in a group purchasing organization (GPO)
that acts as the Companys agent to negotiate with third
party vendors the terms upon which the Company will obtain goods
and services in various designated categories that are used in
the ordinary course of the Companys business. On behalf of
the various participants in its group purchasing program, the
GPO extracts from such vendors pricing terms for such goods and
service that are believed to be more favorable than participants
could obtain for themselves on an individual basis. In
consideration for such favorable pricing terms, each participant
has agreed to obtain from such vendors not less than a specified
percentage of the participants requirements for such goods
and services in the designated categories. In connection with
purchases by participants, the GPO receives a commission from
the vendor in respect of such purchases. In consideration of The
Blackstone Groups facilitating the Companys
F-53
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
participation in the GPO and in monitoring the services that the
GPO provides to the Company, the GPO has agreed to remit to an
affiliate of The Blackstone Group a portion of the commission
received from vendors in respect of purchases by the Company
under the GPO purchasing program. The Companys
participation during 2007 and 2006 was nominal with respect to
purchases by the Company under the GPO purchasing program in
accordance with the terms of this arrangement.
MEGA
Advisory Agreement- Student Insurance and Star HRG
Divisions
Pursuant to the terms of an advisory agreement, dated
August 18, 2006, The Blackstone Group agreed to provide
certain financial and mergers and acquisition advisory services
to MEGA in connection with the sale by MEGA of MEGAs Star
HRG and Student Insurance Divisions. The terms of the advisory
agreement were approved by the Oklahoma Insurance Department
effective September 21, 2006. In accordance with the terms
of the advisory agreement, MEGA paid to an advisory affiliate of
The Blackstone Group a one-time investment banking fee in the
amount of $1.5 million in connection with the sale
completed on July 11, 2006 of substantially all of the
assets comprising MEGAs Star HRG Division and a one-time
investment banking fee in the amount of $1.0 million in
connection with the sale completed on December 1, 2006 of
substantially all of the assets comprising MEGAs Student
Insurance Division. The Company also agreed to reimburse The
Blackstone Group for
out-of-pocket
expenses incurred in connection with the advisory services and
to indemnify The Blackstone Group and its affiliates for certain
claims and expenses incurred in connection with the engagement.
The Company reimbursed The Blackstone Group and its affiliates
$94,000 for expenses incurred with the advisory services.
Pursuant to the terms of an amendment, dated December 29,
2006, to the advisory agreement, The Blackstone Group provided
certain tax structuring advisory services to MEGA in connection
with the sale by MEGA of MEGAs Student Insurance Division,
for which MEGA paid to an advisory affiliate of The Blackstone
Group in 2007, a tax structuring fee in the amount of
$1.0 million. The terms of the amendment were approved by
the Oklahoma Insurance Department effective February 8,
2007. These Advisory Fee expenses were recorded as part of the
gain on sale in Gains (losses) on sale of
investments.
Placement
Agreement
The Company entered into a placement agreement, dated
August 18, 2006, with The Blackstone Group, pursuant to
which the Company paid to an advisory affiliate of The
Blackstone Group a fee in the amount of $1.5 million for
securities placement and structuring services in connection with
a private placement of securities by Grapevine Finance LLC
completed on August 16, 2006. See Note 11 of
Notes to Consolidated Financial Statements. The Company has also
agreed to reimburse The Blackstone Group for
out-of-pocket
expenses incurred in connection with the placement services and
agreed to indemnify The Blackstone Group and its affiliates for
certain claims and expenses incurred in connection with the
engagement.
Registration
Rights Agreement
The Company is a party to a registration rights and coordination
committee agreement, dated as of April 5, 2006 (the
Registration Rights Agreement), with the investment
affiliates of each of the Private Equity Investors, providing
for demand and piggyback registration rights with respect to the
Class A-1
common stock. Certain management stockholders are also expected
to become parties to the Registration Rights Agreement.
Following a future initial public offering of the Companys
stock, the Private Equity Investors affiliated with The
Blackstone Group will have the right to demand such registration
under the Securities Act of its shares for public sale on up to
five occasions, the Private Equity Investors affiliated with
Goldman Sachs Capital Partners will have the right to demand
such registration on up to two occasions, and the Private Equity
Investors affiliated DLJ Merchant Banking Partners will have the
right to demand such registration on one occasion. No more than
one such demand is permitted within any
180-day
period without the consent of the Board of Directors of the
Company.
F-54
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
In addition, the Private Equity Investors have, and, if they
become parties to the Registration Rights Agreement, the
management stockholders will have, so-called
piggy-back rights, which are rights to request that
their shares be included in registrations initiated by the
Company or by any Private Equity Investors. Following an initial
public offering of the Companys stock, sales or other
transfers of the Companys stock by parties to the
Registration Rights Agreement will be subject to pre-approval,
with certain limited exceptions, by a Coordination Committee
that will consist of representatives from each of the Private
Equity Investor groups. In addition, the Coordination Committee
shall have the right to request that the Company effect a
shelf registration.
Investment
in Certain Funds Affiliated with the Private Equity
Investors
On April 20, 2007, the Companys Board of Directors
approved a $10.0 million investment by Mid-West National
Life Insurance Company of Tennessee in Goldman Sachs Real Estate
Partners, L.P., a commercial real estate fund managed by an
affiliate of Goldman Sachs Capital Partners. The Company has
committed such investment to be funded over a series of capital
calls. The Company has funded $3.3 million in capital calls
through December 31, 2007 recorded in Short-term and
other investments.
On April 20, 2007, the Companys Board of Directors
approved a $10.0 million investment by The MEGA Life and
Health Insurance Company in Blackstone Strategic Alliance
Fund L.P., a hedge fund of funds managed by an affiliate of
The Blackstone Group. The Company has committed such investment
to be funded over a series of capital calls. The Company has
funded $1.6 million in capital calls through
December 31, 2007 recorded in Short-term and other
investments.
Extraordinary
Cash Dividend
On May 3, 2007, the Companys Board of Directors
declared an extraordinary cash dividend in the amount of $10.51
per share for
Class A-1
and
Class A-2
common stock to holders of record as of close of business on
May 9, 2007, paid on May 14, 2007. In connection with
the extraordinary cash dividend, affiliates of each of The
Blackstone Group, Goldman Sachs Capital Partners and DLJ
Merchant Banking Partners were paid dividends in the amount of
$173.3 million, $71.0 million and $35.5 million,
respectively.
Transactions
with Certain Members of Management
Transactions
with National Motor Club
William J. Gedwed (a director and the Chief Executive Officer of
the Company) holds a 5.3% equity interest in NMC Holdings, Inc.
(NMC), the ultimate parent company of National Motor
Club of America and subsidiaries (NMCA).
Effective January 1, 2005, MEGA and NMCA entered into a new
three-year administrative agreement (succeeding a prior two year
agreement) for a term ending on December 31, 2007 pursuant
to which MEGA agreed to issue life, accident and health
insurance policies to NMCA for the benefit of NMCA members in
selected states. NMCA, in turn, agreed to provide to MEGA
certain administrative and record keeping services in connection
with the NMCA members for whose benefit the policies have been
issued. MEGA terminated this agreement effective January 1,
2007. During 2007, 2006 and 2005, NMCA paid to MEGA the amount
of $28,000, $1.1 million and $957,000, respectively,
pursuant to the terms of this agreement. The payment received by
MEGA in 2007 was related to 2006 activities.
During 2007, 2006 and 2005, NMCA paid the Company $391,000,
$316,000 and $344,000, respectively, for printing and various
other services.
F-55
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Other
Transactions
On April 1, 2002, the Company, through a subsidiary,
entered into a Loan Servicing Agreement (as amended, the
Servicing Agreement) with Affiliated Computer
Services (formerly known as AFSA Data Corporation)
(ACS), pursuant to which ACS provides computerized
origination, billing, record keeping, accounting, reporting and
loan management services with respect to a portion of the
Companys CFLD-I student loan portfolio. Mr. Dennis
McCuistion, who was a director of the Company effective
May 19, 2004 through April 5, 2006, is also a director
of ACS. During 2006 (covering the period from January 1,
2006 through April 5, 2006) and 2005, the Company paid
ACS $281,000 and $725,000, respectively, pursuant to the terms
of the Servicing Agreement.
Effective June 19, 2006, the Company entered into separate
agreements with each of R.H. Mick Thompson, Dennis McCuistion
and Richard Mockler (directors of the Company until
April 5, 2006), in accordance with which the former
directors agreed to provide certain advisory services and
assistance to the Company and its subsidiaries with respect to
insurance regulatory, governmental affairs, accounting, media
and public relations matters for a one year term commencing on
July 1, 2006 and ending on June 30, 2007. For such
services, the Company agreed to pay to each former director a
consulting fee in the amount of $300,000, which fee was paid in
equal quarterly installments in the amount of $75,000. The
Company recorded an aggregate expense in 2006 of $900,000
related to these agreements. The Company also agreed to
reimburse each former director for reasonable
out-of-pocket
business travel expenses and other reasonable
out-of-pocket
expenses related to the services to be provided under the
agreements, and the Company agreed to indemnify each of the
former directors for certain claims and expenses incurred in
connection with the engagement.
Transactions
with Mrs. Jensen and Affiliates of
Mrs. Jensen
Immediately prior to the Merger, Mrs. Jensen, individually
and in her capacity as executor of the estate of
Mr. Jensen, beneficially held 17.04% of the outstanding
shares of the Company. Mrs. Jensen and affiliates of
Mrs. Jensen ceased to be related parties on April 5,
2006, the date of the Merger with the Private Equity Investors
and the related sale of the Jensen ownership in the Company.
Special
Investment Risks, Ltd.
Special Investment Risks, Ltd. (SIR) (formerly
United Group Association, Inc.) is owned by the estate of Ronald
L. Jensen (the Companys founder and former Chairman), of
which Gladys J. Jensen (Mr. Jensens surviving spouse)
serves as independent executor.
Previously, SIR sold health insurance policies that were issued
by AEGON USA and coinsured by the Company or policies issued
directly by the Company. Effective January 1, 1997, the
Company acquired the agency force of SIR. In accordance with the
terms of the asset sale to the Company, SIR retained the right
to receive certain commissions and renewal commissions. During
the years ended December 31, 2006 (covering the period from
January 1, 2006 through April 5, 2006) and 2005,
the Company paid to SIR $1.8 million and $7.0 million,
respectively, pursuant to this arrangement.
On May 19, 2006, the Company and SIR entered into a
Termination Agreement, pursuant to which SIR received an
aggregate of $47.5 million. All commission payments owed to
SIR under the asset sale agreement were discharged in full, SIR
released the Company from all liability under the asset sale
agreement, and the asset sale agreement was terminated. See
Note 3.
In 2006 (covering the period from January 1, 2006 through
April 5, 2006) and 2005, SIR paid to the Company
$39,000 and $91,000, respectively, to fund obligations of SIR
owing to the Companys agent stock accumulation plans. SIR
incurred this obligation prior to the Companys purchase of
the UGA agency in 1997.
F-56
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Richland
State Bank
Richland State Bank (RSB) is a state-chartered bank
in which Mrs. Jensen, as executor of the estate of
Mr. Jensen, holds a 100% equity interest. RSB provides
student loan origination services for the former College
Fund Life Division of MEGA and Mid-West.
Pursuant to a Loan Origination and Purchase Agreement, dated
June 12, 1999 and as amended, RSB originated student loans
and resold such loans to UICI Funding Corp. 2
(Funding) (a wholly owned subsidiary of the Company)
at par (plus accrued interest). During 2006 (covering the period
from January 1, 2006 through April 5, 2006) and
2005, RSB originated for the Companys College
Fund Life Division student loans in the aggregate principal
amount plus accrued interest of $1.6 million and
$7.6 million, respectively.
On July 28, 2005, the Companys Board of Directors
approved the execution and delivery of a new Loan Origination
and Purchase Agreement among the Company, UICI Funding Corp. 2,
RSB and Richland Loan Processing Center, Inc. (a wholly owned
subsidiary of RSB), pursuant to which RSB originates and funds,
and Richland Loan Processing Center, Inc. provides underwriting,
application review, approval and disbursement services, in
connection with private student loans generated under the
Companys College Fund Life Division Program. For
such services, RSB earns a fee in the amount of 150 basis
points (1.5%) of the original principal amount of each disbursed
student loan. The agreement further provides that UICI Funding
Corp. 2 will continue to purchase (at par) the private loans
funded and originated by Richland State Bank. During 2006
(covering the period from January 1, 2006 through
April 5, 2006) and 2005, RSB generated origination
fees in the amount of $26,000 and $78,000, respectively,
pursuant to the terms of this agreement.
During 2006 (covering the period from January 1, 2006
through April 5, 2006) and 2005, RSB collected on
behalf of, and paid to, UICI Funding Corp. 2 $150,000 and
$696,000, respectively, in guarantee fees paid by student
borrowers in connection with the origination of student loans.
During 2006 and 2005, RSB collected on behalf of and
collectively paid to the Company $0 and $59,000, respectively,
representing origination fees paid by student borrowers in
connection with the origination of student loans.
During 2006 (covering the period from January 1, 2006
through April 5, 2006) and 2005, UICI Funding Corp. 2
received from RSB interest income in the amount of $29,000 and
$16,000, respectively, generated on money market accounts
maintained by the Company at, and on certificates of deposit
issued by, RSB.
Specialized
Association Services, Inc.
Specialized Association Services, Inc. (SAS) (which
is controlled by the adult children of Mrs. Jensen)
provides administrative and other services to the membership
associations that make available to their members the
Companys health insurance products.
Effective December 31, 2002, SAS and Benefit Administration
for the Self-Employed, LLC (BASE 105) (an 80% owned
subsidiary of the Company) entered into an agreement effective
January 1, 2003 (the January 2003 Agreement),
pursuant to which SAS purchased from BASE 105 a benefit provided
to association members. In 2006 (covering the period from
January 1, 2006 through April 5, 2006) and 2005,
SAS paid BASE 105 the amount of $174,000 and $2.0 million,
respectively, in accordance with this arrangement. Effective
January 1, 2006, the January 2003 Agreement was terminated,
and BASE 105 commenced providing the benefit directly to the
membership associations. The payment received by BASE 105 in
2006 was related to 2005 activities. These receipts were
recorded in Other income.
During 2002, SAS began purchasing directly from MEGA certain
ancillary benefit products (including accidental death, hospital
confinement and emergency room benefits) for the benefit of the
membership associations that make available to their members the
Companys health insurance products. In 2006 and 2005, the
aggregate amount paid by SAS to MEGA for these benefit products
was $822,000 and $11.3 million, respectively.
F-57
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
MEGA recorded the payments received from SAS in Health
premiums. Effective January 1, 2006, this arrangement
with SAS was terminated, and MEGA commenced providing the
ancillary benefit products directly to the membership
associations. The payment received by MEGA in 2006 was related
to 2005 activities.
SAS reimburses MEGA for certain billing and collection services
that MEGA provides to membership associations members in
accordance with an agreement entered into effective
January 1, 1998. The aggregate amount paid by SAS to MEGA
for this reimbursement of services was $211,000 in 2005.
Effective July 1, 2005, this arrangement with SAS was
terminated. In addition, during 2005, SAS paid UICI Marketing
$55,000, respectively, for various printing and video services.
The Company also received from SAS $2,000 and $4,000 during 2006
and 2005, respectively, for reimbursement of expenses.
|
|
Note 17.
|
Commitments
and Contingencies
|
The Company is a party to the following material legal
proceedings:
Academic
Management Services Corp. Related
Litigation
As previously disclosed, in May and June 2004, HealthMarkets and
certain officers and current and former directors of
HealthMarkets were named as defendants in class actions later
consolidated as a single action, In re HealthMarkets
Securities Litigation, Case
No. 3-04-CV-1149-P,
pending in the United States District Court for the Northern
District of Texas, Dallas Division, arising out of
HealthMarkets announcement in July 2003 of a shortfall in
the type and amount of collateral supporting securitized student
loan financing facilities of Academic Management Services Corp.
(AMS), formerly a wholly-owned subsidiary of
HealthMarkets until its disposition in November 2003. Plaintiffs
alleged that defendants failed to disclose all material facts
relating to the condition of AMS, in violation of
Section 10(b) of the Securities Exchange Act of 1934 and
Rule 10b-5
thereunder. The parties executed a settlement agreement
resolving this matter on October 4, 2007 on terms that did
not have a material adverse effect upon the Companys
consolidated financial condition or results of operations. A
final settlement hearing occurred on January 23, 2008.
Association
Group Litigation
Introduction
The health insurance products issued by the Companys
insurance subsidiaries in the self-employed market are primarily
issued to members of various membership associations that make
available to their members the health insurance and other
insurance products issued by the Companys insurance
subsidiaries. The associations provide their membership with a
number of benefits and products, including the opportunity to
apply for health insurance underwritten by the Companys
health insurance subsidiaries. The Company
and/or its
insurance company subsidiaries have been a party to several
lawsuits that, among other things, challenge the nature of the
relationship between the Companys insurance companies and
the associations that have made available to their members the
insurance companies health insurance products.
Class Action
Opt Out Litigation
As previously disclosed, during 2004, the Company effected a
settlement of nationwide class action litigation (Eugene A.
Golebiowski, individually and on behalf of others similarly
situated, v. MEGA, UICI, the National Association for the
Self-Employed et al., initially filed in the United States
District Court for the Northern District of Mississippi, Eastern
Division; and Lacy v. The MEGA Life and Health Insurance
Company et al., initially filed in the Superior Court of
California, County of Alameda, Case
No. RG03-092881,
which cases were subsequently transferred to the United States
District Court for the Northern District of Texas, Dallas
Division (In re UICI Association-Group Insurance
Litigation, MDL Docket No. 1578)). As part of the
nationwide class action
F-58
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
settlement process, on August 2, 2004 formal notice of the
settlement terms was sent to 1,162,845 prospective class
members, of which approximately 2,400 prospective class members
(representing less than 0.2% of the class) elected to opt
out of the settlement. By electing to opt out of the
settlement, potential class members (a) elected not to
receive the class relief to which class members are otherwise
entitled under the terms of the settlement and (b) retained
the right to assert claims otherwise released by the class
members.
The Company and MEGA were named as a party defendant in 15
lawsuits brought by plaintiffs represented by a single counsel
who have purportedly opted out of the class action settlement.
Generally, plaintiffs in the cases asserted several causes of
action, including breach of contract, breach of fiduciary and
trust duties, fraudulent suppression, civil conspiracy, unjust
enrichment, fraud, negligence, breach of implied contract to
procure insurance, negligence per se, wantonness, conversion,
bad faith refusal to pay and bad faith refusal to investigate.
At a mediation held on May 31, 2006, HealthMarkets, MEGA
and Mid-West agreed, without admitting or denying liability, to
finally and fully resolve all of these suits on terms
(individually and in the aggregate) that did not have a material
adverse effect upon the consolidated financial condition or
results of operations of HealthMarkets. The settlement also
includes a full release of possible claims by approximately 160
potential opt out claimants who had not yet filed suit. The
settlement of these cases will not affect other ongoing lawsuits
that, as discussed below under the captions California
Litigation and Other Association Group
Litigation, challenge (among other things) the nature
of the relationship between the Companys insurance
companies and the associations that have made available to their
members the insurance companies health insurance products.
California
Litigation
As previously disclosed, on September 26, 2003, the Company
and MEGA were named as cross-defendants in a lawsuit initially
filed on July 30, 2003 (Retailers Credit
Association of Grass Valley, Inc. v. Henderson et
al. v. UICI et al.) in the Superior Court of the State
of California for the County of Nevada, Case No. L69072. In
the suit, cross-plaintiffs asserted several causes of action,
including breach of the implied covenant of good faith and fair
dealing, fraud, violation of California Business and Professions
Code § 17200 and negligent and intentional
misrepresentation, and sought injunctive relief and monetary
damages in an unspecified amount. Following an earlier order for
summary judgment, on August 28, 2006, the Court entered a
final judgment in favor of all named defendants. On
October 27, 2006, plaintiffs filed a notice of appeal and
on March 26, 2008, the California Court of Appeals, Third
Appellate District, affirmed the trial courts judgment.
As previously disclosed, the Company and Mid-West were named as
defendants in an action filed on December 30, 2003
(Montgomery v. UICI et al.) in the Superior Court of
the State of California, County of Los Angeles, Case
No. BC308471. Plaintiff asserted statutory and common law
causes of action for both monetary and injunctive relief based
on a series of allegations concerning marketing and claims
handling practices. On March 1, 2004, the Company and
Mid-West removed the matter to the United States District Court
for the Central District of California, Western Division. On
May 11, 2004, the Judicial Panel on Multidistrict
Litigation issued a transfer order transferring the
Montgomery matter to the United States District Court for
the Northern District of Texas for coordinated pretrial
proceedings (In re UICI Association-Group
Insurance Litigation, MDL Docket No. 1578). On
February 20, 2007, the parties participated in a status
conference in this case and all other cases pending before the
Court in In re UICI Association-Group Insurance
Litigation, MDL Docket No. 1578 during which the Court
directed the parties to confer regarding the briefing schedule
for pretrial motions.
As previously disclosed, the Company and MEGA were named as
defendants in an action filed on January 20, 2004
(Springer et al. v. UICI et al.) in the Superior
Court of the State of California, County of Monterey, Case
No. M68493. On May 12, 2004, the matter was removed to
the United States District Court for the Northern District of
California, San Jose Division, and on July 1, 2004,
was transferred by the Judicial Panel on Multidistrict
Litigation to the United States District Court for the Northern
District of Texas for coordinated pretrial proceedings (In re
UICI Association-Group Insurance Litigation, MDL
Docket No. 1578). Plaintiff alleged that the
F-59
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
undisclosed relationship between MEGA and the NASE constituted
fraudulent and deceptive sales and advertising
practices and asserted several causes of action, including
breach of contract, breach of the duty of good faith and fair
dealing, violation of California Business and Professions Code
§ 17200, fraud and negligent misrepresentation, and
sought injunctive relief and monetary damages in an unspecified
amount. On August 8, 2007, the parties settled this action
on terms that did not have a material adverse effect on the
Companys consolidated financial condition or results of
operations.
HealthMarkets and MEGA were named as defendants in an action
filed on October 5, 2005 (Charles H. Gardner v.
MEGA, HealthMarkets, et al.) pending in the Superior Court
of Los Angeles County, California (the California
Court), Case No. BC340625. The plaintiff has asserted
violations of the California Consumers Legal Remedies Act,
breach of contract, breach of the implied covenant of good faith
and fair dealing, fraud, breach of fiduciary duty, negligence
and unfair competition. The plaintiff seeks monetary damages in
an unspecified amount and injunctive relief. On December 3,
2007, the parties entered into a settlement agreement resolving
this matter on terms that did not have a material adverse effect
on the Companys consolidated financial condition or
results of operation.
As previously disclosed, HealthMarkets and MEGA were named as
defendants in an action filed on May 31, 2006 (Linda L.
Hopkins and Jerry T. Hopkins v. HealthMarkets, MEGA, the
National Association for the Self Employed, et al.) pending
in the Superior Court for the County of Los Angeles, California,
Case No. BC353258. Plaintiffs have alleged several causes
of action, including breach of fiduciary duty, negligent failure
to obtain insurance, intentional misrepresentation, fraud by
concealment, promissory fraud, negligent misrepresentation,
civil conspiracy, professional negligence, negligence,
intentional infliction of emotional distress, and violation of
the California Consumer Legal Remedies, California Civil Code
Section 1750, et seq. Plaintiffs seek injunctive relief,
disgorgement of profits and general and punitive monetary
damages in an unspecified amount. On May 7, 2007, the Court
granted MEGAs motion to dismiss these claims and
HealthMarkets motion to quash. Plaintiff Linda Hopkins
died on May 11, 2007. On June 6, 2007, plaintiff Jerry
Hopkins, as successor in interest to Linda Hopkins, filed an
amended complaint, which MEGA answered on July 11, 2007.
As previously disclosed, HealthMarkets and MEGA were named as
defendants in an action filed on July 25, 2006
(Christopher Closson, individually, and as Successor in
interest to Kathy Closson, deceased v. HealthMarkets, MEGA,
National Association for the Self-Employed, et al.) pending
in the Superior Court for the County of Riverside, California,
Case No. RIC453741. Plaintiff has alleged several causes of
action, including breach of fiduciary duty, negligent failure to
obtain insurance, fraud by concealment, promissory fraud, civil
conspiracy, professional negligence, negligence, intentional
infliction of emotional distress and violation of the California
Consumer Legal Remedies Act. Plaintiff seeks injunctive relief,
and general and punitive monetary damages in an unspecified
amount. On May 2, 2007, the California court dismissed the
causes of action alleging civil conspiracy and intentional
infliction of emotional distress (with leave to amend) and the
cause of action alleging violation of the California Consumer
Legal Remedies Act (without leave to amend). On June 11,
2007, plaintiff filed an amended complaint, which MEGA responded
to on July 16, 2007. On October 31, 2007, MEGA filed a
motion for summary judgment which is pending before the Court.
Other
Association Group Litigation
As previously disclosed, the Company and MEGA were named as
defendants in an action filed on February 11, 2002
(Martha R. Powell and Keith P. Powell v. UICI, MEGA, the
National Association for the Self-Employed et al.) pending
in the Second Judicial District Court for the County of
Bernalillo, New Mexico, Cause
No. CV-2
002-1156.
Plaintiffs have alleged breach of contract, fraud, negligent
misrepresentation, civil conspiracy, breach of third-party
beneficiary contract, breach of the duty of good faith and fair
dealing, breach of fiduciary duty, negligence and violations of
the New Mexico Insurance Practices Act, the New Mexico Insurance
Code and the New Mexico Unfair Practices Act. Plaintiff seeks
injunctive relief and monetary damages in an unspecified amount.
On November 16,
F-60
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
2007, the parties entered into a settlement agreement resolving
this matter on terms that did not have a material adverse effect
on the Companys consolidated financial condition or
results of operations.
The Company currently believes that resolution of the above
proceedings will not have a material adverse effect on the
Companys consolidated financial condition or results of
operations.
Commonwealth
of Massachusetts Litigation
On October 23, 2006, MEGA was named as a defendant in an
action filed by the Commonwealth of Massachusetts
(Commonwealth of Massachusetts v. The MEGA Life and
Health Insurance Company), pending in the Superior Court of
Suffolk County, Massachusetts, Case Number
06-4411. The
Complaint was served on MEGA on or around January 19, 2007.
Plaintiff has alleged that MEGA engaged in unfair and deceptive
practices by issuing policies that contained exclusions of, or
otherwise failed to cover, certain benefits mandated under
Massachusetts law. In addition, plaintiff has alleged that MEGA
violated Massachusetts laws that (i) require health
insurance policies to provide coverage for outpatient
contraceptive services to the extent the policies provide
coverage for other outpatient services and (ii) limit
exclusions of coverage for pre-existing conditions. On
August 22, 2007, the Attorney General filed an amended
complaint which added HealthMarkets and Mid-West as defendants
in this action and broadened plaintiffs original
allegations. The amended complaint includes allegations that the
defendants engaged in unfair and deceptive trade practices and
illegal association membership practices, imposed illegal
waiting periods and restrictions on coverage of pre-existing
conditions and failed to comply with Massachusetts law regarding
mandatory benefits. This proceeding is in an early stage and its
outcome is uncertain. Civil discovery has commenced and motions
on various points of law and procedure have been filed by the
parties. At present, the Company is unable to determine what, if
any, impact this matter may have on the Companys
consolidated financial condition or results of operation.
State
of Maine Rate Inquiry Litigation
MEGA was named as a defendant in an action filed on
November 15, 2007 by the Department of Professional and
Financial Regulation, Maine Bureau of Insurance (In Re: MEGA
Life and Health Insurance Company Rates For Individual
Plans) pending before the Superintendent of the Maine Bureau
of Insurance, Docket
No. Ins-07-1010.
The Maine Attorney General moved to intervene and was granted
status as a party to the action. The action was initiated to
determine whether MEGA is in compliance with Maines
requirement that rates for health insurance not be excessive,
inadequate, or unfairly discriminatory as set forth in
24-A M.R.S.A
§ 2736-C(5) and Maine Rule Ch. 940,
§ 8(A). On March 21, 2008, MEGA, the Maine Bureau
of Insurance and the Attorney General agreed on a preliminary
basis to settle the action on terms that would not have a
material adverse effect upon the Companys consolidated
financial condition or results of operations and would not
require MEGA to admit wrongdoing, liability or violation of law.
The settlement is not final and discovery is ongoing.
Other
Litigation Matters
As previously disclosed, MEGA was named as a defendant in an
action filed on August 31, 2006 (Tracy L. Dobbelaere and
Robert Dobbelaere v. The MEGA Life and Health Insurance
Company, et al.) pending in the Circuit Court of Clinton
County, Missouri, Cause
No. 06CN-CV00618.
Plaintiffs have alleged several causes of action including
negligence, negligent misrepresentation, intentional
misrepresentation, and loss of consortium. Plaintiffs seek
unspecified general and punitive damages, interest and
attorneys fees. On November 6, 2006, MEGA filed a
motion to dismiss, which plaintiffs opposed on December 18,
2006. A ruling on MEGAs motion is pending.
The Company and its subsidiaries are parties to various other
pending and threatened legal proceedings, claims, demands,
disputes and other matters arising in the ordinary course of
business, including some asserting significant liabilities
arising from claims, demands, disputes and other matters with
respect to insurance policies, relationships with agents,
relationships with former or current employees and other
matters. From time to time, some such matters, where
appropriate, may be the subject of internal investigation by
management, the Board of
F-61
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Directors, or a committee of the Board of Directors. The Company
believes that the liability, if any, resulting from the
disposition of such proceedings, claims, demands, disputes or
matters would not be material to the Companys consolidated
financial condition or results of operations.
Regulatory
Matters
Market
Conduct Examinations
In March 2005, HealthMarkets received notification that the
Market Analysis Working Group of the NAIC had chosen the states
of Washington and Alaska to lead a multi-state market conduct
examination of HealthMarkets principal insurance
subsidiaries (the Insurance Subsidiaries) for the
examination period January 1, 2000 through
December 31, 2005. Thirty-six (36) states have elected
to participate in the examination. The examiners completed the
onsite phases of the examination and issued a final examination
report on December 20, 2007.
The findings of the final examination report cite deficiencies
in five major areas of operation: (i) insufficient training
of agents and lack of oversight of agent activities,
(ii) deficient claims handling practices,
(iii) insufficient disclosure of the relationship with
affiliates and the membership associations, (iv) deficient
handling of complaints and grievances, and (v) failure to
maintain a formal corporate compliance plan and centralized
corporate compliance department.
In connection with the issuance of the final examination report,
the Washington Office of Insurance Commissioner issued an order
adopting the findings of the final examination report and
ordering the Insurance Subsidiaries to comply with certain
required actions set forth in the report. The order requires the
Insurance Subsidiaries to file a detailed report specifying how
they have addressed each of the requirements of the order and
another report outlining, by examination area, all business
reforms, improvements and changes to policies and procedures.
During 2004, in response to state specific examination findings,
the Insurance Subsidiaries began making significant changes to
their structure and operational processes. These changes
included the enhancement of its agent training and oversight
programs, the reorganization and consolidation of the
Companys compliance department, the adoption of additional
methods to monitor agent sales activities, the implementation of
a benefits confirmation telephone call program to obtain further
assurances that customers understand their health insurance
coverage and the creation of a Regulatory Advisory Panel
consisting of former regulators to provide objective advice to
the Board and management. The Company believes the Insurance
Subsidiaries have effectively addressed or are in the process of
addressing many of the findings identified in the final
examination report. Many of these enhancements occurred after
the examination period and are therefore not reflected in the
examination report findings.
Following the issuance of the final examination report, the
multi-state market conduct examination entered the
settlement phase, during which the states
participating in this phase are developing a settlement proposal
to close out the examination. Such a settlement could
potentially include, among other things, substantial monetary
assessments (portions of which may be contingent), and a
requirement that the Insurance Subsidiaries take certain
actions, subject to monitoring by certain states participating
in the examination. There can be no assurance that a settlement
of this matter will be achieved or that, if achieved, all states
participating in the examination would approve the terms of such
a settlement. Based on initial preliminary communications with
the states participating in the settlement phase, the Company
has recorded an expense of $20 million as of
December 31, 2007. Depending on the final outcome of the
settlement phase, including the ultimate disposition of any
contingent portion of a final monetary assessment, the actual
amount incurred by the Company could vary from this current
provision in an amount that is material to the Companys
consolidated financial condition or results of operations.
On December 6, 2006, MEGA, Mid-West and Chesapeake, entered
into a settlement agreement with the Massachusetts Division of
Insurance (MA DOI) upon the conclusion of a market conduct
examination by the MA DOI. The examination consisted of a review
of the operations of MEGA, Mid-West and Chesapeake for small
group
F-62
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
health insurance issued to Massachusetts certificate holders for
the period January 1, 2002 to December 31, 2004. The
settlement agreement provides, among other things, for changes
in certain Company operations and procedures, including those
related to claims handling, complaints and grievances, marketing
and sales and underwriting. In addition, MEGA, Mid-West and
Chesapeake agreed to conduct a claims reassessment process,
pursuant to which the companies are contacting certain
Massachusetts claimants and offering to reassess certain denied
claims based on specific codes identified by the MA DOI. The
reassessment covers claims for the period January 1, 2002
through December 31, 2004, as well as claims on
certificates issued through April 30, 2005 or renewed
through July 31, 2005 to the date of their first renewal or
lapse. The claims reassessment is ongoing and the MA DOI
continues to evaluate the Companys compliance with the
terms of the settlement agreement. In entering the settlement,
the Company did not admit, deny or concede any actual or
potential fault, wrongdoing, liability or violation of law. The
MA DOI will not impose fines or take other action against the
Company unless the Company fails to complete the required
actions set forth in the settlement agreement or unless
additional material information related to the required actions
becomes available to the MA DOI. The Company believes that the
terms of the settlement will not have a material adverse effect
upon the Companys consolidated financial condition or
result of operations.
The Companys insurance subsidiaries are subject to various
other pending market conduct or other regulatory examinations,
inquiries or proceedings arising in the ordinary course of
business. State insurance regulatory agencies have authority to
levy significant fines and penalties and require remedial action
resulting from findings made during the course of such matters.
Historically, our insurance subsidiaries have from time to time
been subject to such fines and penalties, none of which
individually or in the aggregate have had a material adverse
effect on our results of operations or financial condition.
However, the multi-state examination and other regulatory
examinations, inquiries or proceedings could result in, among
other things, changes in business practices that require the
Company to incur substantial costs. Such results, singly or in
combination, could injure our reputation, cause negative
publicity, adversely affect our debt and financial strength
ratings, place us at a competitive disadvantage in marketing or
administering our products or impair our ability to sell or
retain insurance policies, thereby adversely affecting our
business, and potentially materially adversely affecting the
results of operations in a period, depending on the results of
operations for the particular period. Determination by
regulatory authorities that we have engaged in improper conduct
could also adversely affect our defense of various lawsuits.
United
States Department of Labor Matter
By letter dated March 11, 2005, the Boston Office of the
U.S. Department of Labor informed the Company that certain
policy forms in use by Mid-West in Massachusetts may not be
compliant with provisions of ERISA and certain other federal
laws applicable to health insurers in the group market. On
November 7, 2005, the Boston Office of the
U.S. Department of Labor informed the Company that it had
concluded a review of insurance contracts marketed by the
Companys insurance subsidiaries in the New England region
and identified certain alleged violations of ERISA. The Company
disputes most of the allegations raised by the Department of
Labor, primarily on the basis that most of the policy forms
under review are not subject to ERISA because they are offered
to and used by individuals, self-employed persons or employers
with less than two participants who are employees as of the
start of any plan year. On February 13, 2008, the parties
executed a settlement agreement to resolve these matters. The
settlement agreement requires the Company to, among other
things, identify the nationwide population of insurance
contracts marketed to ERISA groups, amend or otherwise adjust
these contracts to bring them into compliance with ERISA, submit
any such amended contracts to applicable state insurance
regulatory authorities for approval, issue any such approved
amended contracts to employer groups holding current versions of
policy forms that are subject to ERISA and implement a training
program designed to educate its customer service representatives
and independent agents about the application of ERISA to certain
business. The Company currently does not believe that these
matters, or the terms of the settlement agreement, will have a
material adverse effect on the Companys consolidated
financial condition or results of operations.
F-63
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Other
Commitments and Contingencies
The Company and its subsidiaries lease office space and data
processing equipment under various lease agreements with initial
lease periods of three to ten and one-half years. Minimum lease
commitments at December 31, 2007 were $5.1 million in
2008, $4.2 million in 2009, $2.9 million in 2010,
$1.6 million in 2011, $1.6 million in 2012 and
$1.7 million thereafter. Rent expense was
$6.3 million, $8.5 million and $9.2 million for
the years ended December 31, 2007, 2006 and 2005,
respectively.
Through its former College Fund Life Division life
insurance operations, the Company has committed to assist in
funding the higher education of its insureds with student loans.
As of December 31, 2007, the Company, through its College
Fund Life Insurance Division, had outstanding commitments
to fund student loans for the years 2008 through 2026. The
Company has historically funded its College Fund Life
Division student loan commitments with the proceeds of
indebtedness issued by a bankruptcy-remote special purpose
entity. Beginning February 1, 2007, the Company funds loans
with cash on hand at HealthMarkets LLC. See Note 9.
Loans issued to students under the College Fund Life
Division program are limited to the cost of school or prescribed
maximums. These loans are generally guaranteed as to principal
and interest by an appropriate guarantee agency and are also
collateralized by either the related insurance policy or the
co-signature of a parent or guardian.
The total commitment for the next five school years and
thereafter as well as the amount the Company expects to fund
considering utilization rates and lapses are as follows:
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
Expected
|
|
|
|
Commitment
|
|
|
Funding
|
|
|
|
(In thousands)
|
|
|
2008
|
|
$
|
20,011
|
|
|
$
|
1,367
|
|
2009
|
|
|
16,605
|
|
|
|
1,167
|
|
2010
|
|
|
17,038
|
|
|
|
987
|
|
2011
|
|
|
19,282
|
|
|
|
875
|
|
2012
|
|
|
21,735
|
|
|
|
689
|
|
2013 and thereafter
|
|
|
75,594
|
|
|
|
1,265
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
170,265
|
|
|
$
|
6,350
|
|
|
|
|
|
|
|
|
|
|
Interest rates on the above commitments are principally variable
(prime plus 2%).
At each of December 31, 2007 and 2006, the Company had
$14.3 million and $9.6 million, respectively, of
letters of credit outstanding relating to its insurance
operations.
|
|
Note 18.
|
Investment
Annuity Segregated Accounts
|
At December 31, 2007 and 2006, the Company had deferred
investment annuity policies that have segregated account assets
and liabilities, in the amount of $239.7 million and
$234.3 million, respectively. These policies are funded by
specific assets held in segregated custodian accounts for the
purposes of providing policy benefits and paying applicable
premiums, taxes and other charges as due. Because investment
decisions with respect to these segregated accounts are made by
the policyholders, these assets and liabilities are not
presented in the Companys financial statements. The assets
are held in individual custodian accounts, from which the
Company has received hold harmless agreements and
indemnification.
|
|
Note 19.
|
Segment
Information
|
The Companys business segments for financial reporting
purposes include (i) the Insurance segment, which includes
the businesses of the Companys Self-Employed Agency
Division, the Life Insurance Division and Other Insurance;
(ii) the Other Key Factors segment, which includes
investment income not otherwise allocated to the Insurance
segment, realized gains and losses on sale of investments,
interest expense on corporate debt, variable stock-based
compensation, pre-operational costs associated with the
Companys Medicare Advantage PFFS market
F-64
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
initiative, general expenses relating to corporate operations
and, in 2006, the incremental costs associated with the
acquisition of the Company by a group of private equity
investors, and (iii) the Disposed Operations segment, which
includes the Companys former Star HRG Division and former
Student Insurance Division.
Allocations among segments of investment income and certain
general expenses are based on a number of assumptions and
estimates, and the business segments reported operating results
would change if different allocation methods were applied.
Certain assets are not individually identifiable by segment and,
accordingly, have been allocated by formulas. Segment revenues
include premiums and other policy charges and considerations,
net investment income, and fees and other income. Operations
that do not constitute reportable operating segments are
reported in the Other Key Factors segment. Depreciation expense
and capital expenditures are not considered material. Management
does not allocate income taxes to segments. Transactions between
reportable segments are accounted for under respective
agreements, which provide for such transactions generally at
cost.
Revenues from continuing operations and income from continuing
operations before federal income taxes for each of the years
ended December 31, 2007, 2006 and 2005 are set forth in the
table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
1,417,952
|
|
|
$
|
1,462,088
|
|
|
$
|
1,525,968
|
|
Life Insurance Division
|
|
|
92,022
|
|
|
|
87,782
|
|
|
|
83,037
|
|
Other Insurance
|
|
|
31,866
|
|
|
|
35,337
|
|
|
|
34,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance
|
|
|
1,541,840
|
|
|
|
1,585,207
|
|
|
|
1,643,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Key Factors
|
|
|
54,458
|
|
|
|
246,847
|
|
|
|
41,104
|
|
Intersegment Eliminations
|
|
|
(1,031
|
)
|
|
|
(910
|
)
|
|
|
(706
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues excluding disposed operations
|
|
|
1,595,267
|
|
|
|
1,831,144
|
|
|
|
1,684,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
|
|
|
|
240,050
|
|
|
|
290,378
|
|
Star HRG Division
|
|
|
|
|
|
|
75,377
|
|
|
|
146,638
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Disposed Operations
|
|
|
|
|
|
|
315,427
|
|
|
|
437,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
1,595,267
|
|
|
$
|
2,146,571
|
|
|
$
|
2,121,218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before federal income
taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
150,449
|
|
|
$
|
236,466
|
|
|
$
|
310,466
|
|
Life Insurance Division
|
|
|
2,550
|
|
|
|
5,264
|
|
|
|
7,053
|
|
Other Insurance
|
|
|
7,909
|
|
|
|
5,488
|
|
|
|
4,658
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance
|
|
|
160,908
|
|
|
|
247,218
|
|
|
|
322,177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-65
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
Other Key Factors:
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment income on equity, realized gains and losses, general
corporate expenses and other (including interest on corporate
debt)
|
|
|
(43,927
|
)
|
|
|
(46,507
|
)
|
|
|
14,680
|
|
Gain on Sale of Star HRG and Student Divisions
|
|
|
1,200
|
|
|
|
201,663
|
|
|
|
|
|
Merger transaction costs
|
|
|
|
|
|
|
(48,019
|
)
|
|
|
(9,057
|
)
|
Variable stock-based compensation benefit (expense)
|
|
|
482
|
|
|
|
(16,603
|
)
|
|
|
(7,214
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Other Key Factors
|
|
|
(42,245
|
)
|
|
|
90,534
|
|
|
|
(1,591
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating income excluding disposed operations
|
|
|
118,663
|
|
|
|
337,752
|
|
|
|
320,586
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
192
|
|
|
|
12,238
|
|
|
|
(8,870
|
)
|
Star HRG Division
|
|
|
199
|
|
|
|
2,308
|
|
|
|
1,434
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Disposed Operations
|
|
|
391
|
|
|
|
14,546
|
|
|
|
(7,436
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total income from continuing operations before federal income
taxes
|
|
$
|
119,054
|
|
|
$
|
352,298
|
|
|
$
|
313,150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets by operating segment at December 31, 2007 and 2006
are set forth in the table below:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
Insurance:
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
878,911
|
|
|
$
|
930,856
|
|
Life Insurance Division
|
|
|
540,474
|
|
|
|
552,723
|
|
Other Insurance
|
|
|
21,034
|
|
|
|
20,419
|
|
|
|
|
|
|
|
|
|
|
Total Insurance
|
|
|
1,440,419
|
|
|
|
1,503,998
|
|
Other Key Factors
|
|
|
664,210
|
|
|
|
949,860
|
|
|
|
|
|
|
|
|
|
|
Total assets excluding Disposed Operations
|
|
|
2,104,629
|
|
|
|
2,453,858
|
|
|
|
|
|
|
|
|
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
50,905
|
|
|
|
124,738
|
|
Star HRG Division
|
|
|
48
|
|
|
|
16,233
|
|
|
|
|
|
|
|
|
|
|
Total Disposed Operations
|
|
|
50,953
|
|
|
|
140,971
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
2,155,582
|
|
|
$
|
2,594,829
|
|
|
|
|
|
|
|
|
|
|
The Star HRG Division assets of $48,000 and $16.2 million
at December 31, 2007 and 2006, respectively, represent a
reinsurance receivable associated with a coinsurance agreement
entered into with an insurance affiliate of CIGNA Corporation.
The Student Insurance Division assets of $50.9 million and
$124.7 million at December 31, 2007 and 2006,
respectively, primarily represent a reinsurance receivable
associated with a coinsurance agreement entered into with an
insurance affiliate of UnitedHealth Group. See
Note 2.
F-66
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
Note 20.
|
Earnings
per Share
|
The following table sets forth the computation of basic and
diluted earnings per share for each of the years ended
December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands except per share amounts)
|
|
|
Income available to common shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders
|
|
$
|
69,370
|
|
|
$
|
216,568
|
|
|
$
|
202,970
|
|
Income from discontinued operations
|
|
|
789
|
|
|
|
21,170
|
|
|
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income, basic
|
|
$
|
70,159
|
|
|
$
|
237,738
|
|
|
$
|
203,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding, basic
|
|
|
30,429
|
|
|
|
34,952
|
|
|
|
46,119
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee stock options and other (see Note 15)
|
|
|
907
|
|
|
|
770
|
|
|
|
1,019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding, dilutive
|
|
|
31,336
|
|
|
|
35,722
|
|
|
|
47,138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
2.28
|
|
|
$
|
6.19
|
|
|
$
|
4.40
|
|
Income from discontinued operations
|
|
|
0.03
|
|
|
|
0.61
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
2.31
|
|
|
$
|
6.80
|
|
|
$
|
4.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
2.21
|
|
|
$
|
6.07
|
|
|
$
|
4.31
|
|
Income from discontinued operations
|
|
|
0.03
|
|
|
|
0.59
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share
|
|
$
|
2.24
|
|
|
$
|
6.66
|
|
|
$
|
4.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 21.
|
Discontinued
Operations
|
In years prior to 2005, the Company closed
and/or
disposed of assets and operations not otherwise related to its
core health and life insurance operations, including the
operations of the Companys former Academic Management
Services Corp. (AMS) subsidiary (which was engaged
in the student loan origination and funding business, student
loan servicing business, and tuition installment payment plan
business and which HealthMarkets sold in November 2003) and
the Companys former Special Risk Division, disposed in
2001.
Set forth below is a summary of the Companys reported
results from discontinued operations for each of the years ended
December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Income (loss) by business unit:
|
|
|
|
|
|
|
|
|
|
|
|
|
AMS
|
|
$
|
701
|
|
|
$
|
21,079
|
|
|
$
|
(461
|
)
|
Special Risk
|
|
|
88
|
|
|
|
91
|
|
|
|
992
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations net of tax
|
|
$
|
789
|
|
|
$
|
21,170
|
|
|
$
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-67
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Set forth below is a summary of the Companys net
liabilities from discontinued operations at December 31,
2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Net liabilities by business unit:
|
|
|
|
|
|
|
|
|
AMS
|
|
$
|
400
|
|
|
$
|
1,485
|
|
Special Risk
|
|
|
2,235
|
|
|
|
2,309
|
|
|
|
|
|
|
|
|
|
|
Net liabilities of discontinued operations
|
|
$
|
2,635
|
|
|
$
|
3,794
|
|
|
|
|
|
|
|
|
|
|
Academic
Management Services Corp.
The Companys reported results from discontinued operations
for the years ended December 31, 2007, 2006 and 2005
reflected a partial release of the deferred gain recorded on the
sale of AMS remaining uninsured student loan assets in the
first quarter of 2004 and a decrease in the accrual in both 2005
and 2006, which was originally established in 2004 in connection
with litigation arising out of the Companys announcement
that it had uncovered collateral shortfalls in the type and
amount of collateral supporting two of the securitized student
loan financing facilities of AMS.
The federal income tax benefit with respect to discontinued
operations for the year ended December 31, 2006 of
$19.5 million exceeds the anticipated 35% tax expense of
$537,000 due to the release of certain tax reserves and
valuation allowances on deferred tax assets related to capital
loss carryovers and other capital items of $20.1 million
that are recoverable as a result of the sale of the Star HRG
Division at a gain. A significant portion of the released tax
allowances and reserves was originally established during 2003
primarily because management did not anticipate realizing before
its expiration the tax benefits of the capital loss carryover
from the sale of its former student finance subsidiary.
The federal income tax expense for the year ended
December 31, 2005 for the AMS discontinued operations
reflected an increase in the valuation allowance on deferred tax
assets related to an increase in the capital loss carryover in
excess of the amount previously estimated that is likely to
expire before it can be utilized to offset future capital gains.
|
|
Note 22.
|
Supplemental
Financial Statement Data
|
Set forth below is certain supplemental information concerning
underwriting, policy acquisition costs and insurance expenses
for the years ended December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Amortization of deferred policy acquisition costs
|
|
$
|
138,374
|
|
|
$
|
172,112
|
|
|
$
|
82,567
|
|
Commissions
|
|
|
16,855
|
|
|
|
28,823
|
|
|
|
136,810
|
|
Administrative expenses
|
|
|
343,701
|
|
|
|
333,943
|
|
|
|
348,778
|
|
Premium taxes
|
|
|
35,998
|
|
|
|
43,760
|
|
|
|
49,646
|
|
Intangible asset amortization
|
|
|
1,722
|
|
|
|
2,525
|
|
|
|
3,731
|
|
Variable stock compensation expense (benefit)
|
|
|
(482
|
)
|
|
|
16,603
|
|
|
|
7,214
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
536,168
|
|
|
$
|
597,766
|
|
|
$
|
628,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-68
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
Amortization of deferred policy acquisition costs and
commissions for the 2006 year reflect the change in
accounting policy with respect to the amortization of a portion
of deferred acquisition costs associated with commissions paid
to agents. See Note 1.
|
|
Note 23.
|
Supplemental
Disclosure to Consolidated Statement of Cash Flows
|
Total interest paid with respect to outstanding indebtedness
(exclusive of the secured student loan credit facility) was
$37.1 million, $23.9 million and $1.0 million in
the years ended December 31, 2007, 2006 and 2005,
respectively.
Total interest paid with respect to outstanding indebtedness
under the secured student loan credit facility was
$6.0 million, $6.3 million and $4.8 million for
the years ended December 31, 2007, 2006 and 2005,
respectively.
Total federal income taxes paid were $19.1 million,
$64.6 million and $107.2 million for 2007, 2006 and
2005, respectively.
Supplemental
disclosure of non-cash operating activities:
During the 2007, 2006 and 2005, the Company issued shares to the
Agent Plans with a value of $21.3 million,
$17.5 million and $21.2 million, respectively.
Company-match transactions in the Agent Stock Accumulation Plans
are not reflected in the Statement of Cash Flows since issuance
of equity securities to settle the Companys liabilities
under the Agent Plans are non-cash transactions.
Supplemental
disclosure of non-cash investing activities:
On July 11, 2006, the Company received a promissory Note in
the amount of $150.8 million as consideration for its Star
HRG Division assets. On August 16, 2006, the Company
assigned the $150.8 million promissory Note to Grapevine
Finance LLC. See Note 11.
On December 1, 2006, the Company received a promissory Note
in the principal amount of $94.8 million as consideration
for the sale of the Student Insurance Division assets. See
Note 2.
F-69
HEALTHMARKETS,
INC.
and Subsidiaries
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
|
|
Note 24.
|
Quarterly
Unaudited Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
|
|
December 31,
|
|
|
September 30,
|
|
|
June 30,
|
|
|
March 31,
|
|
|
December 31,
|
|
|
September 30,
|
|
|
June 30,
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
|
(In thousands except per share amounts)
|
|
|
Income Statement Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues from continuing operations
|
|
$
|
388,748
|
|
|
$
|
399,241
|
|
|
$
|
402,657
|
|
|
$
|
404,621
|
|
|
$
|
555,305
|
|
|
$
|
562,568
|
|
|
$
|
515,543
|
|
|
$
|
513,155
|
|
Income (loss) from continuing operations before federal income
taxes
|
|
|
(680
|
)
|
|
|
50,495
|
|
|
|
35,174
|
|
|
|
34,065
|
|
|
|
125,954
|
|
|
|
154,152
|
|
|
|
13,728
|
|
|
|
58,464
|
|
Income (loss) from continuing operations
|
|
|
(9,476
|
)
|
|
|
33,255
|
|
|
|
22,967
|
|
|
|
22,624
|
|
|
|
82,168
|
|
|
|
89,874
|
|
|
|
5,680
|
|
|
|
38,846
|
|
Income (loss) from discontinued operations
|
|
|
100
|
|
|
|
226
|
|
|
|
396
|
|
|
|
67
|
|
|
|
507
|
|
|
|
301
|
|
|
|
19,701
|
|
|
|
661
|
|
Net income (loss)
|
|
$
|
(9,376
|
)
|
|
$
|
33,481
|
|
|
$
|
23,363
|
|
|
$
|
22,691
|
|
|
$
|
82,675
|
|
|
$
|
90,175
|
|
|
$
|
25,381
|
|
|
$
|
39,507
|
|
Per Share Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$
|
(0.31
|
)
|
|
$
|
1.08
|
|
|
$
|
0.76
|
|
|
$
|
0.75
|
|
|
$
|
2.75
|
|
|
$
|
3.01
|
|
|
$
|
0.17
|
|
|
$
|
0.84
|
|
Income (loss) from discontinued operations
|
|
|
|
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
|
|
|
|
0.02
|
|
|
|
0.01
|
|
|
|
0.58
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(0.31
|
)
|
|
$
|
1.09
|
|
|
$
|
0.77
|
|
|
$
|
0.75
|
|
|
$
|
2.77
|
|
|
$
|
3.02
|
|
|
$
|
0.75
|
|
|
$
|
0.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$
|
(0.31
|
)
|
|
$
|
1.05
|
|
|
$
|
0.74
|
|
|
$
|
0.73
|
|
|
$
|
2.67
|
|
|
$
|
2.94
|
|
|
$
|
0.16
|
|
|
$
|
0.83
|
|
Income (loss) from discontinued operations
|
|
|
|
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
|
|
|
|
0.02
|
|
|
|
0.01
|
|
|
|
0.57
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(0.31
|
)
|
|
$
|
1.06
|
|
|
$
|
0.75
|
|
|
$
|
0.73
|
|
|
$
|
2.69
|
|
|
$
|
2.95
|
|
|
$
|
0.73
|
|
|
$
|
0.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computation of earnings (loss) per share for each quarter is
made independently of earnings (loss) per share for the year.
F-70
SCHEDULE II
CONDENSED
FINANCIAL INFORMATION OF REGISTRANT
HEALTHMARKETS, INC. (HOLDING COMPANY)
BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
ASSETS
|
Investments in and advances to subsidiaries*
|
|
$
|
280,411
|
|
|
$
|
491,209
|
|
Cash and cash equivalents
|
|
|
37,675
|
|
|
|
48,578
|
|
Refundable income taxes
|
|
|
14,560
|
|
|
|
27,276
|
|
Deferred income tax
|
|
|
20,387
|
|
|
|
22,567
|
|
Other
|
|
|
599
|
|
|
|
1,056
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
353,632
|
|
|
$
|
590,686
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
|
Accrued expenses and other liabilities
|
|
$
|
10,898
|
|
|
$
|
16,533
|
|
Agent plan liability
|
|
|
33,839
|
|
|
|
45,974
|
|
Net liabilities of discontinued operations
|
|
|
2,635
|
|
|
|
3,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,372
|
|
|
|
66,301
|
|
|
STOCKHOLDERS EQUITY
|
Common stock
|
|
|
310
|
|
|
|
300
|
|
Additional paid-in capital
|
|
|
55,754
|
|
|
|
12,529
|
|
Accumulated other comprehensive loss
|
|
|
(13,132
|
)
|
|
|
(12,552
|
)
|
Retained earnings
|
|
|
281,141
|
|
|
|
527,978
|
|
Treasury stock
|
|
|
(17,813
|
)
|
|
|
(3,870
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
306,260
|
|
|
|
524,385
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
353,632
|
|
|
$
|
590,686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Eliminated in consolidation. |
The condensed financial statements should be read in conjunction
with the consolidated financial statements and notes thereto of
HealthMarkets, Inc. and Subsidiaries.
See report of Independent Registered Public Accounting Firm.
F-71
CONDENSED
FINANCIAL INFORMATION OF REGISTRANT
HEALTHMARKETS, INC. (HOLDING COMPANY)
CONDENSED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends from continuing operations*
|
|
$
|
270,000
|
|
|
$
|
372,428
|
|
|
$
|
171,876
|
|
Interest and other income
|
|
|
2,054
|
|
|
|
3,003
|
|
|
|
3,892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
272,054
|
|
|
|
375,431
|
|
|
|
175,768
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expenses (includes amounts paid to
related parties of $13,735, $19,339 and $565 in 2007, 2006 and
2005, respectively)
|
|
|
34,637
|
|
|
|
115,601
|
|
|
|
40,020
|
|
Interest expense
|
|
|
57
|
|
|
|
332
|
|
|
|
1,148
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,694
|
|
|
|
115,933
|
|
|
|
41,168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before equity in undistributed earnings of subsidiaries
and federal income tax expense
|
|
|
237,360
|
|
|
|
259,498
|
|
|
|
134,600
|
|
Federal income tax benefit
|
|
|
19,094
|
|
|
|
42,075
|
|
|
|
12,087
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before equity in undistributed earnings of subsidiaries
|
|
|
256,454
|
|
|
|
301,573
|
|
|
|
146,687
|
|
(Deficit) equity in undistributed earnings of continuing
operations*
|
|
|
(187,084
|
)
|
|
|
(85,005
|
)
|
|
|
56,283
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
69,370
|
|
|
|
216,568
|
|
|
|
202,970
|
|
Dividends from discontinued operations*
|
|
|
|
|
|
|
90
|
|
|
|
72
|
|
Equity in undistributed earnings (losses) from discontinued
operations*
|
|
|
789
|
|
|
|
21,080
|
|
|
|
459
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations
|
|
|
789
|
|
|
|
21,170
|
|
|
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
70,159
|
|
|
$
|
237,738
|
|
|
$
|
203,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Eliminated in consolidation. |
The condensed financial statements should be read in conjunction
with the consolidated financial statements and notes thereto of
HealthMarkets, Inc. and Subsidiaries.
See report of Independent Registered Public Accounting Firm.
F-72
CONDENSED
FINANCIAL INFORMATION OF REGISTRANT
HEALTHMARKETS, INC. (HOLDING COMPANY)
CONDENSED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
$
|
70,159
|
|
|
$
|
237,738
|
|
|
$
|
203,501
|
|
Adjustments to reconcile net income to net cash (used in)
provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in undistributed loss of subsidiaries of discontinued
operations*
|
|
|
(789
|
)
|
|
|
(21,080
|
)
|
|
|
(459
|
)
|
Deficit (equity) in undistributed earnings of continuing
operations*
|
|
|
187,084
|
|
|
|
85,005
|
|
|
|
(56,283
|
)
|
Equity based compensation
|
|
|
1,808
|
|
|
|
1,243
|
|
|
|
384
|
|
Change in other receivables
|
|
|
479
|
|
|
|
2,771
|
|
|
|
(880
|
)
|
Variable stock compensation expense (benefit)
|
|
|
(482
|
)
|
|
|
16,603
|
|
|
|
7,214
|
|
Change in accrued expenses and other liabilities
|
|
|
(5,635
|
)
|
|
|
14,827
|
|
|
|
14,469
|
|
Deferred income tax (benefit) change
|
|
|
4,612
|
|
|
|
(7,352
|
)
|
|
|
1,811
|
|
Change in federal income tax refundable
|
|
|
12,716
|
|
|
|
(14,023
|
)
|
|
|
(11,138
|
)
|
Other items, net
|
|
|
(26
|
)
|
|
|
(312
|
)
|
|
|
1,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Provided by continuing operations
|
|
|
269,926
|
|
|
|
315,420
|
|
|
|
160,015
|
|
Cash Provided by (Used in) discontinued operations
|
|
|
(1,159
|
)
|
|
|
(1,390
|
)
|
|
|
831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by Operating Activities
|
|
|
268,767
|
|
|
|
314,030
|
|
|
|
160,846
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales, maturities, calls and redemptions of securities available
for sale
|
|
|
|
|
|
|
70
|
|
|
|
2,190
|
|
(Increase) decrease in investments in and advances to
subsidiaries
|
|
|
35,145
|
|
|
|
204,608
|
|
|
|
(8,321
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by (Used in) Investing Activities
|
|
|
35,145
|
|
|
|
204,678
|
|
|
|
(6,131
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of stock options
|
|
|
1,164
|
|
|
|
337
|
|
|
|
2,582
|
|
Tax benefits from share-based compensation
|
|
|
313
|
|
|
|
1,390
|
|
|
|
1,861
|
|
Purchase of treasury stock
|
|
|
(41,535
|
)
|
|
|
(1,620,733
|
)
|
|
|
(13,359
|
)
|
Sale of shares to agents
|
|
|
40,784
|
|
|
|
9,654
|
|
|
|
|
|
Contribution from private equity investors
|
|
|
|
|
|
|
985,000
|
|
|
|
|
|
Payments of dividends to shareholders
|
|
|
(316,996
|
)
|
|
|
|
|
|
|
(34,705
|
)
|
Other changes in equity
|
|
|
1,455
|
|
|
|
2,799
|
|
|
|
756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Used in Financing Activities
|
|
|
(314,815
|
)
|
|
|
(621,553
|
)
|
|
|
(42,865
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in Cash
|
|
|
(10,903
|
)
|
|
|
(102,845
|
)
|
|
|
111,850
|
|
Cash and Cash Equivalents at beginning of period
|
|
|
48,578
|
|
|
|
151,423
|
|
|
|
39,573
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents at end of period
|
|
$
|
37,675
|
|
|
$
|
48,578
|
|
|
$
|
151,423
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Eliminated in consolidation. |
The condensed financial statements should be read in conjunction
with the consolidated financial statements and notes thereto of
HealthMarkets, Inc. and Subsidiaries.
See report of Independent Registered Public Accounting Firm.
F-73
SCHEDULE III
HEALTHMARKETS,
INC.
AND SUBSIDIARIES
SUPPLEMENTARY INSURANCE INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Col. A
|
|
Col. B
|
|
|
Col. C
|
|
|
Col. D
|
|
|
Col. E
|
|
|
|
|
|
|
Future Policy
|
|
|
|
|
|
|
|
|
|
Deferred
|
|
|
Benefits
|
|
|
|
|
|
|
|
|
|
Policy
|
|
|
Losses, Claims,
|
|
|
|
|
|
|
|
|
|
Acquisition
|
|
|
and Loss
|
|
|
Unearned
|
|
|
Policyholder
|
|
|
|
Costs
|
|
|
Expenses
|
|
|
Premiums
|
|
|
Funds
|
|
|
|
(In thousands)
|
|
|
December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
89,104
|
|
|
$
|
478,266
|
|
|
$
|
70,290
|
|
|
$
|
3,458
|
|
Life Insurance Division
|
|
|
108,307
|
|
|
|
379,469
|
|
|
|
4,925
|
|
|
|
7,306
|
|
Other Insurance
|
|
|
568
|
|
|
|
13,747
|
|
|
|
1,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total excluding disposed operations
|
|
|
197,979
|
|
|
|
871,482
|
|
|
|
76,331
|
|
|
|
10,764
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
|
|
|
|
26,846
|
|
|
|
20,535
|
|
|
|
|
|
Star HRG Division
|
|
|
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
197,979
|
|
|
$
|
898,376
|
|
|
$
|
96,866
|
|
|
$
|
10,764
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
101,425
|
|
|
$
|
521,041
|
|
|
$
|
71,679
|
|
|
$
|
4,204
|
|
Life Insurance Division
|
|
|
95,839
|
|
|
|
372,980
|
|
|
|
6,859
|
|
|
|
7,632
|
|
Other Insurance
|
|
|
493
|
|
|
|
14,289
|
|
|
|
1,206
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total excluding disposed operations
|
|
|
197,757
|
|
|
|
908,310
|
|
|
|
79,744
|
|
|
|
11,836
|
|
Disposed Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
|
|
|
|
49,707
|
|
|
|
72,014
|
|
|
|
|
|
Star HRG Division
|
|
|
|
|
|
|
12,830
|
|
|
|
|
|
|
|
733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
197,757
|
|
|
$
|
970,847
|
|
|
$
|
151,758
|
|
|
$
|
12,569
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See report of Independent Registered Public Accounting Firm.
F-74
SCHEDULE III
HEALTHMARKETS,
INC.
AND SUBSIDIARIES
SUPPLEMENTARY
INSURANCE INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Col. F
|
|
|
Col. G
|
|
|
Col. H
|
|
|
Col. I
|
|
|
Col. J
|
|
|
Col. K
|
|
|
|
|
|
|
|
|
|
Benefits,
|
|
|
Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Claims
|
|
|
of Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses, and
|
|
|
Policy
|
|
|
Other
|
|
|
|
|
|
|
Premium
|
|
|
Investment
|
|
|
Settlement
|
|
|
Acquisition
|
|
|
Operating
|
|
|
Premiums
|
|
|
|
Revenue
|
|
|
Income*
|
|
|
Expenses
|
|
|
Costs
|
|
|
Expenses*(1)
|
|
|
Written
|
|
|
|
(In thousands)
|
|
|
2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
1,282,249
|
|
|
$
|
30,840
|
|
|
$
|
735,701
|
|
|
$
|
120,729
|
|
|
$
|
306,210
|
|
|
|
|
|
Life Insurance Division
|
|
|
69,949
|
|
|
|
20,602
|
|
|
|
54,041
|
|
|
|
17,203
|
|
|
|
16,757
|
|
|
|
|
|
Other Insurance
|
|
|
29,995
|
|
|
|
1,599
|
|
|
|
12,643
|
|
|
|
442
|
|
|
|
10,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total excluding disposed operations
|
|
|
1,382,193
|
|
|
|
53,041
|
|
|
|
802,385
|
|
|
|
138,374
|
|
|
|
333,567
|
|
|
|
|
|
Disposed operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
|
|
|
|
|
|
|
|
(634
|
)
|
|
|
|
|
|
|
442
|
|
|
|
|
|
Star HRG Division
|
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
|
|
(231
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,382,193
|
|
|
$
|
53,041
|
|
|
$
|
801,783
|
|
|
$
|
138,374
|
|
|
$
|
333,778
|
|
|
$
|
1,379,522
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
1,330,298
|
|
|
$
|
31,809
|
|
|
$
|
721,689
|
|
|
$
|
143,547
|
|
|
$
|
260,404
|
|
|
|
|
|
Life Insurance Division
|
|
|
65,716
|
|
|
|
20,222
|
|
|
|
44,459
|
|
|
|
20,599
|
|
|
|
15,616
|
|
|
|
|
|
Other Insurance
|
|
|
33,873
|
|
|
|
1,356
|
|
|
|
18,748
|
|
|
|
780
|
|
|
|
10,213
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total excluding disposed operations
|
|
|
1,429,887
|
|
|
|
53,387
|
|
|
|
784,896
|
|
|
|
164,926
|
|
|
|
286,233
|
|
|
|
|
|
Disposed operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
233,280
|
|
|
|
4,882
|
|
|
|
165,334
|
|
|
|
7,186
|
|
|
|
53,404
|
|
|
|
|
|
Star HRG Division
|
|
|
74,079
|
|
|
|
369
|
|
|
|
46,387
|
|
|
|
|
|
|
|
25,753
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,737,246
|
|
|
$
|
58,638
|
|
|
$
|
996,617
|
|
|
$
|
172,112
|
|
|
$
|
365,390
|
|
|
$
|
1,754,579
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Employed Agency Division
|
|
$
|
1,394,644
|
|
|
$
|
32,725
|
|
|
$
|
718,502
|
|
|
$
|
53,304
|
|
|
$
|
345,097
|
|
|
|
|
|
Life Insurance Division
|
|
|
61,936
|
|
|
|
20,349
|
|
|
|
39,684
|
|
|
|
18,671
|
|
|
|
16,877
|
|
|
|
|
|
Other Insurance
|
|
|
33,856
|
|
|
|
784
|
|
|
|
19,509
|
|
|
|
87
|
|
|
|
10,386
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total excluding disposed operations
|
|
|
1,490,436
|
|
|
|
53,858
|
|
|
|
777,695
|
|
|
|
72,062
|
|
|
|
372,360
|
|
|
|
|
|
Disposed operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Insurance Division
|
|
|
282,486
|
|
|
|
6,121
|
|
|
|
222,306
|
|
|
|
10,505
|
|
|
|
64,666
|
|
|
|
|
|
Star HRG Division
|
|
|
144,612
|
|
|
|
703
|
|
|
|
92,135
|
|
|
|
|
|
|
|
51,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,917,534
|
|
|
$
|
60,682
|
|
|
$
|
1,092,136
|
|
|
$
|
82,567
|
|
|
$
|
488,772
|
|
|
$
|
1,895,413
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Allocations of Net Investment Income and Other Operating
Expenses are based on a number of assumptions and estimates, and
the results would change if different methods were applied. |
|
(1) |
|
Other operating expenses include underwriting, policy
acquisition costs, and insurance expenses and other income and
expenses allocable to the respective division. |
See report of Independent Registered Public Accounting Firm.
F-75
SCHEDULE IV
HEALTHMARKETS,
INC.
AND SUBSIDIARIES
REINSURANCE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of Amount
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
|
Amount
|
|
|
Ceded
|
|
|
Assumed
|
|
|
Net Amount
|
|
|
to Net
|
|
|
|
(Dollars in thousands)
|
|
|
Year Ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force
|
|
$
|
9,108,792
|
|
|
$
|
2,318,846
|
|
|
$
|
51,728
|
|
|
$
|
6,841,674
|
|
|
|
0.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums earned:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
78,827
|
|
|
$
|
9,834
|
|
|
$
|
1,467
|
|
|
$
|
70,460
|
|
|
|
2.1
|
%
|
Health insurance
|
|
|
1,479,513
|
|
|
|
196,927
|
|
|
|
29,147
|
|
|
|
1,311,733
|
|
|
|
2.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,558,340
|
|
|
$
|
206,761
|
|
|
$
|
30,614
|
|
|
$
|
1,382,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force
|
|
$
|
9,058,333
|
|
|
$
|
2,151,355
|
|
|
$
|
52,765
|
|
|
$
|
6,959,743
|
|
|
|
0.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums earned:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
73,557
|
|
|
$
|
9,708
|
|
|
$
|
1,826
|
|
|
$
|
65,675
|
|
|
|
2.8
|
%
|
Health insurance
|
|
|
1,746,796
|
|
|
|
111,139
|
|
|
|
35,914
|
|
|
|
1,671,571
|
|
|
|
2.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,820,353
|
|
|
$
|
120,847
|
|
|
$
|
37,740
|
|
|
$
|
1,737,246
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force
|
|
$
|
8,480,598
|
|
|
$
|
2,119,688
|
|
|
$
|
94,549
|
|
|
$
|
6,455,459
|
|
|
|
1.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums earned:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
69,581
|
|
|
$
|
9,967
|
|
|
$
|
1,951
|
|
|
$
|
61,565
|
|
|
|
3.2
|
%
|
Health insurance
|
|
|
1,822,938
|
|
|
|
4,090
|
|
|
|
37,121
|
|
|
|
1,855,969
|
|
|
|
2.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,892,519
|
|
|
$
|
14,057
|
|
|
$
|
39,072
|
|
|
$
|
1,917,534
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See report of Independent Registered Public Accounting Firm.
F-76
SCHEDULE V
HEALTHMARKETS,
INC.
AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recoveries/
|
|
|
Deductions/
|
|
|
|
Balance at
|
|
|
Additions
|
|
|
Increase in
|
|
|
Amounts
|
|
|
Balance at
|
|
|
|
Beginning
|
|
|
Cost and
|
|
|
Carrying
|
|
|
Charged
|
|
|
End of
|
|
|
|
of Period
|
|
|
Expenses
|
|
|
Value
|
|
|
Off
|
|
|
Period
|
|
|
|
(In thousands)
|
|
|
Allowance for losses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agents receivables
|
|
$
|
4,164
|
|
|
$
|
2,937
|
|
|
$
|
|
|
|
$
|
(3,613
|
)
|
|
$
|
3,488
|
|
Other receivables
|
|
|
668
|
|
|
|
|
|
|
|
|
|
|
|
(668
|
)
|
|
|
|
|
Mortgage loans
|
|
|
33
|
|
|
|
|
|
|
|
|
|
|
|
(28
|
)
|
|
|
5
|
|
Student loans
|
|
|
3,256
|
|
|
|
2,025
|
|
|
|
|
|
|
|
(2,356
|
)
|
|
|
2,925
|
|
Year ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agents receivables
|
|
$
|
3,710
|
|
|
$
|
2,896
|
|
|
$
|
|
|
|
$
|
(2,442
|
)
|
|
$
|
4,164
|
|
Other receivables
|
|
|
3,699
|
|
|
|
|
|
|
|
|
|
|
|
(3,031
|
)
|
|
|
668
|
|
Mortgage loans
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
(22
|
)
|
|
|
33
|
|
Student loans
|
|
|
2,722
|
|
|
|
2,186
|
|
|
|
|
|
|
|
(1,652
|
)
|
|
|
3,256
|
|
Year ended December 31, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agents receivables
|
|
$
|
2,967
|
|
|
$
|
3,194
|
|
|
$
|
|
|
|
$
|
(2,451
|
)
|
|
$
|
3,710
|
|
Other receivables
|
|
|
3,699
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,699
|
|
Mortgage loans
|
|
|
324
|
|
|
|
|
|
|
|
|
|
|
|
(269
|
)
|
|
|
55
|
|
Student loans
|
|
|
3,608
|
|
|
|
696
|
|
|
|
|
|
|
|
(1,582
|
)
|
|
|
2,722
|
|
See report of Independent Registered Public Accounting Firm.
F-77
EXHIBIT INDEX
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
|
|
Description of Exhibit
|
|
|
2
|
.1
|
|
|
|
Agreement and Plan of Merger, dated as of September 15,
2005, by and among UICI and Premium Finance LLC, Mulberry
Finance Co., Inc., DLJMB IV First Merger LLC, Premium
Acquisition, Inc., Mulberry Acquisition, Inc., and DLJMB IV
First Merger Co. Acquisition Inc., filed as Exhibit 2.1 to
the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953,
and incorporated by reference herein.
|
|
3
|
.1
|
|
|
|
Certificate of Incorporation of HealthMarkets, Inc. as amended
June 5, 2007, filed as exhibit 3.1 to
Form 10-Q
dated June 30, 2007, (File
No. 001-14953),
and incorporated by reference herein.
|
|
4
|
.1
|
|
|
|
Amended and Restated Trust Agreement, dated as of
April 5, 2006, among HealthMarkets, LLC, La Salle
National Bank National Association, Christiana Bank and
Trust Company, and certain administrative trustees named
therein (HealthMarkets Capital Trust I), filed as
Exhibit 4.1 to the Current Report on Form 8K dated
April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
4
|
.2
|
|
|
|
Amended and Restated Trust Agreement, dated as of
April 5, 2006, among HealthMarkets, LLC, La Salle
National Bank National Association, Christiana Bank and
Trust Company, and certain administrative trustees named
therein (HealthMarkets Capital Trust II), filed as
Exhibit 4.1 to the Current Report on Form 8K dated
April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
4
|
.3
|
|
|
|
Junior Subordinated Indenture, dated as of April 5, 2006,
between HealthMarkets, LLC and La Salle National Bank
National Association (HealthMarkets Capital Trust I), filed
as Exhibit 4.3 to the Current Report on Form 8K dated
April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
4
|
.4
|
|
|
|
Junior Subordinated Indenture, dated as of April 5, 2006,
between HealthMarkets, LLC and La Salle National Bank
National Association (HealthMarkets Capital Trust II),
filed as Exhibit 4.4 to the Current Report on Form 8K
dated April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
4
|
.5
|
|
|
|
Guarantee Agreement, dated as of April 5, 2006, between
HealthMarkets, LLC and La Salle National Bank National
Association (HealthMarkets Capital Trust I), filed as
Exhibit 4.5 to the Current Report on Form 8K dated
April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
4
|
.6
|
|
|
|
Guarantee Agreement, dated as of April 5, 2006 between
HealthMarkets, LLC and La Salle National Bank National
Association (HealthMarkets Capital Trust II), filed as
Exhibit 4.6 to the Current Report on Form 8K dated
April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
4
|
.7
|
|
|
|
Specimen Stock Certificate of
Class A-1
Common Stock, filed as Exhibit 4.2 to the to Post-Effective
Amendment No. 1 to Registration Statement on
Form S-8
filed on April 6, 2006, File
No. 033-77690,
and incorporated by reference herein.
|
|
10
|
.25
|
|
|
|
General Agents Agreement between Mid-West National Life
Insurance Company of Tennessee and United Group Association,
Inc. effective April 1, 1996, and filed as
Exhibit 10.3 to the Companys Report on
Form 8-K
dated April 1, 1996 (File
No. 0-14320),
and incorporated by reference herein.
|
|
10
|
.26
|
|
|
|
General Agents Agreement between The MEGA Life and Health
Insurance Company and United Group Association, Inc. Effective
April 1, 1996, and filed as Exhibit 10.4 to the
Companys Report on
Form 8-K
dated April 1, 1996 (File
No. 0-14320)
and incorporated by reference herein.
|
|
10
|
.27
|
|
|
|
Agreement between United Group Association, Inc. and Cornerstone
Marketing of America effective April 1, 1996, and filed as
Exhibit 10.5 to the Companys Current Report on
Form 8-K
dated April 1, 1996 (File
No. 0-14320)
and incorporated by reference herein.
|
|
10
|
.28
|
|
|
|
Stock Purchase Agreement dated, July 27, 2000, between UICI
and C&J Investments, LLC filed as Exhibit 10.44 to
Form 10-Q
dated June 30, 2000, (File
No. 0-14320),
and incorporated by reference herein.
|
|
10
|
.29
|
|
|
|
General and First Supplemental Indenture between CLFD-I, Inc.
and Zions First National Bank, as Trustee relating to the
Student Loan Asset Backed Notes dated as of April 1, 2001,
filed as Exhibit 10.66 to the Companys 2001 Annual
Report on
Form 10-K,
File
No. 001-14953,
filed with the Securities and Exchange Commission on
March 22, 2002 and incorporated by reference herein.
|
|
10
|
.30
|
|
|
|
Second Supplemental Indenture, dated as of April 1, 2002,
between CFLD-I, Inc. and Zions First National Bank, as Trustee,
relating to $50,000,000 CFLD-I, Inc. Student Loan Asset Backed
Notes, Senior
Series 2002A-1
(Auction Rate Certificates) filed as Exhibit 10.69 to the
Form 10-Q
dated June 30, 2002, File
No. 001-14953
and incorporated by reference herein.
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
|
|
Description of Exhibit
|
|
|
10
|
.31
|
|
|
|
Third Supplemental Indenture, dated as of April 1, 2002,
between CFLD-I, Inc. and Zions First National Bank, as Trustee,
amending General Indenture, dated as of April 1, 2001,
relating to CFLD-I, Inc. Student Loan Asset Backed Notes filed
as Exhibit 10.70 to the
Form 10-Q
dated June 30, 2002, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.32
|
|
|
|
Amended and Restated Trust Agreement among UICI, JP Morgan
Chase Bank, Chase Manhattan Bank USA, National Association, and
The Administrative Trustees dated April 29, 2004, filed as
Exhibit 10.88 to the Companys 2004 Annual Report on
Form 10-K, File
No. 001-14953,
filed with the Securities and Exchange Commission on
March 15, 2004 and incorporated by reference herein.
|
|
10
|
.33
|
|
|
|
Vendor Agreement, dated as of January 1, 2005 between The
MEGA Life and Health Insurance Company and the National
Association for the Self-Employed filed as exhibit 10.91 to
the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.34
|
|
|
|
Vendor Agreement, dated as of January 1, 2005 between The
MEGA Life and Health Insurance Company and Americans for
Financial Security, Inc. filed as exhibit 10.92 to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.35
|
|
|
|
Amended and Restated Vendor Agreement, dated as June 1,
2005, between Mid-West National Life Insurance Company of
Tennessee and Alliance for Affordable Services filed as
exhibit 10.93 to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.36
|
|
|
|
Vendor Agreement, dated as of January 1, 2005 between The
Chesapeake Life Insurance Company and Alliance for Affordable
Services filed as exhibit 10.94 to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.37
|
|
|
|
Master General Agent Agreement, dated April 16, 2003,
between The Chesapeake Life Insurance Company and Tim
McCoy & Associates, Inc. (NEAT) filed as
exhibit 10.95 to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.38
|
|
|
|
Master General Agent Agreement, dated March 29, 2004,
between The Chesapeake Life Insurance Company and Life
Professionals Marketing Group, Inc. filed as exhibit 10.96
to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.39
|
|
|
|
Field Services Agreement, dated as of January 1, 2005,
between Performance Driven Awards, Inc. and the National
Association for the Self-Employed filed as exhibit 10.103
to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.40
|
|
|
|
Field Services Agreement, dated as of January 1, 2005,
between Performance Driven Awards, Inc. and Americans for
Financial Security, Inc. filed as exhibit 10.104 to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.41
|
|
|
|
Field Services Agreement, dated as of January 1, 2005,
between Success Driven Awards, Inc. and Alliance for Affordable
Services filed as exhibit 10.105 to the
Form 10-Q
dated June 30, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.42
|
|
|
|
Non-Compete Agreement, dated as of September 15, 2005,
between UICI and Jeffrey James Jensen filed as Exhibit 10.1
to the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.43
|
|
|
|
Non-Compete Agreement, dated as of September 15, 2005,
between UICI and Jami Jill Jensen filed as Exhibit 10.2 to
the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.44
|
|
|
|
Non-Compete Agreement, dated as of September 15, 2005,
between UICI and Janet Jarie Jensen filed as Exhibit 10.3
to the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.45
|
|
|
|
Non-Compete Agreement, dated as of September 15, 2005,
between UICI and James Joel Jensen filed as Exhibit 10.4 to
the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.46
|
|
|
|
Non-Compete Agreement, dated as of September 15, 2005,
between UICI and Julie Jean Jensen filed as Exhibit 10.5 to
the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
|
|
Description of Exhibit
|
|
|
10
|
.47
|
|
|
|
Non-Compete Agreement, dated as of September 15, 2005,
between UICI and Gladys M. Jensen filed as Exhibit 10.6 to
the Current Report on
Form 8-K
dated September 16, 2005, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.48*
|
|
|
|
Employment Agreement, dated as of April 4, 2006, by and
between UICI and William J. Gedwed, filed as Exhibit 10.1
to the Current Report on
Form 8-K
dated April 4, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.49*
|
|
|
|
Employment Agreement, dated as of April 4, 2006, by and
between UICI and Phillip J. Myhra, filed as Exhibit 10.2 to
the Current Report on
Form 8-K
dated April 4, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.50*
|
|
|
|
Employment Agreement, dated as of April 4, 2006, by and
between UICI and Troy A. McQuagge, filed as Exhibit 10.3 to
the Current Report on
Form 8-K
dated April 4, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.51*
|
|
|
|
Employment Agreement, dated as of April 4, 2006, by and
between UICI and Mark Hauptman, filed as Exhibit 10.5 to
the Current Report on
Form 8-K
dated April 4, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.52*
|
|
|
|
Employment Agreement, dated as of April 4, 2006, by and
between UICI and James N. Plato, filed as Exhibit 10.7 to
the Current Report on
Form 8-K
dated April 4, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.53
|
|
|
|
Credit Agreement, dated as of April 5, 2006, among UICI,
HealthMarkets, LLC, JPMorgan Chase Bank, N.A., as Administrative
Agent and L/C Issuer, each lender from time to time party
thereto, Morgan Stanley Senior Funding Inc., as Syndication
Agent, and Goldman Sachs Credit Partners L.P., as Documentation
Agent, filed as Exhibit 10.1 to the Current Report on
Form 8-K
dated April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.54
|
|
|
|
Stockholders Agreement, dated as of April 5, 2006, by
and among UICI and certain stockholders named therein, filed as
Exhibit 4.1 to Post-Effective Amendment No. 1 to
Registration Statement on
Form S-8
filed on April 6, 2006, File
No. 033-77690,
and incorporated by reference herein.
|
|
10
|
.55*
|
|
|
|
UICI Restated and Amended 1987 Stock Option Plan
(Non-Qualified)(As Amended and Restated Effective May 3,
2007), and incorporated by reference herein.
|
|
10
|
.56
|
|
|
|
Registration Rights and Coordination Committee Agreement, dated
as of April 5, 2006, by and among UICI and certain
stockholders named therein, filed as Exhibit 10.3 to the
Current Report on
Form 8-K
dated April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.57
|
|
|
|
Purchase Agreement, dated as of March 7, 2006, among
Premium Finance LLC, Mulberry Finance Co., Inc., DLJMB IV First
Merger LLC, Merrill Lynch International, and First Tennessee
Bank National Association, filed as Exhibit 10.4 to the
Current Report on
Form 8-K
dated April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.58
|
|
|
|
Assignment and Assumption and Amendment Agreement, dated as of
April 5, 2006, among HealthMarkets, LLC, HealthMarkets
Capital Trust I, HealthMarkets Capital Trust II,
Premium Finance LLC, Mulberry Finance Co., Inc., DLJMB IV First
Merger LLC, First Tennessee Bank National Association, Merrill
Lynch International and ALESCO Preferred Funding X, Ltd., filed
as Exhibit 10.5 to the Current Report on
Form 8-K
dated April 5, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.59
|
|
|
|
HealthMarkets, Inc. Agents Total Ownership Plan (As
Amended and Restated Effective May 3, 2007), and
incorporated by reference herein.
|
|
10
|
.60
|
|
|
|
HealthMarkets, Inc. Agency Matching Total Ownership Plan (As
Amended and Restated Effective May 3, 2007), and
incorporated by reference herein.
|
|
10
|
.61
|
|
|
|
HealthMarkets, Inc. Agents Contribution to Equity Plan (As
Amended and Restated Effective May 3, 2007), and
incorporated by reference herein.
|
|
10
|
.62
|
|
|
|
HealthMarkets, Inc. Matching Agency Contribution Plan (As
Amended and Restated May 3, 2007), and incorporated by
reference herein.
|
|
10
|
.63
|
|
|
|
HealthMarkets, Inc. Initial Total Ownership Plan (As Amended and
Restated Effective April 5, 2006, filed as
Exhibit 10.95 to Companys 2006 Annual Report on
Form 10-K,
File
No. 001-14953,
filed with the Securities and Exchange Commission on
April 2, 2006 and incorporated by reference herein.
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
|
|
Description of Exhibit
|
|
|
10
|
.64
|
|
|
|
HealthMarkets, Inc. Agents Stock Accumulation Plan (As
Amended and Restated Effective April 5, 2006) filed as
Exhibit 10.96 to Companys 2006 Annual Report on
Form 10-K,
File
No. 001-14953,
filed with the Securities and Exchange Commission on
April 2, 2006 and incorporated by reference herein.
|
|
10
|
.65*
|
|
|
|
HealthMarkets 2006 Management Option Plan, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated May 8, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.66*
|
|
|
|
Form of Nonqualified Stock Option Agreement among HealthMarkets,
Inc. and various optionees, filed as Exhibit 10.2 to the
Current Report on
Form 8-K
dated May 8, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.67
|
|
|
|
Future Transactions Fee Agreement, dated as of May 11,
2006, between HealthMarkets, Inc. and Blackstone Management
Partners IV L.L.C., filed as Exhibit 10.1 to the
Current Report on
Form 8-K
dated May 11, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.68
|
|
|
|
Future Transactions Fee Agreement, dated as of May 11,
2006, between HealthMarkets, Inc. and Goldman Sachs &
Co., filed as Exhibit 10.2 to the Current Report on
Form 8-K
dated May 11, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.69
|
|
|
|
Future Transactions Fee Agreement, dated as of May 11,
2006, between HealthMarkets, Inc. and DLJ Merchant Banking,
Inc., filed as Exhibit 10.3 to the Current Report on
Form 8-K
dated May 11, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.70*
|
|
|
|
Agreement, dated as of May 24, 2006, between HealthMarkets,
Inc. and Glenn W. Reed, filed as Exhibit 10.1 to the
Current Report on
Form 8-K
dated May 19, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.71
|
|
|
|
Termination Agreement, dated as of May 19, 2006, between
HealthMarkets, Inc. and Special Investment Risks Limited , filed
as Exhibit 10.2 to the Current Report on
Form 8-K
dated May 19, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.72*
|
|
|
|
Subscription Agreement, dated June 13, 2006, between
HealthMarkets, Inc. and Steven J. Shulman, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated June 9, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.73*
|
|
|
|
Nonqualified Stock Option Agreement dated as of June 9,
2006, between HealthMarkets, Inc. and Steven J. Shulman, filed
as Exhibit 10.2 to the Current Report on
Form 8-K
dated June 9, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.74*
|
|
|
|
Subscription Agreement, dated July 1, 2006, between
HealthMarkets, Inc. and Allen F. Wise, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated July 1, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.75*
|
|
|
|
Nonqualified Stock Option Agreement, dated as of July 1,
2006, between HealthMarkets, Inc. and Allen F. Wise, filed as
Exhibit 10.2 to the Current Report on
Form 8-K
dated July 1, 2006, File
No. 001-14953
and incorporated by reference herein.
|
|
10
|
.76*
|
|
|
|
Nonqualified Stock Option Agreement, dated as of August 30,
2006, between HealthMarkets, Inc. and Andrew S. Kahr, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated August 30, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.77*
|
|
|
|
Employment Agreement, dated as of September 26, 2006, by
and between HealthMarkets, Inc. and Michael E. Boxer, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated September 26, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.78*
|
|
|
|
Nonqualified Stock Option Agreement, dated as of
September 26, 2006, between HealthMarkets, Inc. and Michael
E. Boxer, filed as Exhibit 10.2 to the Current Report on
Form 8-K
dated September 26, 2006, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.79
|
|
|
|
Advisory Fee Agreement, dated as of August 18, 2006,
between The MEGA Life and Health Insurance Company and the
Blackstone Group, L.P. filed as Exhibit 10.111 to
Companys 2006 Annual Report on
Form 10-K,
File
No. 001-14953,
filed with the Securities and Exchange Commission on
March , 2006 and incorporated by reference
herein.
|
|
10
|
.80
|
|
|
|
Placement Fee Agreement, dated as of August 18, 2006,
between HealthMarkets, Inc. and The Blackstone Group, L.P. ,
filed as Exhibit 10.112 to Companys 2006 Annual
Report on
Form 10-K,
File
No. 001-14953,
filed with the Securities and Exchange Commission on
March , 2006 and incorporated by reference
herein.
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
|
|
Description of Exhibit
|
|
|
10
|
.81
|
|
|
|
Amendment dated as of December 29, 2006 to Advisory Fee
Agreement, dated as of August 18, 2006, between The MEGA
Life and Health Insurance Company and the Blackstone Group, L.P.
, filed as Exhibit 10.95 to Companys 2006 Annual
Report on
Form 10-K,
File
No. 001-14953,
filed with the Securities and Exchange Commission on
March , 2006 and incorporated by reference
herein.
|
|
10
|
.82*
|
|
|
|
Letter Agreement, dated as of June 6, 2007, by and between
HealthMarkets, Inc. and Philip Rydzewski, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated August 2, 2007, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.83*
|
|
|
|
Nonqualified Stock Option Agreement, dated as of August 2,
2007, between HealthMarkets, Inc. and Philip Rydzewski, filed as
Exhibit 10.2 to the Current Report on
Form 8-K
dated August 2, 2007, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.84*
|
|
|
|
Nonqualified Stock Option Agreement, dated as of August 30,
2007, between HealthMarkets, Inc. and Harvey C. DeMovick, Jr.
filed as Exhibit 10.1 to the Current Report on
Form 8-K
dated August 30, 2007, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.85*
|
|
|
|
Employment Agreement, dated as of October 29, 2007, by and
between HealthMarkets, Inc. and David W. Fields, filed as
Exhibit 10.1 to the Current Report on
Form 8-K
dated November 1, 2007, File
No. 001-14953,
and incorporated by reference herein.
|
|
10
|
.86*
|
|
|
|
Nonqualified Stock Option Agreement, dated as of
November 1, 2007, between HealthMarkets, Inc. and David W.
Fields, filed as Exhibit 10.2 to the Current Report on
Form 8-K
dated November 1, 2007, File
No. 001-14953,
and incorporated by reference herein.
|
|
14
|
.1
|
|
|
|
HealthMarkets Code of Business Conduct and Ethics, filed as
Exhibit 14.1 to the Current Report on
Form 8-K
dated August 2, 2007, File
No. 001-14953,
and incorporated by reference herein.
|
|
21
|
|
|
|
|
Subsidiaries of HealthMarkets
|
|
23
|
|
|
|
|
Consent of Independent Registered Public Accounting Firm
|
|
24
|
|
|
|
|
Power of Attorney
|
|
31
|
.1
|
|
|
|
Certification of William J. Gedwed, Chief Executive Officer of
the Registrant, required by
Rule 13a-14(a)
or
Rule 15d-14(a)
of the Securities Exchange Act of 1934
|
|
31
|
.2
|
|
|
|
Certification of Michael E. Boxer, Chief Financial Officer of
the Registrant, required by
Rule 13a-14(a)
or
Rule 15d-14(a)
of the Securities Exchange Act of 1934
|
|
32
|
.1
|
|
|
|
Certification of William J. Gedwed, Chief Executive Officer of
the Registrant, pursuant to §906 of the Sarbanes-Oxley Act
of 2002
|
|
32
|
.2
|
|
|
|
Certification of Michael E. Boxer, Chief Financial Officer of
the Registrant, pursuant to §906 of the Sarbanes-Oxley Act
of 2002
|
|
|
|
* |
|
Indicates that exhibit constitutes an Executive Compensation
Plan or Arrangement |